18515973-3	<mark style="background-color:lightblue;" id="91474">7-Ketocholesterol</mark> <mark style="background-color:orange;">upregulates</mark> <mark style="background-color:lightgreen;" id="P41693">interleukin-6</mark> via mechanisms that are distinct from those of <mark style="background-color:lightgreen;" id="Q8JFG3">tumor necrosis factor</mark> -alpha, in vascular smooth muscle cells.
18515973-4	Among the 7 IL examined, only <mark style="background-color:lightgreen;" id="O35736,P05231,P08505,P20607,P26892,P26893,P29455,P41323,P41683,P41693,P46650,P51494,P79341,Q25BC2,Q28319,Q28747,Q28819,Q2MH06,Q5I6E3,Q6V919,Q865W7,Q865X6,Q8MKH0,Q95181,Q9MZR1,Q9XT80">IL-6</mark> transcript was <mark style="background-color:orange;">increased</mark> by <mark style="background-color:lightblue;" id="91474">7-ketocholesterol</mark> treatment in human aorta smooth muscle cells.
18515973-5	<mark style="background-color:lightgreen;" id="O35736,P05231,P08505,P20607,P26892,P26893,P29455,P41323,P41683,P41693,P46650,P51494,P79341,Q25BC2,Q28319,Q28747,Q28819,Q2MH06,Q5I6E3,Q6V919,Q865W7,Q865X6,Q8MKH0,Q95181,Q9MZR1,Q9XT80">IL-6</mark> transcripts <mark style="background-color:orange;">increased</mark> up to 24 h after treatment with <mark style="background-color:lightblue;" id="91474">7-ketocholesterol</mark>, and this <mark style="background-color:orange;">effect</mark> was profoundly <mark style="background-color:orange;">repressed</mark> by treatment with <mark style="background-color:lightgreen;" id="O62618">p38 MAPK</mark> inhibitors and to a lesser extent <mark style="background-color:lightgreen;" id="P92208,Q966Y3">JNK</mark> inhibitors.
18515973-7	Mechanisms of <mark style="background-color:lightgreen;" id="O35736,P05231,P08505,P20607,P26892,P26893,P29455,P41323,P41683,P41693,P46650,P51494,P79341,Q25BC2,Q28319,Q28747,Q28819,Q2MH06,Q5I6E3,Q6V919,Q865W7,Q865X6,Q8MKH0,Q95181,Q9MZR1,Q9XT80">IL-6</mark> induction by <mark style="background-color:lightblue;" id="91474">7-ketocholesterol</mark> were <mark style="background-color:orange;">investigated</mark> in comparison with <mark style="background-color:lightgreen;" id="Q8JFG3">tumor necrosis factor</mark> ( <mark style="background-color:lightgreen;" id="O35734,O77510,O77764,P01375,P04924,P13296,P19101,P23383,P23563,P29553,P33620,P36939,P48094,P51435,P51742,P51743,P59684,P59693,P59694,P59695,P79337,P79374,Q06599,Q19LH4,Q1G1A2,Q1WM27,Q2MH05,Q539C2,Q75N23,Q8HZD9,Q8JFG3,Q8MKG8,Q8WNR1,Q9BEA1">TNF</mark> )-alpha.
18515973-9	<mark style="background-color:lightblue;" id="91474">7-ketocholesterol</mark> significantly <mark style="background-color:orange;">increased</mark> the amount of <mark style="background-color:yellow;" id="GO:0005622,cellular_component">intracellular</mark>  <mark style="background-color:lightgreen;" id="O35736,P05231,P08505,P20607,P26892,P26893,P29455,P41323,P41683,P41693,P46650,P51494,P79341,Q25BC2,Q28319,Q28747,Q28819,Q2MH06,Q5I6E3,Q6V919,Q865W7,Q865X6,Q8MKH0,Q95181,Q9MZR1,Q9XT80">IL-6</mark> protein in the presence of <mark style="background-color:lightblue;" id="5287620">brefeldin A</mark>.
18515973-10	<mark style="background-color:lightblue;" id="91474">7-Ketocholesterol</mark> also <mark style="background-color:orange;">enhanced</mark> <mark style="background-color:lightgreen;" id="O35736,P05231,P08505,P20607,P26892,P26893,P29455,P41323,P41683,P41693,P46650,P51494,P79341,Q25BC2,Q28319,Q28747,Q28819,Q2MH06,Q5I6E3,Q6V919,Q865W7,Q865X6,Q8MKH0,Q95181,Q9MZR1,Q9XT80">IL-6</mark> release from VSMC.
18515973-11	<mark style="background-color:lightgreen;" id="O35736,P05231,P08505,P20607,P26892,P26893,P29455,P41323,P41683,P41693,P46650,P51494,P79341,Q25BC2,Q28319,Q28747,Q28819,Q2MH06,Q5I6E3,Q6V919,Q865W7,Q865X6,Q8MKH0,Q95181,Q9MZR1,Q9XT80">IL-6</mark> <mark style="background-color:orange;">release</mark> by <mark style="background-color:lightblue;" id="91474">7-ketocholesterol</mark>, although significant, was not as remarkable as that <mark style="background-color:orange;">induced</mark> by <mark style="background-color:lightgreen;" id="O35734,O77510,O77764,P01375,P04924,P06804,P13296,P16599,P19101,P23383,P23563,P29553,P33620,P36939,P48094,P51435,P51742,P51743,P59684,P59693,P59694,P59695,P79337,P79374,Q06599,Q19LH4,Q1G1A2,Q1WM27,Q2MH05,Q539C2,Q75N23,Q8HZD9,Q8JFG3,Q8MKG8,Q8WNR1,Q9BEA1">TNF-alpha</mark> .
18515973-12	These data suggest that <mark style="background-color:lightblue;" id="91474">7-ketocholesterol</mark> <mark style="background-color:orange;">upregulates</mark> <mark style="background-color:lightgreen;" id="O35736,P05231,P08505,P20607,P26892,P26893,P29455,P41323,P41683,P41693,P46650,P51494,P79341,Q25BC2,Q28319,Q28747,Q28819,Q2MH06,Q5I6E3,Q6V919,Q865W7,Q865X6,Q8MKH0,Q95181,Q9MZR1,Q9XT80">IL-6</mark> via mechanisms distinct from <mark style="background-color:lightgreen;" id="O35734,O77510,O77764,P01375,P04924,P06804,P13296,P16599,P19101,P23383,P23563,P29553,P33620,P36939,P48094,P51435,P51742,P51743,P59684,P59693,P59694,P59695,P79337,P79374,Q06599,Q19LH4,Q1G1A2,Q1WM27,Q2MH05,Q539C2,Q75N23,Q8HZD9,Q8JFG3,Q8MKG8,Q8WNR1,Q9BEA1">TNF-alpha</mark> and contributes to the intra- and <mark style="background-color:yellow;" id="GO:0005576,cellular_component">extracellular</mark>  <mark style="background-color:lightgreen;" id="O35736,P05231,P08505,P20607,P26892,P26893,P29455,P41323,P41683,P41693,P46650,P51494,P79341,Q25BC2,Q28319,Q28747,Q28819,Q2MH06,Q5I6E3,Q6V919,Q865W7,Q865X6,Q8MKH0,Q95181,Q9MZR1,Q9XT80">IL-6</mark> deposits within the vasculature.
18505747-21	<mark style="background-color:lightgreen;" id="O02768,O19183,O62698,O62725,P27607,P35354,P35355,P70682,P79208,Q05769">Cyclooxygenase-2</mark> , an inducible enzyme important in inflammation, <mark style="background-color:orange;">catalyzes</mark> the production of prostanoids from <mark style="background-color:lightblue;" id="444899">arachidonic acid</mark>.
18286621-29	Affinity electrophoresis analysis provided evidence that carboxymethylated <mark style="background-color:lightblue;" id="4125253,5460037">dextran</mark> polymers <mark style="background-color:orange;">grafted</mark> with high amounts of <mark style="background-color:lightblue;" id="10391">benzylamide</mark> groups (named DMCB) <mark style="background-color:orange;">interact</mark> with <mark style="background-color:lightgreen;" id="O19006,O46564,P12643,P21274,P49001,Q804S2,Q90751">BMP-2</mark> .
18286621-30	A screening study provided evidence that the potentiating effects of the <mark style="background-color:lightblue;" id="4125253,5460037">dextran</mark> derivatives on the <mark style="background-color:lightgreen;" id="O19006,O46564,P12643,P21274,P49001,Q804S2,Q90751">BMP-2</mark> -induced <mark style="background-color:lightgreen;" id="O60109,P81800,P83456">alkaline phosphatase</mark> activity <mark style="background-color:orange;">improved</mark> with their <mark style="background-color:lightblue;" id="10391">benzylamide</mark> groups content and, therefore, with their affinity for the growth factor.
18496518-35	<mark style="background-color:lightgreen;" id="O13186,O46567,O73673,P04150,P06536,P06537,P35547,P49115,P49843,P49844,P59667,P79269,P79686,Q5R9P5,Q6XLJ0,Q95267,Q9N1U3">Glucocorticoid receptor</mark> antagonism <mark style="background-color:orange;">augments</mark> <mark style="background-color:lightblue;" id="3386">fluoxetine</mark>-induced downregulation of the <mark style="background-color:lightblue;" id="5202">5-HT</mark> transporter.
18496518-37	In contrast, chronic <mark style="background-color:lightblue;" id="3386">fluoxetine</mark> markedly <mark style="background-color:orange;">decreased</mark> 5- <mark style="background-color:lightgreen;" id="P31645">HTT</mark> levels in all regions.
18496518-38	This downregulation of 5- <mark style="background-color:lightgreen;" id="P31645">HTT</mark> by <mark style="background-color:lightblue;" id="3386">fluoxetine</mark> and its enhancement by Org 34850 can explain our recent observation that GR antagonists <mark style="background-color:orange;">augment</mark> the SSRI-induced <mark style="background-color:orange;">increase</mark> in <mark style="background-color:yellow;" id="GO:0005576,cellular_component">extracellular</mark> <mark style="background-color:lightblue;" id="5202">5-HT</mark>.
18509591-45	It was found that <mark style="background-color:lightblue;" id="1123">taurine</mark> administration <mark style="background-color:orange;">produced</mark> <mark style="background-color:orange;">lower</mark> <mark style="background-color:orange;">levels</mark> of <mark style="background-color:lightgreen;" id="O33822,O58489,O67781,O86459,O93744,P00509,P14909,P23034,P44425,P53001,P58661,P72173,Q4J8X2,Q55128,Q56114,Q56232,Q59228,Q60013,Q92JE7,Q972A2,Q9V0L2,Q9X0Y2,Q9ZE56">aspartate aminotransferase</mark> and alkaline <mark style="background-color:yellow;" id="GO:0008483,molecular_function">aminotransferase</mark> than that of the untreated group.
18509591-46	In addition, the levels of hepatic total protein, <mark style="background-color:lightblue;" id="124886">glutathione</mark> and <mark style="background-color:lightgreen;" id="O50258">superoxide dismutase</mark> were higher in the <mark style="background-color:lightblue;" id="1123">taurine</mark> treated groups than those in the untreated control or the <mark style="background-color:lightblue;" id="1123">taurine</mark> <mark style="background-color:orange;">depleted</mark> groups, while hepatic <mark style="background-color:lightblue;" id="10964">malondialdehyde</mark> content exhibited the negative effect.
18509591-47	Moreover, the concentrations of hepatic <mark style="background-color:lightblue;" id="825,5810,69248,440015">hydroxyproline</mark>, serum <mark style="background-color:lightblue;" id="24759,453618,3084050,24728612">hyaluronic acid</mark>, interleukin-2, <mark style="background-color:lightgreen;" id="P41693">interleukin-6</mark> , <mark style="background-color:lightgreen;" id="Q8JFG3">tumor necrosis factor</mark> -alpha and <mark style="background-color:lightblue;" id="44342165">laminin</mark> were all <mark style="background-color:orange;">decreased</mark> in the <mark style="background-color:lightblue;" id="1123">taurine</mark> treated groups.
18521540-51	<mark style="background-color:lightblue;" id="216325">AGI-1067</mark> is a novel, phenolic antioxidant, and vascular protectant which dose-dependently <mark style="background-color:orange;">inhibits</mark> <mark style="background-color:lightgreen;" id="P0C1A8,P0C1A9">PEA</mark> biomarkers in vitro.
18500522-58	This study assessed relationships between <mark style="background-color:lightgreen;" id="Q9P121">hNT</mark> <mark style="background-color:orange;">levels</mark> and <mark style="background-color:lightblue;" id="657237">fludarabine</mark> uptake and cytotoxicity in cultures of human renal proximal tubule cells (hRPTCs) that produce multiple transporter types.
18162361-61	<mark style="background-color:lightblue;" id="446157">Rosuvastatin</mark> rapidly <mark style="background-color:orange;">phosphorylated</mark> <mark style="background-color:lightgreen;" id="P31750,Q8INB9">Akt</mark> and endothelial <mark style="background-color:lightgreen;" id="O61309,O61608,Q27571,Q9I9M2">nitric oxide synthase</mark> ( <mark style="background-color:lightgreen;" id="P29473,P29474,P70313,P79209,P97270,Q28969,Q62600">eNOS</mark> ) in human endothelial cells.
18162361-62	Our findings indicate that <mark style="background-color:lightblue;" id="446157">rosuvastatin</mark> <mark style="background-color:orange;">protects</mark> endothelial cells from <mark style="background-color:yellow;" id="GO:0016265,biological_process">death</mark> with <mark style="background-color:yellow;" id="GO:0016310,biological_process">phosphorylation</mark> of <mark style="background-color:lightgreen;" id="P31750,Q8INB9">Akt</mark> and <mark style="background-color:lightgreen;" id="P29473,P29474,P70313,P79209,P97270,Q28969,Q62600">eNOS</mark> .
18407527-68	The effect of this diet alone or after 2 weeks of treatment with <mark style="background-color:lightblue;" id="77999">rosiglitazone</mark> or <mark style="background-color:lightblue;" id="3476">glimepiride</mark> on <mark style="background-color:yellow;" id="GO:0042593,biological_process">glucose homeostasis</mark> , lipid profile, and <mark style="background-color:orange;">levels</mark> of resistin and <mark style="background-color:lightgreen;" id="O02750,O93416,Q28603,Q95189,Q95234">leptin</mark> was studied.
18407527-71	<mark style="background-color:lightblue;" id="77999">Rosiglitazone</mark> corrected the <mark style="background-color:orange;">altered</mark> parameters measured, except for liver <mark style="background-color:lightblue;" id="2724387">TGs</mark>; similarly, <mark style="background-color:lightblue;" id="3476">glimepiride</mark> <mark style="background-color:orange;">reinstated</mark> the inverted parameters but <mark style="background-color:orange;">raised</mark> <mark style="background-color:lightgreen;" id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">insulin</mark> level and, consequently, the HOMA index.
18462831-74	Exogenous <mark style="background-color:lightblue;" id="1102">spermidine</mark>, arsenic and <mark style="background-color:lightblue;" id="10932">beta-aminobutyric acid</mark> <mark style="background-color:orange;">modulate</mark> tobacco resistance to tobacco mosaic virus, and <mark style="background-color:orange;">affect</mark> local and systemic glucosylsalicylic acid <mark style="background-color:orange;">levels</mark> and <mark style="background-color:lightgreen;" id="O81160,O82475,P21885,P22220,P49726,Q39827,Q43075,Q819L4,Q81MS2,Q96412,Q96A70,Q9K9K5,Q9SNN0">arginine decarboxylase</mark> gene expression in tobacco leaves.
18481266-77	In adulthood, <mark style="background-color:lightblue;" id="6013">testosterone</mark> <mark style="background-color:orange;">secreted</mark> by the testes is <mark style="background-color:orange;">converted</mark> into estrogens by the preoptic <mark style="background-color:lightgreen;" id="O42145,O46512,P11511,P19098,P22443,P28649,P46194,P70091,P79304,P79430,P79699,Q29605,Q29624,Q5QQX7,Q69FB6,Q6QHT9,Q6YI21,Q92087,Q92111,Q92112,Q95M61,Q9XS28">aromatase</mark> .
18481276-83	The model was used to investigate how on-treatment <mark style="background-color:lightgreen;" id="O19062,P02741,P02742,P08462,P18151,P21291,P41964,P47875,P49254,P49262,P52753,P67966,P67967,P97315,Q07203">CRP</mark> related to baseline <mark style="background-color:lightgreen;" id="O19062,P02741,P02742,P08462,P18151,P21291,P41964,P47875,P49254,P49262,P52753,P67966,P67967,P97315,Q07203">CRP</mark> and estimated treatment <mark style="background-color:orange;">effects</mark> with <mark style="background-color:lightblue;" id="446157">rosuvastatin</mark>.
18436224-84	<mark style="background-color:lightblue;" id="5280343">Quercetin</mark> <mark style="background-color:orange;">inhibits</mark> vascular <mark style="background-color:lightblue;" id="5359597">superoxide</mark> production <mark style="background-color:orange;">induced</mark> by <mark style="background-color:lightgreen;" id="P05305,Q28469">endothelin-1</mark> : Role of <mark style="background-color:lightblue;" id="5884">NADPH</mark> oxidase, uncoupled <mark style="background-color:lightgreen;" id="P29473,P29474,P70313,P79209,P97270,Q28969,Q62600">eNOS</mark> and <mark style="background-color:lightgreen;" id="P05130,P13677,P13678,P34722">PKC</mark> .
18436224-85	We have investigated the effects of <mark style="background-color:lightblue;" id="5280343">quercetin</mark> and its <mark style="background-color:orange;">methylated</mark> metabolite <mark style="background-color:lightblue;" id="5281654">isorhamnetin</mark> (1-10microM) on endothelial dysfunction and <mark style="background-color:lightblue;" id="5359597">superoxide</mark> (O(2*)(-)) production <mark style="background-color:orange;">induced</mark> by <mark style="background-color:lightgreen;" id="P05305,Q28469">endothelin-1</mark> ( <mark style="background-color:lightgreen;" id="P05305,P09558,P13206,P17322,P22387,P22388,P29560,P97740,Q28469,Q5NRP9,Q5NRQ1,Q9BG76">ET-1</mark> , 10nM).
18436224-86	<mark style="background-color:lightgreen;" id="P05305,P09558,P13206,P17322,P22387,P22388,P29560,P97740,Q28469,Q5NRP9,Q5NRQ1,Q9BG76">ET-1</mark> <mark style="background-color:orange;">increased</mark> the contractile response <mark style="background-color:orange;">induced</mark> by <mark style="background-color:lightblue;" id="4782,6041">phenylephrine</mark> and <mark style="background-color:orange;">reduced</mark> the relaxant responses to <mark style="background-color:lightblue;" id="187">acetylcholine</mark> in <mark style="background-color:lightblue;" id="4782,6041">phenylephrine</mark> contracted intact aorta, and these <mark style="background-color:orange;">effects</mark> were <mark style="background-color:orange;">prevented</mark> by co-incubation with <mark style="background-color:lightblue;" id="5280343">quercetin</mark>, <mark style="background-color:lightblue;" id="5281654">isorhamnetin</mark> or <mark style="background-color:lightblue;" id="2703,411938">chelerythrine</mark> ( <mark style="background-color:lightgreen;" id="P13678,Q25378">protein kinase C</mark> ( <mark style="background-color:lightgreen;" id="P05130,P13677,P13678,P34722">PKC</mark> ) inhibitor).
18436224-88	Moreover, <mark style="background-color:lightblue;" id="2214">apocynin</mark>, endothelium denudation and <mark style="background-color:lightblue;" id="4367,440005">N(G)-nitro-l-arginine</mark> methylester (l-NAME, <mark style="background-color:lightgreen;" id="O61309,O61608,Q27571,Q9I9M2">nitric oxide synthase</mark> inhibitor) <mark style="background-color:orange;">suppressed</mark> the <mark style="background-color:lightgreen;" id="P05305,P09558,P13206,P17322,P22387,P22388,P29560,P97740,Q28469,Q5NRP9,Q5NRQ1,Q9BG76">ET-1</mark> -induced increase in A23187-stimulated O(2*)(-) generation.
18436224-89	Moreover, <mark style="background-color:lightblue;" id="5280343">quercetin</mark> but not <mark style="background-color:lightblue;" id="5281654">isorhamnetin</mark>, <mark style="background-color:orange;">inhibited</mark> the <mark style="background-color:orange;">increased</mark> <mark style="background-color:lightgreen;" id="P05130,P13677,P13678,P34722">PKC</mark> activity <mark style="background-color:orange;">induced</mark> by <mark style="background-color:lightgreen;" id="P05305,P09558,P13206,P17322,P22387,P22388,P29560,P97740,Q28469,Q5NRP9,Q5NRQ1,Q9BG76">ET-1</mark> .
18436224-90	Taken together these results indicate that <mark style="background-color:lightgreen;" id="P05305,P09558,P13206,P17322,P22387,P22388,P29560,P97740,Q28469,Q5NRP9,Q5NRQ1,Q9BG76">ET-1</mark> -induced <mark style="background-color:lightblue;" id="5884">NADPH</mark> oxidase up-regulation and <mark style="background-color:lightgreen;" id="P29473,P29474,P70313,P79209,P97270,Q28969,Q62600">eNOS</mark> uncoupling via <mark style="background-color:lightgreen;" id="P05130,P13677,P13678,P34722">PKC</mark> leading to endothelial dysfunction and these <mark style="background-color:orange;">effects</mark> were <mark style="background-color:orange;">prevented</mark> by <mark style="background-color:lightblue;" id="5280343">quercetin</mark> and <mark style="background-color:lightblue;" id="5281654">isorhamnetin</mark>.
18436227-91	We hypothesized that variants in <mark style="background-color:lightgreen;" id="Q8NBP7">PCSK9</mark> that <mark style="background-color:orange;">lower</mark> LDL <mark style="background-color:lightblue;" id="304,5997,6432564,11025495">cholesterol</mark> <mark style="background-color:orange;">levels</mark> are <mark style="background-color:orange;">associated</mark> with <mark style="background-color:orange;">reduced</mark> prevalence and incidence of peripheral artery disease ( <mark style="background-color:lightgreen;" id="O02849,O07006,P33751,P80668,Q9KPX2">PAD</mark> ).
18423943-93	Polyhydroxy phenolic compounds, such as flavonoids, <mark style="background-color:lightblue;" id="2116,14985,1548900,1742129">vitamin E</mark>, <mark style="background-color:lightblue;" id="5281792">rosmarinic acid</mark> and <mark style="background-color:lightblue;" id="2236">aristolochic acid</mark>, are able to <mark style="background-color:orange;">inhibit</mark> <mark style="background-color:lightgreen;" id="P0C1C0,Q01172,Q6CZT4">PLA</mark> (2) from different sources.
18280595-101	Furthermore, it has also been reported that <mark style="background-color:lightblue;" id="1548943">capsaicin</mark>-treated pigs significantly <mark style="background-color:orange;">increase</mark> mean arterial blood pressure compared with controls and that the <mark style="background-color:orange;">decrease</mark> in <mark style="background-color:lightgreen;" id="P10286,P30880,P30881,P31888,P80511">CGRP</mark> synthesis and release contributes to the elevated blood pressure.
18294936-104	Since <mark style="background-color:lightblue;" id="40400,644073,5311033,6321408,24838065">buprenorphine</mark> is <mark style="background-color:orange;">metabolized</mark> through <mark style="background-color:lightgreen;" id="P08684">cytochrome P450 3A4</mark> , we genotyped six genetic polymorphisms previously described in poor metabolizers but could not confirm these pharmacogenetic bases in this case.
18481313-107	Hepatocyte growth factor, keratinocyte growth factor or <mark style="background-color:lightgreen;" id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">insulin</mark> <mark style="background-color:orange;">prevented</mark> the <mark style="background-color:orange;">effect</mark> of <mark style="background-color:lightblue;" id="702">ethanol</mark> on cell permeability, but not on <mark style="background-color:lightgreen;" id="Q29458">PGE</mark> (2) release.
18481313-108	<mark style="background-color:lightgreen;" id="O02768,O19183,O62698,O62725,P27607,P35354,P35355,P70682,P79208,Q05769">Cyclooxygenase-2</mark> <mark style="background-color:orange;">stimulated</mark> <mark style="background-color:lightgreen;" id="Q29458">PGE</mark> (2) <mark style="background-color:orange;">release</mark> <mark style="background-color:orange;">mediated</mark> the reversible <mark style="background-color:orange;">effect</mark> of <mark style="background-color:lightblue;" id="702">ethanol</mark> on <mark style="background-color:yellow;" id="GO:0005923,cellular_component">tight junctions</mark> and, meanwhile, contributed to cell survival.
18561187-110	DNA array studies have revealed that <mark style="background-color:lightgreen;" id="P42624,P58115">YhaK</mark> is strongly <mark style="background-color:orange;">up-regulated</mark> by nitroso-<mark style="background-color:lightblue;" id="124886">glutathione</mark> (<mark style="background-color:lightblue;" id="3514,104858,10404739">GSNO</mark>) and also displays a 12-fold increase in expression during biofilm growth of E. coli 83972 and VR50 in human urine.
18561187-111	We found that the third <mark style="background-color:lightblue;" id="594,5862,5360637">cysteine</mark> in <mark style="background-color:lightgreen;" id="P42624,P58115">YhaK</mark> , Cys122, is <mark style="background-color:orange;">oxidized</mark> to a <mark style="background-color:lightblue;" id="447587">sulfenic acid</mark>.
18561187-112	E. coli <mark style="background-color:lightgreen;" id="O14313,O22711,O30973,O32823,O43099,O66790,O69777,O83790,O84101,P0A9P4,P0A9P5,P0AE52,P0AE53,P0AE54,P0AE55,P14292,P14293,P21762,P26830,P30044,P34227,P39916,P40553,P43496,P43788,P44411,P44758,P46843,P47348,P49537,P50971,P51272,P51978,P52213,P52214,P52215,P55979,P56431,P56577,P56578,P56876,P57279,P57399,P61076,P65688,P65689,P66010,P66011,P73728,P75531,P80880,P80892,P81433,P94284,P99029,P99101,Q01116,Q05741,Q25861,Q53212,Q55624,Q5HHQ4,Q5HQW4,Q6BIS1,Q6C7L4,Q6FR39,Q6GB66,Q6GIM7,Q75CM8,Q7Z7S3,Q89AJ2,Q89AS1,Q8CPY8,Q8J0U0,Q8K9W0,Q8T6Z1,Q92375,Q928B5,Q92I02,Q98PK9,Q9BGI1,Q9GLW7,Q9GLW9,Q9KSS4,Q9M7T0,Q9PKT7,Q9PR71,Q9R063,Q9Z8M4,Q9ZD97,Q9ZHF0,Q9ZL18,Q9ZMU4">thioredoxin reductase</mark> and <mark style="background-color:lightblue;" id="5884">NADPH</mark> <mark style="background-color:orange;">produced</mark> ROS and caused oxidation and oligomerization of <mark style="background-color:orange;">reduced</mark> <mark style="background-color:lightgreen;" id="P42624,P58115">YhaK</mark> .
18458994-119	There was a significant increase in <mark style="background-color:lightgreen;" id="O07091,O13393,O22642,O93863,P00002,P00003,P00004,P00007,P00008,P00011,P00012,P00013,P00014,P00017,P00018,P00019,P00020,P00021,P00022,P00024,P00025,P00027,P00028,P00029,P00030,P00031,P00032,P00035,P00036,P00037,P00038,P00039,P00040,P00041,P00042,P00043,P00046,P00047,P00048,P00049,P00051,P00052,P00053,P00054,P00055,P00056,P00057,P00058,P00059,P00060,P00061,P00062,P00063,P00064,P00065,P00066,P00067,P00068,P00069,P00070,P00071,P00072,P00073,P00074,P00075,P00076,P00077,P00078,P00079,P12831,P15451,P18822,P19681,P19974,P21665,P22342,P25400,P29380,P32556,P38091,P53698,P56205,P59218,P62772,P62773,P62894,P62895,P62896,P67881,P67882,P68096,P68097,P68098,P68099,P68100,P68517,P68518,P68519,P81280,P81459,P99998,P99999,Q41346,Q4HVX7,Q52V08,Q52V09,Q52V10,Q5RFH4,Q640U4,Q6C9Q0,Q6IQM2,Q6Q4H8,Q6QLW4,Q6WUX8,Q753F4,Q7YR71,Q96VP3">cytochrome-c</mark> oxidase activity at 2.5 mg/L, which might <mark style="background-color:orange;">indicate</mark> <mark style="background-color:lightblue;" id="91590">irgarol</mark>'s disruption of the <mark style="background-color:yellow;" id="GO:0005740,cellular_component">mitochondrial membrane</mark> and subsequently <mark style="background-color:lightblue;" id="5957">ATP</mark> synthesis.
18389169-121	The non-covalent interaction of <mark style="background-color:lightblue;" id="5483782,6085493">brilliant red</mark> (BR) with <mark style="background-color:lightgreen;" id="O64362,O80288,O80292,P00720,P03706,P07540,P09963,P10439,P11187,P13656,P15057,P19385,P19386,P21270,P23472,P23473,P27359,P33486,P37715,P39046,P51771,P62692,P62693,P68920,P68921,P81241,P82174,P82175,P83673,Q27650,Q37875,Q37896,Q48603,Q7SID7,Q9CIT4,Q9T1X2,Q9ZXB7">lysozyme</mark> was <mark style="background-color:orange;">investigated</mark> by the UV spectrometry, circular dichroism (CD) and isothermal titration calorimetry ( <mark style="background-color:lightgreen;" id="Q9Y1U3">ITC</mark> ).
18547755-125	The aim of the present study was to investigate differences in the expression of mRNAs for <mark style="background-color:lightgreen;" id="O42132,P03372,P06211,P06212,P16058,P19785,P49884,P49885,P49886,P50240,P50241,P50242,P57717,P57753,P81559,Q29040,Q53AD2,Q91250,Q91424,Q9PVZ9,Q9QZJ5,Q9TV98,Q9YH33,Q9YHT3,Q9YHZ7">ERalpha</mark> , <mark style="background-color:lightgreen;" id="O08537,O13012,O93511,P57781,P57782,Q62986,Q92731,Q95171,Q9IAK1,Q9PTU5,Q9PVE2,Q9TTE5,Q9TU15,Q9W6M2,Q9XSB5,Q9XSW2,Q9YH32">ERbeta</mark> and PR in the sow uterus at different stages of the estrous cycle as well as in inseminated sows at estrus and during early <mark style="background-color:yellow;" id="GO:0007565,biological_process">pregnancy</mark> by <mark style="background-color:orange;">use</mark> of solution hybridization and in relation to plasma <mark style="background-color:orange;">levels</mark> of <mark style="background-color:lightblue;" id="5757">estradiol</mark> and <mark style="background-color:lightblue;" id="5994">progesterone</mark>.
18467006-128	A series of <mark style="background-color:lightblue;" id="7370">benzenesulfonamide</mark>-substituted 4-(6-alkylpyridin-2-yl)-5-(quinoxalin-6-yl)imidazoles have been <mark style="background-color:orange;">synthesized</mark> and evaluated for their <mark style="background-color:lightgreen;" id="P36897">ALK5</mark> inhibitory activity in cell-based <mark style="background-color:lightgreen;" id="P08659,P13129,Q01158,Q26304,Q27757">luciferase</mark> reporter assays.
18473163-133	<mark style="background-color:lightgreen;" id="O60502,P44955,P49010,P58067,P75949,P96155,P96157,Q04786,Q0TR53,Q2KXM7,Q2P4L0,Q2Y863,Q31G32,Q31ZG4,Q32EW7,Q3BVU6,Q3J953,Q3SKU2,Q3Z310,Q4QLU8,Q4USG7,Q57QE6,Q5FA94,Q5H1Q0,Q5P081,Q5PGT0,Q5QUZ5,Q606N2,Q65VK7,Q669N5,Q6D674,Q6LJ30,Q7N397,Q7NWB7,Q7UCW4,Q7VNI8,Q7VWV8,Q7W9J5,Q7WH65,Q82SJ8,Q87BR5,Q89ZI2,Q8EEW2,Q8FIN2,Q8PB42,Q8PMU1,Q8VIJ5,Q8XL08,Q8Z7I6,Q8ZFS3,Q8ZQ06,Q9CPH0,Q9EQQ9,Q9HZK0,Q9JVT3,Q9K0Q4,Q9KU37,Q9PAZ0">beta-Hexosaminidases</mark> (EC 3.2.1.52) are lysosomal enzymes that <mark style="background-color:orange;">remove</mark> terminal beta-glycosidically <mark style="background-color:orange;">bound</mark> <mark style="background-color:lightblue;" id="24139">N-acetylglucosamine</mark> and <mark style="background-color:lightblue;" id="899,35717,84265,439174">N-acetylgalactosamine</mark> residues from a number of glycoconjugates.
18410530-134	<mark style="background-color:lightblue;" id="6804">CpG</mark> methylation as well as <mark style="background-color:lightgreen;" id="P02299,P07041,P08437,P08898,P22843,P23753,P40285,P50564,P61830,P61831,P61832,P61833,P61834,P61835,P61836,P80553,P83864,P84235,P84236,P84237,P84238,P84239,P90543,Q06196,Q2UCQ0,Q5DWI3,Q757N1,Q7XYZ0,Q98RY4,Q9HDN1,Q9P427,Q9U7D1">histone H3</mark> methylation of lysines 9 and 27 contribute independently to <mark style="background-color:lightgreen;" id="O48920,P34727,P34728,P51823,Q94650">ARF</mark>  <mark style="background-color:yellow;" id="GO:0016458,biological_process">gene silencing</mark> in adenocarcinoma cell lines and can be <mark style="background-color:orange;">reversed</mark> by <mark style="background-color:lightblue;" id="451668">5-aza-2'-deoxycytidine</mark>.
18546023-135	<mark style="background-color:lightgreen;" id="Q7M4U7">Lipase</mark> <mark style="background-color:orange;">immobilized</mark> on <mark style="background-color:lightblue;" id="3485">glutaraldehyde</mark>-crosslinked chitosan yielded the highest efficiency in terms of total coupled protein and protein loading efficiency.
18248398-140	<mark style="background-color:lightgreen;" id="O02750,O93416,Q28603,Q95189,Q95234">Leptin</mark> did not show any <mark style="background-color:orange;">effect</mark> in long photoperiod but <mark style="background-color:orange;">decreased</mark> proliferation by <mark style="background-color:orange;">stimulating</mark> <mark style="background-color:lightblue;" id="896">melatonin</mark> in short photoperiod.
18473182-143	Overexpression of <mark style="background-color:lightgreen;" id="O18963,P05181,P08682,P33266,P51581,P79383,Q6GUQ4">CYP2E1</mark> <mark style="background-color:orange;">induces</mark> HepG2 <mark style="background-color:yellow;" id="GO:0008219,biological_process">cells death</mark> by the <mark style="background-color:lightgreen;" id="O24006">AMP</mark> kinase activator <mark style="background-color:lightblue;" id="16078949">5'-aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside</mark> (AICAR).
18462962-149	She had a mutation in <mark style="background-color:lightgreen;" id="Q9BZ23">PANK2</mark> gene <mark style="background-color:orange;">consisting</mark> of an aminoacid <mark style="background-color:orange;">change</mark> of <mark style="background-color:lightblue;" id="602,4580,5950,71080">Alanine</mark> to <mark style="background-color:lightblue;" id="6287">Valine</mark> in exon 5 (A382V).
18405417-151	Role of <mark style="background-color:lightblue;" id="5202">serotonin</mark> <mark style="background-color:lightgreen;" id="P08908,P19327,P28285,Q64264,Q6XXX9,Q6XXY0,Q98998,Q9N296,Q9N297,Q9N298">5-HT1A</mark> receptors in the antidepressant-like effect and the antinociceptive <mark style="background-color:orange;">effect</mark> of <mark style="background-color:lightblue;" id="5656">venlafaxine</mark> in mice.
18405417-152	The present study was undertaken to evaluate the potential role of <mark style="background-color:lightgreen;" id="P08908,P19327,P28285,Q64264,Q6XXX9,Q6XXY0,Q98998,Q9N296,Q9N297,Q9N298">5-HT1A</mark> receptors in the antidepressant-like effect and antinociceptive <mark style="background-color:orange;">effect</mark> of <mark style="background-color:lightblue;" id="5656">venlafaxine</mark>.
18405417-154	These findings show that <mark style="background-color:lightgreen;" id="P08908,P19327,P28285,Q64264,Q6XXX9,Q6XXY0,Q98998,Q9N296,Q9N297,Q9N298">5-HT1A</mark> receptors play differing roles in <mark style="background-color:orange;">modulating</mark> the antidepressant-like and antinociceptive <mark style="background-color:orange;">effects</mark> of <mark style="background-color:lightblue;" id="5656">venlafaxine</mark> in the models investigated.
18405417-155	In contrast, the antinociceptive effect of <mark style="background-color:lightblue;" id="5656">venlafaxine</mark> is probably <mark style="background-color:orange;">potentiated</mark> due to the blockade of somatodendritic <mark style="background-color:lightgreen;" id="P08908,P19327,P28285,Q64264,Q6XXX9,Q6XXY0,Q98998,Q9N296,Q9N297,Q9N298">5-HT1A</mark> receptors in the same raphe nuclei, facilitating the descending monoaminergic pain control system.
18436346-156	A series of 2-aryl-naphtho[1,2-d]<mark style="background-color:lightblue;" id="9255">oxazole</mark> derivatives have been <mark style="background-color:orange;">synthesized</mark> and evaluated for <mark style="background-color:lightgreen;" id="O13016,P18031,P20417,P35821">PTP-1B</mark> inhibitory activity.
18536704-162	Decreased <mark style="background-color:lightgreen;" id="P21917,P30729,P51436,Q6TLJ0">dopamine D4 receptor</mark> expression <mark style="background-color:orange;">increases</mark> <mark style="background-color:yellow;" id="GO:0005576,cellular_component">extracellular</mark> <mark style="background-color:lightblue;" id="611,23327,33032">glutamate</mark> and alters its regulation in mouse striatum.
18536705-163	injection of <mark style="background-color:lightgreen;" id="O70176,P13589,P16613,P18509,P41535,P41585,P48144,P81039,Q29W19">PACAP</mark> provoked a significant <mark style="background-color:orange;">increase</mark> in plasma <mark style="background-color:lightblue;" id="206,5793,64689,79025">glucose</mark> level.
18436399-180	<mark style="background-color:lightblue;" id="56842239">Polyunsaturated fatty acids</mark> differentially <mark style="background-color:orange;">alter</mark> <mark style="background-color:lightgreen;" id="P49763,Q9XS47">PGF</mark> (2alpha) and <mark style="background-color:lightgreen;" id="Q29458">PGE</mark> (2) release from bovine trophoblast and endometrial tissues during short-term culture.
18436399-181	Two studies tested the hypothesis that eicosapentaenoic (20:5omega3; <mark style="background-color:lightgreen;" id="P01033,P12032">EPA</mark> ), <mark style="background-color:lightblue;" id="6433873">docosahexaenoic acids</mark> (22:6omega3; DHA) or <mark style="background-color:lightblue;" id="5280450">linoleic acid</mark> ( <mark style="background-color:lightgreen;" id="P32217">C18</mark> :2omega6; <mark style="background-color:lightblue;" id="96">LIN</mark>) <mark style="background-color:orange;">reduced</mark> bovine endometrial and trophoblast prostaglandin F(2alpha) ( <mark style="background-color:lightgreen;" id="P49763,Q9XS47">PGF</mark> (2alpha)) and prostaglandin E(2) ( <mark style="background-color:lightgreen;" id="Q29458">PGE</mark> (2)) release during short-term culture.
18553142-186	<mark style="background-color:lightgreen;" id="P79371,Q8JGM4,Q9S850">SOX</mark> deficiency was <mark style="background-color:orange;">established</mark> by feeding rats a low <mark style="background-color:lightblue;" id="6422,23932">molybdenum</mark> diet and <mark style="background-color:orange;">adding</mark> to their drinking water 200 ppm <mark style="background-color:lightblue;" id="23964">tungsten</mark>.
18486994-189	Our results showed 2a, 2d and 2g as the most active compounds that inhibited the HIV-1 reverse <mark style="background-color:lightgreen;" id="O55528,O89344,P03523,P06447,P06829,P11205,P11213,P12576,P12577,P13179,P13615,P16289,P16379,P20894,P24658,P26676,P28887,P30929,P31332,P31352,P35262,P35341,P35946,P35975,P41357,Q03396,Q05318,Q06996,Q5XX01,Q66802,Q6V1Q2,Q88434,Q8JPX5,Q91DD4,Q997F0,Q9DUD8">transcriptase</mark>  <mark style="background-color:yellow;" id="GO:0003824,molecular_function">catalytic activity</mark> with cytotoxicity <mark style="background-color:orange;">lower</mark> than <mark style="background-color:lightblue;" id="35370">AZT</mark> and SI higher than <mark style="background-color:lightgreen;" id="O88533,O96567,O96571,P05031,P14173,P20711,P22781,P27718,P34751,P48861,P54768,P54769,P54770,P54771,P80041">DDC</mark> and DDI.
18458677-190	Functional polymorphisms in the <mark style="background-color:lightgreen;" id="P41693">interleukin-6</mark> and <mark style="background-color:lightblue;" id="5202">serotonin</mark> transporter genes, and depression and fatigue <mark style="background-color:orange;">induced</mark> by interferon-alpha and <mark style="background-color:lightblue;" id="37542">ribavirin</mark> treatment.
17692997-193	Furthermore, <mark style="background-color:lightblue;" id="19001,439196,446094">dithiothreitol</mark> was found to be capable of significantly <mark style="background-color:orange;">preventing</mark> the inhibitory <mark style="background-color:orange;">effect</mark> of <mark style="background-color:lightgreen;" id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">insulin</mark> on Abeta oligomer formation.
18374997-195	In women, <mark style="background-color:lightgreen;" id="P20918,Q01177">Plg</mark> <mark style="background-color:orange;">levels</mark> were higher in individuals with diagnosed ischemic heart disease (IHD) and <mark style="background-color:orange;">increased</mark> with triglycerides (TG) and <mark style="background-color:lightblue;" id="206,5793,64689,79025">glucose</mark> level.
18555241-208	<mark style="background-color:lightblue;" id="969516">Curcumin</mark>, a nutritional supplement with antineoplastic activity, <mark style="background-color:orange;">enhances</mark> leiomyoma cell <mark style="background-color:yellow;" id="GO:0006915,biological_process">apoptosis</mark> and <mark style="background-color:orange;">decreases</mark> <mark style="background-color:lightgreen;" id="P07589,P11722,Q28275,Q28377,Q28749,Q91289,Q91400">fibronectin</mark> expression.
18205042-213	However, we also observed that <mark style="background-color:lightblue;" id="2812">clotrimazol</mark> (1alpha-hydroxylase inhibitor) <mark style="background-color:orange;">enhanced</mark> 25(OH)D(3) -induced <mark style="background-color:lightgreen;" id="Q07973">CYP24</mark> expression in breast cancer cells.
18553215-218	an " <mark style="background-color:lightgreen;" id="O00937,O13419,O16808,O17320,O65314,O65315,O65316,O74258,O81221,P02577,P10365,P10989,P11426,P13363,P14235,P17128,P20904,P24902,P26182,P26183,P30161,P45520,P45521,P48465,P50138,P51775,P53455,P53476,P53477,P53491,P53498,P53499,P53500,P53502,P53689,P60009,P60010,P60011,P68555,P78711,P80709,P81085,P90689,P91754,Q05214,Q11212,Q24733,Q2U7A3,Q39596,Q39758,Q6TCF2,Q75D00,Q8SWN8,Q8X119,Q92192,Q92193,Q99023,Q9P4D1,Q9UVF3,Q9UVX4,Q9UVZ8">actin</mark>  <mark style="background-color:yellow;" id="GO:0005488,molecular_function">binding</mark> domain", as a singlet and which, in addition, <mark style="background-color:orange;">contain</mark> the conserved <mark style="background-color:lightblue;" id="594,5862,5360637">cysteine</mark> rich double Zn finger possessing Lim domain, also as a singlet.
18521741-219	Here we demonstrate that an AR ligand, <mark style="background-color:lightblue;" id="15,10635">5-alpha-dihydrotestosterone</mark> (<mark style="background-color:lightblue;" id="10635">DHT</mark>), <mark style="background-color:orange;">inhibits</mark> MCF-7 breast cancer cell growth <mark style="background-color:orange;">induced</mark> by <mark style="background-color:lightgreen;" id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">insulin</mark> like growth factor 1 ( <mark style="background-color:lightgreen;" id="P05017,P07455,P08025,P10763,P16545,P17085,P17647,P18254,P33712,P51457,P51458,P51462,Q02815,Q28933,Q68LC0,Q6GUL6,Q6IVA5,Q6JLX1,Q95222">IGF-I</mark> ).
18521605-224	<mark style="background-color:lightblue;" id="3637">Hydralazine</mark> <mark style="background-color:orange;">inhibits</mark> human cervical cancer cell growth in vitro in association with <mark style="background-color:lightgreen;" id="P25054">APC</mark> demethylation and re-expression.
18521605-225	Clinically, it has been approved that <mark style="background-color:yellow;" id="GO:0006306,biological_process">DNA methylation</mark> inhibitors, such as <mark style="background-color:lightblue;" id="451668">5-aza-2'-deoxycytidine</mark> (<mark style="background-color:lightblue;" id="451668">5-Aza-dC</mark>), can <mark style="background-color:orange;">reverse</mark> <mark style="background-color:lightgreen;" id="P25054">APC</mark> promoter methylation, but widespread clinical use of these inhibitors is limited by their toxicity and instability in aqueous solution.
18403053-226	We observed that <mark style="background-color:lightblue;" id="3870,3034764,6610292">lactacystin</mark> <mark style="background-color:orange;">inhibited</mark> the proteasome activities and <mark style="background-color:orange;">increased</mark> the <mark style="background-color:orange;">level</mark> and insolubility of different <mark style="background-color:lightgreen;" id="P10637,P16525,P19332,P58384">tau</mark> species, including phosphorylated <mark style="background-color:lightgreen;" id="P10637,P16525,P19332,P58384">tau</mark> .
17629591-228	In addition, we demonstrated that Hsp20, <mark style="background-color:lightgreen;" id="O35878,Q16082,Q99PR8">HspB2</mark> and <mark style="background-color:lightgreen;" id="Q5EAC9,Q5RAB0,Q6SJQ8,Q8MJ36,Q9EPX0,Q9JK92,Q9UJY1">HspB8</mark> <mark style="background-color:orange;">induced</mark> <mark style="background-color:lightgreen;" id="P41693">interleukin-6</mark> production in cultured pericytes and astrocytes, which could be <mark style="background-color:orange;">antagonized</mark> by <mark style="background-color:lightblue;" id="5743">dexamethasone</mark>, whereas other sHsps and A beta were inactive, suggesting that sHsps may be among the key mediators of the local <mark style="background-color:yellow;" id="GO:0006954,biological_process">inflammatory response</mark> associated with HCHWA-D and AD lesions.
18534811-234	The results showed that <mark style="background-color:lightblue;" id="2833,6167,53278">colchicine</mark> <mark style="background-color:orange;">augmented</mark> splenic-specific IgG1 and <mark style="background-color:lightgreen;" id="O77762,P05112,P07750,P20096,P30367,P30368,P42202,P46652,P47966,P51492,P51744,P55030,P79155,P79339,Q04745,Q2PE74,Q3S4V6,Q58M18,Q60440,Q7YS71,Q865X5,Q865Y0,Q8HYB1,Q9MZR8,Q9XS58">IL-4</mark> as well as <mark style="background-color:yellow;" id="GO:0008283,biological_process">cell proliferation</mark> but <mark style="background-color:orange;">suppressed</mark> specific IgG2a and <mark style="background-color:lightgreen;" id="O35497,O35735,O57571,O57603,O57608,O73915,O77763,P01579,P01580,P01581,P07353,P17773,P17803,P28333,P28341,P30123,P42160,P42161,P42162,P46402,P49708,P63309,P63310,P63311,P79154,Q1WM28,Q25BC0,Q2PE75,Q4ZH68,Q5CCK0,Q5I6S9,Q62574,Q647G2,Q7TSP4,Q865W6,Q865X1,Q865Y4,Q866Y6,Q8MKF5,Q8SPW9,Q9QXX2,Q9TTB0,Q9TV67,Q9YGB9">IFN-gamma</mark> levels.
18198986-243	Serum adipocyte <mark style="background-color:lightgreen;" id="O42494,O45035,O76821,P80547,Q17284,Q8MUC1,Q9U5P1">fatty acid binding protein</mark> <mark style="background-color:orange;">levels</mark> in patients with type 2 diabetes mellitus and obesity: the <mark style="background-color:orange;">influence</mark> of <mark style="background-color:lightblue;" id="3339">fenofibrate</mark> treatment.
18198986-246	<mark style="background-color:lightgreen;" id="P80565">FABP</mark> <mark style="background-color:orange;">levels</mark> positively correlated with BMI, triglyceride levels, blood <mark style="background-color:lightblue;" id="206,5793,64689,79025">glucose</mark>, <mark style="background-color:orange;">glycated</mark> <mark style="background-color:lightgreen;" id="P15160,P17724,P73925,Q03459">hemoglobin</mark> , atherogenic index and <mark style="background-color:lightgreen;" id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">insulin</mark> levels.
18198997-256	<mark style="background-color:lightblue;" id="264">Butyrate</mark> enemas <mark style="background-color:orange;">upregulate</mark> <mark style="background-color:lightgreen;" id="P0A9M0">Muc</mark> genes expression but decrease adherent mucus thickness in mice colon.
18198997-257	We demonstrated that <mark style="background-color:lightblue;" id="264">butyrate</mark> <mark style="background-color:orange;">stimulated</mark> the gene expression of both <mark style="background-color:orange;">secreted</mark> ( <mark style="background-color:lightgreen;" id="Q62635">Muc2</mark> ) and <mark style="background-color:yellow;" id="GO:0016020,cellular_component">membrane</mark> -linked ( <mark style="background-color:lightgreen;" id="Q02496">Muc1</mark> , Muc3, Muc4) mucins.
18198997-258	<mark style="background-color:lightblue;" id="264">Butyrate</mark> especially <mark style="background-color:orange;">induced</mark> a 6-fold <mark style="background-color:orange;">increase</mark> in <mark style="background-color:lightgreen;" id="Q62635">Muc2</mark> gene expression in proximal colon.
18508255-264	We found that ZPDC <mark style="background-color:lightgreen;" id="P08163">glycoprotein</mark> has significant scavenging <mark style="background-color:orange;">effect</mark> on the production of <mark style="background-color:yellow;" id="GO:0005622,cellular_component">intracellular</mark> <mark style="background-color:lightblue;" id="784">H2O2</mark> without cytotoxicity in G/GO- or <mark style="background-color:lightblue;" id="790">HX</mark>/XO-treated in Chang liver cells.
18439591-271	To test the hypothesis that increasing <mark style="background-color:lightblue;" id="12594">DHEAS</mark> <mark style="background-color:orange;">levels</mark> is <mark style="background-color:orange;">associated</mark> with <mark style="background-color:orange;">improved</mark> <mark style="background-color:lightgreen;" id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">insulin</mark> resistance in patients with polycystic ovary syndrome (PCOS).
18403016-272	<mark style="background-color:lightgreen;" id="O68838,P0A6W9,P0A6X0,P32477,P57485,P58994,P61379,Q09768,Q20117,Q57KV3,Q5E7F8,Q5LYY5,Q5M3J8,Q5PF10,Q65RX0,Q66E64,Q6ANW2,Q6D1T4,Q6LMV1,Q71VZ1,Q72RD4,Q7MHS5,Q7N7A4,Q7W3F2,Q7WES2,Q82ZG8,Q87LS2,Q88AR1,Q88R90,Q88UW5,Q89AD8,Q8D2V5,Q8DC38,Q8DW15,Q8DXM9,Q8E399,Q8EBF9,Q8F4D5,Q8X0X0,Q8X900,Q8XK30,Q8Y3R3,Q8Z4D6,Q8ZBU2,Q926X7,Q97IV1,Q9CM00,Q9HF78,Q9HTY6,Q9KUG5,Q9NFN6,Q9W3K5">Glutamate cysteine ligase</mark> ( <mark style="background-color:lightgreen;" id="P28676,Q8NEA9,Q96IK5">GCL</mark> ), <mark style="background-color:orange;">synthesizing</mark> <mark style="background-color:lightblue;" id="123938">gamma-glutamylcysteine</mark> from <mark style="background-color:lightblue;" id="611,23327,33032">glutamate</mark> and <mark style="background-color:lightblue;" id="594,5862,5360637">cysteine</mark>, is the rate-limiting enzyme in <mark style="background-color:lightblue;" id="124886">glutathione</mark> (<mark style="background-color:lightblue;" id="124886">GSH</mark>) <mark style="background-color:yellow;" id="GO:0009058,biological_process">biosynthesis</mark> .
18536954-285	In 17 adults on a fixed metabolic diet, an 11-day course of <mark style="background-color:lightblue;" id="156419">cinacalcet</mark> <mark style="background-color:orange;">increased</mark> serum <mark style="background-color:lightgreen;" id="O02686,P01350,P01351,P01352,P01353,P01354,P04563,P04564,P06885,P10034,P33713,P33714,P48757,P55885">gastrin</mark> and basal gastric acid output, but not maximal gastric acid output, compared with a placebo.
18528683-287	The obtained data revealed that <mark style="background-color:lightblue;" id="2578">BCNU</mark> <mark style="background-color:orange;">induced</mark> pathological <mark style="background-color:orange;">changes</mark> and markedly <mark style="background-color:orange;">increased</mark> lung <mark style="background-color:yellow;" id="GO:0005581,cellular_component">collagen</mark> and <mark style="background-color:orange;">level</mark> of <mark style="background-color:lightgreen;" id="P0AA04,P0AA07,P11065,P77335">Hpr</mark> but <mark style="background-color:orange;">decreased</mark> <mark style="background-color:lightblue;" id="124886">GSH</mark> content and GR activity and increased serum <mark style="background-color:lightgreen;" id="O35734,O77510,O77764,P01375,P04924,P06804,P13296,P16599,P19101,P23383,P23563,P29553,P33620,P36939,P48094,P51435,P51742,P51743,P59684,P59693,P59694,P59695,P79337,P79374,Q06599,Q19LH4,Q1G1A2,Q1WM27,Q2MH05,Q539C2,Q75N23,Q8HZD9,Q8JFG3,Q8MKG8,Q8WNR1,Q9BEA1">TNF-alpha</mark> compared to both control and MT-administered rats.
18434046-291	It is suggested that <mark style="background-color:lightblue;" id="119">GABA</mark> <mark style="background-color:orange;">acting</mark> through the <mark style="background-color:lightgreen;" id="P26714,Q08832,Q9BLY8">GABA(A) receptor</mark> mechanism on the expression of <mark style="background-color:lightgreen;" id="P27429">GnRH</mark> gene and <mark style="background-color:lightgreen;" id="O18821,P30968,P30969,P32236,P32237,P49922,Q01776,Q19PY9,Q8CH60,Q8SPZ1,Q9MZI6,Q9TTI8">GnRH-R</mark> gene in the hypothalamus may be involved in two processes: the <mark style="background-color:yellow;" id="GO:0009058,biological_process">biosynthesis</mark> of <mark style="background-color:lightgreen;" id="P27429">GnRH</mark> and the release of this <mark style="background-color:yellow;" id="GO:0005184,molecular_function">neurohormone</mark> in the hypothalamus.
18547799-292	These effects of <mark style="background-color:lightblue;" id="5280961">genistein</mark> during the differentiation period were <mark style="background-color:orange;">associated</mark> with down-regulation of <mark style="background-color:lightgreen;" id="O42132,P03372,P06211,P06212,P16058,P19785,P49884,P49885,P49886,P50240,P50241,P50242,P57717,P57753,P81559,Q29040,Q53AD2,Q91250,Q91424,Q9PVZ9,Q9QZJ5,Q9TV98,Q9YH33,Q9YHT3,Q9YHZ7">ERalpha</mark> and <mark style="background-color:lightgreen;" id="O08537,O13012,O93511,P57781,P57782,Q62986,Q92731,Q95171,Q9IAK1,Q9PTU5,Q9PVE2,Q9TTE5,Q9TU15,Q9W6M2,Q9XSB5,Q9XSW2,Q9YH32">ERbeta</mark> expression.
18528783-293	In search for the pharmacophore and to analyze structure-activity relationships we synthesized a series of truncated derivatives and analogs of <mark style="background-color:lightblue;" id="656725">RB-2</mark>, <mark style="background-color:orange;">including</mark> <mark style="background-color:lightblue;" id="350971">1-amino</mark>-2-sulfo-4-ar( <mark style="background-color:lightgreen;" id="P97793">alk</mark> )ylaminoanthraquinones, <mark style="background-color:lightblue;" id="350971">1-amino</mark>-2-methyl-4-arylaminoanthraquinones, <mark style="background-color:lightblue;" id="22628">1-amino-4-bromoanthraquinone 2-sulfonic acid</mark> esters and <mark style="background-color:lightblue;" id="12145736">sulfonamides</mark>, and <mark style="background-color:lightgreen;" id="Q9JLV1">bis</mark> -(<mark style="background-color:lightblue;" id="627326">1-amino-4-bromoanthraquinone</mark>) <mark style="background-color:lightblue;" id="12145736">sulfonamides</mark>, and <mark style="background-color:orange;">investigated</mark> them in preparations of rat <mark style="background-color:lightgreen;" id="O18956,O93295,P49961,P55772,P97687,Q9MYU4">NTPDase1</mark> , 2, and 3 using a capillary electrophoresis assay.
18393628-298	<mark style="background-color:lightblue;" id="942,89594,157672">Nicotine</mark>, <mark style="background-color:lightblue;" id="9308">muscarine</mark>, and <mark style="background-color:lightblue;" id="2730">chlorpyrifos</mark> <mark style="background-color:orange;">induced</mark> the <mark style="background-color:yellow;" id="GO:0016310,biological_process">phosphorylation</mark> of <mark style="background-color:lightgreen;" id="P21708,P27361,P28869,P42525,Q63844">extracellular signal-regulated kinases 1</mark> and 2.
18262559-301	Systemic administration of <mark style="background-color:lightgreen;" id="P15160,P17724,P73925,Q03459">hemoglobin</mark> vesicle <mark style="background-color:orange;">elevates</mark> tumor tissue <mark style="background-color:lightblue;" id="977">oxygen</mark> tension and modifies tumor response to irradiation.
17003041-302	<mark style="background-color:lightgreen;" id="O76090,O88870,Q21973,Q6UY87,Q8WMR7">Bestrophin-1</mark> <mark style="background-color:orange;">enables</mark> <mark style="background-color:lightgreen;" id="P00920,P27139">Ca2</mark> +-activated <mark style="background-color:lightblue;" id="312">Cl</mark>- conductance in epithelia.
17003041-304	Calcium-dependent <mark style="background-color:lightblue;" id="312">Cl</mark>(-) currents were <mark style="background-color:orange;">activated</mark> by <mark style="background-color:lightblue;" id="5957">ATP</mark> in HEK293 cells <mark style="background-color:orange;">expressing</mark> <mark style="background-color:lightgreen;" id="O76090,Q6UY87,Q8WMR7">BEST1</mark> .
18498083-305	In this work, we identified a high affinity and potency metallocene-containing <mark style="background-color:lightblue;" id="67516">triazole</mark> peptide <mark style="background-color:orange;">conjugate</mark> that <mark style="background-color:orange;">suppresses</mark> the interactions of HIV-1 <mark style="background-color:orange;">envelope</mark> <mark style="background-color:lightgreen;" id="O12164,O41803,O70902,O89292,O91086,P03375,P03377,P03378,P04577,P04578,P04579,P04580,P04581,P04582,P04583,P04624,P05877,P05878,P05879,P05880,P05881,P05882,P05883,P05884,P05885,P05886,P08810,P11267,P12449,P12487,P12488,P12489,P12490,P12491,P12492,P15831,P17281,P17755,P18040,P18094,P18799,P19503,P19549,P19550,P19551,P20871,P20872,P20888,P22380,P24105,P27757,P27977,P31819,P31872,P32536,P35961,Q02837,Q1A243,Q1A261,Q70626,Q73372,Q74126,Q75008,Q76638,Q77377,Q79670,Q89607,Q8AIH5,Q9IDV2,Q9Q714,Q9QBY2,Q9QBZ0,Q9QBZ4,Q9QBZ8,Q9QSQ7,Q9WC60,Q9WC69">gp120</mark> at both its <mark style="background-color:lightgreen;" id="P01730,P05542,P16003,P16004,P33705,P46630,P79184,P79185,Q08336,Q08338,Q08339,Q08340,Q29037,Q9XS78">CD4</mark> and co- <mark style="background-color:yellow;" id="GO:0005102,molecular_function">receptor binding</mark> sites.
18498083-307	The ferrocene <mark style="background-color:lightblue;" id="67516">triazole</mark> <mark style="background-color:orange;">conjugate</mark> <mark style="background-color:orange;">bound</mark> to <mark style="background-color:lightgreen;" id="O12164,O41803,O70902,O89292,O91086,P03375,P03377,P03378,P04577,P04578,P04579,P04580,P04581,P04582,P04583,P04624,P05877,P05878,P05879,P05880,P05881,P05882,P05883,P05884,P05885,P05886,P08810,P11267,P12449,P12487,P12488,P12489,P12490,P12491,P12492,P15831,P17281,P17755,P18040,P18094,P18799,P19503,P19549,P19550,P19551,P20871,P20872,P20888,P22380,P24105,P27757,P27977,P31819,P31872,P32536,P35961,Q02837,Q1A243,Q1A261,Q70626,Q73372,Q74126,Q75008,Q76638,Q77377,Q79670,Q89607,Q8AIH5,Q9IDV2,Q9Q714,Q9QBY2,Q9QBZ0,Q9QBZ4,Q9QBZ8,Q9QSQ7,Q9WC60,Q9WC69">gp120</mark> of both clade A (92UG037-08) and clade B (YU-2 and SF162) virus subtypes with nanomolar KD in direct <mark style="background-color:yellow;" id="GO:0005488,molecular_function">binding</mark> and <mark style="background-color:orange;">inhibited</mark> the <mark style="background-color:yellow;" id="GO:0005488,molecular_function">binding</mark> of <mark style="background-color:lightgreen;" id="O12164,O41803,O70902,O89292,O91086,P03375,P03377,P03378,P04577,P04578,P04579,P04580,P04581,P04582,P04583,P04624,P05877,P05878,P05879,P05880,P05881,P05882,P05883,P05884,P05885,P05886,P08810,P11267,P12449,P12487,P12488,P12489,P12490,P12491,P12492,P15831,P17281,P17755,P18040,P18094,P18799,P19503,P19549,P19550,P19551,P20871,P20872,P20888,P22380,P24105,P27757,P27977,P31819,P31872,P32536,P35961,Q02837,Q1A243,Q1A261,Q70626,Q73372,Q74126,Q75008,Q76638,Q77377,Q79670,Q89607,Q8AIH5,Q9IDV2,Q9Q714,Q9QBY2,Q9QBZ0,Q9QBZ4,Q9QBZ8,Q9QSQ7,Q9WC60,Q9WC69">gp120</mark> to soluble <mark style="background-color:lightgreen;" id="P01730,P05542,P16003,P16004,P33705,P46630,P79184,P79185,Q08336,Q08338,Q08339,Q08340,Q29037,Q9XS78">CD4</mark> and to antibodies that bind to HIV-1YU-2 gp120 at both the <mark style="background-color:lightgreen;" id="P01730,P05542,P16003,P16004,P33705,P46630,P79184,P79185,Q08336,Q08338,Q08339,Q08340,Q29037,Q9XS78">CD4</mark>  <mark style="background-color:yellow;" id="GO:0005488,molecular_function">binding</mark> site and <mark style="background-color:lightgreen;" id="P01730,P05542,P16003,P16004,P33705,P46630,P79184,P79185,Q08336,Q08338,Q08339,Q08340,Q29037,Q9XS78">CD4</mark> -induced <mark style="background-color:yellow;" id="GO:0005488,molecular_function">binding</mark> sites.
18489909-317	Using both physiologically achievable (2 microM) and supraphysiological (10 microM) concentrations, we investigated the ability of <mark style="background-color:lightblue;" id="5280343">quercetin</mark> and its predominant human metabolites to attenuate the expression of vascular <mark style="background-color:yellow;" id="GO:0007155,biological_process">cell adhesion</mark> molecule-1 ( <mark style="background-color:lightgreen;" id="P19320,P29533,P29534,Q28260">VCAM-1</mark> ), intercellular adhesion molecule-1 ( <mark style="background-color:lightgreen;" id="P05362,P13597,P33729,Q00238,Q28806,Q5NKV4,Q5NKV6,Q5NKV9,Q95132">ICAM-1</mark> ) and <mark style="background-color:lightgreen;" id="P10148,P13500,P14844,P28292,P42831,P52203,P61274,P61275,Q08782,Q9TTQ3">monocyte chemoattractant protein-1</mark> ( <mark style="background-color:lightgreen;" id="P10148,P13500,P14844,P28291,P28292,P42831,P52203,P61274,P61275,Q08782,Q9TTQ3">MCP-1</mark> ) in human umbilical artery smooth muscle cells (HUASMC) <mark style="background-color:orange;">activated</mark> by <mark style="background-color:lightgreen;" id="Q8JFG3">tumor necrosis factor</mark> -alpha ( <mark style="background-color:lightgreen;" id="O35734,O77510,O77764,P01375,P04924,P06804,P13296,P16599,P19101,P23383,P23563,P29553,P33620,P36939,P48094,P51435,P51742,P51743,P59684,P59693,P59694,P59695,P79337,P79374,Q06599,Q19LH4,Q1G1A2,Q1WM27,Q2MH05,Q539C2,Q75N23,Q8HZD9,Q8JFG3,Q8MKG8,Q8WNR1,Q9BEA1">TNFalpha</mark> ).
18489909-318	<mark style="background-color:lightblue;" id="5280343">Quercetin</mark> was able to <mark style="background-color:orange;">reduce</mark> <mark style="background-color:lightgreen;" id="O35734,O77510,O77764,P01375,P04924,P06804,P13296,P16599,P19101,P23383,P23563,P29553,P33620,P36939,P48094,P51435,P51742,P51743,P59684,P59693,P59694,P59695,P79337,P79374,Q06599,Q19LH4,Q1G1A2,Q1WM27,Q2MH05,Q539C2,Q75N23,Q8HZD9,Q8JFG3,Q8MKG8,Q8WNR1,Q9BEA1">TNFalpha</mark> -induced upregulation of <mark style="background-color:lightgreen;" id="P19320,P29533,P29534,Q28260">VCAM-1</mark> , <mark style="background-color:lightgreen;" id="P05362,P13597,P33729,Q00238,Q28806,Q5NKV4,Q5NKV6,Q5NKV9,Q95132">ICAM-1</mark> and <mark style="background-color:lightgreen;" id="P10148,P13500,P14844,P28291,P28292,P42831,P52203,P61274,P61275,Q08782,Q9TTQ3">MCP-1</mark> at both the protein and transcript (mRNA) level in HUASMC.
18274872-320	)<mark style="background-color:lightblue;" id="977,5359597">O2</mark>(-) and <mark style="background-color:lightblue;" id="784">H2O2</mark> in H. plumaeforme was respectively related to the low activity of <mark style="background-color:lightgreen;" id="O12933,O22668,O75007,P24705,P51547,P93258,Q01137,Q27666,Q9SM64">SOD</mark> and the <mark style="background-color:orange;">decreased</mark> activity of <mark style="background-color:lightgreen;" id="O62839,O97492,P00432,P00485,P00486,P00487,P04040,P06135,P07641,P11504,P20074,P22782,P25309,P25819,P26825,P26826,P32796,P36882,P36883,P43155,P47934,P49417,P52826,P58777,P62577,P62578,P62579,P62580,P90682,Q00614,Q02736,Q03058,Q5RF10,Q64405,Q704S8,Q9M5L6,Q9PWF7">CAT</mark> .
18037312-321	<mark style="background-color:lightblue;" id="23973">Cadmium</mark> inhalation induced: (1) a transient bronchial inflammation, dominated by neutrophils; (2) a neutrophilia of the blood that persisted for up to 4 weeks; (3) a transient <mark style="background-color:orange;">increased</mark> bronchial reactivity, and (4) a significant <mark style="background-color:orange;">increase</mark> in <mark style="background-color:lightgreen;" id="O18733,P14780,P41245,P41246,P50282,P52176">MMP-9</mark> activity in the BALF.
18393672-326	Adult bone marrow (BM)-derived <mark style="background-color:lightgreen;" id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">insulin</mark> -producing cells (IPCs) are capable of <mark style="background-color:orange;">regulating</mark> blood <mark style="background-color:lightblue;" id="206,5793,64689,79025">glucose</mark> levels in chemically induced hyperglycemic mice.
18393672-328	Treatment with <mark style="background-color:lightblue;" id="3032771">benfotiamine</mark> <mark style="background-color:orange;">activated</mark> <mark style="background-color:yellow;" id="GO:0006006,biological_process">glucose metabolism</mark> in <mark style="background-color:lightgreen;" id="P01308,P01310,P01311,P01313,P01314,P01315,P01316,P01317,P01318,P01319,P01320,P01321,P01324,P01327,P01328,P01329,P01330,P01331,P01333,P01334,P01335,P01336,P01340,P01342,P04667,P06306,P07453,P09476,P09477,P0C236,P12703,P12704,P12705,P12708,P13190,P17715,P18109,P21563,P29335,P30406,P30407,P30410,P41522,P42633,P51463,P67968,P67969,P67970,P67971,P67972,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69045,P69046,P69047,P69048,P81025,P81423,P81881,Q62587,Q6YK33,Q8HXV2,Q91XI3,Q98TA8,Q9TQY7,Q9W7R2">INS</mark> -1 cells in high-<mark style="background-color:lightblue;" id="206,5793,64689,79025">glucose</mark> culture conditions, and appeared to <mark style="background-color:orange;">maximize</mark> the BM-derived IPCs ability to <mark style="background-color:orange;">synthesize</mark> <mark style="background-color:lightgreen;" id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">insulin</mark> .
18393672-329	<mark style="background-color:lightblue;" id="3032771">Benfotiamine</mark> was not shown to <mark style="background-color:orange;">induce</mark> the <mark style="background-color:lightblue;" id="206,5793,64689,79025">glucose</mark> receptor <mark style="background-color:lightgreen;" id="P12336,P14246">Glut-2</mark> , however it was shown to <mark style="background-color:orange;">activate</mark> <mark style="background-color:lightgreen;" id="O25731,P0A4E1,P0A4E2,P0A6V8,P0A6V9,P17712,P21908,P35557,P52792,P54495,P58616,P58617,P58618,P58619,P64253,P64254,P82680,Q55855,Q56198,Q59171,Q668N7,Q6D7C4,Q7N6Y0,Q83K86,Q87EG6,Q8FFD4,Q8FV09,Q8P8U7,Q8PKU2,Q8UIV7,Q8YDC6,Q92407,Q92T27,Q93IM5,Q98DM2,Q9A6N3,Q9HZ46,Q9KCZ4,Q9PEG4,Q9ZKB0">glucokinase</mark> , the enzyme responsible for conversion of <mark style="background-color:lightblue;" id="206,5793,64689,79025">glucose</mark> to <mark style="background-color:lightblue;" id="5958,439284,439427,439958">glucose-6-phosphate</mark>.
18393672-330	However, in cells where the <mark style="background-color:lightblue;" id="854">pentose</mark> <mark style="background-color:lightblue;" id="1061,167704,644102">phosphate</mark> pathway was <mark style="background-color:orange;">blocked</mark> by <mark style="background-color:lightblue;" id="8682">oxythiamine</mark> treatment, there was a clear downregulation of <mark style="background-color:lightgreen;" id="P12336,P14246">Glut-2</mark> , <mark style="background-color:lightgreen;" id="O25731,P0A4E1,P0A4E2,P0A6V8,P0A6V9,P17712,P21908,P35557,P52792,P54495,P58616,P58617,P58618,P58619,P64253,P64254,P82680,Q55855,Q56198,Q59171,Q668N7,Q6D7C4,Q7N6Y0,Q83K86,Q87EG6,Q8FFD4,Q8FV09,Q8P8U7,Q8PKU2,Q8UIV7,Q8YDC6,Q92407,Q92T27,Q93IM5,Q98DM2,Q9A6N3,Q9HZ46,Q9KCZ4,Q9PEG4,Q9ZKB0">glucokinase</mark> , <mark style="background-color:lightgreen;" id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">insulin</mark> , and <mark style="background-color:lightgreen;" id="O01360,O13507,O27090,O28542,O32755,O34425,O42259,O52631,O57479,O57672,O59494,O59841,O67161,O83816,O96423,P00355,P00356,P00357,P00361,P00362,P04406,P04797,P08439,P09124,P09316,P09317,P0A1P0,P0A1P1,P0C0G6,P0C0G7,P10096,P10097,P10618,P15115,P16858,P17244,P17721,P19089,P19314,P19315,P20287,P20445,P22512,P22513,P23722,P24163,P24164,P24166,P24746,P24748,P24749,P24750,P24751,P24753,P25861,P26518,P26519,P26520,P26521,P26988,P27726,P28844,P29272,P29497,P32637,P32638,P34783,P35143,P39460,P44304,P46406,P46713,P46795,P46796,P47543,P48812,P51009,P51469,P51640,P52694,P52987,P53429,P53430,P54117,P54118,P54226,P55070,P55071,P55971,P56649,P57384,P58839,P61879,P61880,P64178,P64179,P68777,P70685,P75358,P80447,P80534,P83601,P87197,P94915,Q00301,Q00584,Q00640,Q01558,Q01597,Q01651,Q01982,Q05025,Q07234,Q12552,Q1DTF9,Q27652,Q27890,Q28259,Q28554,Q2NEN0,Q3IUT3,Q46450,Q48335,Q4J940,Q4KYY3,Q58546,Q59199,Q59309,Q59800,Q59906,Q5JHB5,Q5R2J2,Q5RAB4,Q5V061,Q5XDW3,Q6BMK0,Q6CCU7,Q6L125,Q6M0E6,Q757I2,Q89AK1,Q8J1H3,Q8K8M9,Q8NK47,Q8PTD3,Q8TFJ2,Q8WZN0,Q8X1X3,Q8ZWK7,Q92211,Q92243,Q92263,Q94469,Q96US8,Q971K2,Q97BJ8,Q9HFX1,Q9HGY7,Q9HJ69,Q9HSS7,Q9N2D5,Q9N655,Q9P8C0,Q9PJN6,Q9UR38,Q9UVC0,Q9UW96,Q9V1P1,Q9Y796,Q9Y8E9,Q9YFS9,Q9Z518,Q9Z7T0,Q9ZKT0">GAPDH</mark> .
18487053-332	<mark style="background-color:lightblue;" id="445154">Resveratrol</mark> (4,3',5'-trihydroxystilbene) is a naturally occurring antioxidant that <mark style="background-color:orange;">inhibits</mark> <mark style="background-color:lightgreen;" id="O62664,O97554,P05979,P22437,P23219,Q63921">cyclooxygenase-1</mark> ( <mark style="background-color:lightgreen;" id="O62664,O97554,P05979,P22437,P23219,Q63921,Q9T0N8">COX-1</mark> ), <mark style="background-color:lightgreen;" id="O02768,O19183,O62698,O62725,P27607,P35354,P35355,P70682,P79208,Q05769">cyclooxygenase-2</mark> ( <mark style="background-color:lightgreen;" id="O02768,O19183,O62698,O62725,P27607,P35354,P35355,P70682,P79208,Q05769">COX-2</mark> ) and the <mark style="background-color:yellow;" id="GO:0006350,biological_process">transcription</mark> factor NF-kappaB.
18486150-336	<mark style="background-color:lightblue;" id="2909,5280754,5284373,5458585,5497195,6435893,24883466,49867938">Cyclosporin A</mark> <mark style="background-color:orange;">up-regulates</mark> and <mark style="background-color:orange;">activates</mark> <mark style="background-color:lightgreen;" id="P13678,Q25378">protein kinase C</mark> -zeta in EBV-infected and EBV-transformed human B-cells.
18486150-337	We have proposed that <mark style="background-color:lightblue;" id="2909,5280754,5284373,5458585,5497195,6435893,24883466,49867938">cyclosporin A</mark> (CsA), despite being a <mark style="background-color:lightgreen;" id="O88480,Q9Y6J0">calcineurin inhibitor</mark> , will <mark style="background-color:orange;">activate</mark> <mark style="background-color:lightgreen;" id="P05130,P13677,P13678,P34722">PKC</mark> in B cells, thus promoting Epstein-Barr virus (EBV)-induced transformation.
18317936-346	<mark style="background-color:lightblue;" id="104978">Fluo-3</mark> <mark style="background-color:orange;">staining</mark> <mark style="background-color:orange;">used</mark> in flow cytometry and video microscopy revealed an oxysterol-induced <mark style="background-color:lightblue;" id="271">Ca(2</mark>+) influx, <mark style="background-color:orange;">varying</mark> according to the oxysterol studied, leading to the activation of the <mark style="background-color:lightblue;" id="6569">MEK</mark>/ <mark style="background-color:lightgreen;" id="P27361,P28869,P42525,Q07176">ERK1</mark> /2 pathway as demonstrated by Western blot analysis.
18477686-347	A differential regulation of the two <mark style="background-color:lightblue;" id="119">GABA</mark> <mark style="background-color:orange;">synthesizing</mark> enzymes ( <mark style="background-color:lightgreen;" id="P48321,Q05329,Q4PRC2">GAD65</mark> and <mark style="background-color:lightgreen;" id="P14748,P48319,Q5IS68,Q99259">GAD67</mark> ) parallels GABAergic <mark style="background-color:yellow;" id="GO:0030182,biological_process">neuron differentiation</mark> .
18227836-349	To test this hypothesis, we investigated whether disruption of the <mark style="background-color:lightgreen;" id="P01175,P01176,P01177,P01178,P01179,P13389,P32005,P35454,P69043,P69044,P69056,P69057,P69058">oxytocin</mark> gene ( <mark style="background-color:lightgreen;" id="P01179,P35454,Q5QQ53,Q7KVA1">Oxt</mark> -/-) made mice more susceptible to the psychosis-related <mark style="background-color:orange;">effects</mark> of <mark style="background-color:lightblue;" id="3007,5826,32893">amphetamine</mark> (<mark style="background-color:lightblue;" id="6083">Amp</mark>), <mark style="background-color:lightblue;" id="6005">apomorphine</mark> (Apo) and <mark style="background-color:lightblue;" id="6468">phencyclidine</mark> ( <mark style="background-color:lightgreen;" id="P13497,P19811,P42785,P42852,P51873,P51874,P51889,P80483,P80484,P98063">PCP</mark> ).
18227838-352	The mood stabilizers <mark style="background-color:lightblue;" id="28486,3028194">lithium</mark> and <mark style="background-color:lightblue;" id="3121">valproate</mark> <mark style="background-color:orange;">activate</mark> the <mark style="background-color:lightgreen;" id="P29323">ERK</mark> pathway in prefrontal cortex and hippocampus and potentiate <mark style="background-color:lightgreen;" id="P29323">ERK</mark> pathway-mediated <mark style="background-color:yellow;" id="GO:0007399,biological_process">neurite growth</mark> , neuronal survival and hippocampal <mark style="background-color:yellow;" id="GO:0007399,biological_process">neurogenesis</mark> .
18492032-354	Coexpression pattern with <mark style="background-color:lightgreen;" id="O13124,O42392,P11473,P13053,P48281,P49701,Q28037,Q95MH5">VDR</mark> <mark style="background-color:orange;">provides</mark> an indication that <mark style="background-color:lightblue;" id="5280453">calcitriol</mark> could be the modulator of these adaptive responses to involution and dietary P restriction.
18190985-361	Several studies have shown that <mark style="background-color:lightgreen;" id="P05463">epsilon</mark> 2 carriers have <mark style="background-color:orange;">lower</mark> low-density lipoprotein and apo B <mark style="background-color:orange;">levels</mark> and higher <mark style="background-color:lightgreen;" id="P81182">high-density lipoprotein</mark> <mark style="background-color:lightblue;" id="304,5997,6432564,11025495">cholesterol</mark> and apo A-I levels than <mark style="background-color:lightgreen;" id="P05463">epsilon</mark> 3 carriers.
18445079-363	<mark style="background-color:lightblue;" id="84098">Merlin</mark> is known to <mark style="background-color:orange;">bind</mark> <mark style="background-color:lightgreen;" id="P49023,P49024,Q5R7I1,Q66H76,Q8VI36">paxillin</mark> , beta1 integrin and <mark style="background-color:yellow;" id="GO:0005925,cellular_component">focal adhesion</mark> kinase, members of focal contacts, multi-protein complexes that mediate <mark style="background-color:yellow;" id="GO:0007155,biological_process">cell adhesion</mark> to the <mark style="background-color:yellow;" id="GO:0005578,GO:0048196,cellular_component">extracellular matrix</mark> .
18180755-369	The <mark style="background-color:lightgreen;" id="P0C1J7,Q13451,Q5RF88,Q95L05,Q9XSH5,Q9XSI2,Q9XT11">FKBP5</mark> gene product forms part of a complex with the <mark style="background-color:lightgreen;" id="O13186,O46567,O73673,P04150,P06536,P06537,P35547,P49115,P49843,P49844,P59667,P79269,P79686,Q5R9P5,Q6XLJ0,Q95267,Q9N1U3">glucocorticoid receptor</mark> and can <mark style="background-color:orange;">modulate</mark> <mark style="background-color:lightblue;" id="5754">cortisol</mark>- <mark style="background-color:yellow;" id="GO:0005488,molecular_function">binding</mark> affinity.
18479897-371	Feeding long-chain <mark style="background-color:lightgreen;" id="P25225">n-3</mark> <mark style="background-color:lightblue;" id="56842239">polyunsaturated fatty acids</mark> during <mark style="background-color:yellow;" id="GO:0007565,biological_process">gestation</mark> <mark style="background-color:orange;">increases</mark> intestinal <mark style="background-color:lightblue;" id="206,5793,64689,79025">glucose</mark> absorption potentially via the acute activation of <mark style="background-color:lightgreen;" id="P54646,Q09136,Q9Y478">AMPK</mark> .
18555557-379	<mark style="background-color:lightblue;" id="439176">Methylthioadenosine</mark> phosphorylase ( <mark style="background-color:lightgreen;" id="Q13126">MTAP</mark> ) is involved in the metabolism of purines and <mark style="background-color:orange;">converts</mark> <mark style="background-color:lightblue;" id="439176">methylthioadenosine</mark> ( <mark style="background-color:lightgreen;" id="O93450,O93593,O93609,P04734,P20830,P27086,P52721,P52727,P62338,P62339,P68503,P68504,P68505,P68506,P68507,P68508,Q26497,Q40157,Q8AWG2,Q92044">MTA</mark> ) to <mark style="background-color:lightblue;" id="190">adenine</mark>.
18498673-382	Circulating <mark style="background-color:lightgreen;" id="O02750,O93416,Q28603,Q95189,Q95234">leptin</mark> was negatively correlated with mRNA expression of adiponectin, <mark style="background-color:lightgreen;" id="O02671,O15243,P48357,Q9MYL0">LEPR</mark> and <mark style="background-color:lightgreen;" id="O46647,P06858,P11151,P11152,P11153,P11602,P49060,P49923,P55031,Q06000,Q29524">LPL</mark> , whereas <mark style="background-color:lightblue;" id="853,5819">thyroxine</mark> was positively correlated with <mark style="background-color:orange;">levels</mark> of <mark style="background-color:lightgreen;" id="Q865B6,Q865B7,Q9UBK2">PPARGC1A</mark> .
18340529-389	Myeloperoxidase ( <mark style="background-color:lightgreen;" id="P05164,P11247">MPO</mark> ) is an endogenous oxidant enzyme that <mark style="background-color:orange;">generates</mark> reactive <mark style="background-color:lightblue;" id="977">oxygen</mark> species (ROS).
18554690-393	The differences in tissue distribution and protein levels of <mark style="background-color:lightgreen;" id="O18473,O18531,P34021,P49880,P49881,P49882,P49883">EcR</mark> -B1 during the <mark style="background-color:yellow;" id="GO:0012501,biological_process">programmed cell death</mark> <mark style="background-color:orange;">indicate</mark> that the receptor plays a major role in the modulation and function of <mark style="background-color:lightblue;" id="19212,4233007,5316996">ecdysone</mark> activity in Bombyx anterior silk glands.
18543297-399	Metabolism of <mark style="background-color:lightblue;" id="3918,5360697">dextrorphan</mark> by <mark style="background-color:lightgreen;" id="P10635,Q2XNC8,Q2XNC9">CYP2D6</mark> in different recombinantly <mark style="background-color:orange;">expressed</mark> systems and its implications for the in vitro assessment of <mark style="background-color:lightblue;" id="3008,5360696,5362449,12305042">dextromethorphan</mark> metabolism.
18543297-400	<mark style="background-color:lightgreen;" id="P10635,Q2XNC8,Q2XNC9">Cytochrome P450 2D6</mark> ( <mark style="background-color:lightgreen;" id="P10635,Q2XNC8,Q2XNC9">CYP2D6</mark> ) <mark style="background-color:orange;">mediated</mark> formation of <mark style="background-color:lightblue;" id="3918,5360697">dextrorphan</mark> (<mark style="background-color:lightblue;" id="439216">DOR</mark>) from <mark style="background-color:lightblue;" id="3008,5360696,5362449,12305042">dextromethorphan</mark> ( <mark style="background-color:lightgreen;" id="P48845">DEX</mark> ) is widely used as a marker to assess the activity of this enzyme both in vitro and in vivo.
18543297-402	The extent of metabolism was investigated for a range of <mark style="background-color:lightgreen;" id="P48845">DEX</mark> and <mark style="background-color:lightblue;" id="439216">DOR</mark> concentrations in microsomal preparations from three different rCYPs <mark style="background-color:orange;">expressing</mark> human <mark style="background-color:lightgreen;" id="P10635,Q2XNC8,Q2XNC9">CYP2D6</mark> (yeast, Supersomes and Bactosomes) containing 10 pmol of the enzyme.
18543297-403	Two novel <mark style="background-color:lightgreen;" id="P10635,Q2XNC8,Q2XNC9">CYP2D6</mark> related metabolites were identified in Bactosomes, and <mark style="background-color:orange;">assigned</mark> as single hydroxylations in the phenyl rings of <mark style="background-color:lightblue;" id="439216">DOR</mark> and <mark style="background-color:lightblue;" id="11840954">HYM</mark> using ion-trap mass spectrometry.
18262738-416	The participation of <mark style="background-color:lightgreen;" id="Q05608,Q9RI12">protein kinase A</mark> ( <mark style="background-color:yellow;" id="GO:0004691,molecular_function">PKA</mark> ), <mark style="background-color:lightgreen;" id="P13678,Q25378">protein kinase C</mark> ( <mark style="background-color:lightgreen;" id="P05130,P13677,P13678,P34722">PKC</mark> ) and protein <mark style="background-color:lightblue;" id="1153,6057,5460803">tyrosine</mark> kinase (<mark style="background-color:lightblue;" id="81017">PTK</mark>) in capacitation <mark style="background-color:orange;">induced</mark> by <mark style="background-color:lightblue;" id="5460609">ONOO</mark>(-) was evaluated by incubation with specific inhibitors (50 microM H-89, 0.1 microM <mark style="background-color:lightblue;" id="2396">bisindolylmaleimide I</mark>, and 3 microM <mark style="background-color:lightblue;" id="5280961">genistein</mark>, respectively).
18543330-427	The metal-coordinating residues in the active site of <mark style="background-color:lightgreen;" id="P54970">ILL2</mark> <mark style="background-color:orange;">include</mark> a conserved <mark style="background-color:lightblue;" id="594,5862,5360637">cysteine</mark> that clearly distinguishes this protein from previously structurally characterized members of the M20 peptidase family.
18543330-428	Finally, the active site of <mark style="background-color:lightgreen;" id="P54970">ILL2</mark> <mark style="background-color:orange;">harbors</mark> an absolutely conserved <mark style="background-color:lightblue;" id="611,23327,33032">glutamate</mark> (Glu172), which is well positioned to act as a general acid-base residue.
18514659-430	However, <mark style="background-color:lightblue;" id="5280497">TXA(2</mark>) formation remains <mark style="background-color:orange;">elevated</mark> in patients with cardiovascular disease on doses of <mark style="background-color:lightblue;" id="2244">aspirin</mark> that fully <mark style="background-color:orange;">suppress</mark> platelet <mark style="background-color:lightgreen;" id="O62664,O97554,P05979,P22437,P23219,Q63921,Q9T0N8">COX-1</mark> , suggesting other tissue sources for <mark style="background-color:lightblue;" id="5280497">TXA(2</mark>) formation.
18221806-436	Short-term withdrawal of <mark style="background-color:lightblue;" id="54454,4677798">simvastatin</mark> <mark style="background-color:orange;">induces</mark> endothelial dysfunction in patients with coronary artery disease: a dose-response <mark style="background-color:orange;">effect</mark> dependent on endothelial <mark style="background-color:lightgreen;" id="O61309,O61608,Q27571,Q9I9M2">nitric oxide synthase</mark> .
18227970-442	In the root <mark style="background-color:yellow;" id="GO:0005625,cellular_component">soluble fraction</mark> , the suicide inhibitor alpha-<mark style="background-color:lightblue;" id="137670">difluoromethyl</mark>-<mark style="background-color:lightblue;" id="866,5962">lysine</mark> <mark style="background-color:orange;">suppressed</mark> the activity of <mark style="background-color:lightgreen;" id="P05033">lysine decarboxylase</mark> and of <mark style="background-color:lightgreen;" id="O22616,P00860,P07805,P08432,P09057,P11926,P14019,P27116,P27117,P27118,P27119,P27121,P41931,P44317,P49725,P50134,P78599,Q8S3N2,Q92445,Q9UQW9">ornithine decarboxylase</mark> to the same extent, but had no <mark style="background-color:orange;">effect</mark> on <mark style="background-color:lightgreen;" id="O81160,O82475,P21885,P22220,P49726,Q39827,Q43075,Q819L4,Q81MS2,Q96412,Q96A70,Q9K9K5,Q9SNN0">arginine decarboxylase</mark> activity.
18397960-447	Earlier publications have suggested a possible role for the efflux transporter <mark style="background-color:lightgreen;" id="Q9UNQ0">breast cancer resistance protein</mark> ( <mark style="background-color:lightgreen;" id="Q9UNQ0">BCRP</mark> ) in <mark style="background-color:orange;">acquired</mark> resistance to disease-modifying antirheumatic drugs (DMARDs) such as <mark style="background-color:lightblue;" id="3899">leflunomide</mark> and its metabolite <mark style="background-color:lightblue;" id="54684141">A771726</mark> (<mark style="background-color:lightblue;" id="54684141">teriflunomide</mark>).
18479896-454	<mark style="background-color:lightblue;" id="445580">Docosahexaenoic acid</mark> <mark style="background-color:orange;">induces</mark> <mark style="background-color:yellow;" id="GO:0006915,biological_process">apoptosis</mark> in colorectal carcinoma cells by <mark style="background-color:orange;">modulating</mark> the <mark style="background-color:lightgreen;" id="P42347,P42348,P54673,P54674,P54675,P54676">PI3 kinase</mark> and <mark style="background-color:lightgreen;" id="O62618">p38 MAPK</mark> pathways.
18555679-458	Long-chain <mark style="background-color:lightblue;" id="62238">fatty alcohols</mark> also <mark style="background-color:orange;">reduced</mark> <mark style="background-color:lightgreen;" id="Q8JFG3">tumor necrosis factor</mark> -alpha and prostaglandin E(2) production, although the potency of inhibition for the latter was lower.
18541345-459	<mark style="background-color:lightblue;" id="3475">Gliclazide</mark> can <mark style="background-color:orange;">change</mark> the conformation of the active sites and <mark style="background-color:orange;">decrease</mark> obviously the affinities between <mark style="background-color:lightblue;" id="3475">gliclazide</mark> in the active site and enzymes when it is <mark style="background-color:orange;">docked</mark> in the second active sites in <mark style="background-color:lightgreen;" id="P11712">CYP2C9</mark> and <mark style="background-color:lightgreen;" id="P33261">CYP2C19</mark> .
18068270-466	In vitro, the degradation of synthetic Abeta substrate added to <mark style="background-color:lightgreen;" id="O62757,P01587,P04141,P11052,P28773,P48749,P48750,P51748,Q0MUT8,Q29118,Q60481">CSF</mark> was markedly <mark style="background-color:orange;">accelerated</mark> by low <mark style="background-color:orange;">levels</mark> (2microM) of exogenous zinc and <mark style="background-color:lightblue;" id="23978">copper</mark>.
18400050-469	mRNA expressions of matrix metallopeptidase-9, inducible <mark style="background-color:lightgreen;" id="O61309,O61608,Q27571,Q9I9M2">nitric oxide synthase</mark> and pro-inflammatory cytokines interleukin-1 beta and tumour necrosis factor-alpha in <mark style="background-color:lightblue;" id="6432248">EAN</mark> sciatic nerves were greatly <mark style="background-color:orange;">decreased</mark> by administration of <mark style="background-color:lightblue;" id="54675783">minocycline</mark> as well.
18381637-476	Rabbit marrow mesenchymal stem cells ( <mark style="background-color:lightgreen;" id="O60682">MSCs</mark> ) and gelatin microparticles (MPs) loaded with <mark style="background-color:lightgreen;" id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">insulin</mark> -like growth factor-1 ( <mark style="background-color:lightgreen;" id="Q95222">IGF-1</mark> ), <mark style="background-color:orange;">transforming</mark> growth factor-beta1 ( <mark style="background-color:lightgreen;" id="O19011,O93449,P01137,P04202,P07200,P09531,P09533,P16176,P17246,P18341,P50414,P54831,Q38HS2,Q9PTQ2,Q9Z1Y6">TGF-beta1</mark> ), or a combination of both growth factors were mixed with OPF, a <mark style="background-color:lightblue;" id="16212859">poly(ethylene glycol)-diacrylate</mark> crosslinker and the radical initiators <mark style="background-color:lightblue;" id="223">ammonium</mark> <mark style="background-color:lightblue;" id="107879">persulfate</mark> and <mark style="background-color:lightblue;" id="8037">N,N,N',N'-tetramethylethylenediamine</mark>, and then crosslinked at 37 degrees C for 8 min to form hydrogel composites.
18381638-477	<mark style="background-color:lightgreen;" id="P07589,P11722,Q28275,Q28377,Q28749,Q91289,Q91400">Fibronectin</mark> <mark style="background-color:orange;">modulates</mark> osteoblast <mark style="background-color:yellow;" id="GO:0007610,biological_process">behavior</mark> on <mark style="background-color:lightblue;" id="3081502">Nitinol</mark>.
18490188-482	In its active form, <mark style="background-color:lightblue;" id="1132">thiamin pyrophosphate</mark> ( <mark style="background-color:lightgreen;" id="P10463,P31678,P31688,P55611,P78875,Q8SSL0,Q9L894">TPP</mark> ), it is a co-enzyme for several enzymes, <mark style="background-color:orange;">including</mark> <mark style="background-color:lightgreen;" id="O06811,O67642,O83571,P29277,P29401,P34736,P40142,P43757,P45694,P46708,P47312,P50137,P51010,P56900,P57195,P58333,P59956,P66962,P66963,P75611,P84540,P99161,Q12630,Q52723,Q5HG77,Q5HPJ9,Q5R1W6,Q5R4C1,Q60HC7,Q6B855,Q6G9L6,Q6GH64,Q89AY2,Q8CPC7,Q8KA26,Q9KAD7">transketolase</mark> .
18547170-484	Amyloglucosidase from Rhizopus mould and <mark style="background-color:lightgreen;" id="P12614,P15885,P27034,P29091,P40740,Q03506,Q46684">beta-glucosidase</mark> from sweet almond were <mark style="background-color:orange;">employed</mark> for the preparation of phenolic and vitamin glycosides of <mark style="background-color:lightblue;" id="1183">vanillin</mark>, <mark style="background-color:lightblue;" id="2998">N-vanillylnonanamide</mark>, <mark style="background-color:lightblue;" id="836">DL-dopa</mark>, <mark style="background-color:lightblue;" id="681">dopamine</mark>, <mark style="background-color:lightblue;" id="969516">curcumin</mark>, <mark style="background-color:lightblue;" id="2116,14985">alpha-tocopherol</mark> (<mark style="background-color:lightblue;" id="2116,14985,1548900,1742129">vitamin E</mark>), <mark style="background-color:lightblue;" id="1054">pyridoxine</mark> (vitamin B(6)), <mark style="background-color:lightblue;" id="3249">ergocalciferol (vitamin D</mark>(2)), <mark style="background-color:lightblue;" id="1130">thiamin</mark> (vitamin B(1)) and <mark style="background-color:lightblue;" id="1072,6759,493570">riboflavin</mark> (vitamin B(2)).
18479950-485	Prior to <mark style="background-color:lightblue;" id="2116,14985,1548900,1742129">vitamin E</mark> supplementation, exercise <mark style="background-color:orange;">induced</mark> a significant <mark style="background-color:orange;">decrease</mark> in <mark style="background-color:lightgreen;" id="P27169,P27170">PON1</mark> activity, <mark style="background-color:lightblue;" id="23644574">EMF</mark>, <mark style="background-color:lightblue;" id="2116,14985,1548900,1742129">vitamin E</mark> concentration and a significant increase in MDA concentration at t+1d.
18479950-486	After a 10 week <mark style="background-color:lightblue;" id="2116,14985,1548900,1742129">vitamin E</mark> supplementation period, these exercise-induced <mark style="background-color:orange;">changes</mark> in <mark style="background-color:lightgreen;" id="P27169,P27170">PON1</mark> activity, <mark style="background-color:lightblue;" id="23644574">EMF</mark> and MDA concentration were still significant in the control group, but not in the supplemented group.
18539357-492	Tumor <mark style="background-color:lightgreen;" id="P08640,P15941,Q29435,Q60528">MUC1</mark> differs from normal <mark style="background-color:lightgreen;" id="P08640,P15941,Q29435,Q60528">MUC1</mark> by <mark style="background-color:orange;">modified</mark> <mark style="background-color:lightblue;" id="871">glycan</mark> side chains.
18494609-496	The cells exposed to 10 microM (<mark style="background-color:lightblue;" id="5280893">15S)-HPETE</mark> for 3 h or to 40 microM (<mark style="background-color:lightblue;" id="5280724">15S)-HETE</mark> for 6 h showed increased expression of <mark style="background-color:lightgreen;" id="P36940,P41047,P48023,P63306,P63307,P63308,Q861W5,Q9BDN1,Q9BEA8">Fas ligand</mark> and <mark style="background-color:lightgreen;" id="P46310,Q13158">FADD</mark> ( <mark style="background-color:lightgreen;" id="P25446,Q63199">Fas</mark> -associated <mark style="background-color:yellow;" id="GO:0016265,biological_process">death</mark> domain), caspase 8 activation, Bid ( <mark style="background-color:lightgreen;" id="P55957,P70444,Q4JHS0,Q8JGM8,Q9JLT6">BH3-interacting domain death agonist</mark> ) cleavage, <mark style="background-color:orange;">decrease</mark> in <mark style="background-color:yellow;" id="GO:0005740,cellular_component">mitochondrial membrane</mark> potential, <mark style="background-color:lightgreen;" id="O07091,O13393,O22642,O93863,P00002,P00003,P00004,P00007,P00008,P00011,P00012,P00013,P00014,P00017,P00018,P00019,P00020,P00021,P00022,P00024,P00025,P00027,P00028,P00029,P00030,P00031,P00032,P00035,P00036,P00037,P00038,P00039,P00040,P00041,P00042,P00043,P00046,P00047,P00048,P00049,P00051,P00052,P00053,P00054,P00055,P00056,P00057,P00058,P00059,P00060,P00061,P00062,P00063,P00064,P00065,P00066,P00067,P00068,P00069,P00070,P00071,P00072,P00073,P00074,P00075,P00076,P00077,P00078,P00079,P12831,P15451,P18822,P19681,P19974,P21665,P22342,P25400,P29380,P32556,P38091,P53698,P56205,P59218,P62772,P62773,P62894,P62895,P62896,P67881,P67882,P68096,P68097,P68098,P68099,P68100,P68517,P68518,P68519,P81280,P81459,P99998,P99999,Q41346,Q4HVX7,Q52V08,Q52V09,Q52V10,Q5RFH4,Q640U4,Q6C9Q0,Q6IQM2,Q6Q4H8,Q6QLW4,Q6WUX8,Q753F4,Q7YR71,Q96VP3">cytochrome c</mark> release, caspase 3 activation, <mark style="background-color:lightgreen;" id="P09874,P11103,P18493,P26446,P27008,Q7EYV7,Q9R152,Q9ZP54,Q9ZSV1">PARP-1</mark> [poly( <mark style="background-color:lightgreen;" id="P02783">ADP</mark> -ribose) polymerase-1] cleavage and DNA fragmentation, suggesting the involvement of both extrinsic and intrinsic <mark style="background-color:yellow;" id="GO:0016265,biological_process">death</mark> pathways.
18346857-498	Results showed that a moderate dose of <mark style="background-color:lightgreen;" id="O02750,O93416,Q28603,Q95189,Q95234">leptin</mark> (250 microg/kg body weight/day) injected during the re-feeding period: (i) <mark style="background-color:orange;">promoted</mark> the recovery of the <mark style="background-color:orange;">regressed</mark> ovary as evidenced by an <mark style="background-color:orange;">increase</mark> in ovary weight and recovery of yellow hierarchical follicles; (ii) <mark style="background-color:orange;">elevated</mark> the plasma <mark style="background-color:lightblue;" id="5757">17beta-estradiol</mark> (E(2)) level; (iii) <mark style="background-color:orange;">increased</mark> the mRNA <mark style="background-color:orange;">levels</mark> of ovary follicle-stimulating hormone receptor ( <mark style="background-color:lightgreen;" id="P23945,P32212,P35376,P35379,P47799,P49059,P79763,Q5GJ04,Q6R6L8,Q6YNB6,Q7ZTV5,Q8R428,Q95179">FSHR</mark> ), <mark style="background-color:lightgreen;" id="O02721,P16235,P16582,P22888,P30730,Q28005,Q28585,Q90674">luteinizing hormone receptor</mark> ( <mark style="background-color:lightgreen;" id="P16070,P22888,Q28585">LHR</mark> ) and <mark style="background-color:lightgreen;" id="O08537,O13012,O93511,P57781,P57782,Q62986,Q92731,Q95171,Q9IAK1,Q9PTU5,Q9PVE2,Q9TTE5,Q9TU15,Q9W6M2,Q9XSB5,Q9XSW2,Q9YH32">estrogen receptor-beta</mark> ( <mark style="background-color:lightgreen;" id="O08537,O13012,O93511,P57781,P57782,Q62986,Q92731,Q95171,Q9IAK1,Q9PTU5,Q9PVE2,Q9TTE5,Q9TU15,Q9W6M2,Q9XSB5,Q9XSW2,Q9YH32">ER-beta</mark> ).
18375536-500	To investigate overnight variations in absolute values and patterns of cytokines including <mark style="background-color:lightgreen;" id="P41693">interleukin 6</mark> ( <mark style="background-color:lightgreen;" id="O35736,P05231,P26892,P26893,P29455,P41323,P41683,P41693,P46650,P51494,P79341,Q25BC2,Q28319,Q28747,Q28819,Q2MH06,Q5I6E3,Q6V919,Q865W7,Q865X6,Q8MKH0,Q95181,Q9MZR1,Q9XT80">IL6</mark> ) and tumour necrosis factor alpha ( <mark style="background-color:lightgreen;" id="O35734,O77510,O77764,P01375,P04924,P06804,P13296,P16599,P19101,P23383,P23563,P29553,P33620,P36939,P48094,P51435,P51742,P51743,P59684,P59693,P59694,P59695,P79337,P79374,Q06599,Q19LH4,Q1G1A2,Q1WM27,Q2MH05,Q539C2,Q75N23,Q8HZD9,Q8JFG3,Q8MKG8,Q8WNR1,Q9BEA1">TNFalpha</mark> ) in rheumatoid arthritis (RA), and to relate any <mark style="background-color:orange;">changes</mark> to those occurring in blood <mark style="background-color:lightblue;" id="5754">cortisol</mark>.
18479251-501	The production of rhG- <mark style="background-color:lightgreen;" id="O62757,P01587,P04141,P11052,P28773,P48749,P48750,P51748,Q0MUT8,Q29118,Q60481">CSF</mark> was <mark style="background-color:orange;">induced</mark> by switching from growth on <mark style="background-color:lightblue;" id="753">glycerol</mark> to growth on <mark style="background-color:lightblue;" id="887,19314">methanol</mark>.
18479251-502	In the induction phase, the <mark style="background-color:lightblue;" id="887,19314">methanol</mark> feed rate had a significant <mark style="background-color:orange;">effect</mark> on the specific expression rate of rhG- <mark style="background-color:lightgreen;" id="O62757,P01587,P04141,P11052,P28773,P48749,P48750,P51748,Q0MUT8,Q29118,Q60481">CSF</mark> .
18479251-503	Under this condition, a maximum concentration of 300 mg/l of rhG- <mark style="background-color:lightgreen;" id="O62757,P01587,P04141,P11052,P28773,P48749,P48750,P51748,Q0MUT8,Q29118,Q60481">CSF</mark> and the expression <mark style="background-color:orange;">yield</mark> of 0.6 mg of rhG- <mark style="background-color:lightgreen;" id="O62757,P01587,P04141,P11052,P28773,P48749,P48750,P51748,Q0MUT8,Q29118,Q60481">CSF</mark> /g of <mark style="background-color:lightblue;" id="887,19314">methanol</mark> were attained.
18479251-504	Among seven additives tested, <mark style="background-color:lightblue;" id="443314">Tween 20</mark>, Tween 80 and <mark style="background-color:lightblue;" id="248">betaine</mark> exhibited the best results in respect of <mark style="background-color:orange;">preventing</mark> the formation of rhG- <mark style="background-color:lightgreen;" id="O62757,P01587,P04141,P11052,P28773,P48749,P48750,P51748,Q0MUT8,Q29118,Q60481">CSF</mark> protein aggregates.
18539387-509	Mineralization and dehalogenation of <mark style="background-color:lightblue;" id="6914">2,4,6-TCP</mark> was evidenced by high <mark style="background-color:lightgreen;" id="P14678">COD</mark> removal efficiencies ( approximately 95%), and by the stoichiometric <mark style="background-color:orange;">release</mark> of <mark style="background-color:lightblue;" id="312">chloride</mark> ions from the halogenated compound ( approximately 80%).
18330498-512	<mark style="background-color:lightblue;" id="2719">Chloroquine</mark> and <mark style="background-color:lightblue;" id="312145">wortmannin</mark> <mark style="background-color:orange;">inhibited</mark> the upregulation <mark style="background-color:orange;">induced</mark> by <mark style="background-color:lightgreen;" id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">insulin</mark> stimulation and amino acid deprivation but not that induced by osmotic shock.
18330498-513	Moreover, <mark style="background-color:lightblue;" id="4713">PD98059</mark> and <mark style="background-color:lightblue;" id="8515">SP600125</mark> inhibited only amino acid deprivation-induced upregulation and <mark style="background-color:lightblue;" id="5353940">SB202190</mark> <mark style="background-color:orange;">inhibited</mark> only <mark style="background-color:lightgreen;" id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">insulin</mark> -induced upregulation.
18484100-516	Organic cations (<mark style="background-color:lightblue;" id="72886">OCs</mark>) are primarily <mark style="background-color:orange;">excreted</mark> via vectorial <mark style="background-color:yellow;" id="GO:0006810,biological_process">transport</mark> by various renal organic cation transporters ( <mark style="background-color:lightgreen;" id="O75051">OCTs</mark> ).
18484100-517	In a rat <mark style="background-color:lightgreen;" id="O48920,P34727,P34728,P51823,Q94650">ARF</mark> model, induction of <mark style="background-color:lightgreen;" id="O48920,P34727,P34728,P51823,Q94650">ARF</mark> by <mark style="background-color:lightblue;" id="24933">uranyl nitrate</mark> (UN) treatment significantly <mark style="background-color:orange;">decreased</mark> the <mark style="background-color:orange;">levels</mark> of <mark style="background-color:lightgreen;" id="Q00196">Oct2</mark> (slc22a2) mRNA and protein in the kidney medulla.
18506631-523	To achieve enzymatic production of <mark style="background-color:lightblue;" id="5281">calcium-stearate</mark> at unfavorable conditions, i.e., pH 10 and 60 degrees C, suitable <mark style="background-color:lightgreen;" id="Q7M4U7">lipase</mark> was selected and reaction conditions were <mark style="background-color:orange;">optimized</mark> <mark style="background-color:orange;">using</mark> calcium <mark style="background-color:lightblue;" id="961">hydroxide</mark> and hydrogenated beef tallow as substrates.
18506631-524	Under optimum conditions, 95% of beef tallow, in 2.5 h, was converted into <mark style="background-color:lightblue;" id="5281">calcium-stearate</mark> by <mark style="background-color:orange;">using</mark> commercial <mark style="background-color:lightgreen;" id="Q7M4U7">lipase</mark> SDL 451.
18492301-527	Dietary <mark style="background-color:lightgreen;" id="Q6RY07,Q91XA9">chia</mark> seed (Salvia hispanica L.) rich in <mark style="background-color:lightblue;" id="5280934">alpha-linolenic acid</mark> <mark style="background-color:orange;">improves</mark> adiposity and normalises hypertriacylglycerolaemia and <mark style="background-color:lightgreen;" id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">insulin</mark> resistance in dyslipaemic rats.
18492301-528	The present study investigates the benefits of the dietary intake of <mark style="background-color:lightgreen;" id="Q6RY07,Q91XA9">chia</mark> seed (Salvia hispanica L.) rich in <mark style="background-color:lightblue;" id="5280934">alpha-linolenic acid</mark> and fibre upon dyslipidaemia and <mark style="background-color:lightgreen;" id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">insulin</mark> resistance (IR), <mark style="background-color:orange;">induced</mark> by intake of a <mark style="background-color:lightblue;" id="5988">sucrose</mark>-rich (62.5 %) diet (SRD).
18492302-529	Pigs fed the high-<mark style="background-color:lightblue;" id="866,5962">lysine</mark> diet moreover had an <mark style="background-color:orange;">increased</mark> concentration of <mark style="background-color:lightblue;" id="440121">trimethyllysine</mark> (TML), a <mark style="background-color:orange;">reduced</mark> mRNA abundance of <mark style="background-color:lightgreen;" id="Q0VC74,Q5F4B3,Q91ZE0,Q91ZW6,Q96UB1,Q9NVH6">TML dioxygenase</mark> and reduced concentrations of <mark style="background-color:lightblue;" id="134">gamma-butyrobetaine</mark> (BB) in muscle, indicating that the conversion of TML into BB in muscle was impaired.
18404246-532	<mark style="background-color:lightblue;" id="5951">Serine</mark> and <mark style="background-color:lightblue;" id="594,5862,5360637">cysteine</mark> <mark style="background-color:lightgreen;" id="O41798,O89290,O89940,O91080,O93215,P03311,P03353,P03355,P03356,P03362,P03363,P03366,P03367,P03369,P03370,P04023,P04024,P04323,P04584,P04585,P04587,P04588,P04589,P05959,P05960,P05961,P05962,P07570,P0C210,P0C211,P10210,P10265,P10270,P10271,P10272,P10273,P10274,P10394,P10978,P11227,P11365,P12451,P12497,P12498,P12499,P14074,P14078,P15833,P16046,P16423,P16901,P17757,P18042,P18096,P18802,P19028,P19199,P19560,P19561,P20825,P20875,P20876,P20892,P21407,P21414,P24107,P24740,P26808,P26809,P26810,P27502,P28936,P31822,P35956,P35963,P51518,P63119,P63120,P63121,P63122,P63123,P63124,P63125,P63127,P63128,P63129,P63131,P84454,Q09SZ9,Q0R5R2,Q0R5R3,Q1A249,Q1A267,Q4U0X6,Q73368,Q74120,Q75002,Q76634,Q77373,Q79666,Q89928,Q8AII1,Q8I7P9,Q9IDV9,Q9Q720,Q9QBY3,Q9QBZ1,Q9QBZ5,Q9QSR3,Q9WC54,Q9WC63,Q9Y6I0">proteases</mark> proved to be suitable tools for the production of amino acids and peptides <mark style="background-color:orange;">conjugated</mark> to <mark style="background-color:lightblue;" id="2151">4-aminoantipyrine</mark>, whereas metalloproteases do not seem to be very qualified for accepting this nucleophile.
18367388-537	<mark style="background-color:lightblue;" id="445154">Resveratrol</mark> did not attenuate GA-induced generation of <mark style="background-color:lightblue;" id="784">hydrogen peroxide</mark>, but it did <mark style="background-color:orange;">block</mark> GA-induced <mark style="background-color:yellow;" id="GO:0016310,biological_process">phosphorylation</mark> of <mark style="background-color:lightgreen;" id="O57474,P08050,P14154,P16863,P17302,P18246,P23242,Q29101,Q6S9C0">connexin 43</mark> ( <mark style="background-color:lightgreen;" id="O57474,P08050,P14154,P16863,P17302,P18246,P23242,Q29101,Q6S9C0">Cx43</mark> ), a key modulator of GJIC.
18367388-538	Furthermore, <mark style="background-color:lightblue;" id="445154">resveratrol</mark> <mark style="background-color:orange;">down-regulated</mark> GA-induced <mark style="background-color:yellow;" id="GO:0016310,biological_process">phosphorylation</mark> of <mark style="background-color:yellow;" id="GO:0005576,cellular_component">extracellular</mark> signal-regulated kinase ( <mark style="background-color:lightgreen;" id="P29323">ERK</mark> )1/2, one of the critical regulators of <mark style="background-color:lightgreen;" id="O57474,P08050,P14154,P16863,P17302,P18246,P23242,Q29101,Q6S9C0">Cx43</mark> .
18410309-540	<mark style="background-color:lightblue;" id="896">Melatonin</mark> <mark style="background-color:orange;">protects</mark> from hepatic reperfusion injury through inhibition of IKK and <mark style="background-color:lightgreen;" id="P92208,Q966Y3">JNK</mark> pathways and modification of <mark style="background-color:yellow;" id="GO:0008283,biological_process">cell proliferation</mark> .
18410309-541	<mark style="background-color:lightblue;" id="896">Melatonin</mark> significantly <mark style="background-color:orange;">improved</mark> animal survival and <mark style="background-color:orange;">decreased</mark> transaminase levels, the indices for necrosis, liver damage, leukocyte infiltration, and <mark style="background-color:lightgreen;" id="O19114,O46660,O54705,O62699,P29477,P35228,P79290,Q06518,Q27995,Q28314,Q90703,Q92037,Q92091">iNOS</mark> expression.
18410309-542	At the same time, <mark style="background-color:lightblue;" id="896">melatonin</mark> <mark style="background-color:orange;">reduced</mark> the expression of both <mark style="background-color:lightgreen;" id="O01377,O02115,O10308,O16852,O27367,O29912,O58398,O73947,O82134,O82797,P04961,P11038,P12004,P15873,P17070,P17917,P17918,P18248,P22177,P24314,P31008,P53358,P57761,P61074,P61258,Q00265,Q00268,Q03392,Q43124,Q43266,Q57697,Q6B6N4,Q6KZF1,Q6LWJ8,Q74MV1,Q7T6Y0,Q8PX25,Q8TUF7,Q8TWK3,Q979S2,Q9DDF1,Q9DEA3,Q9HJQ0,Q9HN45,Q9M7Q7,Q9MAY3,Q9P9H8,Q9PTP1,Q9UWR9,Q9UYX8,Q9W644">PCNA</mark> 0.05).
18410309-543	<mark style="background-color:lightblue;" id="896">Melatonin</mark> is hepatoprotective most likely via mechanisms <mark style="background-color:orange;">including</mark> inhibition of IKK and <mark style="background-color:lightgreen;" id="P92208,Q966Y3">JNK</mark> pathways and <mark style="background-color:yellow;" id="GO:0042127,biological_process">regulation of cell proliferation</mark> .
17943458-544	<mark style="background-color:lightblue;" id="65065">N-acetylaspartic acid</mark> (NAA) is <mark style="background-color:orange;">converted</mark> into <mark style="background-color:lightblue;" id="5960">aspartate</mark> and <mark style="background-color:lightblue;" id="53627460">acetate</mark> by <mark style="background-color:lightgreen;" id="P45381,P46446,Q60HH2,Q8R3P0,Q9R1T5">aspartoacylase</mark> .
18228136-548	The array and western blotting showed that <mark style="background-color:lightgreen;" id="P10417,P49950">Bcl2</mark> and <mark style="background-color:lightgreen;" id="O01377,O16852,P04961,P12004,P17070,P17917,P17918,P18248,P22177,P24314,P31008,P53358,P61074,Q00265,Q00268">Cyclin</mark> D1 expression were down regulated; <mark style="background-color:lightgreen;" id="O09185,O12946,O57538,O93379,P02340,P04637,P10361,P19558,P19559,P56423,P56424,P61260,P79820,P79892,Q29537,Q42578,Q8SPZ3,Q92143,Q9TTA1,Q9TUB2,Q9W678,Q9W679">P53</mark> expression was not <mark style="background-color:orange;">affected</mark> while <mark style="background-color:lightgreen;" id="P08183,P13568,P16875,P28873,P53258,Q06034,Q9LJX0,Q9ZR72">MDR1</mark> was over <mark style="background-color:orange;">expressed</mark> by combination of <mark style="background-color:lightblue;" id="10903">2ME</mark> with Dox.
18228136-549	In conclusion, <mark style="background-color:lightblue;" id="10903">2ME</mark> chemosensitizes resistant breast cancer cells to Dox cytotoxicity by down <mark style="background-color:orange;">regulating</mark> expression of <mark style="background-color:lightgreen;" id="P10417,P49950">Bcl2</mark> and <mark style="background-color:lightgreen;" id="O01377,O16852,P04961,P12004,P17070,P17917,P17918,P18248,P22177,P24314,P31008,P53358,P61074,Q00265,Q00268">Cyclin</mark> D1, augmenting caspase 3 activity as well as inducing <mark style="background-color:yellow;" id="GO:0007049,biological_process">cell cycle</mark> block in G(1) and <mark style="background-color:yellow;" id="GO:0051320,biological_process">S phases</mark> .
18222028-559	It has been shown that the removal efficiency of <mark style="background-color:lightgreen;" id="P14678">COD</mark> <mark style="background-color:orange;">increased</mark> with the <mark style="background-color:orange;">increasing</mark> applied current density and increasing PAC and <mark style="background-color:lightblue;" id="923,373840">Na</mark>(2)SO(4) dosage and the most effective removal capacity was achieved at the pH 7.
18500430-564	In the absence of exogenous <mark style="background-color:lightblue;" id="271">Ca(2</mark>+) and Mg(2+) and in the presence of <mark style="background-color:lightblue;" id="6207">EGTA</mark>, which favours the <mark style="background-color:orange;">release</mark> of endogenous <mark style="background-color:lightblue;" id="271">Ca(2</mark>+), the polyamine <mark style="background-color:lightblue;" id="1103">spermine</mark> is able to <mark style="background-color:orange;">stimulate</mark> the activity of <mark style="background-color:yellow;" id="GO:0005967,GO:0045250,GO:0045254,GO:0010240,cellular_component">pyruvate dehydrogenase complex</mark> ( <mark style="background-color:lightgreen;" id="O77560,P06672,P19632,P20941,P28516,P34734,P41686,P51845,P51846,P51847,P51848,P51849,P51850,P51851,Q05326,Q05327,Q6FJA3,Q9XS39">PDC</mark> ) of energized rat liver mitochondria (RLM).
18500430-565	At concentrations higher than 0.5 mM, <mark style="background-color:lightblue;" id="1103">spermine</mark> still <mark style="background-color:orange;">stimulates</mark> <mark style="background-color:lightgreen;" id="O77560,P06672,P19632,P20941,P28516,P34734,P41686,P51845,P51846,P51847,P51848,P51849,P51850,P51851,Q05326,Q05327,Q6FJA3,Q9XS39">PDC</mark> , when compared with the control, but shows a slight dose-dependent decrease.
18500430-566	Changes in <mark style="background-color:lightgreen;" id="O77560,P06672,P19632,P20941,P28516,P34734,P41686,P51845,P51846,P51847,P51848,P51849,P51850,P51851,Q05326,Q05327,Q6FJA3,Q9XS39">PDC</mark> stimulation are very close to the <mark style="background-color:yellow;" id="GO:0016310,biological_process">phosphorylation</mark> <mark style="background-color:orange;">level</mark> of the E(1alpha) subunit of <mark style="background-color:lightgreen;" id="O77560,P06672,P19632,P20941,P28516,P34734,P41686,P51845,P51846,P51847,P51848,P51849,P51850,P51851,Q05326,Q05327,Q6FJA3,Q9XS39">PDC</mark> , which <mark style="background-color:orange;">regulates</mark> the activity of the complex, but it is also the <mark style="background-color:orange;">target</mark> of <mark style="background-color:lightblue;" id="1103">spermine</mark>.
18500430-567	These results provide the first evidence that, when transported in RLM, <mark style="background-color:lightblue;" id="1103">spermine</mark> can <mark style="background-color:orange;">interact</mark> in various ways with <mark style="background-color:lightgreen;" id="O77560,P06672,P19632,P20941,P28516,P34734,P41686,P51845,P51846,P51847,P51848,P51849,P51850,P51851,Q05326,Q05327,Q6FJA3,Q9XS39">PDC</mark> , showing dose-dependent <mark style="background-color:yellow;" id="GO:0007610,biological_process">behaviour</mark> .
18283487-569	Since then, the efforts of numerous investigators have led to the following conclusions: (a) This enzyme is indeed the molecular machine for the <mark style="background-color:lightblue;" id="5957">ATP</mark>-dependent and -coupled <mark style="background-color:yellow;" id="GO:0006810,biological_process">transport</mark> of <mark style="background-color:lightblue;" id="923,373840">Na</mark>(+) and K(+) across the <mark style="background-color:yellow;" id="GO:0005886,cellular_component">plasma membrane</mark> of a living cell in which such a <mark style="background-color:orange;">process</mark> ( <mark style="background-color:lightgreen;" id="P13607,P17326,P28774,P35317">sodium pump</mark> ) is detected.
18515453-577	From these findings, it is suggested that <mark style="background-color:lightblue;" id="3116">distigmine bromide</mark> may <mark style="background-color:orange;">produce</mark> centrally <mark style="background-color:orange;">mediated</mark> behavioural signs by <mark style="background-color:orange;">increasing</mark> the ACh <mark style="background-color:orange;">levels</mark> in the brain, resulting from its <mark style="background-color:lightgreen;" id="O42275,O62763,P04058,P07140,P07692,P21836,P22303,P23795,P36196,P37136,P56161,Q27677,Q29499,Q867X2,Q867X3,Q869C3,Q86GC8,Q86GC9,Q92035,Q92081,Q9DDE3">AChE</mark> and BuChE inhibitions.
18328561-582	Depletion of <mark style="background-color:lightblue;" id="124886">GSH</mark> <mark style="background-color:orange;">levels</mark> was accompanied by the induction of <mark style="background-color:lightgreen;" id="O15770,P06715,P11804,P23189,P41921,P43783,P48638,P48639,P70619,P78965,Q60151,Q6BPI1,Q6C5H4,Q6FRV2,Q6HA23,Q74ZK4,Q873E8,Q94655">glutathione reductase</mark> (GR) after 24h exposure with each of the four carbamates to CHO-K1 cells.
18471929-584	Furthermore, among the ROS scavenging antioxidant defense genes studied here, mRNA levels of <mark style="background-color:lightblue;" id="338">salicylic acid</mark>- <mark style="background-color:yellow;" id="GO:0005488,molecular_function">binding</mark> (SAbind) <mark style="background-color:lightgreen;" id="O24339,O52762,O62839,O68146,O77229,O93662,O97492,P00432,P04040,P04762,P07145,P0A323,P0A324,P0A325,P0A326,P0A327,P11934,P17336,P24168,P24270,P25890,P29422,P30265,P30266,P32290,P42321,P44390,P45737,P45739,P55304,P55306,P55310,P55311,P55313,P77872,P81138,P90682,Q27710,Q49XC1,Q4L643,Q59296,Q59337,Q59602,Q59714,Q5HG86,Q5HPK8,Q5RF10,Q64405,Q6G9M4,Q6GH72,Q7A5T2,Q8CPD0,Q8FWU0,Q8NWV5,Q8X1P0,Q8Y3P9,Q926X0,Q99UE2,Q9AXH0,Q9KW19,Q9L4S1,Q9M5L6,Q9PT92,Q9PWF7,Q9Z598,Q9ZKX5,Q9ZN99">catalase</mark> ( <mark style="background-color:lightgreen;" id="O62839,O97492,P00432,P00485,P00486,P00487,P04040,P06135,P07641,P11504,P20074,P22782,P25309,P25819,P26825,P26826,P32796,P36882,P36883,P43155,P47934,P49417,P52826,P58777,P62577,P62578,P62579,P62580,P90682,Q00614,Q02736,Q03058,Q5RF10,Q64405,Q704S8,Q9M5L6,Q9PWF7">CAT</mark> ) and lignin-forming <mark style="background-color:lightgreen;" id="P15984,P16147,P84714">peroxidase</mark> ( <mark style="background-color:lightgreen;" id="P07003,P37063,P92983,Q54970">POX</mark> ) were found to be <mark style="background-color:orange;">increased</mark> by <mark style="background-color:lightblue;" id="614,8988,145742">proline</mark> and <mark style="background-color:lightblue;" id="248">betaine</mark> under salt stress.
18497707-589	Differential gene expression of <mark style="background-color:lightgreen;" id="P51617,Q62406">interleukin-1 receptor associated kinase-1</mark> and interleukin-1 receptor <mark style="background-color:orange;">associated</mark> kinase-M in peripheral blood mononuclear cells of young and aged rats following <mark style="background-color:orange;">preconditioning</mark> with <mark style="background-color:lightblue;" id="44268108">endotoxin</mark>.
18497707-590	The IL-1 receptor-associated kinase 1 ( <mark style="background-color:lightgreen;" id="P51617,Q62406">IRAK-1</mark> ) and <mark style="background-color:lightgreen;" id="Q8K4B2,Q9Y616">IRAK-M</mark> are key signaling molecules in cellular responses to <mark style="background-color:lightblue;" id="44268108">endotoxin</mark> <mark style="background-color:orange;">initiated</mark> through the Toll-like receptors ( <mark style="background-color:lightgreen;" id="P23799">TLRs</mark> ).
18497707-591	The aim of this study was to evaluate the effect of age on the modulation of <mark style="background-color:lightgreen;" id="P23799">TLRs</mark> and <mark style="background-color:lightgreen;" id="P51617,Q62406">IRAK-1</mark> and <mark style="background-color:lightgreen;" id="Q8K4B2,Q9Y616">IRAK-M</mark> in peripheral blood mononuclear cells (PBMCs) <mark style="background-color:orange;">exposed</mark> in vitro to <mark style="background-color:lightblue;" id="44268108">endotoxin</mark> under conditions that could induce <mark style="background-color:lightblue;" id="44268108">endotoxin</mark> tolerance.
18515457-594	Using DBA/2OlaHsd mice, we investigated the effects of chronic social defeat and concomitant treatment with <mark style="background-color:lightblue;" id="9821250">R121919</mark>/<mark style="background-color:lightblue;" id="720051">NBI</mark> 30775 on 1) the behavioural profile in the <mark style="background-color:orange;">modified</mark> hole board test and 2) in-situ hybridization analysis-based expression of <mark style="background-color:lightblue;" id="8230,644077,44285245">arginine vasopressin</mark> ( <mark style="background-color:lightgreen;" id="P01180,P01181,P01182,P01183,P01184,P01185,P10769,P31414,P81768">AVP</mark> ) and <mark style="background-color:lightgreen;" id="P01142,P06296,P06850,P49926,Q95MI6,Q9PTS1">CRH</mark> mRNA in both the hypothalamic paraventricular <mark style="background-color:yellow;" id="GO:0005634,cellular_component">nucleus</mark> and supraoptic <mark style="background-color:yellow;" id="GO:0005634,cellular_component">nucleus</mark> .
18506760-597	<mark style="background-color:lightblue;" id="2662">Celecoxib</mark> could selectively <mark style="background-color:orange;">inhibited</mark> <mark style="background-color:lightgreen;" id="O02768,O19183,O62698,O62725,P27607,P35354,P35355,P70682,P79208,Q05769">COX-2</mark> expression and <mark style="background-color:lightblue;" id="5280360">PGE2</mark> production.
18506760-598	<mark style="background-color:lightblue;" id="2662">Celecoxib</mark> also <mark style="background-color:orange;">inhibited</mark> p(473Ser) <mark style="background-color:lightgreen;" id="P31750,Q8INB9">Akt</mark> , <mark style="background-color:lightgreen;" id="P09560,P11345,Q80VX4,Q8C0C0">raf</mark> and <mark style="background-color:lightgreen;" id="O09185,O12946,O57538,O93379,P02340,P04637,P10361,P19558,P19559,P56423,P56424,P61260,P79820,P79892,Q29537,Q42578,Q8SPZ3,Q92143,Q9TTA1,Q9TUB2,Q9W678,Q9W679">p53</mark> expression, and <mark style="background-color:orange;">induced</mark> <mark style="background-color:yellow;" id="GO:0006915,biological_process">apoptosis</mark> by <mark style="background-color:orange;">release</mark> of <mark style="background-color:lightgreen;" id="O07091,O13393,O22642,O93863,P00002,P00003,P00004,P00007,P00008,P00011,P00012,P00013,P00014,P00017,P00018,P00019,P00020,P00021,P00022,P00024,P00025,P00027,P00028,P00029,P00030,P00031,P00032,P00035,P00036,P00037,P00038,P00039,P00040,P00041,P00042,P00043,P00046,P00047,P00048,P00049,P00051,P00052,P00053,P00054,P00055,P00056,P00057,P00058,P00059,P00060,P00061,P00062,P00063,P00064,P00065,P00066,P00067,P00068,P00069,P00070,P00071,P00072,P00073,P00074,P00075,P00076,P00077,P00078,P00079,P12831,P15451,P18822,P19681,P19974,P21665,P22342,P25400,P29380,P32556,P38091,P53698,P56205,P59218,P62772,P62773,P62894,P62895,P62896,P67881,P67882,P68096,P68097,P68098,P68099,P68100,P68517,P68518,P68519,P81280,P81459,P99998,P99999,Q41346,Q4HVX7,Q52V08,Q52V09,Q52V10,Q5RFH4,Q640U4,Q6C9Q0,Q6IQM2,Q6Q4H8,Q6QLW4,Q6WUX8,Q753F4,Q7YR71,Q96VP3">cytochrome c</mark> and activation of caspase 9, 3, and 6, which were more remarkably in HBx positive cells than in control cells.
17882129-602	<mark style="background-color:lightblue;" id="2116,14985">Alpha-tocopherol</mark> supplementation <mark style="background-color:orange;">prevents</mark> the exercise-induced reduction of serum paraoxonase 1/ <mark style="background-color:lightgreen;" id="P22862">arylesterase</mark> activities in healthy individuals.
18418709-605	Treating MCF-7 cells with <mark style="background-color:lightblue;" id="16070039">AVE</mark>-1642 Qdots, but not unconjugated Qdots alone, <mark style="background-color:orange;">downregulated</mark> <mark style="background-color:lightgreen;" id="P08069,Q05688,Q29000">IGF1R</mark> <mark style="background-color:orange;">levels</mark> and rendered cells refractory to <mark style="background-color:lightgreen;" id="P05017,P07455,P08025,P10763,P16545,P17085,P17647,P18254,P33712,P51457,P51458,P51462,Q02815,Q28933,Q68LC0,Q6GUL6,Q6IVA5,Q6JLX1,Q95222">IGF-I</mark> stimulation.
18418709-606	Our data suggest that <mark style="background-color:lightblue;" id="16070039">AVE</mark>-1642 Qdots can be <mark style="background-color:orange;">used</mark> to detect <mark style="background-color:lightgreen;" id="P08069,Q05688,Q29000">IGF1R</mark> expression and measure changes in <mark style="background-color:yellow;" id="GO:0009928,GO:0009986,cellular_component">cell surface</mark> receptor levels.
18410522-612	We also find that <mark style="background-color:lightblue;" id="5280445">luteolin</mark> <mark style="background-color:orange;">induces</mark> <mark style="background-color:orange;">changes</mark> consistent with <mark style="background-color:lightgreen;" id="P51136,P83101">GSK-3</mark> inhibition that (i) <mark style="background-color:orange;">decrease</mark> amyloidogenic gamma-secretase <mark style="background-color:lightgreen;" id="O73683,O93279,P05067,P08592,P0A3Z1,P0A3Z2,P0A3Z3,P0A3Z4,P12023,P29216,P47566,P53601,P75313,P79307,Q11207,Q28053,Q28280,Q28748,Q28757,Q29149,Q5IS80,Q60495,Q95241">APP</mark> processing, and (ii) <mark style="background-color:orange;">promote</mark> <mark style="background-color:lightgreen;" id="O12976,P49768,P49769,P79802,P97887,Q4JIM4,Q5R780,Q6RH31,Q8HXW5,Q9W6T7,Q9XT97">presenilin-1</mark> ( <mark style="background-color:lightgreen;" id="P49768,P79802,Q8HXW5,Q9W6T7">PS1</mark> ) carboxyl-terminal fragment ( <mark style="background-color:lightgreen;" id="O00712,P08651,P09414,P13622,P13623,P14057,P17923,P17924,P17926,P21999,P40396,P70255,P70257,P97863,Q02780,Q12857,Q14938,Q90932">CTF</mark> ) <mark style="background-color:yellow;" id="GO:0016310,biological_process">phosphorylation</mark> .
18410522-613	As validation of these findings in vivo, we find that <mark style="background-color:lightblue;" id="5280445">luteolin</mark>, when applied to the Tg2576 mouse model of AD, <mark style="background-color:orange;">decreases</mark> soluble Abeta levels, <mark style="background-color:orange;">reduces</mark> <mark style="background-color:lightgreen;" id="P51136,P83101">GSK-3</mark> activity, and <mark style="background-color:orange;">disrupts</mark> <mark style="background-color:lightgreen;" id="P49768,P79802,Q8HXW5,Q9W6T7">PS1</mark> - <mark style="background-color:lightgreen;" id="O73683,O93279,P05067,P08592,P0A3Z1,P0A3Z2,P0A3Z3,P0A3Z4,P12023,P29216,P47566,P53601,P75313,P79307,Q11207,Q28053,Q28280,Q28748,Q28757,Q29149,Q5IS80,Q60495,Q95241">APP</mark> association.
18410527-619	Since <mark style="background-color:lightblue;" id="5280353,5315455,5353439,6183357">biliverdin</mark> and <mark style="background-color:lightblue;" id="5280352">bilirubin</mark> are downstream products of <mark style="background-color:lightblue;" id="4971">heme</mark> degradation by <mark style="background-color:lightgreen;" id="O19998,O73688,O78497,P51271,P71119">heme oxygenase</mark> (HO), it has been suggested that HO-activity <mark style="background-color:orange;">protects</mark> against <mark style="background-color:lightblue;" id="969516">curcumin</mark>-induced <mark style="background-color:yellow;" id="GO:0006915,biological_process">apoptosis</mark> .
18256928-625	However, when <mark style="background-color:lightgreen;" id="O42132,P03372,P06211,P06212,P16058,P19785,P49884,P49885,P49886,P50240,P50241,P50242,P57717,P57753,P81559,Q29040,Q53AD2,Q91250,Q91424,Q9PVZ9,Q9QZJ5,Q9TV98,Q9YH33,Q9YHT3,Q9YHZ7">ERalpha</mark> negative MDA-MB-435 cells were treated with <mark style="background-color:lightblue;" id="4091">metformin</mark>, they demonstrated <mark style="background-color:orange;">increased</mark> expression of vascular endothelial growth factor ( <mark style="background-color:lightgreen;" id="P15691,P15692,P26617,P49151,P50412,P67964,P67965,Q99PS1,Q9GKR0,Q9MYV3">VEGF</mark> ) in an <mark style="background-color:lightgreen;" id="P54646,Q09136,Q9Y478">AMPK</mark> dependent manner; while the <mark style="background-color:lightgreen;" id="O42132,P03372,P06211,P06212,P16058,P19785,P49884,P49885,P49886,P50240,P50241,P50242,P57717,P57753,P81559,Q29040,Q53AD2,Q91250,Q91424,Q9PVZ9,Q9QZJ5,Q9TV98,Q9YH33,Q9YHT3,Q9YHZ7">ERalpha</mark> positive MCF-7 cells did not.
18256928-626	The <mark style="background-color:lightblue;" id="4091">metformin</mark>-treated group showed <mark style="background-color:orange;">increased</mark> <mark style="background-color:lightgreen;" id="P15691,P15692,P26617,P49151,P50412,P67964,P67965,Q99PS1,Q9GKR0,Q9MYV3">VEGF</mark> expression, intratumoral microvascular density and reduced necrosis.
18256928-627	<mark style="background-color:lightblue;" id="4091">Metformin</mark> treatment was sufficient, however, to <mark style="background-color:orange;">reduce</mark> systemic <mark style="background-color:lightgreen;" id="Q95222">IGF-1</mark> and the proliferation rate of tumor cells in vascularized regions.
18410529-630	<mark style="background-color:lightgreen;" id="P27361,P28869,P42525,Q07176">ERK1</mark> and 2 activation <mark style="background-color:orange;">stimulated</mark> <mark style="background-color:lightgreen;" id="P79365">GLUT-1</mark> synthesis and resulted in <mark style="background-color:orange;">increase</mark> of placental <mark style="background-color:lightblue;" id="206,5793,64689,79025">glucose</mark> uptake.
18410529-631	High resistin levels (50-100 ng/ml) seem able to affect <mark style="background-color:lightblue;" id="206,5793,64689,79025">glucose</mark>-uptake, presumably by <mark style="background-color:orange;">decreasing</mark> the <mark style="background-color:yellow;" id="GO:0009928,GO:0009986,cellular_component">cell surface</mark>  <mark style="background-color:lightgreen;" id="P23586">glucose transporter</mark> .
18547754-637	Parthenogenetic porcine blastocysts were generated by the following methods: (1) electroporation followed by blocking the activity of specific <mark style="background-color:lightgreen;" id="P00513,P25848">protein kinases</mark> with <mark style="background-color:lightblue;" id="123740,5235506,51340302">butyrolactone I</mark>; (2) electroporation followed by inhibition of protein synthesis <mark style="background-color:orange;">using</mark> <mark style="background-color:lightblue;" id="6197">cycloheximide</mark>; and (3) electroporation only (control).
18551377-641	Transformation was achieved using a vector that targets genes to the rrn16/ <mark style="background-color:lightgreen;" id="O14062,P02368,P06368,P11524,P13576,P14149,P17293,P17294,P19461,P29161,P39573,P41196,P42344,P46296,P46308,P47333,P47840,P48856,P49168,P49500,P51289,P52762,P56354,P59168,P61941,P62127,P63196,P63199,P63200,P63323,P63324,P74230,Q2JMY0,Q2JUX7,Q318N2,Q3AMT3,Q3AW56,Q3MDM2,Q46IW1,Q5F1R7,Q68S28,Q6B8X8,Q6ENC0,Q6L3C7,Q6YXM6,Q70XU7,Q7NAV1,Q7NEF4,Q7U4D4,Q7UZY4,Q7V503,Q7VA02,Q85BW6,Q85FG4,Q85X49,Q8KTP6,Q8MA18,Q8RUK6,Q8VMU2,Q8YP60,Q9AIG9,Q9CL86,Q9MUP2,Q9PPW5,Q9TJR0,Q9TKZ7,Q9TLV6,Q9XQE1">rps12</mark> intergenic region of the sugar beet plastome, <mark style="background-color:orange;">employing</mark> the <mark style="background-color:lightgreen;" id="P08881,P0AG05,P0AG06">aadA</mark> gene as a selectable marker against <mark style="background-color:lightblue;" id="15541">spectinomycin</mark> and the gfp gene for visual screening of <mark style="background-color:yellow;" id="GO:0009536,cellular_component">plastid</mark> transformants.
18207583-646	Expression of <mark style="background-color:yellow;" id="GO:0007568,GO:0010149,biological_process">senescence</mark> -associated <mark style="background-color:lightgreen;" id="O33815,O52629,O52847,P00722,P00723,P06219,P0C1Y0,P14288,P22498,P23989,P24131,P26257,P30812,P50388,P70753,P77989,P81650,Q1G9Z4,Q47077,Q48727,Q56307,Q59140,Q59750,Q9K9C6">beta-galactosidase</mark> (SA-beta- <mark style="background-color:lightgreen;" id="P10683,P11886,P47212">Gal</mark> ) by human skin fibroblasts, <mark style="background-color:orange;">effect</mark> of advanced glycation end-products and <mark style="background-color:lightblue;" id="840,17106,19466,94270,439554">fucose</mark> or rhamnose-rich polysaccharides.
18449471-648	<mark style="background-color:lightblue;" id="5291">Imatinib</mark> is <mark style="background-color:orange;">transported</mark> by P- <mark style="background-color:lightgreen;" id="P08163">glycoprotein</mark> (P-gp) and <mark style="background-color:lightgreen;" id="Q9UNQ0">Breast Cancer Resistance Protein</mark> ( <mark style="background-color:lightgreen;" id="Q9UNQ0">BCRP</mark> ), however, the exact impact of these transporters on absorption, distribution, metabolism and <mark style="background-color:yellow;" id="GO:0007588,biological_process">excretion</mark> (ADME) of <mark style="background-color:lightblue;" id="5291">imatinib</mark> is not fully understood due to incomplete data.
18449471-650	In conclusion, P-gp and <mark style="background-color:lightgreen;" id="Q9UNQ0">BCRP</mark> have only a modest <mark style="background-color:orange;">effect</mark> on the ADME of <mark style="background-color:lightblue;" id="5291">imatinib</mark> in comparison to metabolic elimination.
18449471-651	The considerable drug-drug interaction observed with <mark style="background-color:lightblue;" id="119373">elacridar</mark> or <mark style="background-color:lightblue;" id="4679">pantoprazole</mark> is only partly <mark style="background-color:orange;">mediated</mark> by inhibition of P-gp and <mark style="background-color:lightgreen;" id="Q9UNQ0">BCRP</mark> and far more by the inhibition of other elimination pathways.
18506817-653	It has been proposed as a substrate of P- <mark style="background-color:lightgreen;" id="P08163">glycoprotein</mark> (P-gp), an efflux transporter, that may contribute to <mark style="background-color:orange;">limit</mark> <mark style="background-color:lightblue;" id="5362440">indinavir</mark> bioavailability.
18407279-655	Moreover, <mark style="background-color:lightgreen;" id="P05804">beta-glucuronidase</mark> hydrolysis of <mark style="background-color:lightblue;" id="64982">baicalin</mark> sequentially <mark style="background-color:orange;">yielded</mark> glucuronic acid and <mark style="background-color:lightblue;" id="5281605">baicalein</mark> as confirmed by co-TLC with authentic samples.
18547796-661	Increased incorporation of dietary plant sterols and <mark style="background-color:lightblue;" id="304,5997,6432564,11025495">cholesterol</mark> correlates with <mark style="background-color:orange;">decreased</mark> expression of hepatic and intestinal <mark style="background-color:lightgreen;" id="Q99PE7,Q99PE8">Abcg5</mark> and <mark style="background-color:lightgreen;" id="P58428,Q9DBM0">Abcg8</mark> in diabetic BB rats.
18547796-662	This increase in <mark style="background-color:lightblue;" id="304,5997,6432564,11025495">cholesterol</mark> and plant sterols and stanols was <mark style="background-color:orange;">associated</mark> with a <mark style="background-color:orange;">marked</mark> <mark style="background-color:orange;">decrease</mark> in hepatic and intestinal <mark style="background-color:lightgreen;" id="Q99PE7,Q99PE8">Abcg5</mark> ( <mark style="background-color:yellow;" id="GO:0005524,molecular_function">ATP-binding</mark> cassette transporter G5) and <mark style="background-color:lightgreen;" id="P58428,Q9DBM0">Abcg8</mark> ( <mark style="background-color:yellow;" id="GO:0005524,molecular_function">ATP-binding</mark> cassette transporter G8) expressions in diabetic rats, as well as decreased mRNA levels of several other genes involved in sterol regulation.
18547796-663	Therefore, lower expression levels of <mark style="background-color:lightgreen;" id="Q99PE7,Q99PE8">Abcg5</mark> / <mark style="background-color:lightgreen;" id="P58428,Q9DBM0">Abcg8</mark> in diabetic rats may account for the <mark style="background-color:orange;">increased</mark> accumulation of plant sterols and <mark style="background-color:lightblue;" id="304,5997,6432564,11025495">cholesterol</mark> in these rats.
18536700-664	<mark style="background-color:lightgreen;" id="P97738">Narp</mark> deletion <mark style="background-color:orange;">blocks</mark> extinction of <mark style="background-color:lightblue;" id="5288826,5479215">morphine</mark> place preference conditioning.
18547798-666	<mark style="background-color:lightblue;" id="370">Gallic acid</mark>, <mark style="background-color:lightblue;" id="445858">ferulic acid</mark> and <mark style="background-color:lightblue;" id="637542">p-coumaric acid</mark> at a dosage of 100 mg kg(-1) body weight significantly <mark style="background-color:orange;">increased</mark> the activities of cardiac <mark style="background-color:lightgreen;" id="O50258">superoxide dismutase</mark> , <mark style="background-color:lightgreen;" id="O32770,O59858,Q00277,Q9CFV1">glutathione peroxidase</mark> (GPx) and <mark style="background-color:lightgreen;" id="O24339,O52762,O62839,O68146,O77229,O93662,O97492,P00432,P04040,P04762,P07145,P0A323,P0A324,P0A325,P0A326,P0A327,P11934,P17336,P24168,P24270,P25890,P29422,P30265,P30266,P32290,P42321,P44390,P45737,P45739,P55304,P55306,P55310,P55311,P55313,P77872,P81138,P90682,Q27710,Q49XC1,Q4L643,Q59296,Q59337,Q59602,Q59714,Q5HG86,Q5HPK8,Q5RF10,Q64405,Q6G9M4,Q6GH72,Q7A5T2,Q8CPD0,Q8FWU0,Q8NWV5,Q8X1P0,Q8Y3P9,Q926X0,Q99UE2,Q9AXH0,Q9KW19,Q9L4S1,Q9M5L6,Q9PT92,Q9PWF7,Q9Z598,Q9ZKX5,Q9ZN99">catalase</mark> ( <mark style="background-color:lightgreen;" id="O62839,O97492,P00432,P00485,P00486,P00487,P04040,P06135,P07641,P11504,P20074,P22782,P25309,P25819,P26825,P26826,P32796,P36882,P36883,P43155,P47934,P49417,P52826,P58777,P62577,P62578,P62579,P62580,P90682,Q00614,Q02736,Q03058,Q5RF10,Q64405,Q704S8,Q9M5L6,Q9PWF7">CAT</mark> .05).
18191451-670	Toxicity and characterization of <mark style="background-color:lightgreen;" id="P32749,P32750,P32751,P32752,P32753,P81908">cholinesterase</mark> -inhibition <mark style="background-color:orange;">induced</mark> by <mark style="background-color:lightblue;" id="5936">diisopropyl fluorophosphate</mark> in Artemia <mark style="background-color:lightblue;" id="5161">salina</mark> larvae.
18556000-671	<mark style="background-color:lightblue;" id="4455">Neopterin</mark> is <mark style="background-color:orange;">released</mark> from human monocyte-derived macrophages upon stimulation with <mark style="background-color:lightgreen;" id="Q9TTB0">interferon-gamma</mark> and is a sensitive indicator for cellular immune activation.
18373731-672	<mark style="background-color:lightblue;" id="65137">Cyclo(His-Pro</mark>) <mark style="background-color:orange;">promotes</mark> cytoprotection by <mark style="background-color:orange;">activating</mark> <mark style="background-color:lightgreen;" id="O54968,Q60795">Nrf2</mark> -mediated up-regulation of antioxidant defence.
18373731-674	Here, we addressed this issue and found that <mark style="background-color:lightblue;" id="65137">cyclo(His-Pro</mark>) <mark style="background-color:orange;">triggered</mark> nuclear accumulation of <mark style="background-color:lightgreen;" id="O54968,Q16236,Q60795">NF-E2-related factor-2</mark> ( <mark style="background-color:lightgreen;" id="O54968,Q60795">Nrf2</mark> ), a <mark style="background-color:yellow;" id="GO:0006350,biological_process">transcription</mark> factor that up-regulates antioxidant-/electrophile-responsive element (ARE-EpRE)-related genes, in PC12 cells.
18449536-687	There is clear evidence for <mark style="background-color:lightgreen;" id="O95069">TREK</mark> -1 and <mark style="background-color:lightgreen;" id="O14649">TASK</mark> -1 in the heart and these channels are likely to <mark style="background-color:orange;">regulate</mark> cardiac action potential duration through their regulation by stretch, <mark style="background-color:lightblue;" id="56842239">polyunsaturated fatty acids</mark>, pH, and neurotransmitters.
18449536-688	<mark style="background-color:lightgreen;" id="O95069">TREK</mark> -1 may also have a critical role in <mark style="background-color:orange;">mediating</mark> the vasodilator response of resistance arteries to <mark style="background-color:lightblue;" id="56842239">polyunsaturated fatty acids</mark>, thus contributing to their protective effect on the cardiovascular system.
18496650-691	Moreover, intestinal, colonic and caecal TBARS, LOOH, CD and also the antioxidants <mark style="background-color:lightgreen;" id="O50258">superoxide dismutase</mark> ( <mark style="background-color:lightgreen;" id="O12933,O22668,O75007,P24705,P51547,P93258,Q01137,Q27666,Q9SM64">SOD</mark> ), <mark style="background-color:lightgreen;" id="O24339,O52762,O62839,O68146,O77229,O93662,O97492,P00432,P04040,P04762,P07145,P0A323,P0A324,P0A325,P0A326,P0A327,P11934,P17336,P24168,P24270,P25890,P29422,P30265,P30266,P32290,P42321,P44390,P45737,P45739,P55304,P55306,P55310,P55311,P55313,P77872,P81138,P90682,Q27710,Q49XC1,Q4L643,Q59296,Q59337,Q59602,Q59714,Q5HG86,Q5HPK8,Q5RF10,Q64405,Q6G9M4,Q6GH72,Q7A5T2,Q8CPD0,Q8FWU0,Q8NWV5,Q8X1P0,Q8Y3P9,Q926X0,Q99UE2,Q9AXH0,Q9KW19,Q9L4S1,Q9M5L6,Q9PT92,Q9PWF7,Q9Z598,Q9ZKX5,Q9ZN99">catalase</mark> ( <mark style="background-color:lightgreen;" id="O62839,O97492,P00432,P00485,P00486,P00487,P04040,P06135,P07641,P11504,P20074,P22782,P25309,P25819,P26825,P26826,P32796,P36882,P36883,P43155,P47934,P49417,P52826,P58777,P62577,P62578,P62579,P62580,P90682,Q00614,Q02736,Q03058,Q5RF10,Q64405,Q704S8,Q9M5L6,Q9PWF7">CAT</mark> ), <mark style="background-color:lightgreen;" id="O04437,O18598,P0A9D2,P0A9D3,P30116,P44521,P46088,P46419,P46423,P46426,P46428,P46437,P48438,P80894,P81065,P82996,P82997,P82998,P82999,P83000,P83001,P83246,Q04522,Q08392,Q08393,Q0ZS46,Q7REH6,Q8ILQ7,Q8MU52,Q96324">glutathione S-transferase</mark> ( <mark style="background-color:lightgreen;" id="P20432,P30104,P30106,P30107,P30108,Q04522,Q0ZS46,Q7REH6,Q8ILQ7,Q8MU52">GST</mark> ), <mark style="background-color:lightgreen;" id="O32770,O59858,Q00277,Q9CFV1">glutathione peroxidase</mark> (GPx), <mark style="background-color:lightgreen;" id="O15770,P06715,P11804,P23189,P41921,P43783,P48638,P48639,P70619,P78965,Q60151,Q6BPI1,Q6C5H4,Q6FRV2,Q6HA23,Q74ZK4,Q873E8,Q94655">glutathione reductase</mark> (GR) and <mark style="background-color:lightblue;" id="124886">reduced glutathione</mark> (<mark style="background-color:lightblue;" id="124886">GSH</mark>) were significantly <mark style="background-color:orange;">diminished</mark> in <mark style="background-color:lightgreen;" id="O94833,Q03001,Q8WXK8">DMH</mark> 0.05) <mark style="background-color:orange;">elevated</mark> on simultaneous <mark style="background-color:lightblue;" id="5281670">morin</mark> supplementation.
18400404-699	Then the review evaluates the involvement of <mark style="background-color:lightgreen;" id="O70503,Q4R5G7,Q53GQ0,Q5E9H7,Q6P7R8">KARs</mark> <mark style="background-color:orange;">activated</mark> by the endogenous agonist <mark style="background-color:lightblue;" id="611,23327,33032">glutamate</mark> in the generation and propagation of epileptiform activity.
17321121-703	The absorption spectrum of the <mark style="background-color:lightgreen;" id="P80509,P80510">hydrogenase</mark> enzyme showed an absorption peak at 425nm <mark style="background-color:orange;">indicating</mark> that the enzyme had iron-<mark style="background-color:lightblue;" id="402">sulfur</mark> clusters.
18495456-706	However, the <mark style="background-color:lightgreen;" id="P42898,Q5I598,Q60HE5">MTHFR</mark> C677T genotype, alone or together with a diet, <mark style="background-color:orange;">influenced</mark> <mark style="background-color:lightblue;" id="248">betaine</mark> (P=.03) and phosphatidylcholine (P=.03).
18495456-707	In addition, the <mark style="background-color:lightgreen;" id="P42898,Q5I598,Q60HE5">MTHFR</mark> C677T genotype appears to <mark style="background-color:orange;">influence</mark> the direction and <mark style="background-color:orange;">use</mark> of <mark style="background-color:lightblue;" id="305">choline</mark> moieties in this group of women.
18556087-712	Both activity and expression of <mark style="background-color:lightgreen;" id="O70531,P50443,Q62273">sulfate transporters</mark> and <mark style="background-color:lightgreen;" id="O14492,P04802,P07288,P22325,P33619,P55228,Q12650,Q6DT45">APS</mark> reductase in plants are <mark style="background-color:orange;">modulated</mark> by the <mark style="background-color:lightblue;" id="402">sulfur</mark> status of the plant.
18396355-716	In-vitro regeneration of <mark style="background-color:lightblue;" id="7871">sarin</mark> <mark style="background-color:orange;">inhibited</mark> electric eel <mark style="background-color:lightgreen;" id="Q867X2,Q867X3,Q86GC9,Q92081">acetylcholinesterase</mark> by <mark style="background-color:lightgreen;" id="Q9JLV1">bis</mark> -<mark style="background-color:lightblue;" id="1049">pyridinium</mark> <mark style="background-color:lightblue;" id="6350">oximes</mark> bearing <mark style="background-color:lightblue;" id="7237">xylene</mark> linker.
18396355-717	A series of <mark style="background-color:lightgreen;" id="Q9JLV1">bis</mark> -<mark style="background-color:lightblue;" id="1049">pyridinium</mark> <mark style="background-color:lightblue;" id="6350">oximes</mark> <mark style="background-color:orange;">connected</mark> by <mark style="background-color:lightblue;" id="7237">xylene</mark> linker were <mark style="background-color:orange;">synthesized</mark> and their in-vitro reactivation potential was evaluated against <mark style="background-color:lightgreen;" id="Q867X2,Q867X3,Q86GC9,Q92081">acetylcholinesterase</mark> ( <mark style="background-color:lightgreen;" id="O42275,O62763,P04058,P07140,P07692,P21836,P22303,P23795,P36196,P37136,P56161,Q27677,Q29499,Q867X2,Q867X3,Q869C3,Q86GC8,Q86GC9,Q92035,Q92081,Q9DDE3">AChE</mark> ) <mark style="background-color:orange;">inhibited</mark> by nerve agent, <mark style="background-color:lightblue;" id="7871">sarin</mark>.
18396355-718	Among the synthesized compounds, alpha,alpha'<mark style="background-color:lightblue;" id="7237">xylene</mark>- <mark style="background-color:lightgreen;" id="Q9JLV1">bis</mark> -[3,3'-(hydroxyiminomethyl) <mark style="background-color:lightblue;" id="1049">pyridinium</mark>] dibromide (3b) was found to be most potent reactivator for <mark style="background-color:lightgreen;" id="O42275,O62763,P04058,P07140,P07692,P21836,P22303,P23795,P36196,P37136,P56161,Q27677,Q29499,Q867X2,Q867X3,Q869C3,Q86GC8,Q86GC9,Q92035,Q92081,Q9DDE3">AChE</mark> <mark style="background-color:orange;">inhibited</mark> by <mark style="background-color:lightblue;" id="7871">sarin</mark>.
18396356-720	Of the compounds synthesized, <mark style="background-color:lightblue;" id="398803">compound 2a</mark>, which has a primary amide at warhead region of the inhibitor most potently <mark style="background-color:orange;">inhibited</mark> mu- <mark style="background-color:lightgreen;" id="P27730">calpain</mark> with an IC(50) value of 2.81+/-1.26 microM, which is ca.
18506630-727	Purified <mark style="background-color:lightgreen;" id="P06181,P11542,P11543,P20010,P20011,P20012,P20013,P21764,P31837,P31838,P49012,P50622">lignin peroxidase</mark> was able to <mark style="background-color:orange;">oxidize</mark> a variety of substrates <mark style="background-color:orange;">including</mark> <mark style="background-color:lightblue;" id="27854">Mn2</mark>+, <mark style="background-color:lightblue;" id="1148,6305,9060,5460840">tryptophan</mark>, <mark style="background-color:lightblue;" id="3862">mimosine</mark>, <mark style="background-color:lightblue;" id="6047">L-Dopa</mark>, <mark style="background-color:lightblue;" id="785">hydroquinone</mark>, xylidine, <mark style="background-color:lightblue;" id="1031">n-propanol</mark>, <mark style="background-color:lightblue;" id="7118">veratryl alcohol</mark>, and ten textile <mark style="background-color:orange;">dyes</mark> of various groups <mark style="background-color:orange;">indicating</mark> as a versatile <mark style="background-color:lightgreen;" id="P15984,P16147,P84714">peroxidase</mark> .
18506630-728	<mark style="background-color:lightblue;" id="1148,6305,9060,5460840">Tryptophan</mark> <mark style="background-color:orange;">stabilizes</mark> the <mark style="background-color:lightgreen;" id="P06181,P11542,P11543,P20010,P20011,P20012,P20013,P21764,P31837,P31838,P49012,P50622">lignin peroxidase</mark> activity during decolorization of dyes.
18560889-729	<mark style="background-color:lightgreen;" id="Q07842">Complex I</mark> deficiency is a novel cause of secretory diarrhea and may <mark style="background-color:orange;">act</mark> via <mark style="background-color:orange;">disrupting</mark> the supply of <mark style="background-color:lightblue;" id="5957">adenosine triphosphate</mark> (<mark style="background-color:lightblue;" id="5957">ATP</mark>) needed for the maintenance of ion gradients across <mark style="background-color:yellow;" id="GO:0016020,cellular_component">membranes</mark> .
18253022-733	Surprisingly, a deletion of the <mark style="background-color:lightgreen;" id="Q00934">pilR</mark> gene <mark style="background-color:orange;">affected</mark> not only insoluble <mark style="background-color:lightblue;" id="29936">Fe(III</mark>) reduction, which requires pili, but also soluble <mark style="background-color:lightblue;" id="29936">Fe(III</mark>) reduction, which, in contrast, does not require pili.
17968352-734	Based on these validities we identified alterations in the <mark style="background-color:lightgreen;" id="O76024,P56695">Wolframin</mark> gene in the <mark style="background-color:lightgreen;" id="P00915,P00916,P00917,P07452,P20507,P27140,P35217,P48282,P53461,P54087,P54088,P54089,P54090,P54209,Q1LZA1,Q7M316,Q7M317,Q8HY33,Q99153">CA1</mark> and amygdala regions, specifically in <mark style="background-color:orange;">exposed</mark> PTSD-like rats, which were normalized after treatment with <mark style="background-color:lightblue;" id="2771,146570">citalopram</mark>.
18472163-737	Significant <mark style="background-color:lightgreen;" id="P03973,P12547,P22298,P28296,P29118,P35211,P83610,P97430,Q03420,Q53GG5,Q9H0A0,Q9PU47,Q9Z1X0">ALP</mark> activity changes, sensitivity of isozyme patterns (Mr of 60, 64, and 85kDa) and <mark style="background-color:orange;">increased</mark> variation in <mark style="background-color:lightgreen;" id="P03973,P12547,P22298,P28296,P29118,P35211,P83610,P97430,Q03420,Q53GG5,Q9H0A0,Q9PU47,Q9Z1X0">ALP</mark> plasticity during acute exposure to <mark style="background-color:lightblue;" id="23973">cadmium</mark> point to its possible aplication as an exposure biomarker.
18511076-738	Changes in <mark style="background-color:lightgreen;" id="O18752,O18753,O18755,O70183,O97759,P14082,P21237,P23363,P23560,P25429,P25430,P25431,P25432,Q02193,Q06225,Q3SAT7,Q4L0Y3,Q5IS78,Q6LCI5,Q7YRB4,Q90322,Q95106,Q9TST3">BDNF</mark> serum <mark style="background-color:orange;">levels</mark> in patients with major depression disorder ( <mark style="background-color:lightgreen;" id="P32377">MDD</mark> ) after 6 months treatment with <mark style="background-color:lightblue;" id="68617">sertraline</mark>, <mark style="background-color:lightblue;" id="146570">escitalopram</mark>, or <mark style="background-color:lightblue;" id="5656">venlafaxine</mark>.
18511076-739	We assessed serum <mark style="background-color:lightgreen;" id="O18752,O18753,O18755,O70183,O97759,P14082,P21237,P23363,P23560,P25429,P25430,P25431,P25432,Q02193,Q06225,Q3SAT7,Q4L0Y3,Q5IS78,Q6LCI5,Q7YRB4,Q90322,Q95106,Q9TST3">BDNF</mark> <mark style="background-color:orange;">levels</mark> in 21 patients with major depressive episode treated with <mark style="background-color:lightblue;" id="68617">sertraline</mark>, <mark style="background-color:lightblue;" id="146570">escitalopram</mark>, or <mark style="background-color:lightblue;" id="5656">venlafaxine</mark> and 20 healthy controls.
18511076-740	<mark style="background-color:lightblue;" id="68617">Sertraline</mark> <mark style="background-color:orange;">increased</mark> <mark style="background-color:lightgreen;" id="O18752,O18753,O18755,O70183,O97759,P14082,P21237,P23363,P23560,P25429,P25430,P25431,P25432,Q02193,Q06225,Q3SAT7,Q4L0Y3,Q5IS78,Q6LCI5,Q7YRB4,Q90322,Q95106,Q9TST3">BDNF</mark> levels after 5 weeks and 6 months of treatment.
18511076-741	<mark style="background-color:lightblue;" id="5656">Venlafaxine</mark> <mark style="background-color:orange;">increased</mark> <mark style="background-color:lightgreen;" id="O18752,O18753,O18755,O70183,O97759,P14082,P21237,P23363,P23560,P25429,P25430,P25431,P25432,Q02193,Q06225,Q3SAT7,Q4L0Y3,Q5IS78,Q6LCI5,Q7YRB4,Q90322,Q95106,Q9TST3">BDNF</mark> levels only after 6 months.
18414844-751	The homomeric <mark style="background-color:lightgreen;" id="P13900,P16604">P2X</mark> (7) receptor is extraordinary in that in addition to distinctive <mark style="background-color:yellow;" id="GO:0051179,biological_process">localization</mark> and biological functions it exhibits several hallmark properties, for example, the receptor is potently <mark style="background-color:orange;">inhibited</mark> by divalent cations such as calcium, <mark style="background-color:lightblue;" id="5462224">magnesium</mark>, zinc and <mark style="background-color:lightblue;" id="23978">copper</mark>.
18496767-753	Using in vitro <mark style="background-color:yellow;" id="GO:0005488,molecular_function">binding</mark> assays we have demonstrated that <mark style="background-color:lightgreen;" id="O70494,Q02447,Q90WR8">transcription factors Sp3</mark> , ZBP-89 and NF-Y are capable of <mark style="background-color:yellow;" id="GO:0005488,molecular_function">binding</mark> to the <mark style="background-color:lightgreen;" id="P35713">SOX18</mark> promoter region spanning the sequence -200 to -162 relative to ATG and that formation of complexes could be efficiently <mark style="background-color:orange;">reduced</mark> by <mark style="background-color:lightblue;" id="29051,163659,230076,6326719">mithramycin A</mark>.
18195714-756	<mark style="background-color:lightblue;" id="11970143">Lipopolysaccharide</mark>-induced depressive-like <mark style="background-color:yellow;" id="GO:0007610,biological_process">behavior</mark> is <mark style="background-color:orange;">mediated</mark> by <mark style="background-color:lightgreen;" id="P14902,P28776">indoleamine 2,3-dioxygenase</mark> activation in mice.
18195714-757	We report that peripheral administration of <mark style="background-color:lightblue;" id="11970143">lipopolysaccharide</mark> (LPS) <mark style="background-color:orange;">activates</mark> <mark style="background-color:lightgreen;" id="P14902,P28776">IDO</mark> and culminates in a distinct depressive-like behavioral syndrome, measured by increased duration of immobility in both the forced-swim and tail suspension tests.
18195714-758	Administration of L-<mark style="background-color:lightblue;" id="846">kynurenine</mark>, a metabolite of <mark style="background-color:lightblue;" id="1148,6305,9060,5460840">tryptophan</mark> that is <mark style="background-color:orange;">generated</mark> by <mark style="background-color:lightgreen;" id="P14902,P28776">IDO</mark> , to naive mice dose dependently induces depressive-like <mark style="background-color:yellow;" id="GO:0007610,biological_process">behavior</mark> .
18253697-765	Furthermore, the suppressive effects of P on <mark style="background-color:lightgreen;" id="O07091,O13393,O22642,O93863,P00002,P00003,P00004,P00007,P00008,P00011,P00012,P00013,P00014,P00017,P00018,P00019,P00020,P00021,P00022,P00024,P00025,P00027,P00028,P00029,P00030,P00031,P00032,P00035,P00036,P00037,P00038,P00039,P00040,P00041,P00042,P00043,P00046,P00047,P00048,P00049,P00051,P00052,P00053,P00054,P00055,P00056,P00057,P00058,P00059,P00060,P00061,P00062,P00063,P00064,P00065,P00066,P00067,P00068,P00069,P00070,P00071,P00072,P00073,P00074,P00075,P00076,P00077,P00078,P00079,P12831,P15451,P18822,P19681,P19974,P21665,P22342,P25400,P29380,P32556,P38091,P53698,P56205,P59218,P62772,P62773,P62894,P62895,P62896,P67881,P67882,P68096,P68097,P68098,P68099,P68100,P68517,P68518,P68519,P81280,P81459,P99998,P99999,Q41346,Q4HVX7,Q52V08,Q52V09,Q52V10,Q5RFH4,Q640U4,Q6C9Q0,Q6IQM2,Q6Q4H8,Q6QLW4,Q6WUX8,Q753F4,Q7YR71,Q96VP3">cytochrome c</mark> <mark style="background-color:orange;">release</mark> and caspase-9 and caspase-3 activation in serum-deprived MC3T3- <mark style="background-color:yellow;" id="GO:0004839,molecular_function">E1</mark> cells were also <mark style="background-color:orange;">reversed</mark> by <mark style="background-color:lightblue;" id="55245">RU486</mark>.
18357521-771	The anti-neoplastic drug <mark style="background-color:lightblue;" id="4666,36314,441276">taxol</mark> <mark style="background-color:orange;">binds</mark> to <mark style="background-color:lightgreen;" id="O04386,O42786,O44388,O59837,P02554,P02556,P02557,P04107,P05219,P05220,P05304,P08562,P10875,P10876,P10878,P11482,P11833,P11857,P12457,P14140,P14643,P16040,P17938,P18699,P18700,P20365,P20802,P21148,P22012,P22852,P24637,P28551,P30668,P32256,P33127,P34108,P35394,P41352,P41385,P41386,P41387,P41388,P41741,P41742,P41799,P53373,P53374,P53375,P53376,P79008,P93176,Q00264,Q04709,Q08115,Q24829,Q27380,Q2U2U3,Q39445,Q3KVN1,Q4HZS8,Q4P235,Q4R9N3,Q4WA70,Q52NY7,Q5UBX3,Q6QDC9,Q7KQL5,Q86ZP5,Q8SS99,Q8WZE0,Q91240,Q92268,Q96TU8,Q9GSR5,Q9HFQ3,Q9LKI8,Q9N2N6,Q9UV72">beta-tubulin</mark> to prevent tumor <mark style="background-color:yellow;" id="GO:0051301,biological_process">cell division</mark> , promoting <mark style="background-color:yellow;" id="GO:0008219,biological_process">cell death</mark> .
18357521-772	In the current study, we knocked down <mark style="background-color:lightgreen;" id="P10417,P49950">Bcl-2</mark> expression <mark style="background-color:orange;">using</mark> cognate siRNA during low-dose <mark style="background-color:lightblue;" id="4666,36314,441276">taxol</mark> treatment to induce <mark style="background-color:yellow;" id="GO:0006915,biological_process">apoptosis</mark> in two human glioblastoma U138MG and U251MG cell lines.
18357521-773	The cells were treated with either 100 nM <mark style="background-color:lightblue;" id="4666,36314,441276">taxol</mark> or 100 nM <mark style="background-color:lightgreen;" id="P10417,P49950">Bcl-2</mark> siRNA or both for 72 h. Immunofluorescent stainings for <mark style="background-color:lightgreen;" id="P27730">calpain</mark> and active caspase-3 showed <mark style="background-color:orange;">increases</mark> in expression and co- <mark style="background-color:yellow;" id="GO:0051179,biological_process">localization</mark> of these <mark style="background-color:lightgreen;" id="O41798,O89290,O89940,O91080,O93215,P03311,P03353,P03355,P03356,P03362,P03363,P03366,P03367,P03369,P03370,P04023,P04024,P04323,P04584,P04585,P04587,P04588,P04589,P05959,P05960,P05961,P05962,P07570,P0C210,P0C211,P10210,P10265,P10270,P10271,P10272,P10273,P10274,P10394,P10978,P11227,P11365,P12451,P12497,P12498,P12499,P14074,P14078,P15833,P16046,P16423,P16901,P17757,P18042,P18096,P18802,P19028,P19199,P19560,P19561,P20825,P20875,P20876,P20892,P21407,P21414,P24107,P24740,P26808,P26809,P26810,P27502,P28936,P31822,P35956,P35963,P51518,P63119,P63120,P63121,P63122,P63123,P63124,P63125,P63127,P63128,P63129,P63131,P84454,Q09SZ9,Q0R5R2,Q0R5R3,Q1A249,Q1A267,Q4U0X6,Q73368,Q74120,Q75002,Q76634,Q77373,Q79666,Q89928,Q8AII1,Q8I7P9,Q9IDV9,Q9Q720,Q9QBY3,Q9QBZ1,Q9QBZ5,Q9QSR3,Q9WC54,Q9WC63,Q9Y6I0">proteases</mark> in apoptotic cells.
18357521-774	Our current study demonstrated that <mark style="background-color:lightgreen;" id="P10417,P49950">Bcl-2</mark> siRNA significantly <mark style="background-color:orange;">augmented</mark> <mark style="background-color:lightblue;" id="4666,36314,441276">taxol</mark> <mark style="background-color:orange;">mediated</mark> <mark style="background-color:yellow;" id="GO:0006915,biological_process">apoptosis</mark> in different human glioblastoma cells through induction of <mark style="background-color:lightgreen;" id="P27730">calpain</mark> and caspase proteolytic activities.
18357522-775	Based on these findings, altered expression of <mark style="background-color:lightgreen;" id="P04116,P23289,P23294,P47789,P47790,P60201,Q04004,Q08868,Q8HXW7">PLP1</mark> in most areas of the striatum suggests that widespread <mark style="background-color:orange;">changes</mark> to the myelin structure could be <mark style="background-color:orange;">associated</mark> with the adaptive changes following chronic <mark style="background-color:lightblue;" id="2826,5760,439497,446220,644017,54613779">cocaine</mark> abuse.
18538372-777	We showed that after treatment of HCT116 cells with a low dose of <mark style="background-color:lightblue;" id="31703">doxorubicin</mark> most of them <mark style="background-color:orange;">stopped</mark> proliferation as documented by SA- <mark style="background-color:lightgreen;" id="O33815,O52629,O52847,P00722,P00723,P06219,P0C1Y0,P14288,P22498,P23989,P24131,P26257,P30812,P50388,P70753,P77989,P81650,Q1G9Z4,Q47077,Q48727,Q56307,Q59140,Q59750,Q9K9C6">beta-galactosidase</mark> activity and the lack of Ki67 expression.
17888546-781	<mark style="background-color:lightgreen;" id="P02649,P02650,P05770,P08226,P10517,P18287,P18649,P18650,P23529,Q03247,Q28502,Q28995,Q7M2U7,Q7M2U8,Q9GJU3,Q9GLC0,Q9GLM6,Q9GLM7,Q9GLM8">ApoE</mark> <mark style="background-color:orange;">modified</mark> the association between <mark style="background-color:lightblue;" id="304,5997,6432564,11025495">cholesterol</mark> and cognitive decline, and the association between the ratio of <mark style="background-color:lightblue;" id="99470,123976,50990021">27-hydroxycholesterol</mark> to <mark style="background-color:lightblue;" id="304,5997,6432564,11025495">cholesterol</mark> and cognitive functioning.
18384163-783	Real-time RT- <mark style="background-color:lightgreen;" id="O66148,O80333,P15904,Q01289,Q39617,Q41249,Q59987,Q9SDT1">PCR</mark> showed that the expression of osteoblast marker genes such as <mark style="background-color:lightgreen;" id="Q08775,Q13950,Q9XSB7,Q9Z2J9">CBFalpha1</mark> and <mark style="background-color:lightgreen;" id="O60109,P81800,P83456">alkaline phosphatase</mark> was <mark style="background-color:orange;">increased</mark> in <mark style="background-color:lightblue;" id="24759,453618,3084050,24728612">hyaluronic acid</mark>-based hydrogel, and the expression <mark style="background-color:orange;">level</mark> was dependent on the molecular weight of <mark style="background-color:lightblue;" id="24759,453618,3084050,24728612">hyaluronic acid</mark>, <mark style="background-color:lightblue;" id="104802">RGD peptide</mark>, and <mark style="background-color:lightgreen;" id="O19006,O46564,P12643,P21274,P49001,Q804S2,Q90751">BMP-2</mark> .
18459941-785	Furthermore <mark style="background-color:lightblue;" id="60823">atorvastatin</mark> treatment markedly <mark style="background-color:orange;">decreased</mark> the <mark style="background-color:orange;">levels</mark> of <mark style="background-color:lightgreen;" id="O35734,O77510,O77764,P01375,P04924,P06804,P13296,P16599,P19101,P23383,P23563,P29553,P33620,P36939,P48094,P51435,P51742,P51743,P59684,P59693,P59694,P59695,P79337,P79374,Q06599,Q19LH4,Q1G1A2,Q1WM27,Q2MH05,Q539C2,Q75N23,Q8HZD9,Q8JFG3,Q8MKG8,Q8WNR1,Q9BEA1">TNF-alpha</mark> , <mark style="background-color:lightgreen;" id="O35736,P05231,P08505,P20607,P26892,P26893,P29455,P41323,P41683,P41693,P46650,P51494,P79341,Q25BC2,Q28319,Q28747,Q28819,Q2MH06,Q5I6E3,Q6V919,Q865W7,Q865X6,Q8MKH0,Q95181,Q9MZR1,Q9XT80">IL-6</mark> and <mark style="background-color:lightgreen;" id="P10148,P13500,P14844,P28291,P28292,P42831,P52203,P61274,P61275,Q08782,Q9TTQ3">MCP-1</mark> , <mark style="background-color:orange;">reduced</mark> myocardial infiltration of macrophages and significantly <mark style="background-color:orange;">increased</mark> myocardial and serum levels of the anti-inflammatory cytokine <mark style="background-color:lightgreen;" id="O46673,O97798,P18893,P22301,P29456,P43480,P46651,P47965,P48411,P51496,P51497,P51746,P55029,P79338,Q0Z972,Q25BC1,Q28374,Q29055,Q29408,Q2PE73,Q5Q0V6,Q865X4,Q8MKG9,Q9JHK7,Q9TSJ4,Q9Z1Y5">IL-10</mark> .
18459944-788	In addition, <mark style="background-color:lightblue;" id="10069117">AUDA</mark> treatment attenuated macrophage infiltration and <mark style="background-color:orange;">inhibited</mark> urinary <mark style="background-color:yellow;" id="GO:0007588,biological_process">excretion</mark> of <mark style="background-color:lightgreen;" id="P10148,P13500,P14844,P28291,P28292,P42831,P52203,P61274,P61275,Q08782,Q9TTQ3">MCP-1</mark> ( <mark style="background-color:lightgreen;" id="P10148,P13500,P14844,P28292,P42831,P52203,P61274,P61275,Q08782,Q9TTQ3">monocyte chemoattractant protein-1</mark> ) and kidney cortex <mark style="background-color:lightgreen;" id="P10148,P13500,P14844,P28291,P28292,P42831,P52203,P61274,P61275,Q08782,Q9TTQ3">MCP-1</mark> gene expression.
18522674-789	<mark style="background-color:lightblue;" id="2662">Celecoxib</mark> caused a 60% reduction in testicular interstitial fluid (IF) prostaglandin E(2) ( <mark style="background-color:lightgreen;" id="Q29458">PGE</mark> (2)) concentrations, accompanied by a compensatory <mark style="background-color:orange;">increase</mark> in <mark style="background-color:lightgreen;" id="O02768,O19183,O62698,O62725,P27607,P35354,P35355,P70682,P79208,Q05769">COX-2</mark> mRNA expression.
18522674-791	These data indicate that <mark style="background-color:lightblue;" id="2662">celecoxib</mark> <mark style="background-color:orange;">reduces</mark> intratesticular activity of <mark style="background-color:lightgreen;" id="O02768,O19183,O62698,O62725,P27607,P35354,P35355,P70682,P79208,Q05769">COX-2</mark> (as <mark style="background-color:orange;">indicated</mark> by <mark style="background-color:lightgreen;" id="Q29458">PGE</mark> (2) levels) and inhibits IF formation in the testis, but has no appreciable effect on <mark style="background-color:yellow;" id="GO:0006694,biological_process">steroidogenesis</mark> or <mark style="background-color:yellow;" id="GO:0007283,biological_process">spermatogenesis</mark> , at least in the short term.
18522674-792	These results indicate significant roles for products of the <mark style="background-color:lightgreen;" id="O02768,O19183,O62698,O62725,P27607,P35354,P35355,P70682,P79208,Q05769">COX-2</mark> pathway in testicular vascular control and <mark style="background-color:yellow;" id="GO:0006694,biological_process">steroidogenesis</mark> , which may have implications for men with marginal fertility <mark style="background-color:orange;">taking</mark> <mark style="background-color:lightblue;" id="2662">celecoxib</mark> for extended periods, but also highlight the potential of this drug to ameliorate testicular damage caused by systemic or local inflammation.
18550063-794	<mark style="background-color:lightgreen;" id="Q8JFG3">Tumor necrosis factor</mark> -alpha inhibition <mark style="background-color:orange;">protects</mark> against <mark style="background-color:lightblue;" id="44268108">endotoxin</mark>-induced endothelial <mark style="background-color:yellow;" id="GO:0030112,cellular_component">glycocalyx</mark> perturbation.
18079026-797	In the present study, we investigated the effects of <mark style="background-color:lightblue;" id="5002">quetiapine</mark> on <mark style="background-color:yellow;" id="GO:0007613,biological_process">memory</mark> impairment and pathological <mark style="background-color:orange;">changes</mark> in an amyloid precursor protein ( <mark style="background-color:lightgreen;" id="O73683,O93279,P05067,P08592,P0A3Z1,P0A3Z2,P0A3Z3,P0A3Z4,P12023,P29216,P47566,P53601,P75313,P79307,Q11207,Q28053,Q28280,Q28748,Q28757,Q29149,Q5IS80,Q60495,Q95241">APP</mark> )/ <mark style="background-color:lightgreen;" id="O12976,P49768,P49769,P79802,P97887,Q4JIM4,Q5R780,Q6RH31,Q8HXW5,Q9W6T7,Q9XT97">presenilin-1</mark> ( <mark style="background-color:lightgreen;" id="P49768,P49769,P79802,P84566,P97887,Q5R780,Q6RH31,Q8HXW5,Q9XT97">PS-1</mark> ) double transgenic mouse model of Alzheimer's disease (AD).
18079026-798	<mark style="background-color:lightblue;" id="5002">Quetiapine</mark> also <mark style="background-color:orange;">decreased</mark> brain Abeta peptides, beta-secretase activity and expression, and the <mark style="background-color:orange;">level</mark> of <mark style="background-color:lightgreen;" id="P05067,P08592,P12023,P53601,P79307,Q5IS80,Q95241">C99</mark> (an <mark style="background-color:lightgreen;" id="O73683,O93279,P05067,P08592,P0A3Z1,P0A3Z2,P0A3Z3,P0A3Z4,P12023,P29216,P47566,P53601,P75313,P79307,Q11207,Q28053,Q28280,Q28748,Q28757,Q29149,Q5IS80,Q60495,Q95241">APP</mark> C-terminal fragment following cleavage by beta-secretase) in the transgenic mice.
18079026-799	Furthermore, <mark style="background-color:lightblue;" id="5002">quetiapine</mark> attenuated anxiety-like <mark style="background-color:yellow;" id="GO:0007610,biological_process">behavior</mark> , <mark style="background-color:orange;">up-regulated</mark> cerebral <mark style="background-color:lightgreen;" id="P10417,P49950">Bcl-2</mark> protein, and decreased cerebral nitrotyrosine in the transgenic mice.
18548275-801	<mark style="background-color:lightblue;" id="104818">Sulfonylurea</mark> (SU) treatment <mark style="background-color:orange;">restores</mark> <mark style="background-color:lightgreen;" id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">insulin</mark>  <mark style="background-color:yellow;" id="GO:0046903,biological_process">secretion</mark> in patients with <mark style="background-color:lightgreen;" id="O02822,Q14654,Q9JHJ9">KCNJ11</mark> mutations.
18042181-811	To assess whether follicle-stimulating hormone (FSH) and <mark style="background-color:lightgreen;" id="P03969,P09038,P12226,P13109,P15655,P20003,P48798,P48799,P48800,Q60487">basic fibroblast growth factor</mark> (bFGF) <mark style="background-color:orange;">modulate</mark> <mark style="background-color:lightblue;" id="124886">GSH</mark> production in Sertoli cells by <mark style="background-color:orange;">regulating</mark> the expression of <mark style="background-color:lightgreen;" id="P48506">GCLC</mark> , <mark style="background-color:lightgreen;" id="P48507,Q2T9Y6">GCLM</mark> and/or GR, we performed in vitro studies using rat Sertoli cells in primary culture.
18042181-812	In conclusion, our results show that FSH and bFGF increase <mark style="background-color:lightblue;" id="124886">GSH</mark> <mark style="background-color:orange;">levels</mark> in Sertoli cells through stimulation of the de novo synthesis and recycling by <mark style="background-color:orange;">upregulating</mark> <mark style="background-color:lightgreen;" id="P48507,Q2T9Y6">GCLM</mark> and GR expression respectively.
18496865-833	<mark style="background-color:lightblue;" id="8925">Tetraglyme</mark> coatings <mark style="background-color:orange;">reduce</mark> <mark style="background-color:lightgreen;" id="P22775,P81070">fibrinogen</mark> and <mark style="background-color:lightgreen;" id="Q62935">von Willebrand factor</mark> adsorption and platelet adhesion under both static and flow conditions.
18496865-834	Previous studies have showed that radio-frequency plasma deposited <mark style="background-color:lightblue;" id="8925">tetraglyme</mark> coatings greatly <mark style="background-color:orange;">reduced</mark> <mark style="background-color:lightgreen;" id="P22775,P81070">fibrinogen</mark> adsorption (Gamma(Fg)) from highly diluted plasmas (0.1 and 1%) and subsequent platelet adhesion under static conditions.
18230627-837	Randomised trials have demonstrated that the efficacy of anti-tumour necrosis factor ( <mark style="background-color:lightgreen;" id="O35734,O77510,O77764,P01375,P04924,P13296,P19101,P23383,P23563,P29553,P33620,P36939,P48094,P51435,P51742,P51743,P59684,P59693,P59694,P59695,P79337,P79374,Q06599,Q19LH4,Q1G1A2,Q1WM27,Q2MH05,Q539C2,Q75N23,Q8HZD9,Q8JFG3,Q8MKG8,Q8WNR1,Q9BEA1">TNF</mark> ) agents is significantly <mark style="background-color:orange;">increased</mark> by concomitant <mark style="background-color:lightblue;" id="126941">methotrexate</mark> ( <mark style="background-color:lightgreen;" id="P80719,Q13505">MTX</mark> ) in rheumatoid arthritis (RA).
18371961-849	Because <mark style="background-color:lightgreen;" id="P08758,P14668,P17153,P48036,P70075,P81287,Q4R4H7,Q5R1W0">annexin V</mark> <mark style="background-color:orange;">binds</mark> <mark style="background-color:lightblue;" id="445141,6323481,44147587">phosphatidylserine</mark>, this study is using this feature to select functional spermatozoa.
18414974-853	<mark style="background-color:lightblue;" id="23973">Cadmium</mark> exposure <mark style="background-color:orange;">diminished</mark> the activities of enzymatic antioxidants, <mark style="background-color:lightgreen;" id="O50258">superoxide dismutase</mark> ( <mark style="background-color:lightgreen;" id="O12933,O22668,O75007,P24705,P51547,P93258,Q01137,Q27666,Q9SM64">SOD</mark> ), <mark style="background-color:lightgreen;" id="O24339,O52762,O62839,O68146,O77229,O93662,O97492,P00432,P04040,P04762,P07145,P0A323,P0A324,P0A325,P0A326,P0A327,P11934,P17336,P24168,P24270,P25890,P29422,P30265,P30266,P32290,P42321,P44390,P45737,P45739,P55304,P55306,P55310,P55311,P55313,P77872,P81138,P90682,Q27710,Q49XC1,Q4L643,Q59296,Q59337,Q59602,Q59714,Q5HG86,Q5HPK8,Q5RF10,Q64405,Q6G9M4,Q6GH72,Q7A5T2,Q8CPD0,Q8FWU0,Q8NWV5,Q8X1P0,Q8Y3P9,Q926X0,Q99UE2,Q9AXH0,Q9KW19,Q9L4S1,Q9M5L6,Q9PT92,Q9PWF7,Q9Z598,Q9ZKX5,Q9ZN99">catalase</mark> ( <mark style="background-color:lightgreen;" id="O62839,O97492,P00432,P00485,P00486,P00487,P04040,P06135,P07641,P11504,P20074,P22782,P25309,P25819,P26825,P26826,P32796,P36882,P36883,P43155,P47934,P49417,P52826,P58777,P62577,P62578,P62579,P62580,P90682,Q00614,Q02736,Q03058,Q5RF10,Q64405,Q704S8,Q9M5L6,Q9PWF7">CAT</mark> ), <mark style="background-color:lightgreen;" id="O04437,O18598,P0A9D2,P0A9D3,P30116,P44521,P46088,P46419,P46423,P46426,P46428,P46437,P48438,P80894,P81065,P82996,P82997,P82998,P82999,P83000,P83001,P83246,Q04522,Q08392,Q08393,Q0ZS46,Q7REH6,Q8ILQ7,Q8MU52,Q96324">glutathione-S-transferase</mark> ( <mark style="background-color:lightgreen;" id="P20432,P30104,P30106,P30107,P30108,Q04522,Q0ZS46,Q7REH6,Q8ILQ7,Q8MU52">GST</mark> ), <mark style="background-color:lightgreen;" id="O15770,P06715,P11804,P23189,P41921,P43783,P48638,P48639,P70619,P78965,Q60151,Q6BPI1,Q6C5H4,Q6FRV2,Q6HA23,Q74ZK4,Q873E8,Q94655">glutathione reductase</mark> (GR), <mark style="background-color:lightgreen;" id="O32770,O59858,Q00277,Q9CFV1">glutathione peroxidase</mark> (GPx) and <mark style="background-color:lightblue;" id="5958,439284,439427,439958">glucose-6-phosphate</mark> dehydrogenase ( <mark style="background-color:lightgreen;" id="O00091,O24357,O51581,O54537,O55044,O68282,O83491,O84188,P05370,P0A584,P0A585,P0A586,P0A587,P0AC53,P0AC54,P11410,P11411,P11412,P11413,P12646,P15588,P21907,P29686,P37830,P37986,P41571,P41764,P44311,P48826,P48828,P48848,P48992,P54547,P54996,P56110,P57405,P73411,P77809,P80619,P97324,Q00612,Q23711,Q24625,Q25019,Q25537,Q27464,Q27638,Q29492,Q42919,Q43793,Q43839,Q7YS37,Q89AI7,Q8K9M2,Q8XCJ6,Q9PKK8,Q9X0N9,Q9Z3S2,Q9Z8U6,Q9ZKB2">G6PD</mark> ) as well as non-enzymatic antioxidant, <mark style="background-color:lightblue;" id="124886">reduced glutathione</mark> (<mark style="background-color:lightblue;" id="124886">GSH</mark>) and total thiols.
18414974-854	On the other hand, the levels of <mark style="background-color:lightblue;" id="975,65359">oxidized glutathione</mark> (<mark style="background-color:lightblue;" id="65359">GSSG</mark>), lipid peroxidation, protein carbonylation, DNA fragmentation, concentration of <mark style="background-color:lightblue;" id="5359597">superoxide</mark> radicals and activities of <mark style="background-color:lightgreen;" id="O08469">cytochrome P450</mark> enzymes ( <mark style="background-color:lightgreen;" id="P21568,P21569,P24525,P34887,Q26551">CYP</mark> P450s) have been found to <mark style="background-color:orange;">increase</mark> due to <mark style="background-color:lightblue;" id="23973">cadmium</mark> intoxication.
18068871-859	<mark style="background-color:lightgreen;" id="O12976,P49768,P49769,P79802,P97887,Q4JIM4,Q5R780,Q6RH31,Q8HXW5,Q9W6T7,Q9XT97">Presenilin-1</mark> mutation <mark style="background-color:orange;">impairs</mark> cholinergic modulation of synaptic plasticity and <mark style="background-color:orange;">suppresses</mark> <mark style="background-color:lightblue;" id="22880">NMDA</mark> currents in hippocampus slices.
18398609-866	Inhibition of <mark style="background-color:lightgreen;" id="P0ABF6,P0ABF7,P19079,P32320,P44325,P47298,P47718,P56389,P75051,Q06549,Q322V3,Q32EM3,Q3IBX5,Q3Z062,Q4QK60,Q57MF5,Q5E4R6,Q5PE68,Q65RG8,Q66C79,Q6D3B4,Q6LRI0,Q7MK48,Q7N6K3,Q7VMJ6,Q87Q52,Q8DA31,Q8EDG1,Q8FFV3,Q8X648,Q8Z5A8,Q8ZG08,Q8ZNM0,Q9CP11,Q9KD53,Q9KSM5,Q9S3M0">cytidine deaminase</mark> by <mark style="background-color:lightblue;" id="100016,328839,16760709,46783268">zebularine</mark> <mark style="background-color:orange;">enhances</mark> the antineoplastic action of <mark style="background-color:lightblue;" id="451668">5-aza-2'-deoxycytidine</mark>.
18398611-867	An individual's response to <mark style="background-color:lightblue;" id="657237">fludarabine</mark> may be <mark style="background-color:orange;">influenced</mark> by the amount of <mark style="background-color:lightgreen;" id="P01730,P05542,P16003,P16004,P33705,P46630,P79184,P79185,Q08336,Q08338,Q08339,Q08340,Q29037,Q9XS78">CD4</mark> (+) and CD8(+) T-lymphocyte suppression.
18550164-868	The amino acid sequence deduced from the coding sequence encodes for <mark style="background-color:lightgreen;" id="P03161,P03610,P03631,P03632,P07394,P15966,P25243,P25244,P35823,P98005">a protein</mark> of 73 amino acids <mark style="background-color:orange;">containing</mark> 21 <mark style="background-color:lightblue;" id="594,5862,5360637">cysteine</mark> residues.
18437529-872	<mark style="background-color:lightgreen;" id="O25121,O67036,O83796,O84335,P0A554,P0A555,P26242,P45205,P54523,P57536,P57848,P73067,P77488,Q0S1H1,Q0SS05,Q0TKM1,Q0TPD8,Q0VMI4,Q11KE0,Q11NY7,Q12CQ9,Q13RX1,Q18B68,Q1BLY7,Q1C4I9,Q1CL87,Q1CUF6,Q1D3G4,Q1GCG4,Q1GQK9,Q1GZD7,Q1IZP0,Q1LK34,Q1LTI9,Q1MKN4,Q1MRB3,Q1QE74,Q1QQ40,Q1R1E5,Q1RFC0,Q21A74,Q21F93,Q21UG7,Q24V05,Q253R7,Q2A3D3,Q2GC13,Q2IPZ2,Q2IRL7,Q2JDD9,Q2JK64,Q2JTX2,Q2KBR2,Q2KZ15,Q2LUA7,Q2NV94,Q2P472,Q2RIB9,Q2SA08,Q2T7N5,Q2W367,Q2YCH7,Q2YMF0,Q30TC5,Q30Z99,Q31AZ2,Q325I1,Q32JH8,Q393P4,Q3A3Z6,Q3AAN0,Q3AJP8,Q3AXZ4,Q3B5P3,Q3BRW8,Q3II09,Q3JAD1,Q3JKA3,Q3K660,Q3KM28,Q3M4F6,Q3SKF1,Q3SUZ1,Q3Z4Y9,Q3Z8G9,Q3ZXC2,Q46L36,Q474C2,Q47BJ0,Q47NL9,Q487D3,Q48NX0,Q493G7,Q4FN07,Q4FV64,Q4JVB5,Q4K5A5,Q4QKG6,Q4UW29,Q4ZYU8,Q50000,Q57ET1,Q57SE2,Q5E6Z0,Q5FAI2,Q5FUB1,Q5H1A0,Q5HWF0,Q5L6H4,Q5LH44,Q5LX42,Q5NG39,Q5P228,Q5PFR6,Q5QVE8,Q5SMD7,Q5WF63,Q5YTA2,Q60AN1,Q62DU1,Q635A7,Q63JF4,Q64Y02,Q65HJ2,Q65TP4,Q66DV4,Q67NB6,Q6A8V3,Q6AFD5,Q6AJQ1,Q6D844,Q6F7N5,Q6G0D4,Q6G4D1,Q6HDY8,Q6LU07,Q6MDK6,Q6NB76,Q6NGV3,Q71ZV7,Q72CD3,Q72H81,Q72U01,Q731B7,Q73LF4,Q73W57,Q75TB7,Q7M7Z0,Q7MN49,Q7MSZ3,Q7N0J7,Q7NP63,Q7NUK5,Q7U6P6,Q7UWB7,Q7V1G6,Q7V7Q3,Q7VC14,Q7VIJ7,Q7VNP7,Q7VRH9,Q7VV87,Q7W7Q0,Q7WL37,Q818R9,Q81M54,Q823V1,Q82VD3,Q83G46,Q83I20,Q83SG2,Q87C03,Q87RU0,Q889Q1,Q88QG7,Q894H0,Q89RW1,Q8A0C2,Q8D357,Q8DFA3,Q8DL74,Q8EGR9,Q8EWX7,Q8F153,Q8FKB9,Q8FPI2,Q8G292,Q8GAA0,Q8K9A1,Q8KFI9,Q8NPB2,Q8P815,Q8PJG7,Q8R639,Q8RAC5,Q8UHD7,Q8XE76,Q8XJE1,Q8XX95,Q8Y7C1,Q8YFM2,Q8YZ80,Q8Z8X3,Q8ZC45,Q8ZRD1,Q92BZ0,Q92RJ1,Q97HD5,Q985Y3,Q9A6M5,Q9JW13,Q9JXV7,Q9K971,Q9KGU7,Q9KTL3,Q9PB95,Q9PIH8,Q9PK62,Q9R6S7,Q9RBN6,Q9RUB5,Q9X291,Q9Z6J9,Q9ZM94">1-Deoxy-D-xylulose-5-phosphate synthase</mark> (DXS) <mark style="background-color:orange;">catalyses</mark> the first committed step of the 2C-methyl-<mark style="background-color:lightblue;" id="192838,3262721">D-erythritol-4-phosphate</mark> (<mark style="background-color:lightblue;" id="7728">MEP</mark>) pathway, which is an alternative isoprenoids biosynthetic route that has been recently discovered.
18497703-873	Effects of inhibition of <mark style="background-color:lightgreen;" id="O54705,O61309,O61608,Q26240,Q28969,Q9I9M2">NOS</mark> , <mark style="background-color:lightgreen;" id="O19114,O46660,O54705,O62699,P29477,P35228,P79290,Q06518,Q27995,Q28314,Q90703,Q92037,Q92091">iNOS</mark> , and <mark style="background-color:lightgreen;" id="O19132,O61309,P29475,P29476,Q9Z0J4">nNOS</mark> by N-nitro-<mark style="background-color:lightblue;" id="92932,550788">L-arginine methyl ester</mark> (L-NAME), <mark style="background-color:lightblue;" id="2146">aminoguanidine</mark>, and <mark style="background-color:lightblue;" id="1893">7-nitroindazole</mark>, respectively, were determined on the antigen-induced systemic hypotension and portal hypertension in conscious Sprague-Dawley rats <mark style="background-color:orange;">sensitized</mark> with the <mark style="background-color:lightgreen;" id="O73860,P01012,P19104,Q6V115">ovalbumin</mark> antigen.
18544044-880	In this study, we tested the hypothesis that the Angiopoietin 1 ( <mark style="background-color:lightgreen;" id="P21570">Ang1</mark> )/ <mark style="background-color:lightgreen;" id="O73791,Q02858">Tie2</mark> pathway <mark style="background-color:orange;">mediates</mark> <mark style="background-color:lightblue;" id="54454,4677798">simvastatin</mark>-induced vascular integrity and migration of neuroblasts after stroke.
18544044-881	<mark style="background-color:lightblue;" id="54454,4677798">Simvastatin</mark> treatment significantly <mark style="background-color:orange;">decreased</mark> blood-brain barrier (BBB) leakage and concomitantly, <mark style="background-color:orange;">increased</mark> <mark style="background-color:lightgreen;" id="P21570">Ang1</mark> , <mark style="background-color:lightgreen;" id="O73791,Q02858">Tie2</mark> and <mark style="background-color:lightgreen;" id="Q16625,Q28269,Q28793,Q5RFS5,Q61146,Q6P6T5,Q91049,Q9PUN1">Occludin</mark> expression in the ischaemic border (IBZ) compared to the MCAo control group.
18544044-882	<mark style="background-color:lightblue;" id="54454,4677798">Simvastatin</mark> also significantly <mark style="background-color:orange;">increased</mark> doublecortin ( <mark style="background-color:lightgreen;" id="O43602">DCX</mark> , a marker of migrating neuroblasts) expression in the IBZ compared to control MCAo rats.
18544044-883	The data show that <mark style="background-color:lightblue;" id="54454,4677798">simvastatin</mark> treatment of RBMEC <mark style="background-color:orange;">increased</mark> <mark style="background-color:lightgreen;" id="P21570">Ang1</mark> and <mark style="background-color:lightgreen;" id="O73791,Q02858">Tie2</mark> gene and protein expression and promoted phosphorylated- <mark style="background-color:lightgreen;" id="O73791,Q02858">Tie2</mark> activity.
18544044-884	<mark style="background-color:lightblue;" id="54454,4677798">Simvastatin</mark> treatment of stroke <mark style="background-color:orange;">increases</mark> <mark style="background-color:lightgreen;" id="P21570">Ang1</mark> / <mark style="background-color:lightgreen;" id="O73791,Q02858">Tie2</mark> expression and thereby reduces BBB leakage and promotes vascular stabilization.
18544044-885	<mark style="background-color:lightgreen;" id="P21570">Ang1</mark> / <mark style="background-color:lightgreen;" id="O73791,Q02858">Tie2</mark> expression <mark style="background-color:orange;">induced</mark> by <mark style="background-color:lightblue;" id="54454,4677798">simvastatin</mark> treatment promotes neuroblast micro-vascular coupling after stroke.
18544047-888	Suppressing the activity of <mark style="background-color:lightgreen;" id="O08580,P11474">ERRalpha</mark> in 3T3-L1 adipocytes <mark style="background-color:orange;">reduces</mark> mitochondrial biogenesis but <mark style="background-color:orange;">enhances</mark> <mark style="background-color:yellow;" id="GO:0006096,biological_process">glycolysis</mark> and basal <mark style="background-color:lightblue;" id="206,5793,64689,79025">glucose</mark> uptake.
18544047-891	Therefore, <mark style="background-color:lightgreen;" id="O08580,P11474">ERRalpha</mark> stands at the crossroad of <mark style="background-color:lightblue;" id="206,5793,64689,79025">glucose</mark> and fatty acid utilization and <mark style="background-color:orange;">acts</mark> as a homeostatic switch to <mark style="background-color:orange;">regulate</mark> the flux of <mark style="background-color:lightgreen;" id="P56626">TCA</mark> cycle, <mark style="background-color:yellow;" id="GO:0005740,cellular_component">mitochondrial membrane</mark> potential and <mark style="background-color:yellow;" id="GO:0006096,biological_process">glycolysis</mark> to <mark style="background-color:orange;">maintain</mark> a steady <mark style="background-color:orange;">level</mark> of <mark style="background-color:lightblue;" id="5957">ATP</mark> production, particularly, when mitochondrial biogenesis is reduced.
18437557-896	To get insight into the underlying mechanisms, we compared the ability of recombinant wild type and variant (D327N) <mark style="background-color:lightgreen;" id="P04278,P08689,P15196,P97497,Q62588">SHBG</mark> to <mark style="background-color:orange;">influence</mark> <mark style="background-color:lightblue;" id="5757">estradiol</mark> effects in MCF-7 breast cancer cells.
18437557-897	D327N <mark style="background-color:lightgreen;" id="P04278,P08689,P15196,P97497,Q62588">SHBG</mark> was more effective than wild type protein in <mark style="background-color:orange;">inhibiting</mark> <mark style="background-color:lightblue;" id="5757">estradiol</mark>-induced <mark style="background-color:yellow;" id="GO:0008283,biological_process">cell proliferation</mark> and <mark style="background-color:yellow;" id="GO:0006916,biological_process">anti-apoptosis</mark> .
18222543-918	The protective effects of novel synthetic organoselenium compounds (Se I and Se II) against <mark style="background-color:lightblue;" id="6001">DMBA</mark>-induced <mark style="background-color:orange;">changes</mark> in <mark style="background-color:orange;">levels</mark> of some [ <mark style="background-color:lightgreen;" id="O50258">superoxide dismutase</mark> ( <mark style="background-color:lightgreen;" id="O12933,O22668,O75007,P24705,P51547,P93258,Q01137,Q27666,Q9SM64">SOD</mark> ), <mark style="background-color:lightgreen;" id="O24339,O52762,O62839,O68146,O77229,O93662,O97492,P00432,P04040,P04762,P07145,P0A323,P0A324,P0A325,P0A326,P0A327,P11934,P17336,P24168,P24270,P25890,P29422,P30265,P30266,P32290,P42321,P44390,P45737,P45739,P55304,P55306,P55310,P55311,P55313,P77872,P81138,P90682,Q27710,Q49XC1,Q4L643,Q59296,Q59337,Q59602,Q59714,Q5HG86,Q5HPK8,Q5RF10,Q64405,Q6G9M4,Q6GH72,Q7A5T2,Q8CPD0,Q8FWU0,Q8NWV5,Q8X1P0,Q8Y3P9,Q926X0,Q99UE2,Q9AXH0,Q9KW19,Q9L4S1,Q9M5L6,Q9PT92,Q9PWF7,Q9Z598,Q9ZKX5,Q9ZN99">catalase</mark> ( <mark style="background-color:lightgreen;" id="O62839,O97492,P00432,P00485,P00486,P00487,P04040,P06135,P07641,P11504,P20074,P22782,P25309,P25819,P26825,P26826,P32796,P36882,P36883,P43155,P47934,P49417,P52826,P58777,P62577,P62578,P62579,P62580,P90682,Q00614,Q02736,Q03058,Q5RF10,Q64405,Q704S8,Q9M5L6,Q9PWF7">CAT</mark> ), <mark style="background-color:lightgreen;" id="O32770,O59858,Q00277,Q9CFV1">glutathione peroxidase</mark> (GPx), and <mark style="background-color:lightgreen;" id="O15770,P06715,P11804,P23189,P41921,P43783,P48638,P48639,P70619,P78965,Q60151,Q6BPI1,Q6C5H4,Q6FRV2,Q6HA23,Q74ZK4,Q873E8,Q94655">glutathione reductase</mark> (GR) activities and total <mark style="background-color:lightblue;" id="124886">glutathione</mark> (<mark style="background-color:lightblue;" id="124886">GSH</mark>), malonedialdehyde (MDA)] parameters in rat lung and kidney were investigated.
18503570-926	From the known regulatory mechanisms of Arc expression, HFD reduced <mark style="background-color:lightgreen;" id="P35439,Q9R1M7">N-methyl-D-aspartate receptor</mark> (NMDAR) activity, as seen by <mark style="background-color:orange;">decreases</mark> in <mark style="background-color:lightblue;" id="1153,6057,5460803">tyrosine</mark> <mark style="background-color:yellow;" id="GO:0016310,biological_process">phosphorylation</mark> of <mark style="background-color:lightgreen;" id="P35436,Q00959,Q12879,Q5IS45">NMDAR2A</mark> and <mark style="background-color:orange;">levels</mark> of <mark style="background-color:lightgreen;" id="Q05586,Q5R1P0">NMDAR1</mark> .
18503570-927	Additionally, we demonstrated that <mark style="background-color:lightblue;" id="99470,123976,50990021">27-hydroxycholesterol</mark>, a <mark style="background-color:lightblue;" id="304,5997,6432564,11025495">cholesterol</mark> metabolite that <mark style="background-color:orange;">enters</mark> the brain from the blood, <mark style="background-color:orange;">decreases</mark> Arc <mark style="background-color:orange;">levels</mark> as well as NMDAR and <mark style="background-color:lightgreen;" id="P05480,Q9WUD9">Src</mark>  <mark style="background-color:yellow;" id="GO:0016301,molecular_function">kinase activities</mark> in rat primary hippocampal neurons.
18472187-928	To decrease the level of androgen <mark style="background-color:lightblue;" id="6013">testosterone</mark> in the prostate, we are interested in <mark style="background-color:orange;">developing</mark> inhibitors of <mark style="background-color:lightgreen;" id="P42330,Q5R7C9">17beta-hydroxysteroid dehydrogenase type 5</mark> ( <mark style="background-color:lightgreen;" id="P42330,P70694,Q5R7C9">17beta-HSD5</mark> ).
18410982-929	<mark style="background-color:lightblue;" id="79101">Gly-Pro</mark>-, <mark style="background-color:lightblue;" id="79101">Gly-Pro</mark>-Met- and Ala-<mark style="background-color:lightblue;" id="2080">Ala-Phe</mark>-N'-(2-<mark style="background-color:lightblue;" id="8576">hexyl</mark>-1,3-<mark style="background-color:lightblue;" id="104785,6381339">dioxo</mark>-2,3-dihydro-1H-benzo[de]isoquinolin-6-yl)-hydrazides are <mark style="background-color:orange;">synthesized</mark> by <mark style="background-color:lightblue;" id="3520">guanidinium</mark>/uronium type condensing reagent and <mark style="background-color:orange;">used</mark> as fluorogenic substrates to localize <mark style="background-color:lightgreen;" id="P14740,P22411,P27487,P28843,P81425,Q9N2I7">dipeptidyl peptidase IV</mark> and <mark style="background-color:lightgreen;" id="O14773,O89023,Q5IS74,Q5RFL1,Q60HH1,Q71JP6,Q9EQV6,Q9XSB8">tripeptidyl peptidase I</mark> activities in mammalian tissue sections.
18179560-930	The long pentraxin 3 ( <mark style="background-color:lightgreen;" id="O75364,P26022">PTX3</mark> ) is a multifunctional soluble pattern recognition receptor, involved in several <mark style="background-color:orange;">processes</mark> ranging from innate resistance and inflammation to clearance of apoptotic cells and organization of <mark style="background-color:lightblue;" id="24759,453618,3084050,24728612">hyaluronic acid</mark>-rich <mark style="background-color:yellow;" id="GO:0005576,cellular_component">extracellular</mark> matrices.
18436348-931	A new series of <mark style="background-color:lightblue;" id="6735">indanone</mark> and aurone derivatives have been <mark style="background-color:orange;">synthesized</mark> and tested for in vitro <mark style="background-color:lightgreen;" id="O42275,O62763,P04058,P07140,P07692,P21836,P22303,P23795,P36196,P37136,P56161,Q27677,Q29499,Q867X2,Q867X3,Q869C3,Q86GC8,Q86GC9,Q92035,Q92081,Q9DDE3">AChE</mark> inhibitory activity by modified Ellman method.
18177531-936	<mark style="background-color:lightblue;" id="281">Carbon monoxide</mark> is an endogenous vasodilator gas <mark style="background-color:orange;">produced</mark> by the enzyme <mark style="background-color:lightgreen;" id="O19998,O73688,O78497,P51271,P71119">heme oxygenase</mark> (HO).
17616381-938	The <mark style="background-color:lightgreen;" id="O41798,O89290,O89940,O91080,O93215,P03311,P03353,P03355,P03356,P03362,P03363,P03366,P03367,P03369,P03370,P04023,P04024,P04323,P04584,P04585,P04587,P04588,P04589,P05959,P05960,P05961,P05962,P07570,P0C210,P0C211,P10210,P10265,P10270,P10271,P10272,P10273,P10274,P10394,P10978,P11227,P11365,P12451,P12497,P12498,P12499,P14074,P14078,P15833,P16046,P16423,P16901,P17757,P18042,P18096,P18802,P19028,P19199,P19560,P19561,P20825,P20875,P20876,P20892,P21407,P21414,P24107,P24740,P26808,P26809,P26810,P27502,P28936,P31822,P35956,P35963,P51518,P63119,P63120,P63121,P63122,P63123,P63124,P63125,P63127,P63128,P63129,P63131,P84454,Q09SZ9,Q0R5R2,Q0R5R3,Q1A249,Q1A267,Q4U0X6,Q73368,Q74120,Q75002,Q76634,Q77373,Q79666,Q89928,Q8AII1,Q8I7P9,Q9IDV9,Q9Q720,Q9QBY3,Q9QBZ1,Q9QBZ5,Q9QSR3,Q9WC54,Q9WC63,Q9Y6I0">protease</mark> was purified to homogeneity <mark style="background-color:orange;">using</mark> <mark style="background-color:lightblue;" id="223">ammonium</mark> <mark style="background-color:lightblue;" id="1117">sulfate</mark> precipitation, and ion exchange chromatography with a fold purification of 1.8 and a recovery of 49%.
18509327-948	However, the simultaneous presence of the <mark style="background-color:lightgreen;" id="P08684">CYP3A4</mark> *1B and <mark style="background-color:lightgreen;" id="P20815">CYP3A5</mark> *1A alleles was <mark style="background-color:orange;">associated</mark> with a 64% <mark style="background-color:orange;">increase</mark> in <mark style="background-color:lightblue;" id="148124">docetaxel</mark> clearance (P = 0.0015), independent of both sex and CYP3A activity (as determined <mark style="background-color:orange;">using</mark> the <mark style="background-color:lightblue;" id="12560">erythromycin</mark> breath test).
18415121-949	The discovery of the <mark style="background-color:lightgreen;" id="P26677,P26678,P61012,P61013,P61015">PLN</mark> / <mark style="background-color:lightgreen;" id="O00165,O35387">HAX-1</mark> interaction therefore unveils an important new <mark style="background-color:orange;">link</mark> between <mark style="background-color:lightblue;" id="271">Ca(2</mark>+) <mark style="background-color:yellow;" id="GO:0042592,biological_process">homeostasis</mark> and cell survival, with significant therapeutic potential.
18485500-951	Platelet reactivity and <mark style="background-color:lightblue;" id="2806,60606">clopidogrel</mark> resistance are <mark style="background-color:orange;">associated</mark> with the H2 haplotype of the <mark style="background-color:lightgreen;" id="Q95KC3,Q9CPV9,Q9EPX4,Q9H244">P2Y12</mark> - <mark style="background-color:lightgreen;" id="P02783">ADP</mark> receptor gene.
18449944-953	Alumina ceramic particles, in comparison with <mark style="background-color:lightblue;" id="23963">titanium</mark> particles, hardly <mark style="background-color:orange;">affect</mark> the expression of <mark style="background-color:lightgreen;" id="Q9Y6Q6">RANK</mark> -, <mark style="background-color:lightgreen;" id="O35734,O77510,O77764,P01375,P04924,P06804,P13296,P16599,P19101,P23383,P23563,P29553,P33620,P36939,P48094,P51435,P51742,P51743,P59684,P59693,P59694,P59695,P79337,P79374,Q06599,Q19LH4,Q1G1A2,Q1WM27,Q2MH05,Q539C2,Q75N23,Q8HZD9,Q8JFG3,Q8MKG8,Q8WNR1,Q9BEA1">TNF-alpha</mark> -, and <mark style="background-color:lightgreen;" id="O00300">OPG</mark> -mRNA in the <mark style="background-color:lightgreen;" id="P07911,P10070,P27590,P48733,Q862Z3,Q91X17">THP</mark> -1 human monocytic cell line.
18534874-957	<mark style="background-color:lightblue;" id="5329102">Sunitinib malate</mark> (Pfizer, Inc.) is a multitargeted kinase inhibitor that <mark style="background-color:orange;">inhibits</mark> vascular endothelial growth factor ( <mark style="background-color:lightgreen;" id="P15691,P15692,P26617,P49151,P50412,P67964,P67965,Q99PS1,Q9GKR0,Q9MYV3">VEGF</mark> ) receptor (R)-1, 2 and 3, platelet-derived growth factor receptors (PDGFR)-alpha and beta, <mark style="background-color:lightgreen;" id="Q00342">Flt3</mark> , <mark style="background-color:lightgreen;" id="P07949">RET</mark> , and Kit.
17968676-958	<mark style="background-color:lightgreen;" id="O02768,O19183,O62698,O62725,P27607,P35354,P35355,P70682,P79208,Q05769">Cyclooxygenase-2</mark> ( <mark style="background-color:lightgreen;" id="P00411,P24894,P35355,Q05769,Q8HEC3,Q8SEM9">Cox-2</mark> ) is a key enzyme in the conversion of <mark style="background-color:lightblue;" id="444899">arachidonic acid</mark> to prostaglandins that has been shown to have a particular importance in the progression of several malignancies <mark style="background-color:orange;">including</mark> nasopharyngeal carcinoma ( <mark style="background-color:lightgreen;" id="P82535">NPC</mark> ).
18497709-959	We also previously demonstrated that <mark style="background-color:lightblue;" id="738,5961">glutamine</mark> ( <mark style="background-color:lightgreen;" id="Q12613,Q42624,Q9XQ94">GLN</mark> ) significantly <mark style="background-color:orange;">induced</mark> <mark style="background-color:lightgreen;" id="P06762,P09601,P14791,P14901,P32394,Q5E9F2">HO-1</mark> in the lower intestinal tract.
18497709-961	<mark style="background-color:lightblue;" id="738,5961">Glutamine</mark> treatment before <mark style="background-color:lightblue;" id="5047209,46173182">HS</mark> (MAP of 30 mmHg for 60 min) significantly ameliorated <mark style="background-color:lightblue;" id="5047209,46173182">HS</mark>-induced mucosal inflammation and apoptotic <mark style="background-color:yellow;" id="GO:0008219,biological_process">cell death</mark> in the ileum, as judged by significant <mark style="background-color:orange;">decreases</mark> in gene expression of <mark style="background-color:lightgreen;" id="O35734,O77510,O77764,P01375,P04924,P06804,P13296,P16599,P19101,P23383,P23563,P29553,P33620,P36939,P48094,P51435,P51742,P51743,P59684,P59693,P59694,P59695,P79337,P79374,Q06599,Q19LH4,Q1G1A2,Q1WM27,Q2MH05,Q539C2,Q75N23,Q8HZD9,Q8JFG3,Q8MKG8,Q8WNR1,Q9BEA1">TNF-alpha</mark> , <mark style="background-color:lightgreen;" id="O19114,O46660,O54705,O62699,P29477,P35228,P79290,Q06518,Q27995,Q28314,Q90703,Q92037,Q92091">iNOS</mark> , intercellular adhesion molecule 1, and vascular <mark style="background-color:yellow;" id="GO:0007155,biological_process">cell adhesion</mark> molecule 1, myeloperoxidase activity, the number of infiltrated neutrophils, DNA fragmentation by in situ oligo ligation assay, and <mark style="background-color:orange;">activated</mark> caspase-3 expression, and by <mark style="background-color:orange;">increases</mark> in gene expression of <mark style="background-color:lightgreen;" id="O46673,O97798,P18893,P22301,P29456,P43480,P46651,P47965,P48411,P51496,P51497,P51746,P55029,P79338,Q0Z972,Q25BC1,Q28374,Q29055,Q29408,Q2PE73,Q5Q0V6,Q865X4,Q8MKG9,Q9JHK7,Q9TSJ4,Q9Z1Y5">IL-10</mark> and <mark style="background-color:lightgreen;" id="P10417,P49950">Bcl-2</mark> .
18497709-964	<mark style="background-color:lightblue;" id="738,5961">Glutamine</mark> treatment may thus <mark style="background-color:orange;">protect</mark> mucosal cells from <mark style="background-color:lightblue;" id="5047209,46173182">HS</mark>-induced oxidative <mark style="background-color:orange;">damage</mark> via the anti-inflammatory and antiapoptotic properties of <mark style="background-color:lightgreen;" id="P06762,P09601,P14791,P14901,P32394,Q5E9F2">HO-1</mark> .
18482727-966	Interestingly, <mark style="background-color:lightblue;" id="60823">atorvastatin</mark> <mark style="background-color:orange;">inhibited</mark> the expression of ICAM and <mark style="background-color:lightgreen;" id="P10148,P13500,P14844,P28291,P28292,P42831,P52203,P61274,P61275,Q08782,Q9TTQ3">MCP-1</mark> , followed by the suppression of macrophage recruitment into the aortic wall at 1 week after operation.
18482727-967	In addition, synthesis of <mark style="background-color:yellow;" id="GO:0005581,cellular_component">collagen</mark> and <mark style="background-color:lightgreen;" id="P11547">elastin</mark> in the vascular wall were significantly <mark style="background-color:orange;">increased</mark> by <mark style="background-color:lightblue;" id="60823">atorvastatin</mark>.
18390571-968	Recent studies suggest that crystals of <mark style="background-color:lightblue;" id="1175">monosodium urate</mark> (MSU), deposited in joints of patients with acute gouty arthritis, <mark style="background-color:orange;">activate</mark> the NACHT domain, <mark style="background-color:lightblue;" id="857,6106,439524">leucine</mark>-rich repeat and <mark style="background-color:lightgreen;" id="O15553,Q9JJ25,Q9JJ26">pyrin</mark> domain-containing protein (NALP)3 inflammasome.
18466349-969	Decreased hepatic <mark style="background-color:lightgreen;" id="P02753,P06912,P18902,P27485,P41263,P61641,Q28369">RBP4</mark>  <mark style="background-color:yellow;" id="GO:0046903,biological_process">secretion</mark> is correlated with <mark style="background-color:orange;">reduced</mark> hepatic <mark style="background-color:lightblue;" id="206,5793,64689,79025">glucose</mark> production but is not <mark style="background-color:orange;">associated</mark> with <mark style="background-color:lightgreen;" id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">insulin</mark> resistance in patients with liver cirrhosis.
18466352-971	<mark style="background-color:lightblue;" id="6442177">RAD001</mark>-induced growth suppression was <mark style="background-color:orange;">associated</mark> with inactivation of downstream <mark style="background-color:orange;">targets</mark> of <mark style="background-color:lightgreen;" id="P42345,P42346,Q9JLN9">mTOR</mark> , reduction in <mark style="background-color:lightgreen;" id="P15691,P15692,P26617,P49151,P50412,P67964,P67965,Q99PS1,Q9GKR0,Q9MYV3">VEGF</mark> expression and microvessel density, inhibition of <mark style="background-color:yellow;" id="GO:0008283,biological_process">cell proliferation</mark> , up-regulation of <mark style="background-color:lightgreen;" id="O11451,O11452,O11453,O39927,O39928,O39929,O91936,O92529,O92530,O92531,O92532,P06934,P16342,P19751,P25880,P25881,P25882,P25884,P25989,P26660,P26661,P26662,P26663,P26664,P27958,P29833,P29846,P29996,P29997,P40305,P68763,P68764,P68765,P69180,P69181,P69182,P69183,P69184,P69618,P69619,Q00269,Q43735,Q5I2N3,Q66198,Q68749,Q68798,Q68801,Q81258,Q81487,Q81495,Q81754,Q81835,Q81842,Q8V439,Q8V6W7,Q913D4,Q91A29,Q91DH7,Q91DH8,Q91DH9,Q99IB8,Q9DHD6,Q9E925,Q9PYA3,Q9QAX1,Q9WMX2">p27</mark> (Kip1) and down-regulation of <mark style="background-color:lightgreen;" id="O19002,O39927,O39928,O39929,O91936,O92529,O92530,O92531,O92532,P26660,P26661,P26662,P26663,P26664,P27954,P27955,P27956,P27957,P27958,P27959,P27960,P27961,P29846,P38936,P39689,P61585,P63028,Q00269,Q01403,Q01404,Q07828,Q11118,Q42580,Q5EG65,Q5I2N3,Q62092,Q68749,Q68798,Q68801,Q81258,Q81487,Q81495,Q81754,Q913D4,Q99IB8,Q9DHD6,Q9QAX1,Q9WMX2">p21</mark> ( <mark style="background-color:lightgreen;" id="O42923,P39689">Cip1</mark> / <mark style="background-color:lightgreen;" id="P39689">Waf1</mark> ), <mark style="background-color:lightgreen;" id="O05982">Cdk</mark> -6, <mark style="background-color:lightgreen;" id="O05982">Cdk</mark> -2, <mark style="background-color:lightgreen;" id="O05982">Cdk</mark> -4, cdc-25C, <mark style="background-color:lightgreen;" id="O01377,O16852,P04961,P12004,P17070,P17917,P17918,P18248,P22177,P24314,P31008,P53358,P61074,Q00265,Q00268">cyclin</mark> B1 and <mark style="background-color:lightgreen;" id="P01109,P06646,P49709,P52160,Q17103">c-Myc</mark> .
18443829-973	The hydrolysis reaction of <mark style="background-color:lightblue;" id="75834">p-nitrophenyl butyrate</mark> <mark style="background-color:orange;">catalyzed</mark> by <mark style="background-color:lightgreen;" id="Q7M4U7">lipases</mark> was followed with in situ UV/vis diode array spectrophotometry.
18437699-978	Our results suggest that <mark style="background-color:lightblue;" id="934">Ni(II</mark>)-induced changes in <mark style="background-color:yellow;" id="GO:0050663,biological_process">cytokine secretion</mark> by monocytes are diverse and may be <mark style="background-color:orange;">influenced</mark> by <mark style="background-color:lightgreen;" id="O54968,Q60795">Nrf2</mark> but are not likely influenced by <mark style="background-color:orange;">changes</mark> in whole-cell <mark style="background-color:lightgreen;" id="O14463,P29445,Q8KEA4">Trx1</mark> levels.
17768029-984	<mark style="background-color:lightblue;" id="5781">Alloxan</mark> is believed to confer its diabetogenic <mark style="background-color:orange;">effect</mark> by <mark style="background-color:orange;">inhibiting</mark> pancreatic <mark style="background-color:lightgreen;" id="O25731,P0A4E1,P0A4E2,P0A6V8,P0A6V9,P17712,P21908,P35557,P52792,P54495,P58616,P58617,P58618,P58619,P64253,P64254,P82680,Q55855,Q56198,Q59171,Q668N7,Q6D7C4,Q7N6Y0,Q83K86,Q87EG6,Q8FFD4,Q8FV09,Q8P8U7,Q8PKU2,Q8UIV7,Q8YDC6,Q92407,Q92T27,Q93IM5,Q98DM2,Q9A6N3,Q9HZ46,Q9KCZ4,Q9PEG4,Q9ZKB0">glucokinase</mark> activity, leading to pancreatic beta- <mark style="background-color:yellow;" id="GO:0008219,biological_process">cell death</mark> .
18431601-998	Permeabilization of K. marxianus cells in relation to <mark style="background-color:lightgreen;" id="O33815,O52629,O52847,P00722,P00723,P06219,P0C1Y0,P14288,P22498,P23989,P24131,P26257,P30812,P50388,P70753,P77989,P81650,Q1G9Z4,Q47077,Q48727,Q56307,Q59140,Q59750,Q9K9C6">beta-galactosidase</mark> activity was <mark style="background-color:orange;">carried</mark> out <mark style="background-color:orange;">using</mark> cetyltrimethyl <mark style="background-color:lightblue;" id="25514">ammonium bromide</mark> (<mark style="background-color:lightblue;" id="2681">CTAB</mark>) to avoid the problem of enzyme extraction.
18304632-1001	<mark style="background-color:lightgreen;" id="P00448,P66828,P66829,Q8Z2V9,Q9RUV2">MnSOD</mark> and two additional <mark style="background-color:lightgreen;" id="O24339,O52762,O62839,O68146,O77229,O93662,O97492,P00432,P04040,P04762,P07145,P0A323,P0A324,P0A325,P0A326,P0A327,P11934,P17336,P24168,P24270,P25890,P29422,P30265,P30266,P32290,P42321,P44390,P45737,P45739,P55304,P55306,P55310,P55311,P55313,P77872,P81138,P90682,Q27710,Q49XC1,Q4L643,Q59296,Q59337,Q59602,Q59714,Q5HG86,Q5HPK8,Q5RF10,Q64405,Q6G9M4,Q6GH72,Q7A5T2,Q8CPD0,Q8FWU0,Q8NWV5,Q8X1P0,Q8Y3P9,Q926X0,Q99UE2,Q9AXH0,Q9KW19,Q9L4S1,Q9M5L6,Q9PT92,Q9PWF7,Q9Z598,Q9ZKX5,Q9ZN99">catalase</mark> isozymes were <mark style="background-color:orange;">induced</mark> by <mark style="background-color:lightblue;" id="91739">quinclorac</mark> or <mark style="background-color:lightblue;" id="54960">bensulfuron-methyl</mark> in S. maltophilia <mark style="background-color:lightblue;" id="24832033">WZ2</mark>, but not in E. coli <mark style="background-color:lightgreen;" id="Q28706,Q64291,Q99456">K12</mark> .
18304632-1002	Results indicate that <mark style="background-color:lightgreen;" id="O24339,O52762,O62839,O68146,O77229,O93662,O97492,P00432,P04040,P04762,P07145,P0A323,P0A324,P0A325,P0A326,P0A327,P11934,P17336,P24168,P24270,P25890,P29422,P30265,P30266,P32290,P42321,P44390,P45737,P45739,P55304,P55306,P55310,P55311,P55313,P77872,P81138,P90682,Q27710,Q49XC1,Q4L643,Q59296,Q59337,Q59602,Q59714,Q5HG86,Q5HPK8,Q5RF10,Q64405,Q6G9M4,Q6GH72,Q7A5T2,Q8CPD0,Q8FWU0,Q8NWV5,Q8X1P0,Q8Y3P9,Q926X0,Q99UE2,Q9AXH0,Q9KW19,Q9L4S1,Q9M5L6,Q9PT92,Q9PWF7,Q9Z598,Q9ZKX5,Q9ZN99">catalase</mark> has a much weakly role in the defense against <mark style="background-color:lightblue;" id="91739">quinclorac</mark> or <mark style="background-color:lightblue;" id="54960">bensulfuron-methyl</mark> <mark style="background-color:orange;">induced</mark> oxidative stress, whereas <mark style="background-color:lightgreen;" id="O12933,O22668,O75007,P24705,P51547,P93258,Q01137,Q27666,Q9SM64">SOD</mark> could be critical.
18443897-1003	mRNA and protein levels of <mark style="background-color:lightgreen;" id="O35734,O77510,O77764,P01375,P04924,P06804,P13296,P16599,P19101,P23383,P23563,P29553,P33620,P36939,P48094,P51435,P51742,P51743,P59684,P59693,P59694,P59695,P79337,P79374,Q06599,Q19LH4,Q1G1A2,Q1WM27,Q2MH05,Q539C2,Q75N23,Q8HZD9,Q8JFG3,Q8MKG8,Q8WNR1,Q9BEA1">TNF-alpha</mark> , <mark style="background-color:lightgreen;" id="P25446,Q63199">Fas</mark> , and caspase-8, which are closely related to cell <mark style="background-color:yellow;" id="GO:0006915,biological_process">apoptosis</mark> by a <mark style="background-color:yellow;" id="GO:0016265,biological_process">death</mark> ligand/receptor-dependent <mark style="background-color:yellow;" id="GO:0006915,biological_process">apoptosis</mark> pathway, were <mark style="background-color:orange;">increased</mark> by <mark style="background-color:lightblue;" id="10918">L-carnitine</mark> treatment.
18443897-1004	In addition, <mark style="background-color:lightblue;" id="10918">L-carnitine</mark> treatment <mark style="background-color:orange;">regulated</mark> mitochondria-dependent <mark style="background-color:yellow;" id="GO:0006915,biological_process">apoptosis</mark> pathways by <mark style="background-color:orange;">inducing</mark> the up-regulation of caspase-9 and caspase-3 and the down-regulation of <mark style="background-color:lightgreen;" id="P10417,P49950">Bcl-2</mark> in hepa1c1c 7 cells.
18443897-1005	Taken together, the findings of this study have demonstrated that <mark style="background-color:lightblue;" id="10918">L-carnitine</mark> could <mark style="background-color:orange;">induce</mark> <mark style="background-color:yellow;" id="GO:0006915,biological_process">apoptosis</mark> in hepa1c1c7 cells by <mark style="background-color:orange;">regulating</mark> <mark style="background-color:lightgreen;" id="P36940,P41047,P48023,P63306,P63307,P63308,Q861W5,Q9BDN1,Q9BEA8">Fas ligands</mark> and <mark style="background-color:orange;">inhibiting</mark> the expression of <mark style="background-color:lightgreen;" id="P10417,P49950">Bcl-2</mark> .
18409068-1012	<mark style="background-color:lightblue;" id="10302451">AZD0530</mark> inhibited tumor growth in a manner independent of dose and <mark style="background-color:orange;">inhibited</mark> <mark style="background-color:yellow;" id="GO:0016310,biological_process">phosphorylation</mark> of <mark style="background-color:lightgreen;" id="Q00944,Q05397">FAK</mark> and <mark style="background-color:lightgreen;" id="P49023,P49024,Q5R7I1,Q66H76,Q8VI36">paxillin</mark> in a dose-dependent manner in a <mark style="background-color:lightgreen;" id="O35783,O35887">Calu</mark> -6 xenograft model.
18521740-1013	The androgen metabolite <mark style="background-color:lightblue;" id="242332">5alpha-androstane-3beta,17beta-diol</mark> (3betaAdiol) <mark style="background-color:orange;">induces</mark> breast cancer growth via <mark style="background-color:lightgreen;" id="O42132,P03372,P06211,P06212,P16058,P19785,P49884,P49885,P49886,P50240,P50241,P50242,P57717,P57753,P81559,Q29040,Q53AD2,Q91250,Q91424,Q9PVZ9,Q9QZJ5,Q9TV98,Q9YH33,Q9YHT3,Q9YHZ7">estrogen receptor</mark> : implications for <mark style="background-color:lightgreen;" id="O42145,O46512,P11511,P19098,P22443,P28649,P46194,P70091,P79304,P79430,P79699,Q29605,Q29624,Q5QQX7,Q69FB6,Q6QHT9,Q6YI21,Q92087,Q92111,Q92112,Q95M61,Q9XS28">aromatase</mark> inhibitor resistance.
18521740-1015	Lastly, we found that the downstream metabolite of <mark style="background-color:lightblue;" id="10635">5alpha-dihydrotestosterone</mark>, <mark style="background-color:lightblue;" id="242332">5alpha-androstane-3beta,17beta-diol</mark> (3betaAdiol), is estrogenic in breast cancer cells, and <mark style="background-color:orange;">induces</mark> growth and <mark style="background-color:yellow;" id="GO:0005783,cellular_component">ER</mark> -signaling via activation of <mark style="background-color:lightgreen;" id="O42132,P03372,P06211,P06212,P16058,P19785,P49884,P49885,P49886,P50240,P50241,P50242,P57717,P57753,P81559,Q29040,Q53AD2,Q91250,Q91424,Q9PVZ9,Q9QZJ5,Q9TV98,Q9YH33,Q9YHT3,Q9YHZ7">ERalpha</mark> .
18314895-1018	Specifically, <mark style="background-color:lightblue;" id="8172">TEG</mark> was shown to <mark style="background-color:orange;">alter</mark> S. mutans gene expression <mark style="background-color:orange;">levels</mark> of <mark style="background-color:lightgreen;" id="P08987">gtfB</mark> , a known virulence factor, and yfiV, a putative <mark style="background-color:lightgreen;" id="Q9CJ45">transcriptional regulator</mark> of <mark style="background-color:yellow;" id="GO:0009928,GO:0009986,cellular_component">cell-surface</mark> fatty acid genes.
18475288-1021	In androgen-independent PC-3 cells, <mark style="background-color:lightblue;" id="2375">bicalutamide</mark> also <mark style="background-color:orange;">induced</mark> <mark style="background-color:yellow;" id="GO:0006915,biological_process">apoptosis</mark> by mechanisms that were partially <mark style="background-color:orange;">inhibited</mark> by pan-caspase inhibition but were partially <mark style="background-color:lightgreen;" id="P27730">calpain</mark> dependent.
18314898-1022	Degradation analysis over 8 weeks in the presence of 10 mg/L <mark style="background-color:lightgreen;" id="O64362,O80288,O80292,P00720,P03706,P07540,P09963,P10439,P11187,P13656,P15057,P19385,P19386,P21270,P23472,P23473,P27359,P33486,P37715,P39046,P51771,P62692,P62693,P68920,P68921,P81241,P82174,P82175,P83673,Q27650,Q37875,Q37896,Q48603,Q7SID7,Q9CIT4,Q9T1X2,Q9ZXB7">lysozyme</mark> showed a 50% decrease in total weight and an 80% <mark style="background-color:orange;">decrease</mark> in <mark style="background-color:lightblue;" id="36797">PLGA</mark> molecular weight.
18413206-1026	The expressions of <mark style="background-color:lightgreen;" id="P10148,P13500,P14844,P28291,P28292,P42831,P52203,P61274,P61275,Q08782,Q9TTQ3">MCP-1</mark> mRNA in renal tissues were markedly <mark style="background-color:orange;">up-regulated</mark> in untreated diabetic rats, and these could be notably <mark style="background-color:orange;">reduced</mark> by <mark style="background-color:lightblue;" id="77999">rosiglitazone</mark> treatment.
18413206-1027	In conclusion, <mark style="background-color:lightblue;" id="77999">rosiglitazone</mark> may have a potential therapeutic <mark style="background-color:orange;">target</mark> in DN, which may be partly attributed to <mark style="background-color:orange;">lowering</mark> of the expression of <mark style="background-color:lightgreen;" id="P10148,P13500,P14844,P28291,P28292,P42831,P52203,P61274,P61275,Q08782,Q9TTQ3">MCP-1</mark> in the local kidney and the urinary <mark style="background-color:yellow;" id="GO:0007588,biological_process">excretion</mark> of <mark style="background-color:lightgreen;" id="P10148,P13500,P14844,P28291,P28292,P42831,P52203,P61274,P61275,Q08782,Q9TTQ3">MCP-1</mark> .
18495129-1029	<mark style="background-color:lightblue;" id="145858">Anthocyanin</mark> attenuates <mark style="background-color:lightgreen;" id="P25942,Q28203,Q3LRP1,Q3ZTK5,Q7YRL5,Q8SQ34">CD40</mark> -mediated <mark style="background-color:yellow;" id="GO:0042118,biological_process">endothelial cell activation</mark> and <mark style="background-color:yellow;" id="GO:0006915,biological_process">apoptosis</mark> by <mark style="background-color:orange;">inhibiting</mark> <mark style="background-color:lightgreen;" id="P25942,Q28203,Q3LRP1,Q3ZTK5,Q7YRL5,Q8SQ34">CD40</mark> -induced <mark style="background-color:lightgreen;" id="O42781,P27638,Q00859">MAPK</mark> activation.
18495129-1030	Treatment of ECs with anthocyanins <mark style="background-color:lightblue;" id="128861">cyanidin</mark>-3-O-beta-<mark style="background-color:lightblue;" id="64689">glucoside</mark> (Cy-3-g) and <mark style="background-color:lightblue;" id="53398755">peonidin-3-O-beta-glucoside</mark> (Pn-3-g) <mark style="background-color:orange;">prevents</mark> <mark style="background-color:lightgreen;" id="P25942,Q28203,Q3LRP1,Q3ZTK5,Q7YRL5,Q8SQ34">CD40</mark> -induced endothelial activation by inhibiting production of proinflammatory cytokines and matrix metalloproteinases (MMPs).
18495129-1031	Collectively, our findings suggested that the inhibition of <mark style="background-color:lightgreen;" id="P92208,Q966Y3">JNK</mark> and <mark style="background-color:lightgreen;" id="O24473,O75791,O95433,O97628,P46108,P80350,P82869,Q01552,Q04929,Q63768,Q64010,Q9LDA4,Q9Y2S7">p38</mark> activation <mark style="background-color:orange;">interrupts</mark> <mark style="background-color:lightgreen;" id="P25942,Q28203,Q3LRP1,Q3ZTK5,Q7YRL5,Q8SQ34">CD40</mark> <mark style="background-color:orange;">induced</mark> <mark style="background-color:yellow;" id="GO:0042118,biological_process">endothelial cell activation</mark> and <mark style="background-color:yellow;" id="GO:0006915,biological_process">apoptosis</mark> , which thereby may represent a mechanism that would explain the <mark style="background-color:yellow;" id="GO:0030236,biological_process">anti-inflammatory response</mark> of <mark style="background-color:lightblue;" id="145858">anthocyanin</mark> and its athero-protective function.
18502597-1034	Multiple metabolic and neuroendocrine mechanisms are responsible for the <mark style="background-color:lightblue;" id="23976">CR</mark>-mediated anti-inflammatory effects, <mark style="background-color:orange;">including</mark> <mark style="background-color:orange;">reduced</mark> adiposity and <mark style="background-color:yellow;" id="GO:0046903,biological_process">secretion</mark> of pro-inflammatory adipokines, <mark style="background-color:orange;">enhanced</mark> glucocorticoid production, reduced plasma <mark style="background-color:lightblue;" id="206,5793,64689,79025">glucose</mark> and advanced glycation end-product concentrations, increased parasympathetic tone, and <mark style="background-color:orange;">increased</mark> <mark style="background-color:lightgreen;" id="Q6BEG6,Q6BEG7,Q9BDJ6,Q9BEF8,Q9EQX0,Q9GKY5,Q9QYH7,Q9UBU3">ghrelin</mark> production.
17925795-1037	The mood stabilizers <mark style="background-color:lightblue;" id="28486,3028194">lithium</mark> and <mark style="background-color:lightblue;" id="3121">valproate</mark> selectively <mark style="background-color:orange;">activate</mark> the promoter IV of <mark style="background-color:lightgreen;" id="P25430,P25431,P25432,Q06225">brain-derived neurotrophic factor</mark> in neurons.
17925795-1038	Treatment of cultured rat cortical neurons with therapeutic concentrations of <mark style="background-color:lightblue;" id="433294">LiCl</mark> or VPA selectively <mark style="background-color:orange;">increased</mark> the <mark style="background-color:orange;">levels</mark> of exon IV (formerly rat exon III)-containing <mark style="background-color:lightgreen;" id="O18752,O18753,O18755,O70183,O97759,P14082,P21237,P23363,P23560,P25429,P25430,P25431,P25432,Q02193,Q06225,Q3SAT7,Q4L0Y3,Q5IS78,Q6LCI5,Q7YRB4,Q90322,Q95106,Q9TST3">BDNF</mark> mRNA, and the activity of <mark style="background-color:lightgreen;" id="O18752,O18753,O18755,O70183,O97759,P14082,P21237,P23363,P23560,P25429,P25430,P25431,P25432,Q02193,Q06225,Q3SAT7,Q4L0Y3,Q5IS78,Q6LCI5,Q7YRB4,Q90322,Q95106,Q9TST3">BDNF</mark> promoter IV.
17925795-1039	We showed that <mark style="background-color:lightblue;" id="28486,3028194">lithium</mark>-induced activation of promoter IV was <mark style="background-color:orange;">mimicked</mark> by pharmacological inhibition of <mark style="background-color:lightgreen;" id="P51136,P83101">GSK-3</mark> or short <mark style="background-color:orange;">interfering</mark> RNA (siRNA)-mediated <mark style="background-color:yellow;" id="GO:0016458,biological_process">gene silencing</mark> of <mark style="background-color:lightgreen;" id="P18265,P49840">GSK-3alpha</mark> or <mark style="background-color:lightgreen;" id="P18266,P49841,Q5YJC2,Q9WV60">GSK-3beta</mark> isoforms.
17925795-1041	Our study demonstrates for the first time that <mark style="background-color:lightgreen;" id="P51136,P83101">GSK-3</mark> and HDAC are respective initial <mark style="background-color:orange;">targets</mark> for <mark style="background-color:lightblue;" id="28486,3028194">lithium</mark> and VPA to <mark style="background-color:orange;">activate</mark> <mark style="background-color:lightgreen;" id="O18752,O18753,O18755,O70183,O97759,P14082,P21237,P23363,P23560,P25429,P25430,P25431,P25432,Q02193,Q06225,Q3SAT7,Q4L0Y3,Q5IS78,Q6LCI5,Q7YRB4,Q90322,Q95106,Q9TST3">BDNF</mark> promoter IV, and that this <mark style="background-color:lightgreen;" id="O18752,O18753,O18755,O70183,O97759,P14082,P21237,P23363,P23560,P25429,P25430,P25431,P25432,Q02193,Q06225,Q3SAT7,Q4L0Y3,Q5IS78,Q6LCI5,Q7YRB4,Q90322,Q95106,Q9TST3">BDNF</mark> induction involves a novel responsive region in promoter IV of the <mark style="background-color:lightgreen;" id="O18752,O18753,O18755,O70183,O97759,P14082,P21237,P23363,P23560,P25429,P25430,P25431,P25432,Q02193,Q06225,Q3SAT7,Q4L0Y3,Q5IS78,Q6LCI5,Q7YRB4,Q90322,Q95106,Q9TST3">BDNF</mark> gene.
18249399-1054	Common 677C--&gt;T mutation of the <mark style="background-color:lightgreen;" id="O54235,O67422,P0AEZ1,P0AEZ2,P11003,P45208,P57154,P71319,Q89B13,Q8KA62">5,10-methylenetetrahydrofolate reductase</mark> gene <mark style="background-color:orange;">affects</mark> follicular <mark style="background-color:lightblue;" id="5757">estradiol</mark> synthesis.
18552508-1057	<mark style="background-color:lightblue;" id="2662">Celecoxib</mark> <mark style="background-color:orange;">inhibits</mark> serum amyloid a-induced <mark style="background-color:lightgreen;" id="O55123,P07152,P09238">matrix metalloproteinase-10</mark> expression in human endothelial cells.
18298570-1059	Our results showed that <mark style="background-color:lightgreen;" id="O24339,O52762,O62839,O68146,O77229,O93662,O97492,P00432,P04040,P04762,P07145,P0A323,P0A324,P0A325,P0A326,P0A327,P11934,P17336,P24168,P24270,P25890,P29422,P30265,P30266,P32290,P42321,P44390,P45737,P45739,P55304,P55306,P55310,P55311,P55313,P77872,P81138,P90682,Q27710,Q49XC1,Q4L643,Q59296,Q59337,Q59602,Q59714,Q5HG86,Q5HPK8,Q5RF10,Q64405,Q6G9M4,Q6GH72,Q7A5T2,Q8CPD0,Q8FWU0,Q8NWV5,Q8X1P0,Q8Y3P9,Q926X0,Q99UE2,Q9AXH0,Q9KW19,Q9L4S1,Q9M5L6,Q9PT92,Q9PWF7,Q9Z598,Q9ZKX5,Q9ZN99">catalase</mark> abolished the <mark style="background-color:orange;">effect</mark> of the oxidant, <mark style="background-color:orange;">protecting</mark> spermatozoa against reactive <mark style="background-color:lightblue;" id="977">oxygen</mark> species, and improving both <mark style="background-color:yellow;" id="GO:0030317,biological_process">sperm motility</mark> and <mark style="background-color:yellow;" id="GO:0000785,cellular_component">chromatin</mark> status during incubation.
18394828-1061	) and two <mark style="background-color:lightblue;" id="977">oxygen</mark> tensions (5 and 20%) were compared for their ability to <mark style="background-color:orange;">sustain</mark> blastocyst survival and <mark style="background-color:lightgreen;" id="O46633,P28171,P28172,Q95187">IFNT</mark> production from days 8 to 11 post- <mark style="background-color:yellow;" id="GO:0007320,biological_process">insemination</mark> .
18394828-1062	In conclusion, culturing blastocysts of cattle in a 5% <mark style="background-color:lightblue;" id="977">oxygen</mark> environment with M199 <mark style="background-color:orange;">containing</mark> serum <mark style="background-color:orange;">sustains</mark> embryo viability and permits constitutive and inducible <mark style="background-color:lightgreen;" id="O46633,P28171,P28172,Q95187">IFNT</mark> production.
18394828-1063	Incubation in 20% <mark style="background-color:lightblue;" id="977">oxygen</mark> <mark style="background-color:orange;">increases</mark> <mark style="background-color:lightgreen;" id="O46633,P28171,P28172,Q95187">IFNT</mark> production.
18343629-1065	The results showed that combination of <mark style="background-color:lightblue;" id="3220">emodin</mark> and <mark style="background-color:lightblue;" id="64982">baicalin</mark> significantly <mark style="background-color:orange;">reduced</mark> serum amylase, <mark style="background-color:lightgreen;" id="Q8JFG3">tumor necrosis factor</mark> -alpha and <mark style="background-color:lightgreen;" id="P41693">interleukin-6</mark> , attenuated pancreatic and pulmonary damage, also <mark style="background-color:orange;">suppressed</mark> <mark style="background-color:lightgreen;" id="O00206,P58727,Q2V898,Q68Y56,Q8SPE8,Q8SPE9,Q9GL65,Q9MYW3,Q9TSP2,Q9TTN0,Q9WV82">TLR4</mark> expression in pancreas and lung.
17403602-1067	When Vitreoscilla were grown in medium containing 60mM <mark style="background-color:lightblue;" id="23668193">sodium nitrite</mark> under both normal and <mark style="background-color:orange;">limited</mark> aeration conditions, the levels of Vitreoscilla <mark style="background-color:lightgreen;" id="P15160,P17724,P73925,Q03459">hemoglobin</mark> (VHb) were decreased by greater than 90%, while the <mark style="background-color:orange;">levels</mark> of the terminal respiratory oxidase, cytochrome <mark style="background-color:lightblue;" id="5460518,6327189,6327675">bo</mark>, were increased 350% under normal aeration and 7-23% under limited aeration.
18554595-1071	To test the hypothesis that <mark style="background-color:lightblue;" id="12594">DHEAS</mark> production from <mark style="background-color:lightblue;" id="5881">DHEA</mark> occurs in hepatic cells and that this production is <mark style="background-color:orange;">augmented</mark> by the presence of sex steroids or <mark style="background-color:lightgreen;" id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">insulin</mark> .
18470629-1072	However, <mark style="background-color:lightblue;" id="5353758">methomyl</mark> exhibited more potency in <mark style="background-color:orange;">reducing</mark> <mark style="background-color:lightgreen;" id="O42275,O62763,P04058,P07140,P07692,P21836,P22303,P23795,P36196,P37136,P56161,Q27677,Q29499,Q867X2,Q867X3,Q869C3,Q86GC8,Q86GC9,Q92035,Q92081,Q9DDE3">AChE</mark> activity than <mark style="background-color:lightblue;" id="16248">methiocarb</mark>.
18554598-1073	Changes in <mark style="background-color:lightgreen;" id="Q8JFG3">tumor necrosis factor</mark> ( <mark style="background-color:lightgreen;" id="O35734,O77510,O77764,P01375,P04924,P13296,P19101,P23383,P23563,P29553,P33620,P36939,P48094,P51435,P51742,P51743,P59684,P59693,P59694,P59695,P79337,P79374,Q06599,Q19LH4,Q1G1A2,Q1WM27,Q2MH05,Q539C2,Q75N23,Q8HZD9,Q8JFG3,Q8MKG8,Q8WNR1,Q9BEA1">TNF</mark> ) production by <mark style="background-color:lightblue;" id="11970143">lipopolysaccharide</mark>-stimulated peripheral blood mononuclear cells significantly correlated with serum P <mark style="background-color:orange;">levels</mark> in postmenopausal women subjected to estrogen/<mark style="background-color:lightblue;" id="10631">medroxyprogesterone</mark> therapy.
18304748-1077	Moreover, <mark style="background-color:lightgreen;" id="Q99JR5">TARPs</mark> (except gamma4) <mark style="background-color:orange;">reduce</mark> the ion channel <mark style="background-color:orange;">block</mark> by the synthetic <mark style="background-color:lightblue;" id="119582,5311197">Joro spider toxin</mark> analog <mark style="background-color:lightblue;" id="129695">1-naphthylacetyl spermine</mark> ( <mark style="background-color:lightgreen;" id="P27123,P49321,Q2T9P4,Q99MD9">NASP</mark> ).
18521846-1089	We found that <mark style="background-color:lightblue;" id="66414">2-methoxyestradiol</mark> <mark style="background-color:orange;">induced</mark> the activation of <mark style="background-color:lightgreen;" id="P92208,Q966Y3">JNK</mark> , <mark style="background-color:lightgreen;" id="P29323">ERK</mark> , and <mark style="background-color:lightgreen;" id="O62618">p38 MAPKs</mark> .
18521846-1090	<mark style="background-color:lightblue;" id="66414">2-methoxyestradiol</mark>-induced <mark style="background-color:lightgreen;" id="P92208,Q966Y3">JNK</mark> activation was <mark style="background-color:orange;">associated</mark> with the <mark style="background-color:yellow;" id="GO:0006917,biological_process">induction of apoptosis</mark> through the mitochondrial pathways as a result of <mark style="background-color:orange;">increased</mark> <mark style="background-color:yellow;" id="GO:0016310,biological_process">phosphorylation</mark> (inactivation) of the anti-apoptotic <mark style="background-color:lightgreen;" id="P10417,P49950">Bcl-2</mark> and Bcl-xL proteins.
18521846-1091	In comparison, <mark style="background-color:lightblue;" id="66414">2-methoxyestradiol</mark>-induced activation of <mark style="background-color:lightgreen;" id="P29323">ERK</mark> and <mark style="background-color:lightgreen;" id="O24473,O75791,O95433,O97628,P46108,P80350,P82869,Q01552,Q04929,Q63768,Q64010,Q9LDA4,Q9Y2S7">p38</mark> in these cells was found to have a protective <mark style="background-color:orange;">effect</mark> against 2-<mark style="background-color:lightblue;" id="128395">MeO</mark>-E(2)-induced <mark style="background-color:yellow;" id="GO:0006915,biological_process">apoptosis</mark> .
18380539-1099	A recently discussed cardiovascular risk factor, <mark style="background-color:lightblue;" id="123831">asymmetric dimethylarginine</mark> (<mark style="background-color:lightblue;" id="123831">ADMA</mark>), is known to <mark style="background-color:orange;">act</mark> as an endogenous inhibitor of endothelial <mark style="background-color:lightgreen;" id="O61309,O61608,Q27571,Q9I9M2">nitric oxide synthase</mark> .
18468607-1101	Genetic variation in <mark style="background-color:lightgreen;" id="P11597,P22687,P25914,P47896">CETP</mark> ( <mark style="background-color:lightgreen;" id="P25914">cholesteryl ester transfer protein</mark> ) has been clearly <mark style="background-color:orange;">associated</mark> with HDL <mark style="background-color:lightblue;" id="304,5997,6432564,11025495">cholesterol</mark> levels but its association with cardiovascular disease and related phenotypes has been more controversial, possibly due to variability of polymorphisms and their frequencies across different ethnic populations.
18380545-1104	<mark style="background-color:lightblue;" id="60961">Adenosine</mark> A(3) receptor agonist N(6)-(3-iodobenzyl) <mark style="background-color:lightgreen;" id="Q9I7S8">adenosine-5</mark> '-N-methyluronamide (<mark style="background-color:lightblue;" id="123683">IB-MECA</mark>) has been tested from the point of view of <mark style="background-color:orange;">potentiating</mark> the <mark style="background-color:orange;">effects</mark> of <mark style="background-color:lightgreen;" id="P01586,P04823,P06740,P08700,P25140,P49875,P51445,Q06435,Q28334,Q28809,Q9BDX4">hematopoietic growth factors</mark> interleukin-3 ( <mark style="background-color:lightgreen;" id="P01586,P04823,P06740,P08700,P25140,P49875,P51445,Q06435,Q28334,Q28809,Q9BDX4">IL-3</mark> ), <mark style="background-color:lightgreen;" id="P20826,P21581,P21583,P79169,P79368,Q06220,Q09108,Q28132,Q29030,Q90314,Q95M19,Q95MD2,Q95N18">stem cell factor</mark> ( <mark style="background-color:lightgreen;" id="P20826,P21581,P21583,P79169,P79368,Q06220,Q09108,Q28132,Q29030,Q90314,Q95M19,Q95MD2,Q95N18">SCF</mark> ), <mark style="background-color:lightgreen;" id="P48750">granulocyte-macrophage colony-stimulating factor</mark> ( <mark style="background-color:lightgreen;" id="O62757,P01587,P04141,P11052,P28773,P48749,P48750,P51748,Q0MUT8,Q29118,Q60481">GM-CSF</mark> ), and <mark style="background-color:lightgreen;" id="P35834,Q28746">granulocyte colony-stimulating factor</mark> ( <mark style="background-color:lightgreen;" id="O02708,O02837,P09919,P09920,P35833,P35834,Q28746">G-CSF</mark> ) on the growth of hematopoietic progenitor cells for granulocytes and macrophages (GM-<mark style="background-color:lightblue;" id="11984819">CFC</mark>) in suspension of normal mouse bone marrow cells in vitro.
18521859-1108	Accumulating evidence suggests that <mark style="background-color:lightblue;" id="53477912">phosphatidylinositol</mark> (PI) pathways have been involved in the <mark style="background-color:yellow;" id="GO:0046903,biological_process">secretion</mark> of <mark style="background-color:lightblue;" id="681">dopamine</mark> (DA) and the regulation of <mark style="background-color:lightgreen;" id="P23977,P27922,Q01959,Q03614,Q61327,Q9GJT6">DA transporter</mark> , which is a <mark style="background-color:orange;">target</mark> of <mark style="background-color:lightblue;" id="1206,10836,36604">methamphetamine</mark> (METH).
18423787-1115	We detected a marked decrease in target mRNA, an accumulation of short interfering RNAs (siRNAs), and a decrease in <mark style="background-color:lightblue;" id="5280343">quercetin content</mark> relative to <mark style="background-color:lightblue;" id="5280863">kaempferol</mark> in leaf tissues, <mark style="background-color:orange;">indicating</mark> that sequence-specific mRNA degradation of the <mark style="background-color:lightgreen;" id="Q9SD85">F3'H</mark> gene was induced.
18484622-1118	In all final products, <mark style="background-color:lightblue;" id="679">dimethylsulfoxide</mark> <mark style="background-color:orange;">used</mark> to prepare the <mark style="background-color:lightgreen;" id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">insulin</mark> /lipid mixture was below 20 ppm.
17950491-1121	In addition, treatment with <mark style="background-color:lightblue;" id="77999">rosiglitazone</mark> <mark style="background-color:orange;">increased</mark> interleukin-4 ( <mark style="background-color:lightgreen;" id="O77762,P05112,P07750,P20096,P30367,P30368,P42202,P46652,P47966,P51492,P51744,P55030,P79155,P79339,Q04745,Q2PE74,Q3S4V6,Q58M18,Q60440,Q7YS71,Q865X5,Q865Y0,Q8HYB1,Q9MZR8,Q9XS58">IL-4</mark> ) mRNA and reversed the age-related decrease in hippocampal <mark style="background-color:lightgreen;" id="O77762,P05112,P07750,P20096,P30367,P30368,P42202,P46652,P47966,P51492,P51744,P55030,P79155,P79339,Q04745,Q2PE74,Q3S4V6,Q58M18,Q60440,Q7YS71,Q865X5,Q865Y0,Q8HYB1,Q9MZR8,Q9XS58">IL-4</mark> concentration.
18431776-1124	To determine the capabilities of previously used microsphere scaffold to deliver growth factors simultaneously, this work investigated a long-term (about three months) release of bovine <mark style="background-color:lightgreen;" id="P21847,P83517">serum albumin</mark> ( <mark style="background-color:lightgreen;" id="P02769">BSA</mark> ) from microsphere scaffolds fabricated by <mark style="background-color:orange;">using</mark> two different polymers, <mark style="background-color:lightblue;" id="107801">poly(3-hydroxybutyrate-co-3-hydroxyvalerate</mark>) (PHBV, 8% PHV), <mark style="background-color:lightblue;" id="23111554">poly(lactide-co-glycolide</mark>) acid (<mark style="background-color:lightblue;" id="36797">PLGA</mark>, 5050) and a blend of <mark style="background-color:lightblue;" id="36797">PLGA</mark> and PHBV.
18243368-1130	In this systematic review, we have analyzed the results of 52 clinical trials, including 72 intervention groups and 6290 patients, on <mark style="background-color:lightblue;" id="5280795">vitamin D</mark> supplementation in order to evaluate the experimental evidence and the <mark style="background-color:orange;">effects</mark> of age and chronic immobility on responses of parathyroid hormone ( <mark style="background-color:lightgreen;" id="O27732,O28185,O66677,O74017,O74806,O83975,O84806,O85235,P01268,P01269,P01270,P04089,P0A281,P0A282,P0A7D1,P0A7D2,P0A7D3,P15743,P37470,P38876,P44682,P47329,P47714,P49607,P52212,P56077,P57287,P57820,P59490,P61234,P61235,P61414,P65863,P65864,P65865,P65866,P65867,P65868,P65869,P78034,Q27IM2,Q57NM8,Q59989,Q5F9L4,Q5FFA3,Q5FMA9,Q5FRT7,Q5GTI9,Q5GWR6,Q5HC85,Q5HIH3,Q5HRQ3,Q5HWF9,Q5JDB8,Q5L3U7,Q5LV91,Q5M222,Q5M6L4,Q5N2J4,Q5NGZ6,Q5NL75,Q5P722,Q5P9A6,Q5PCR7,Q5QV03,Q5SHZ2,Q5V1D3,Q5WAD6,Q5WTE7,Q5X1N7,Q5XEM3,Q5YPZ6,Q5ZS66,Q601M5,Q60363,Q60A14,Q62FC1,Q63HI2,Q63XM0,Q64X30,Q65PG8,Q65V47,Q65ZY7,Q66AY1,Q67JD0,Q68WD4,Q6AAC7,Q6ADQ8,Q6AJL9,Q6D557,Q6F240,Q6F8I7,Q6G0F9,Q6G2L1,Q6GBY6,Q6GJG9,Q6HPW6,Q6KHA3,Q6LNA9,Q6MJR3,Q6MS28,Q6N1P9,Q6NI78,Q6YP15,Q6YR64,Q724K0,Q72BR1,Q72IA8,Q72RZ0,Q73FF7,Q73II8,Q73Q01,Q741V9,Q74FE6,Q74LA8,Q7M7U8,Q7MMZ2,Q7MXK9,Q7N5A1,Q7NN75,Q7NQT1,Q7U9I5,Q7UKV0,Q7V342,Q7V4V4,Q7VDT7,Q7VG29,Q7VMI1,Q7VUH3,Q7W179,Q7WNY2,Q81J96,Q81VY9,Q821W6,Q82HE5,Q82TQ6,Q839C0,Q83AP0,Q83FR1,Q83HD8,Q83LE1,Q86Y79,Q877G5,Q87A24,Q87RN9,Q888C8,Q88PX8,Q88Z39,Q899I4,Q89DJ9,Q89YZ2,Q8BW00,Q8CQU9,Q8CXP8,Q8D2K4,Q8DFF4,Q8DJ45,Q8DRQ2,Q8DWN5,Q8E2I1,Q8E7Y8,Q8EHN5,Q8EWQ8,Q8F3Q2,Q8FQV6,Q8G5I6,Q8K8Z7,Q8K9V3,Q8KD05,Q8P327,Q8PC61,Q8PNT8,Q8Q0M4,Q8R757,Q8RIJ5,Q8RLD7,Q8TKX4,Q8TV04,Q8U0N0,Q8UD97,Q8XHJ8,Q8Y2E3,Q8YAD1,Q8YYK4,Q8ZEY4,Q8ZYM4,Q92F62,Q92H41,Q92N67,Q976I0,Q97CB4,Q97E97,Q97TD1,Q980V1,Q98HV6,Q98PE2,Q9A206,Q9AAV9,Q9AEQ5,Q9CD49,Q9CJI1,Q9F8Q3,Q9GL67,Q9HLW6,Q9HVC3,Q9J5H2,Q9JV42,Q9K029,Q9K3T8,Q9KGJ3,Q9KQ21,Q9PA78,Q9PII7,Q9PR67,Q9RRW3,Q9V108,Q9X1W1,Q9XT35,Q9YBD6,Q9Z6V6,Q9ZCV4,Q9ZJC3">PTH</mark> ).
18243368-1131	The <mark style="background-color:lightblue;" id="5280795">vitamin D</mark> supplementation of the chronically immobile patients resulted in a smaller <mark style="background-color:orange;">decrease</mark> in <mark style="background-color:lightgreen;" id="O27732,O28185,O66677,O74017,O74806,O83975,O84806,O85235,P01268,P01269,P01270,P04089,P0A281,P0A282,P0A7D1,P0A7D2,P0A7D3,P15743,P37470,P38876,P44682,P47329,P47714,P49607,P52212,P56077,P57287,P57820,P59490,P61234,P61235,P61414,P65863,P65864,P65865,P65866,P65867,P65868,P65869,P78034,Q27IM2,Q57NM8,Q59989,Q5F9L4,Q5FFA3,Q5FMA9,Q5FRT7,Q5GTI9,Q5GWR6,Q5HC85,Q5HIH3,Q5HRQ3,Q5HWF9,Q5JDB8,Q5L3U7,Q5LV91,Q5M222,Q5M6L4,Q5N2J4,Q5NGZ6,Q5NL75,Q5P722,Q5P9A6,Q5PCR7,Q5QV03,Q5SHZ2,Q5V1D3,Q5WAD6,Q5WTE7,Q5X1N7,Q5XEM3,Q5YPZ6,Q5ZS66,Q601M5,Q60363,Q60A14,Q62FC1,Q63HI2,Q63XM0,Q64X30,Q65PG8,Q65V47,Q65ZY7,Q66AY1,Q67JD0,Q68WD4,Q6AAC7,Q6ADQ8,Q6AJL9,Q6D557,Q6F240,Q6F8I7,Q6G0F9,Q6G2L1,Q6GBY6,Q6GJG9,Q6HPW6,Q6KHA3,Q6LNA9,Q6MJR3,Q6MS28,Q6N1P9,Q6NI78,Q6YP15,Q6YR64,Q724K0,Q72BR1,Q72IA8,Q72RZ0,Q73FF7,Q73II8,Q73Q01,Q741V9,Q74FE6,Q74LA8,Q7M7U8,Q7MMZ2,Q7MXK9,Q7N5A1,Q7NN75,Q7NQT1,Q7U9I5,Q7UKV0,Q7V342,Q7V4V4,Q7VDT7,Q7VG29,Q7VMI1,Q7VUH3,Q7W179,Q7WNY2,Q81J96,Q81VY9,Q821W6,Q82HE5,Q82TQ6,Q839C0,Q83AP0,Q83FR1,Q83HD8,Q83LE1,Q86Y79,Q877G5,Q87A24,Q87RN9,Q888C8,Q88PX8,Q88Z39,Q899I4,Q89DJ9,Q89YZ2,Q8BW00,Q8CQU9,Q8CXP8,Q8D2K4,Q8DFF4,Q8DJ45,Q8DRQ2,Q8DWN5,Q8E2I1,Q8E7Y8,Q8EHN5,Q8EWQ8,Q8F3Q2,Q8FQV6,Q8G5I6,Q8K8Z7,Q8K9V3,Q8KD05,Q8P327,Q8PC61,Q8PNT8,Q8Q0M4,Q8R757,Q8RIJ5,Q8RLD7,Q8TKX4,Q8TV04,Q8U0N0,Q8UD97,Q8XHJ8,Q8Y2E3,Q8YAD1,Q8YYK4,Q8ZEY4,Q8ZYM4,Q92F62,Q92H41,Q92N67,Q976I0,Q97CB4,Q97E97,Q97TD1,Q980V1,Q98HV6,Q98PE2,Q9A206,Q9AAV9,Q9AEQ5,Q9CD49,Q9CJI1,Q9F8Q3,Q9GL67,Q9HLW6,Q9HVC3,Q9J5H2,Q9JV42,Q9K029,Q9K3T8,Q9KGJ3,Q9KQ21,Q9PA78,Q9PII7,Q9PR67,Q9RRW3,Q9V108,Q9X1W1,Q9XT35,Q9YBD6,Q9Z6V6,Q9ZCV4,Q9ZJC3">PTH</mark> 0.001).
18243368-1132	Our results also suggest that <mark style="background-color:lightgreen;" id="O27732,O28185,O66677,O74017,O74806,O83975,O84806,O85235,P01268,P01269,P01270,P04089,P0A281,P0A282,P0A7D1,P0A7D2,P0A7D3,P15743,P37470,P38876,P44682,P47329,P47714,P49607,P52212,P56077,P57287,P57820,P59490,P61234,P61235,P61414,P65863,P65864,P65865,P65866,P65867,P65868,P65869,P78034,Q27IM2,Q57NM8,Q59989,Q5F9L4,Q5FFA3,Q5FMA9,Q5FRT7,Q5GTI9,Q5GWR6,Q5HC85,Q5HIH3,Q5HRQ3,Q5HWF9,Q5JDB8,Q5L3U7,Q5LV91,Q5M222,Q5M6L4,Q5N2J4,Q5NGZ6,Q5NL75,Q5P722,Q5P9A6,Q5PCR7,Q5QV03,Q5SHZ2,Q5V1D3,Q5WAD6,Q5WTE7,Q5X1N7,Q5XEM3,Q5YPZ6,Q5ZS66,Q601M5,Q60363,Q60A14,Q62FC1,Q63HI2,Q63XM0,Q64X30,Q65PG8,Q65V47,Q65ZY7,Q66AY1,Q67JD0,Q68WD4,Q6AAC7,Q6ADQ8,Q6AJL9,Q6D557,Q6F240,Q6F8I7,Q6G0F9,Q6G2L1,Q6GBY6,Q6GJG9,Q6HPW6,Q6KHA3,Q6LNA9,Q6MJR3,Q6MS28,Q6N1P9,Q6NI78,Q6YP15,Q6YR64,Q724K0,Q72BR1,Q72IA8,Q72RZ0,Q73FF7,Q73II8,Q73Q01,Q741V9,Q74FE6,Q74LA8,Q7M7U8,Q7MMZ2,Q7MXK9,Q7N5A1,Q7NN75,Q7NQT1,Q7U9I5,Q7UKV0,Q7V342,Q7V4V4,Q7VDT7,Q7VG29,Q7VMI1,Q7VUH3,Q7W179,Q7WNY2,Q81J96,Q81VY9,Q821W6,Q82HE5,Q82TQ6,Q839C0,Q83AP0,Q83FR1,Q83HD8,Q83LE1,Q86Y79,Q877G5,Q87A24,Q87RN9,Q888C8,Q88PX8,Q88Z39,Q899I4,Q89DJ9,Q89YZ2,Q8BW00,Q8CQU9,Q8CXP8,Q8D2K4,Q8DFF4,Q8DJ45,Q8DRQ2,Q8DWN5,Q8E2I1,Q8E7Y8,Q8EHN5,Q8EWQ8,Q8F3Q2,Q8FQV6,Q8G5I6,Q8K8Z7,Q8K9V3,Q8KD05,Q8P327,Q8PC61,Q8PNT8,Q8Q0M4,Q8R757,Q8RIJ5,Q8RLD7,Q8TKX4,Q8TV04,Q8U0N0,Q8UD97,Q8XHJ8,Q8Y2E3,Q8YAD1,Q8YYK4,Q8ZEY4,Q8ZYM4,Q92F62,Q92H41,Q92N67,Q976I0,Q97CB4,Q97E97,Q97TD1,Q980V1,Q98HV6,Q98PE2,Q9A206,Q9AAV9,Q9AEQ5,Q9CD49,Q9CJI1,Q9F8Q3,Q9GL67,Q9HLW6,Q9HVC3,Q9J5H2,Q9JV42,Q9K029,Q9K3T8,Q9KGJ3,Q9KQ21,Q9PA78,Q9PII7,Q9PR67,Q9RRW3,Q9V108,Q9X1W1,Q9XT35,Q9YBD6,Q9Z6V6,Q9ZCV4,Q9ZJC3">PTH</mark> <mark style="background-color:orange;">decreases</mark> quite linearly during <mark style="background-color:lightblue;" id="5280795">vitamin D</mark> supplementation at any given 25-OHD level.
18513727-1142	The increase of <mark style="background-color:lightblue;" id="304,5997,6432564,11025495">cholesterol</mark> was accompanied by a <mark style="background-color:orange;">marked</mark> posttranslational down-regulation of liver <mark style="background-color:lightgreen;" id="O18824,P97943,Q60417,Q61009,Q8SQC1,Q8WTV0">SR-BI</mark> expression.
18513727-1143	Taken together, a diet-induced increase of plasma and hepatic <mark style="background-color:lightblue;" id="304,5997,6432564,11025495">cholesterol</mark> <mark style="background-color:orange;">levels</mark> leads to a posttranscriptional down-regulation of <mark style="background-color:lightgreen;" id="O18824,P97943,Q60417,Q61009,Q8SQC1,Q8WTV0">SR-BI</mark> in mouse liver via a mechanism likely involving <mark style="background-color:lightgreen;" id="Q3T0X8,Q5RCF7,Q5T2W1,Q865P3">PDZK1</mark> .
18550596-1150	<mark style="background-color:lightgreen;" id="Q24546">Synapsin</mark> -dependent facilitation in MF <mark style="background-color:yellow;" id="GO:0045202,cellular_component">synapses</mark> of WT mice was attenuated by <mark style="background-color:orange;">blocking</mark> F- <mark style="background-color:lightgreen;" id="O00937,O13419,O16808,O17320,O65314,O65315,O65316,O74258,O81221,P02577,P10365,P10989,P11426,P13363,P14235,P17128,P20904,P24902,P26182,P26183,P30161,P45520,P45521,P48465,P50138,P51775,P53455,P53476,P53477,P53491,P53498,P53499,P53500,P53502,P53689,P60009,P60010,P60011,P68555,P78711,P80709,P81085,P90689,P91754,Q05214,Q11212,Q24733,Q2U7A3,Q39596,Q39758,Q6TCF2,Q75D00,Q8SWN8,Q8X119,Q92192,Q92193,Q99023,Q9P4D1,Q9UVF3,Q9UVX4,Q9UVZ8">actin</mark> polymerization with <mark style="background-color:lightblue;" id="2919,5311281,5368686,5836499,6364615,6433621">cytochalasin B</mark> in hippocampal slices.
18509644-1152	Pharmacological (<mark style="background-color:lightblue;" id="5287969">flavopiridol</mark>) and molecular (shRNA) <mark style="background-color:yellow;" id="GO:0006350,biological_process">transcription</mark> inhibitor were <mark style="background-color:orange;">used</mark> to <mark style="background-color:orange;">impede</mark> formation of <mark style="background-color:lightgreen;" id="P08581,Q07DV8,Q07DY1,Q07DZ1,Q07E01,Q07E24,Q07E37,Q07E48,Q09YH7,Q09YI9,Q09YK0,Q09YL1,Q09YN5,Q108U6,Q2IBA6,Q2IBC0,Q2IBD8,Q2IBF2,Q2IBG7,Q2QL89,Q2QLA9,Q2QLC0,Q2QLE0,Q2QLF1,Q2QLG5,Q2QLH6,Q42662,Q75ZY9">MET</mark> transcripts.
18443843-1158	<mark style="background-color:lightgreen;" id="O24339,O52762,O62839,O68146,O77229,O93662,O97492,P00432,P04040,P04762,P07145,P0A323,P0A324,P0A325,P0A326,P0A327,P11934,P17336,P24168,P24270,P25890,P29422,P30265,P30266,P32290,P42321,P44390,P45737,P45739,P55304,P55306,P55310,P55311,P55313,P77872,P81138,P90682,Q27710,Q49XC1,Q4L643,Q59296,Q59337,Q59602,Q59714,Q5HG86,Q5HPK8,Q5RF10,Q64405,Q6G9M4,Q6GH72,Q7A5T2,Q8CPD0,Q8FWU0,Q8NWV5,Q8X1P0,Q8Y3P9,Q926X0,Q99UE2,Q9AXH0,Q9KW19,Q9L4S1,Q9M5L6,Q9PT92,Q9PWF7,Q9Z598,Q9ZKX5,Q9ZN99">Catalase</mark> was decreased with <mark style="background-color:lightblue;" id="3224">endosulfan</mark> and the coexposure, but not with arsenic, whereas <mark style="background-color:lightblue;" id="124886">GSH</mark> was <mark style="background-color:orange;">decreased</mark> with arsenic and <mark style="background-color:lightblue;" id="3224">endosulfan</mark>, but not with the coexposure.
18443843-1159	<mark style="background-color:lightgreen;" id="P13607,P17326,P28774,P35317">Na+-K+-ATPase</mark> activity was <mark style="background-color:orange;">decreased</mark> in the <mark style="background-color:lightblue;" id="3224">endosulfan</mark>-treated and the coexposed birds.
18442069-1161	The gene expressions of <mark style="background-color:lightgreen;" id="O42231,O42430,O42457,P00185,P04798,P05176,P33616,P56590,P56591,P79716,P98181,Q00557,Q06367,Q3LFU0,Q5KQT7,Q6GUR1,Q6JZS3,Q92039,Q92095,Q92100,Q92109,Q92110,Q92116,Q92148,Q9W683,Q9YH64">CYP1A1</mark> and <mark style="background-color:lightgreen;" id="O18963,P05181,P08682,P33266,P51581,P79383,Q6GUQ4">CYP2E1</mark> in the placenta <mark style="background-color:orange;">increased</mark> significantly in <mark style="background-color:lightblue;" id="942,89594,157672">nicotine</mark>-treated groups on GD 15 and GD 18, but returned to the level similar to the corresponding control on GD 21.
18442069-1162	In <mark style="background-color:lightblue;" id="942,89594,157672">nicotine</mark> group, there was a <mark style="background-color:orange;">decrease</mark> of <mark style="background-color:lightgreen;" id="P21447">mdr1a</mark> expression on GD 15, GD 18, and GD 21, with the most significant decrease on GD 15.
18442070-1163	The present study was designed to understand the effects of sublethal concentrations of <mark style="background-color:lightblue;" id="3039">dichlorvos</mark> ( <mark style="background-color:lightgreen;" id="Q9UBX3">DIC</mark> ) on hematological constituent [red blood corpuscles, white blood corpuscles (WBC), mean cell volume, mean corpuscular <mark style="background-color:lightgreen;" id="P15160,P17724,P73925,Q03459">hemoglobin</mark> , mean corpuscular <mark style="background-color:lightgreen;" id="P15160,P17724,P73925,Q03459">hemoglobin</mark> concentration, platelet counts, <mark style="background-color:lightgreen;" id="P15160,P17724,P73925,Q03459">hemoglobin</mark> and hematocrite levels] and serum <mark style="background-color:orange;">damage</mark> marker enzymes ( <mark style="background-color:lightgreen;" id="O33822,O58489,O67781,O86459,O93744,P00509,P14909,P23034,P44425,P53001,P58661,P72173,Q4J8X2,Q55128,Q56114,Q56232,Q59228,Q60013,Q92JE7,Q972A2,Q9V0L2,Q9X0Y2,Q9ZE56">aspartate aminotransferase</mark> , <mark style="background-color:lightblue;" id="602">alanin</mark> <mark style="background-color:yellow;" id="GO:0008483,molecular_function">aminotransferase</mark> , <mark style="background-color:lightgreen;" id="O60109,P81800,P83456">alkaline phosphatase</mark> , and <mark style="background-color:lightblue;" id="612">lactate</mark> dehydrogenase) in rats at subacute period under laboratory conditions.
18495461-1165	Lack of <mark style="background-color:lightblue;" id="445354">vitamin A</mark> significantly <mark style="background-color:orange;">changed</mark> mucin (MUC) dynamics, as reflected by the <mark style="background-color:orange;">enlarged</mark> goblet-cell "cup" area relative to controls; <mark style="background-color:orange;">decreased</mark> <mark style="background-color:lightgreen;" id="Q02817">MUC2</mark> mRNA expression in the jejunum, ileum and colon of <mark style="background-color:lightblue;" id="5289545">VAD</mark> rats and <mark style="background-color:orange;">increased</mark> <mark style="background-color:lightgreen;" id="Q02505">MUC3</mark> mRNA expression in the ileum and colon of these rats.
18495461-1166	In addition, <mark style="background-color:lightblue;" id="445354">vitamin A</mark> deficiency <mark style="background-color:orange;">down-regulated</mark> <mark style="background-color:lightgreen;" id="P17722,P37364,P80154,P80407,P81462,Q10745">defensin</mark> 6 mRNA expression while up-regulating toll-like receptors 2 and 5 mRNA expressions.
18456422-1170	Only the <mark style="background-color:lightgreen;" id="P80298,P80545,P81173">beta-lactamases</mark> of pI 5.4 and superior to 7.6 <mark style="background-color:orange;">hydrolyze</mark> the <mark style="background-color:lightblue;" id="5479527,5742673,6540461">cefotaxime</mark>.
17719144-1171	The scavenger receptor, <mark style="background-color:lightgreen;" id="P21988,P21989,P21990,P21991,P21992">class B</mark> , type I ( <mark style="background-color:lightgreen;" id="O18824,P97943,Q60417,Q61009,Q8SQC1,Q8WTV0">SR-BI</mark> ) is critical in <mark style="background-color:orange;">maintaining</mark> the <mark style="background-color:yellow;" id="GO:0042592,biological_process">homeostasis</mark> of <mark style="background-color:lightblue;" id="304,5997,6432564,11025495">cholesterol</mark> and <mark style="background-color:lightblue;" id="2116,14985">alpha-tocopherol</mark>.
17719144-1172	<mark style="background-color:lightgreen;" id="O18824,P97943,Q60417,Q61009,Q8SQC1,Q8WTV0">SR-BI</mark> <mark style="background-color:orange;">binds</mark> <mark style="background-color:lightgreen;" id="P81182">high-density lipoproteins</mark> (HDL) and <mark style="background-color:orange;">mediates</mark> the selective <mark style="background-color:orange;">transfer</mark> of cholesteryl esters and <mark style="background-color:lightblue;" id="2116,14985">alpha-tocopherol</mark> from circulating HDL to cells.
18495357-1187	Postsynaptic action of <mark style="background-color:lightblue;" id="5957">ATP</mark> is <mark style="background-color:orange;">mediated</mark> through metabotropic <mark style="background-color:yellow;" id="GO:0045028,molecular_function">P2Y</mark> and ionotropic <mark style="background-color:lightgreen;" id="P13900,P16604">P2X</mark> receptors abundantly expressed in neural cells.
18548615-1193	The purpose of this study was to investigate the effect of three zinc salts (i.e., <mark style="background-color:lightblue;" id="14806">zinc oxide</mark>, <mark style="background-color:lightblue;" id="767">zinc carbonate</mark>, and <mark style="background-color:lightblue;" id="176">zinc acetate</mark>) on <mark style="background-color:lightgreen;" id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">insulin</mark> encapsulation efficiency (EE), stability, and in vitro <mark style="background-color:orange;">release</mark> kinetics from poly(lactic-co-<mark style="background-color:lightblue;" id="757">glycolic acid</mark>) (<mark style="background-color:lightblue;" id="36797">PLGA</mark>) microspheres.
18433938-1194	Prediction of <mark style="background-color:lightgreen;" id="O62743,O97878,O97879,O97880,O97881,O97882,O97883,O97962,O97975,P51681,P56439,P56440,P56493,P60574,P61755,P61756,P61757,P61813,P61814,P61815,P68269,P68270,Q1ZY22,Q2HJ17,Q5ECR9,Q6WN98,Q71UI8,Q8HZT9,Q95NC0,Q95NC1,Q95NC2,Q95NC3,Q95NC4,Q95NC5,Q95NC6,Q95NC7,Q95NC8,Q95NC9,Q95ND0,Q95ND1,Q95ND2,Q95NE8,Q9BGN6,Q9TV42,Q9TV43,Q9TV45,Q9TV47,Q9TV48,Q9TV49,Q9XT76">CCR5</mark>  <mark style="background-color:yellow;" id="GO:0005102,molecular_function">receptor binding</mark> affinity of <mark style="background-color:orange;">substituted</mark> 1-(3,3-diphenylpropyl)-<mark style="background-color:lightblue;" id="5376415">piperidinyl</mark> amides and ureas based on the heuristic method, support vector machine and projection pursuit regression.
18433938-1195	Quantitative structure-activity relationship (QSAR) models were developed to predict for <mark style="background-color:lightgreen;" id="O62743,O97878,O97879,O97880,O97881,O97882,O97883,O97962,O97975,P51681,P56439,P56440,P56493,P60574,P61755,P61756,P61757,P61813,P61814,P61815,P68269,P68270,Q1ZY22,Q2HJ17,Q5ECR9,Q6WN98,Q71UI8,Q8HZT9,Q95NC0,Q95NC1,Q95NC2,Q95NC3,Q95NC4,Q95NC5,Q95NC6,Q95NC7,Q95NC8,Q95NC9,Q95ND0,Q95ND1,Q95ND2,Q95NE8,Q9BGN6,Q9TV42,Q9TV43,Q9TV45,Q9TV47,Q9TV48,Q9TV49,Q9XT76">CCR5</mark>  <mark style="background-color:yellow;" id="GO:0005488,molecular_function">binding</mark> affinity of <mark style="background-color:orange;">substituted</mark> 1-(3,3-diphenylpropyl)-<mark style="background-color:lightblue;" id="5376415">piperidinyl</mark> amides and ureas using linear free energy relationship (LFER).
18427801-1197	Cross-linked <mark style="background-color:lightgreen;" id="P13900,P16604">P2X</mark> (1/2) heteromers showed strongly <mark style="background-color:orange;">reduced</mark> or absent function that was selectively recovered upon treatment with <mark style="background-color:lightblue;" id="439196,439352,446094">DTT</mark>.
18331557-1201	The role of phosphorylated <mark style="background-color:lightgreen;" id="P31750,Q8INB9">Akt</mark> (p- <mark style="background-color:lightgreen;" id="P31750,Q8INB9">Akt</mark> ) in oral carcinogenesis <mark style="background-color:orange;">induced</mark> by <mark style="background-color:lightblue;" id="942,89594,157672">nicotine</mark> and alkaline environments was investigated.
18458952-1204	An alpha-numeric code for representing N-linked <mark style="background-color:lightblue;" id="871">glycan</mark> structures in <mark style="background-color:orange;">secreted</mark> <mark style="background-color:lightgreen;" id="P08163">glycoproteins</mark> .
18458952-1205	Towards this end, we propose a fixed-length alpha-numeric code for representing N-linked <mark style="background-color:lightblue;" id="871">glycan</mark> structures commonly found in <mark style="background-color:orange;">secreted</mark> <mark style="background-color:lightgreen;" id="P08163">glycoproteins</mark> from mammalian cell cultures.
18509748-1206	Effect of small interference RNA targeting <mark style="background-color:lightgreen;" id="O35800,Q0PGG7,Q16665,Q309Z6,Q61221,Q98SW2,Q9I8A9,Q9XTA5,Q9YIB9">HIF-1alpha</mark> <mark style="background-color:orange;">mediated</mark> by rAAV combined <mark style="background-color:lightblue;" id="54690394">L: -ascorbate</mark> on pancreatic tumors in athymic mice.
18509748-1207	Moreover, rAAV-siHIF and <mark style="background-color:lightblue;" id="54690394">L: -ascorbate</mark> could all <mark style="background-color:orange;">inhibit</mark> the <mark style="background-color:yellow;" id="GO:0046903,biological_process">secretion</mark> of vascular <mark style="background-color:lightgreen;" id="P15691,P15692,P26617,P49151,P50412,P67964,P67965,Q99PS1,Q9GKR0,Q9MYV3">VEGF</mark> .
18513857-1213	A 5.5 kilobase-pair ( <mark style="background-color:lightgreen;" id="Q91756">kbp</mark> ) <mark style="background-color:lightgreen;" id="Q09750">Pst1</mark> -Kpn1 fragment <mark style="background-color:orange;">containing</mark> gene(s) encoding for <mark style="background-color:lightblue;" id="5281576">zearalenone</mark> degradation was cloned.
18544592-1218	A significant decrease in mean total <mark style="background-color:lightblue;" id="145068">nitric oxide</mark> (NOx), nitrite, and <mark style="background-color:lightblue;" id="943">nitrate</mark> <mark style="background-color:orange;">levels</mark> was also found after <mark style="background-color:lightgreen;" id="O02708,O02837,P09919,P09920,P35833,P35834,Q28746">G-CSF</mark> plus <mark style="background-color:lightblue;" id="5743">dexamethasone</mark> administration.
18544592-1219	Even if partially compensated with u-PA and <mark style="background-color:lightgreen;" id="O55527,O55779,P02810,P03314,P03424,P04861,P04862,P06022,P06164,P06165,P06941,P07602,P08097,P10030,P14253,P14254,P14340,P26035,P26779,P27384,P28055,P29165,P32533,P32534,P32535,P35940,P35948,P35977,P69738,Q00794,Q03339,Q074N0,Q1X880,Q1X881,Q6DV88,Q6J3P1,Q89277,Q98803,Q997F1,Q9DUE0,Q9WS38,Q9YRV3">protein C</mark> , <mark style="background-color:orange;">increased</mark> FVIII and <mark style="background-color:lightgreen;" id="P04275,P80012,Q28295,Q28833,Q8CIZ8">vWF</mark> activity, and <mark style="background-color:orange;">decreased</mark> <mark style="background-color:lightblue;" id="145068">nitric oxide</mark> <mark style="background-color:orange;">levels</mark> may still partially contribute to <mark style="background-color:orange;">progress</mark> of thrombosis risk in rhG- <mark style="background-color:lightgreen;" id="O62757,P01587,P04141,P11052,P28773,P48749,P48750,P51748,Q0MUT8,Q29118,Q60481">CSF</mark> plus <mark style="background-color:lightblue;" id="5743">dexamethasone</mark> administered healthy granulocyte donors.
18368465-1220	<mark style="background-color:lightblue;" id="3009">DFMO</mark> accumulated cells in <mark style="background-color:yellow;" id="GO:0051320,biological_process">S phase</mark> of the <mark style="background-color:yellow;" id="GO:0007049,biological_process">cell cycle</mark> and <mark style="background-color:orange;">reduced</mark> <mark style="background-color:lightgreen;" id="P20248,P30274,P37881,P43449,P51943,Q92161">cyclin A</mark> expression.
18538450-1221	Molecular modeling of the <mark style="background-color:yellow;" id="GO:0005488,molecular_function">binding</mark> of the <mark style="background-color:lightblue;" id="7583">diphenyl ether</mark> derivatives on enoyl- <mark style="background-color:lightgreen;" id="O14561,O19921,O34163,O51647,O67611,O69475,O83786,O84239,P07088,P08971,P0A001,P0A002,P0A003,P0A199,P0A1A0,P0A2W0,P0A2W1,P0A2W2,P0A2W3,P0A4W6,P0A4W7,P0A6A8,P0A6A9,P0A6B0,P0A6B1,P0A6B2,P0A6B3,P10352,P10977,P11829,P11830,P11943,P12784,P12884,P12885,P17650,P19372,P20803,P20804,P23153,P25701,P25702,P27060,P29189,P32463,P32887,P41174,P43677,P43709,P47529,P48078,P49517,P51280,P52411,P52412,P52413,P52414,P52505,P53665,P56464,P57433,P58553,P59449,P61156,P63437,P63438,P63439,P63440,P63441,P63442,P63443,P63444,P63445,P63446,P63447,P63448,P63449,P63452,P63453,P75378,P80643,P80916,P80917,P80918,P80919,P80920,P80921,P80922,P80923,P94123,Q00663,Q02054,Q02570,Q05363,Q0MQC1,Q0MQC2,Q0MQC3,Q10217,Q1BBA1,Q49X16,Q4L5T4,Q56035,Q5HGK0,Q5HPV9,Q5WFM5,Q5XAE1,Q606L6,Q62LT9,Q636H6,Q63S86,Q64ZV7,Q65RC8,Q660G8,Q669L4,Q6B8U3,Q6D687,Q6FDT7,Q6G056,Q6G442,Q6G9Y1,Q6GHK3,Q6HEW5,Q6MAF8,Q6MLJ8,Q6YPI8,Q71YL0,Q732M0,Q73ZP6,Q74CR8,Q75FW6,Q7M9W1,Q7MLZ9,Q7MU10,Q7U9V9,Q7UYY2,Q7V4J6,Q7V9R0,Q7VI80,Q7VKH6,Q7VR21,Q7VW32,Q7W5I7,Q7WD23,Q819V7,Q81WI7,Q823D5,Q83N02,Q83NH7,Q85FZ0,Q88LL5,Q89MV8,Q8A2E6,Q8CPI2,Q8D3A9,Q8D8G9,Q8DHS3,Q8EDH4,Q8ER06,Q8EXX4,Q8K9J4,Q8KAN9,Q8R9W1,Q8RGX5,Q8UGE2,Q8XJN7,Q8Z495,Q8ZFT4,Q92GD8,Q94519,Q97HJ4,Q97IA5,Q984T3,Q98QK3,Q9A7P3,Q9CHF9,Q9CJS5,Q9CR21,Q9EZI1,Q9KA04,Q9KQH8,Q9PI64,Q9PKF8,Q9PPY4,Q9R6Z3,Q9RA32,Q9RG22,Q9RK61,Q9RT27,Q9WZD0,Q9Z8P3,Q9ZCH9,Q9ZLS1">ACP</mark> reductase, the molecular <mark style="background-color:orange;">target</mark> site of <mark style="background-color:lightblue;" id="5564">triclosan</mark>, indicated that these compounds fit within the <mark style="background-color:yellow;" id="GO:0005488,molecular_function">binding</mark> domain occupied by <mark style="background-color:lightblue;" id="5564">triclosan</mark>.
18547363-1222	<mark style="background-color:lightblue;" id="442530">Ochratoxin A</mark> <mark style="background-color:orange;">impairs</mark> <mark style="background-color:lightgreen;" id="O54968,Q60795">Nrf2</mark> -dependent gene expression in porcine kidney tubulus cells.
18547363-1223	Therefore, in the present study, the effects of <mark style="background-color:lightblue;" id="444766">OTA</mark> on the nuclear translocation and transactivation of the <mark style="background-color:yellow;" id="GO:0006350,biological_process">transcription</mark> factor <mark style="background-color:lightgreen;" id="O54968,Q60795">Nrf2</mark> as well as mRNA <mark style="background-color:orange;">levels</mark> of <mark style="background-color:lightgreen;" id="O54968,Q60795">Nrf2</mark> <mark style="background-color:orange;">target</mark> genes <mark style="background-color:orange;">including</mark> <mark style="background-color:lightgreen;" id="O04437,O18598,P0A9D2,P0A9D3,P30116,P44521,P46088,P46419,P46423,P46426,P46428,P46437,P48438,P80894,P81065,P82996,P82997,P82998,P82999,P83000,P83001,P83246,Q04522,Q08392,Q08393,Q0ZS46,Q7REH6,Q8ILQ7,Q8MU52,Q96324">glutathione-S-transferase</mark> and gamma-glutamylcysteinyl synthetase have been studied in cultured porcine kidney tubulus cells (<mark style="background-color:lightblue;" id="104946">LLC</mark>- <mark style="background-color:lightgreen;" id="O10269,P17801,P30613,P34100,P41415,P41719,P41720">PK1</mark> ).
18547363-1224	<mark style="background-color:lightgreen;" id="O54968,Q60795">Nrf2</mark> was <mark style="background-color:orange;">induced</mark> by <mark style="background-color:lightblue;" id="5350">sulforaphane</mark>, a well-known activator of this <mark style="background-color:yellow;" id="GO:0006350,biological_process">transcription</mark> factor.
18547363-1225	<mark style="background-color:lightblue;" id="442530">Ochratoxin A</mark> significantly <mark style="background-color:orange;">decreased</mark> gamma-glutamylcysteinyl synthetase and <mark style="background-color:lightgreen;" id="O04437,O18598,P0A9D2,P0A9D3,P30116,P44521,P46088,P46419,P46423,P46426,P46428,P46437,P48438,P80894,P81065,P82996,P82997,P82998,P82999,P83000,P83001,P83246,Q04522,Q08392,Q08393,Q0ZS46,Q7REH6,Q8ILQ7,Q8MU52,Q96324">glutathione-S-transferase</mark> mRNA <mark style="background-color:orange;">levels</mark> in <mark style="background-color:lightblue;" id="104946">LLC</mark>- <mark style="background-color:lightgreen;" id="O10269,P17801,P30613,P34100,P41415,P41719,P41720">PK1</mark> cells.
18547363-1226	Furthermore, <mark style="background-color:lightblue;" id="444766">OTA</mark> also <mark style="background-color:orange;">lowered</mark> <mark style="background-color:lightgreen;" id="O54968,Q60795">Nrf2</mark> mRNA levels.
18547363-1227	Current data indicate that <mark style="background-color:lightblue;" id="444766">OTA</mark> nephrotoxicity may be, at least partly, <mark style="background-color:orange;">mediated</mark> by an <mark style="background-color:lightgreen;" id="O54968,Q60795">Nrf2</mark> -dependent signal <mark style="background-color:yellow;" id="GO:0009293,biological_process">transduction</mark> pathway.
17590240-1233	<mark style="background-color:lightblue;" id="65064">Epigallocatechin gallate (EGCG</mark>) <mark style="background-color:orange;">suppresses</mark> beta-amyloid-induced neurotoxicity through <mark style="background-color:orange;">inhibiting</mark> c- <mark style="background-color:lightgreen;" id="P00520,P00522">Abl</mark> / <mark style="background-color:lightgreen;" id="O00213">FE65</mark> nuclear translocation and <mark style="background-color:lightgreen;" id="P18266,P49841,Q5YJC2,Q9WV60">GSK3 beta</mark> activation.
17590240-1234	Here, we used a human neuronal cell line MC65 conditional expression of an amyloid precursor protein fragment ( <mark style="background-color:lightgreen;" id="P12023">APP-C99</mark> ) to <mark style="background-color:orange;">investigate</mark> the protection mechanism of <mark style="background-color:lightblue;" id="65064">epigallocatechin gallate (EGCG</mark>), the main constituent of <mark style="background-color:lightblue;" id="4630">green tea</mark>.
18495458-1236	<mark style="background-color:lightblue;" id="1203,72276,182232">Epicatechin</mark>-induced survival was a rapid event that was accompanied by early and <mark style="background-color:orange;">sustained</mark> activation of major survival signaling proteins, such as AKT/<mark style="background-color:lightblue;" id="53477912">phosphatidylinositol</mark> 3-kinase and <mark style="background-color:yellow;" id="GO:0005576,cellular_component">extracellular</mark> -regulated kinase (activated from 5 min to 18 h), as well as <mark style="background-color:lightgreen;" id="P13678,Q25378">protein kinase C</mark> ( <mark style="background-color:lightgreen;" id="P05130,P13677,P13678,P34722">PKC</mark> )-alpha (30 min to 18 h), in concert with unaltered c- <mark style="background-color:lightgreen;" id="P05627,P17325,P18289">jun</mark> N-amino terminal kinase <mark style="background-color:orange;">levels</mark> and early inactivation of key <mark style="background-color:yellow;" id="GO:0016265,biological_process">death</mark> -related signals like <mark style="background-color:lightgreen;" id="P10829">PKC-delta</mark> (5 min to 18 h).
18495460-1238	Phospholipidosis and down-regulation of the <mark style="background-color:lightgreen;" id="P19957">PI3</mark> -K/ <mark style="background-color:lightgreen;" id="P22221,Q42736">PDK</mark> -1/ <mark style="background-color:lightgreen;" id="P31750,Q8INB9">Akt</mark> signalling pathway are <mark style="background-color:lightblue;" id="2116,14985,1548900,1742129">vitamin E</mark> inhibitable events <mark style="background-color:orange;">associated</mark> with <mark style="background-color:lightblue;" id="91474">7-ketocholesterol</mark>-induced <mark style="background-color:yellow;" id="GO:0006915,biological_process">apoptosis</mark> .
18368485-1240	Indeed, treatment of cells with 1 muM <mark style="background-color:lightblue;" id="444795">all-trans retinoic acid</mark> (<mark style="background-color:lightblue;" id="444795">ATRA</mark>) or 1 muM 13- <mark style="background-color:lightgreen;" id="Q62225">cis</mark> <mark style="background-color:lightblue;" id="444795">retinoic acid</mark> (13- <mark style="background-color:lightgreen;" id="P04923">CRA</mark> ) for 7 days <mark style="background-color:orange;">induced</mark> astrocytic differentiation with upregulation of glial fibrillary <mark style="background-color:lightgreen;" id="P01538,P01543,P01544,P01545,P08772,P08943,P09617,P09618,P21742,P32032,Q05806,Q42596,Q42597,Q42838,Q8H0Q5,Q8VZK8,Q9C8D6,Q9SBK8">acidic protein</mark> ( <mark style="background-color:lightgreen;" id="P03995,P14136,P47819,Q28115">GFAP</mark> ) and down regulation of <mark style="background-color:yellow;" id="GO:0003720,molecular_function">telomerase activity</mark> .
18495463-1243	<mark style="background-color:lightblue;" id="969516">Curcumin</mark>, <mark style="background-color:lightblue;" id="5324476">demethoxycurcumin</mark> and <mark style="background-color:lightblue;" id="5315472">bisdemethoxycurcumin</mark> differentially <mark style="background-color:orange;">inhibit</mark> cancer cell invasion through the down-regulation of MMPs and <mark style="background-color:lightgreen;" id="P00749,P04185,P06869,P15120,P16227,P29598,Q05589">uPA</mark> .
18450412-1248	<mark style="background-color:lightblue;" id="5326739">Indirubin-3-oxime</mark>-induced growth inhibition was <mark style="background-color:orange;">associated</mark> with induction of <mark style="background-color:lightgreen;" id="O05982">Cdk</mark> inhibitor <mark style="background-color:lightgreen;" id="O19002,O39927,O39928,O39929,O91936,O92529,O92530,O92531,O92532,P26660,P26661,P26662,P26663,P26664,P27954,P27955,P27956,P27957,P27958,P27959,P27960,P27961,P29846,P38936,P39689,P61585,P63028,Q00269,Q01403,Q01404,Q07828,Q11118,Q42580,Q5EG65,Q5I2N3,Q62092,Q68749,Q68798,Q68801,Q81258,Q81487,Q81495,Q81754,Q913D4,Q99IB8,Q9DHD6,Q9QAX1,Q9WMX2">p21</mark> , inhibition of <mark style="background-color:lightgreen;" id="O01377,O16852,P04961,P12004,P17070,P17917,P17918,P18248,P22177,P24314,P31008,P53358,P61074,Q00265,Q00268">cyclin</mark> D1 and activation of caspase-3.
18268501-1260	The effect of the polymorphism is non-conservative and results in a <mark style="background-color:lightblue;" id="738,5961">glutamine</mark> to <mark style="background-color:lightblue;" id="232,4367,6322">arginine</mark> <mark style="background-color:orange;">change</mark> (Gln460Arg), which is likely to <mark style="background-color:orange;">affect</mark> <mark style="background-color:lightgreen;" id="Q99572">P2RX7</mark> dimerization and protein-protein interactions.
18681858-1	In men there is a large interindividual variation of <mark style="background-color:lightgreen;" id="P04278,P08689,P15196,P97497,Q62588">SHBG</mark> <mark style="background-color:orange;">levels</mark> and consequently of <mark style="background-color:lightblue;" id="6013">testosterone</mark> (T) and E(2) levels.
18691757-12	Ligand-induced <mark style="background-color:lightgreen;" id="Q00342">Flt3</mark> -downregulation <mark style="background-color:orange;">modulates</mark> <mark style="background-color:yellow;" id="GO:0008219,biological_process">cell death</mark> <mark style="background-color:orange;">associated</mark> proteins and <mark style="background-color:orange;">enhances</mark> chemosensitivity to <mark style="background-color:lightblue;" id="42890">idarubicin</mark> in <mark style="background-color:lightgreen;" id="P07911,P10070,P27590,P48733,Q862Z3,Q91X17">THP</mark> -1 acute myeloid leukemia cells.
18587665-16	<mark style="background-color:lightblue;" id="5281807,5385074,5486172,44257207,53384442">Puerarin</mark> <mark style="background-color:orange;">regulates</mark> expressions of <mark style="background-color:lightgreen;" id="P15691,P15692,P26617,P49151,P50412,P67964,P67965,Q99PS1,Q9GKR0,Q9MYV3">VEGF</mark> and <mark style="background-color:lightgreen;" id="O35800,Q0PGG7,Q16665,Q309Z6,Q61221,Q98SW2,Q9I8A9,Q9XTA5,Q9YIB9">HIF-1alpha</mark> <mark style="background-color:orange;">stimulated</mark> by <mark style="background-color:lightgreen;" id="Q11206">STZ</mark> .
18679831-20	In this study, we report that AR-<mark style="background-color:lightblue;" id="77681">M1896</mark>, a non-GalR1 agonist, <mark style="background-color:orange;">inhibited</mark> plasma extravasation <mark style="background-color:orange;">induced</mark> by <mark style="background-color:lightgreen;" id="P01289,P06767,P19850,P20366,P28498,P28499,P41333,P41539,P41540,P67932,P67933,Q60541">substance P</mark> and <mark style="background-color:lightgreen;" id="P30880,P30881,P31888">calcitonin gene-related peptide</mark> in a manner similar to <mark style="background-color:lightgreen;" id="P07480,P10683,P11242,P22466,P30802,P31234,P33710,P47212,P47213,P47214,P47215,P47216,Q9W6M9">galanin</mark> , confirming a non-GalR1-mediated effect.
18632742-27	Here we show that <mark style="background-color:lightgreen;" id="Q99988,Q9JKM5">NRG-1</mark> selectively <mark style="background-color:orange;">increases</mark> the power of <mark style="background-color:lightblue;" id="10255">kainate</mark>-induced, but not <mark style="background-color:lightblue;" id="2551">carbachol</mark>-induced, gamma oscillations in acute hippocampal slices.
18688040-30	The <mark style="background-color:lightgreen;" id="P20109,P35225,P42203,P61126,Q5I6E4,Q864V6,Q865W5,Q865X3,Q95J68,Q9N0W9,Q9XSV9">IL-13</mark> -induced up-regulation of <mark style="background-color:lightgreen;" id="Q9C3Y4">RhoA</mark> was <mark style="background-color:orange;">inhibited</mark> by <mark style="background-color:lightblue;" id="3899">leflunomide</mark>, an inhibitor of signal transducer and activator of <mark style="background-color:yellow;" id="GO:0006350,biological_process">transcription</mark> 6 ( <mark style="background-color:lightgreen;" id="P42226">STAT6</mark> ).
18649135-39	Activation of <mark style="background-color:lightgreen;" id="P41693">interleukin-6</mark> / <mark style="background-color:lightgreen;" id="P40763,P61635">STAT3</mark> in rat cholangiocyte proliferation <mark style="background-color:orange;">induced</mark> by <mark style="background-color:lightblue;" id="11970143">lipopolysaccharide</mark>.
18629640-41	Oral administration of <mark style="background-color:lightblue;" id="5281670">morin</mark> remarkably <mark style="background-color:orange;">prevented</mark> weight loss in the body and liver from <mark style="background-color:lightgreen;" id="O15061">DMN</mark> and <mark style="background-color:orange;">inhibited</mark> the elevation of serum <mark style="background-color:lightblue;" id="602,4580,5950,71080">alanine</mark> transaminase (ALT), <mark style="background-color:lightblue;" id="5960">aspartate</mark> transaminase ( <mark style="background-color:lightgreen;" id="P0AE37,P0AE38,P80357,P80358,Q0TH83,Q1C8B0,Q1RB46,Q321N9,Q32G89,Q3Z294,Q5PHB9,Q66B20,Q7N2G8,Q83L52,Q8FH00,Q8Z6G0,Q8ZPV1,Q9NRA2,Q9ZC67">AST</mark> ), and total <mark style="background-color:lightblue;" id="5280352">bilirubin</mark> levels.
18671672-48	<mark style="background-color:lightblue;" id="11984615">CLNO2</mark> <mark style="background-color:orange;">levels</mark> were found to increase approximately 20-fold 24 h after <mark style="background-color:yellow;" id="GO:0042116,biological_process">macrophage activation</mark> with Escherichia coli <mark style="background-color:lightblue;" id="11970143">lipopolysaccharide</mark> plus <mark style="background-color:lightgreen;" id="Q9TTB0">interferon-gamma</mark> ; this response was concurrent with an <mark style="background-color:orange;">increase</mark> in the expression of <mark style="background-color:lightgreen;" id="O19114,O46660,O54705,O62699,P35228,P60321,P79290,Q27995,Q28314,Q90703,Q92037,Q92091">NOS2</mark> (inducible <mark style="background-color:lightgreen;" id="O61309,O61608,Q27571,Q9I9M2">nitric oxide synthase</mark> ) and was <mark style="background-color:orange;">inhibited</mark> by the (*)NO (<mark style="background-color:lightblue;" id="145068">nitric oxide</mark>) inhibitor L-NAME (<mark style="background-color:lightblue;" id="39836">N(G)-nitro-L-arginine methyl ester</mark>).
18686014-51	In preeclamptic patients, serum <mark style="background-color:lightgreen;" id="P30722,P47547,P49463,P75344,Q7YQC6,Q8TQR2,Q9UXR0,Q9WYK6">Hsp70</mark> levels showed significant correlations with serum <mark style="background-color:lightgreen;" id="O19062,P02741,P02742,P08462,P18151,P21291,P41964,P47875,P49254,P49262,P52753,P67966,P67967,P97315,Q07203">CRP</mark> <mark style="background-color:orange;">levels</mark> (Spearman R = 0.32, p = 0.010), serum <mark style="background-color:lightgreen;" id="O33822,O58489,O67781,O86459,O93744,P00509,P14909,P23034,P44425,P53001,P58661,P72173,Q4J8X2,Q55128,Q56114,Q56232,Q59228,Q60013,Q92JE7,Q972A2,Q9V0L2,Q9X0Y2,Q9ZE56">aspartate aminotransferase</mark> (R = 0.32, p = 0.008) and <mark style="background-color:lightgreen;" id="P29038,P33571,P93052,Q27797,Q27888,Q95028,Q99289">LDH</mark> (0.001), as well as with plasma <mark style="background-color:lightblue;" id="10964">malondialdehyde</mark> levels (R = 0.25, p = 0.043).
18673333-52	Beta1,4- <mark style="background-color:lightgreen;" id="P14769,P23336,P50127">galactosyltransferase</mark> -I ( <mark style="background-color:lightgreen;" id="P08037,P15291">B4GALT1</mark> ), one of seven beta1,4- <mark style="background-color:lightgreen;" id="P14769,P23336,P50127">galactosyltransferases</mark> , is an enzyme commonly found in the trans- <mark style="background-color:yellow;" id="GO:0005794,cellular_component">Golgi complex</mark> that <mark style="background-color:orange;">adds</mark> <mark style="background-color:lightblue;" id="6036,439353,439357">galactose</mark> to oligosaccharides.
18673333-53	When compared to the other mammalian <mark style="background-color:lightgreen;" id="P08037,P15291">B4GALT1</mark> genes, the porcine coding sequence <mark style="background-color:orange;">contained</mark> a single <mark style="background-color:lightblue;" id="6288">threonine</mark> codon inserted into the region encoding the cytoplasmic domain.
18696256-54	Solute carrier family 27 (fatty acid transporter), member 4 ( <mark style="background-color:lightgreen;" id="Q4R3Y4,Q5RDY4,Q6P1M0">SLC27A4</mark> ) is a fatty <mark style="background-color:lightgreen;" id="P0A4X8,P0A4X9,P38135,P54200,P63523,P63524,P69451,P69452,Q02278,Q10776,Q10976,Q4L3Q0,Q50586,Q5HIA1,Q5HRH4,Q6GBR2,Q6GJ94,Q7A1Q0,Q7A769,Q8CQ67,Q8XDR6,Q99W34,Q9KWK5">acyl-CoA synthetase</mark> <mark style="background-color:orange;">producing</mark> very <mark style="background-color:lightblue;" id="284">long chain fatty acid</mark>-CoA for lipid metabolic pathways, suggesting that the <mark style="background-color:lightgreen;" id="Q4R3Y4,Q5RDY4,Q6P1M0">SLC27A4</mark> gene is a potential candidate gene for traits related to fat deposition in animals.
18668351-55	It was observed that administration of the <mark style="background-color:lightgreen;" id="P05130,P13677,P13678,P34722">PKC</mark> inhibitor <mark style="background-color:lightblue;" id="2703">chelerythrine chloride</mark> (5 mg/kg) <mark style="background-color:orange;">suppressed</mark> the activation of three exercise-induced <mark style="background-color:lightgreen;" id="P05130,P13677,P13678,P34722">PKC</mark> isoforms ( <mark style="background-color:lightgreen;" id="P04409,P05696,P10102,P17252,P20444">PKCalpha</mark> , <mark style="background-color:lightgreen;" id="P10829">PKCdelta</mark> , and PKCepsilon) and attenuated the exercise-mediated reduction of myocardial infarct size during ischemia-reperfusion injury.
18683233-58	The culture tests using <mark style="background-color:lightgreen;" id="O60682">MSCs</mark> show that the <mark style="background-color:orange;">level</mark> of <mark style="background-color:lightgreen;" id="O60109,P81800,P83456">alkaline phosphatase</mark> ( <mark style="background-color:lightgreen;" id="P03973,P12547,P22298,P28296,P29118,P35211,P83610,P97430,Q03420,Q53GG5,Q9H0A0,Q9PU47,Q9Z1X0">ALP</mark> ) activity in the cells cultured on <mark style="background-color:lightblue;" id="440717">SPV</mark>-H <mark style="background-color:orange;">increased</mark> during the 21-day culture in a medium without <mark style="background-color:lightgreen;" id="P39653,Q59979">Dex</mark> and <mark style="background-color:lightblue;" id="2526">beta-GP</mark>.
18683233-59	The level was unchanged in <mark style="background-color:lightgreen;" id="O60682">MSCs</mark> cultured on <mark style="background-color:lightgreen;" id="P03422,P06940,P11207,P11208,P16072,P16595,P19717,P19847,P21738,P21739,P21740,P22044,P23055,P23056,P23057,P26033,P26036,P30927,P30928,P33483,P35939,P35941,P35945,P35974,P36315,P60166,P60167,P60168,P60169,Q00793,Q03335,Q03340,Q06427,Q06428,Q86606,Q9EMA9,Q9IC37,Q9QM81,Q9WS39">PV</mark> -H. In the case of supplementing <mark style="background-color:lightgreen;" id="P39653,Q59979">Dex</mark> and <mark style="background-color:lightblue;" id="2526">beta-GP</mark> to the medium, the <mark style="background-color:orange;">level</mark> of <mark style="background-color:lightgreen;" id="P03973,P12547,P22298,P28296,P29118,P35211,P83610,P97430,Q03420,Q53GG5,Q9H0A0,Q9PU47,Q9Z1X0">ALP</mark> activity in <mark style="background-color:lightgreen;" id="O60682">MSCs</mark> cultured on <mark style="background-color:lightblue;" id="440717">SPV</mark>-H was higher than that on <mark style="background-color:lightgreen;" id="P03422,P06940,P11207,P11208,P16072,P16595,P19717,P19847,P21738,P21739,P21740,P22044,P23055,P23056,P23057,P26033,P26036,P30927,P30928,P33483,P35939,P35941,P35945,P35974,P36315,P60166,P60167,P60168,P60169,Q00793,Q03335,Q03340,Q06427,Q06428,Q86606,Q9EMA9,Q9IC37,Q9QM81,Q9WS39">PV</mark> -H at all time points during the 21-day culture.
18698333-76	Cisternal SAH- <mark style="background-color:lightgreen;" id="O62757,P01587,P04141,P11052,P28773,P48749,P48750,P51748,Q0MUT8,Q29118,Q60481">CSF</mark> <mark style="background-color:orange;">induces</mark> cytosolic <mark style="background-color:lightblue;" id="271">Ca(2</mark>+) oscillations in <mark style="background-color:lightblue;" id="194176">HCEC</mark> that results in cellular constriction, NF-kappaB activation, and <mark style="background-color:lightgreen;" id="P19320,P29533,P29534,Q28260">VCAM-1</mark> expression.
18647134-77	<mark style="background-color:lightgreen;" id="P01180,P01181,P01183,P01185,P01186,P10769,P35455">Copeptin</mark> , <mark style="background-color:orange;">derived</mark> from the C-terminal portion of the precursor to <mark style="background-color:lightgreen;" id="P01180,P01181,P01182,P01183,P01184,P01185,P10769,P31414,P81768">AVP</mark> (<mark style="background-color:lightblue;" id="8230,644077,44285245">arginine vasopressin</mark>), is secreted stoichiometrically with vasopressin, hence it can be used as a surrogate marker of the <mark style="background-color:lightgreen;" id="P01180,P01181,P01182,P01183,P01184,P01185,P10769,P31414,P81768">AVP</mark> system.
18647135-78	The <mark style="background-color:lightgreen;" id="Q10751">angiotensin-converting enzyme</mark> insertion/deletion polymorphism is <mark style="background-color:orange;">associated</mark> with phagocytic <mark style="background-color:lightblue;" id="5884">NADPH</mark> oxidase-dependent <mark style="background-color:lightblue;" id="5359597">superoxide</mark> generation: potential implication in hypertension.
18615705-83	All these results clearly indicated that the observed <mark style="background-color:lightblue;" id="4004">malathion</mark> resistance in the FR was conferred by multiple mechanisms, <mark style="background-color:orange;">including</mark> <mark style="background-color:orange;">increased</mark> detoxification by ESTs and <mark style="background-color:lightgreen;" id="P20432,P30104,P30106,P30107,P30108,Q04522,Q0ZS46,Q7REH6,Q8ILQ7,Q8MU52">GSTs</mark> , and increased activity and <mark style="background-color:orange;">reduced</mark> sensitivity of <mark style="background-color:lightgreen;" id="O42275,O62763,P04058,P07140,P07692,P21836,P22303,P23795,P36196,P37136,P56161,Q27677,Q29499,Q867X2,Q867X3,Q869C3,Q86GC8,Q86GC9,Q92035,Q92081,Q9DDE3">AChE</mark> to OP inhibition.
18701427-85	The aim of this phase 0 study was to investigate whether <mark style="background-color:lightblue;" id="60750">gemcitabine</mark> passes the blood-tumor barrier, and is <mark style="background-color:orange;">phosphorylated</mark> in the tumor by <mark style="background-color:lightgreen;" id="P27707,P43346,P48769">deoxycytidine kinase</mark> ( <mark style="background-color:lightgreen;" id="P21974,P27707,P43346,P48769,Q9J579">dCK</mark> ) to <mark style="background-color:lightblue;" id="60750">gemcitabine</mark> nucleotides in order to enable radiosensitization, and whether it is deaminated by <mark style="background-color:lightblue;" id="13711">deoxycytidine</mark> deaminase (dCDA) to dFdU.
18633436-86	Of various agents tested in HaCaT cell cultures, only <mark style="background-color:lightblue;" id="444795">retinoic acid</mark> (10(-6) M) and <mark style="background-color:lightblue;" id="5279,44259,451705,5311103,5459111,6419748,6711321,9956178,44299148">staurosporine</mark> (2.5 x 10(-8) M) <mark style="background-color:orange;">upregulated</mark> <mark style="background-color:lightgreen;" id="O75900,O93470,Q8K3F2,Q8N119,Q90YC2,Q9R0S2">MMP-21</mark> mRNA and protein expression, whereas tumor promoters, hormones, or <mark style="background-color:lightblue;" id="5743">dexamethasone</mark> were without effect.
18668222-95	<mark style="background-color:lightblue;" id="2730">Chlorpyrifos</mark> ( <mark style="background-color:lightgreen;" id="O00482">CPF</mark> ), a commonly <mark style="background-color:orange;">used</mark> organophosphorus insecticide, <mark style="background-color:orange;">induces</mark> <mark style="background-color:lightgreen;" id="Q867X2,Q867X3,Q86GC9,Q92081">acetylcholinesterase</mark> inhibition and cholinergic toxicity.
18585720-96	Di-<mark style="background-color:lightblue;" id="5885531">oleoyl</mark> phosphatidylcholine (PC-18:1) <mark style="background-color:orange;">stimulates</mark> paraoxonase 1 ( <mark style="background-color:lightgreen;" id="P27169,P27170">PON1</mark> ) enzymatic and biological activities: in vitro and in vivo studies.
18585721-97	With the exception of specific genetic defects in <mark style="background-color:lightblue;" id="1044">purine</mark> metabolism, <mark style="background-color:orange;">increased</mark> <mark style="background-color:lightblue;" id="1175">uric acid</mark> is generally <mark style="background-color:orange;">associated</mark> with important risk factors for atherosclerosis like hypertension, abdominal obesity, <mark style="background-color:lightgreen;" id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">insulin</mark> resistance, the metabolic syndrome and renal failure.
18663559-103	Hypothetically, <mark style="background-color:lightgreen;" id="P10635,Q2XNC8,Q2XNC9">cytochrome P450 2D6</mark> <mark style="background-color:orange;">influences</mark> the <mark style="background-color:yellow;" id="GO:0006810,biological_process">transport</mark> of <mark style="background-color:lightblue;" id="1123">taurine</mark> across the blood-brain barrier.
18585744-108	The distribution of sugar moieties within the epididymal region of the Sudani duck was investigated using ten different <mark style="background-color:lightblue;" id="18730">fluorescein isothiocyanate</mark> (<mark style="background-color:lightblue;" id="18730">FITC</mark>) <mark style="background-color:orange;">conjugated</mark> <mark style="background-color:lightgreen;" id="P02871,P02873,P02874,P02875,P07386,P16108,P16349,P16351,P16352,P33888,P38662,P42088,P83410,P83511,P84987,Q41114">lectins</mark> .
18671761-109	<mark style="background-color:lightblue;" id="3290">Parkin</mark>-mediated ubiquitination <mark style="background-color:orange;">regulates</mark> <mark style="background-color:lightgreen;" id="P08487,P10686,P19174,Q62077">phospholipase C-gamma1</mark> .
18626709-112	The <mark style="background-color:lightgreen;" id="P13656,P14529,P23472,P23473,P81241,P84754">chitinase</mark> activity was <mark style="background-color:orange;">increased</mark> by <mark style="background-color:lightblue;" id="27854">Mn(2</mark>+), <mark style="background-color:lightblue;" id="27099">Cu(2</mark>+), and Mg(2+), while strongly <mark style="background-color:orange;">inhibited</mark> by <mark style="background-color:lightblue;" id="27284">Fe(2</mark>+) and <mark style="background-color:lightblue;" id="104810">Ba(2</mark>+).
18626709-113	Meanwhile, <mark style="background-color:lightgreen;" id="P20132">SDS</mark> , ethyleneglycoltetraacetic acid, <mark style="background-color:lightblue;" id="1176,265993">urea</mark>, and <mark style="background-color:lightblue;" id="6049">ethylenediaminetetraacetic acid</mark> were found to have significantly inhibitory <mark style="background-color:orange;">effect</mark> on <mark style="background-color:lightgreen;" id="P13656,P14529,P23472,P23473,P81241,P84754">chitinase</mark> activity.
18694296-116	Both <mark style="background-color:lightblue;" id="5311">SAHA</mark> and <mark style="background-color:lightblue;" id="4261">MS-275</mark> <mark style="background-color:orange;">induced</mark> an arrest in the <mark style="background-color:yellow;" id="GO:0007049,biological_process">cell cycle</mark> along with the induction of apoptotic pathways as evidenced by flow cytometry, annexin assay, detection of <mark style="background-color:orange;">activated</mark> caspase 9, and molecular analysis of <mark style="background-color:lightgreen;" id="P27297,Q07813,Q63690">Bax</mark> / <mark style="background-color:lightgreen;" id="P10417,P49950">Bcl-2</mark> expression.
18704543-120	<mark style="background-color:lightgreen;" id="P09848,P09849">LCT</mark> 13910 CC genotype is <mark style="background-color:orange;">associated</mark> with <mark style="background-color:lightblue;" id="294,6134,84571,440995">lactose</mark> intolerance, a condition often resulting in reduced milk intake.
18626726-122	In the present study, we screened the inhibitory effect of the extract from 50 Thai medicinal plants on an inducible- <mark style="background-color:lightgreen;" id="O61309,O61608,Q27571,Q9I9M2">nitric oxide synthase</mark> ( <mark style="background-color:lightgreen;" id="O19114,O46660,O54705,O62699,P29477,P35228,P79290,Q06518,Q27995,Q28314,Q90703,Q92037,Q92091">iNOS</mark> ) expression <mark style="background-color:orange;">induced</mark> by <mark style="background-color:lightblue;" id="11970143">lipopolysaccharide</mark> (LPS) in mouse macrophages RAW 264.7.
18671795-129	Short-acting <mark style="background-color:lightgreen;" id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">insulin</mark> analogues, in comparison with regular human <mark style="background-color:lightgreen;" id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">insulin</mark> ( <mark style="background-color:lightgreen;" id="P33279,Q9BQI3">HRI</mark> ), <mark style="background-color:orange;">provide</mark> a greater control of postprandial <mark style="background-color:lightblue;" id="206,5793,64689,79025">glucose</mark>, while their superiority on haemoglobin A1c (HbA1c) is controversial.
18686136-131	In this study we investigated the <mark style="background-color:lightblue;" id="5359597">superoxide</mark> radicals scavenging <mark style="background-color:orange;">effect</mark> and <mark style="background-color:lightgreen;" id="P22985,P47989,P47990,P80457,Q00519,Q9MYW6">xanthine oxidase</mark> inhibitory activity by <mark style="background-color:lightblue;" id="6451084">magnesium lithospermate B</mark>, which was originally isolated from the roots of Salvia miltiorrhiza (also named Danshen or Dansham), an important herb in Oriental medicine.
18686136-132	<mark style="background-color:lightblue;" id="5359597">Superoxide</mark> radicals were <mark style="background-color:orange;">generated</mark> both in <mark style="background-color:lightblue;" id="928,439153,11250888">beta-NADH</mark>/<mark style="background-color:lightblue;" id="9286">PMS</mark> system and <mark style="background-color:lightblue;" id="1188">xanthine</mark>/ <mark style="background-color:lightgreen;" id="P22985,P47989,P47990,P80457,Q00519,Q9MYW6">xanthine oxidase</mark> system.
18686136-133	Further study suggested that <mark style="background-color:lightblue;" id="6451084">magnesium lithospermate B</mark> can directly <mark style="background-color:orange;">inhibit</mark> <mark style="background-color:lightgreen;" id="P22985,P47989,P47990,P80457,Q00519,Q9MYW6">xanthine oxidase</mark> and exhibits competitive inhibition.
18686136-134	In addition, <mark style="background-color:lightblue;" id="6451084">magnesium lithospermate B</mark> significantly <mark style="background-color:orange;">protected</mark> HL-60 cells from <mark style="background-color:lightblue;" id="5359597">superoxide</mark> radicals-induced <mark style="background-color:yellow;" id="GO:0006915,biological_process">apoptosis</mark> in the <mark style="background-color:lightblue;" id="1188">xanthine</mark>/ <mark style="background-color:lightgreen;" id="P22985,P47989,P47990,P80457,Q00519,Q9MYW6">xanthine oxidase</mark> reactions.
18696216-140	<mark style="background-color:lightblue;" id="232,4367,6322">Arginine</mark>-specific <mark style="background-color:lightgreen;" id="P14299">ADP-ribosyltransferase</mark> (Art) <mark style="background-color:orange;">catalyzes</mark> the mono- <mark style="background-color:lightgreen;" id="P02783">ADP</mark> -ribosylation, in which it <mark style="background-color:orange;">transfers</mark> a single <mark style="background-color:lightgreen;" id="P02783">ADP</mark> -ribose moiety of <mark style="background-color:lightblue;" id="5893">NAD</mark> to the <mark style="background-color:lightblue;" id="232,4367,6322">arginine</mark> residue(s) of target proteins, and may regulate the function of the proteins or peptides in cellular processes.
18704417-141	Achieving CCgR within 12 months and maintaining it without an increase in <mark style="background-color:lightgreen;" id="P11274">BCR</mark> - <mark style="background-color:lightgreen;" id="P00519,P00521,P10447,P11681,Q00022">ABL</mark> transcripts might <mark style="background-color:orange;">indicate</mark> that low-dose <mark style="background-color:lightblue;" id="5291">imatinib</mark> therapy can produce acceptable outcomes without excess toxicity.
18711728-143	Furthermore, <mark style="background-color:lightgreen;" id="Q90YJ2,Q99JA8,Q9ER97">Ngb</mark> overexpression <mark style="background-color:orange;">reduced</mark> <mark style="background-color:lightblue;" id="5359597">superoxide</mark> anion generation after H/R, whereas <mark style="background-color:lightblue;" id="124886">glutathione</mark> levels were significantly improved compared with WT controls.
18690792-146	We show that the effects of both <mark style="background-color:lightgreen;" id="P03969,P20003,P48800,Q60487">FGF-2</mark> and <mark style="background-color:lightblue;" id="5047209,46173182">HS</mark> are <mark style="background-color:orange;">mediated</mark> through <mark style="background-color:lightgreen;" id="O10284,P41444">FGF</mark> receptor 1 ( <mark style="background-color:lightgreen;" id="P11362,P21804,Q8MY86,Q91285">FGFR1</mark> ) and that inhibition of signaling through this receptor arrests cell growth, resulting in the cells being unable to reach the critical density necessary to induce differentiation.
18690792-147	It also confirms the importance of <mark style="background-color:lightblue;" id="5047209,46173182">HS</mark> as a coreceptor for the signaling of endogenous <mark style="background-color:lightgreen;" id="P03969,P20003,P48800,Q60487">FGF-2</mark> and suggests that purified glycosaminoglycans may be attractive alternatives to growth factors for <mark style="background-color:orange;">improved</mark> ex vivo growth and differentiation of <mark style="background-color:lightgreen;" id="O60682">MSCs</mark> .
18563306-164	<mark style="background-color:lightblue;" id="54454,4677798">Simvastatin</mark> treatment significantly <mark style="background-color:orange;">increased</mark> the number of peripheral blood <mark style="background-color:lightgreen;" id="P28906,Q28270">CD34</mark> + CD133+ cells, and serum concentration of vascular endothelial growth factor ( <mark style="background-color:lightgreen;" id="P15691,P15692,P26617,P49151,P50412,P67964,P67965,Q99PS1,Q9GKR0,Q9MYV3">VEGF</mark> ) and AKT was markedly increased in vivo.
18563306-165	In cultured EPC, <mark style="background-color:lightblue;" id="54454,4677798">simvastatin</mark> <mark style="background-color:orange;">increased</mark> the concentrations of <mark style="background-color:lightgreen;" id="P15691,P15692,P26617,P49151,P50412,P67964,P67965,Q99PS1,Q9GKR0,Q9MYV3">VEGF</mark> , AKT and <mark style="background-color:lightgreen;" id="P29473,P29474,P70313,P79209,P97270,Q28969,Q62600">eNOS</mark> .
18563306-166	Western blots analysis showed that <mark style="background-color:lightblue;" id="54454,4677798">simvastatin</mark> <mark style="background-color:orange;">increased</mark> the <mark style="background-color:yellow;" id="GO:0016310,biological_process">phosphorylation</mark> of <mark style="background-color:lightgreen;" id="P29473,P29474,P70313,P79209,P97270,Q28969,Q62600">eNOS</mark> and <mark style="background-color:lightgreen;" id="O43524">FKHRL1</mark> , which can be <mark style="background-color:orange;">blocked</mark> by the <mark style="background-color:lightgreen;" id="O00329,O02697,O35904,P23727,P26450,P27986,P32871,P42336,P42337,P42338,P42347,P42348,P48736,P54673,P54674,P54675,P54676,Q63787,Q8BTI9,Q8UUU2,Q9JHG7,Q9Z1L0">PI3K</mark> /AKT pathway blocker <mark style="background-color:lightblue;" id="3973">LY294002</mark>.
18563306-167	In in vitro study, <mark style="background-color:lightblue;" id="54454,4677798">simvastatin</mark> <mark style="background-color:orange;">increases</mark> the <mark style="background-color:yellow;" id="GO:0016310,biological_process">phosphorylation</mark> of <mark style="background-color:lightgreen;" id="P29473,P29474,P70313,P79209,P97270,Q28969,Q62600">eNOS</mark> and of <mark style="background-color:lightgreen;" id="O43524">FKHRL1</mark> through the <mark style="background-color:lightgreen;" id="O00329,O02697,O35904,P23727,P26450,P27986,P32871,P42336,P42337,P42338,P42347,P42348,P48736,P54673,P54674,P54675,P54676,Q63787,Q8BTI9,Q8UUU2,Q9JHG7,Q9Z1L0">PI3K</mark> /AKT signaling pathway.
18663659-168	Most genes involved in <mark style="background-color:yellow;" id="GO:0006629,biological_process">lipid metabolism</mark> and especially in <mark style="background-color:yellow;" id="GO:0006696,biological_process">ergosterol biosynthesis</mark> were up-regulated in response to <mark style="background-color:lightblue;" id="3793,55283,6917738,14179013">itraconazole</mark>, <mark style="background-color:orange;">including</mark> <mark style="background-color:lightgreen;" id="O74198,P25087,Q5EN22,Q6BRB7,Q6C2D9,Q6CYB3,Q6FRZ7,Q759S7,Q875K1">ERG6</mark> , <mark style="background-color:lightgreen;" id="P38604,Q04782,Q96WJ0">ERG7</mark> , <mark style="background-color:lightgreen;" id="P10613,P10614,P14263,P49602,P50859,Q759W0">ERG11</mark> , <mark style="background-color:lightgreen;" id="P32462">ERG24</mark> , <mark style="background-color:lightgreen;" id="O59933,P53045,Q15800">ERG25</mark> and <mark style="background-color:lightgreen;" id="P53199">ERG26</mark> .
18624760-178	<mark style="background-color:lightblue;" id="5284513">Acitretin</mark> <mark style="background-color:orange;">increased</mark> the <mark style="background-color:orange;">levels</mark> of CD95 ( <mark style="background-color:lightgreen;" id="P25446,Q63199">Fas</mark> ), CD95-ligand and <mark style="background-color:lightgreen;" id="P25446,Q63199">Fas</mark> -associated <mark style="background-color:yellow;" id="GO:0016265,biological_process">death</mark> domain.
18624766-181	Since <mark style="background-color:lightblue;" id="28486,3028194">lithium</mark> and <mark style="background-color:lightblue;" id="4210951">SB-415286</mark>-induced G(2)/M arrest we studied <mark style="background-color:orange;">changes</mark> in the expression of proteins involved in this phase, specifically <mark style="background-color:lightgreen;" id="O01377,O16852,P04961,P12004,P17070,P17917,P17918,P18248,P22177,P24314,P31008,P53358,P61074,Q00265,Q00268">cyclin</mark> B, <mark style="background-color:lightgreen;" id="P04551,P11440,P23572,P39951">cdc2</mark> and the phosphorylated form of this protein (tyr15- <mark style="background-color:lightgreen;" id="P04551,P11440,P23572,P39951">cdc2</mark> ).
18624766-182	On the other hand, <mark style="background-color:lightblue;" id="4210951">SB-415286</mark> <mark style="background-color:orange;">increased</mark> the expression of <mark style="background-color:lightgreen;" id="Q4R834,Q5RBF1,Q8IXJ6">SIRT2</mark> , involved in the regulation of proliferation.
18624766-184	We conclude that inhibitors of <mark style="background-color:lightgreen;" id="P51136,P83101">GSK-3</mark> <mark style="background-color:orange;">induced</mark> <mark style="background-color:yellow;" id="GO:0007050,biological_process">cell-cycle arrest</mark> , <mark style="background-color:orange;">mediated</mark> by the <mark style="background-color:yellow;" id="GO:0016310,biological_process">phosphorylation</mark> of <mark style="background-color:lightgreen;" id="P04551,P11440,P23572,P39951">cdc2</mark> and, in the case of <mark style="background-color:lightblue;" id="4210951">SB-415286</mark>, <mark style="background-color:lightgreen;" id="Q4R834,Q5RBF1,Q8IXJ6">SIRT2</mark> expression, which induced <mark style="background-color:yellow;" id="GO:0006915,biological_process">apoptosis</mark> in a caspase-independent manner.
18622720-187	These findings indicated that combined treatment with <mark style="background-color:lightblue;" id="938">niacin</mark> and <mark style="background-color:lightblue;" id="23976">chromium</mark> has potential therapeutic protection of endothelial function by <mark style="background-color:orange;">down-regulating</mark> ox-LDL/ <mark style="background-color:lightgreen;" id="O70156,P78380,P79391,Q9EQ09,Q9TTK7,Q9XTA8">LOX-1</mark> signaling pathway.
18624772-191	Reduced <mark style="background-color:lightgreen;" id="P29473,P29474,P70313,P79209,P97270,Q28969,Q62600">eNOS</mark> protein <mark style="background-color:orange;">levels</mark> were accompanied by an increase in <mark style="background-color:yellow;" id="GO:0005622,cellular_component">intracellular</mark> <mark style="background-color:lightblue;" id="271">Ca(2</mark>+), <mark style="background-color:orange;">augmented</mark> production of reactive <mark style="background-color:lightblue;" id="977">oxygen</mark> species (ROS) and induction of <mark style="background-color:lightblue;" id="271">Ca(2</mark>+)-dependent <mark style="background-color:lightgreen;" id="P27730">calpain</mark> activity.
18624772-192	Reduction of <mark style="background-color:yellow;" id="GO:0005622,cellular_component">intracellular</mark> <mark style="background-color:lightblue;" id="271">Ca(2</mark>+) <mark style="background-color:orange;">levels</mark> abolished <mark style="background-color:lightgreen;" id="P29473,P29474,P70313,P79209,P97270,Q28969,Q62600">eNOS</mark> reduction by HOG-LDL, as did pharmacological or genetic through calcium channel blockers or calcium chelator <mark style="background-color:lightblue;" id="104751">BAPTA</mark> or inhibition of <mark style="background-color:lightblue;" id="5893">NAD</mark>(P)H oxidase (with <mark style="background-color:lightblue;" id="2214">apocynin</mark>) or inhibition of <mark style="background-color:lightgreen;" id="P27730">calpain</mark> ( <mark style="background-color:lightgreen;" id="P27730">calpain</mark> 1-specific siRNA).
18704651-196	Osteointegration of <mark style="background-color:lightblue;" id="23963">titanium</mark> or its alloy with bone can be greatly <mark style="background-color:orange;">improved</mark> by <mark style="background-color:lightblue;" id="24441,24456,24632">calcium phosphate</mark> coatings, and further <mark style="background-color:orange;">enhanced</mark> by an <mark style="background-color:yellow;" id="GO:0005576,cellular_component">extracellular</mark>  <mark style="background-color:lightgreen;" id="O12705,O18559,O57299,O89341,P03314,P03344,P03419,P03426,P03519,P04876,P04888,P05769,P06157,P06166,P06446,P06502,P06503,P06935,P06942,P06943,P07564,P07720,P07873,P08325,P08671,P09732,P09866,P11206,P12446,P12823,P13616,P13844,P14335,P14336,P14340,P14403,P15200,P16287,P16628,P16629,P17748,P17763,P18356,P18611,P19110,P19692,P19718,P22046,P22338,P24266,P24615,P25058,P25182,P25223,P25224,P26034,P27019,P27020,P27287,P27395,P27663,P27910,P27912,P27913,P27915,P29165,P29837,P29838,P29983,P29984,P29990,P29991,P30026,P31035,P31620,P32886,P33478,P33482,P33515,P35947,P35976,P36355,P36356,P41358,P52637,P62683,P62684,P62685,P62689,P62690,P63117,P63126,P63128,P63130,P63145,P87577,P87889,Q01299,Q01427,Q04538,Q074N0,Q1X880,Q1X881,Q66112,Q6DV88,Q6J3P1,Q7LDI9,Q84131,Q88266,Q88428,Q89277,Q91B74,Q96PI4,Q98803,Q9HDB9,Q9IK90,Q9JAF2,Q9NRZ4,Q9UKH8,Q9YNA8,Q9YRV3">matrix protein</mark> layer such as <mark style="background-color:yellow;" id="GO:0005581,cellular_component">collagen</mark> .
18704653-197	Use of <mark style="background-color:lightgreen;" id="P08587,P21980,P21981,P51176,P52181,Q01841">tissue transglutaminase</mark> and <mark style="background-color:lightgreen;" id="P07589,P11722,Q28275,Q28377,Q28749,Q91289,Q91400">fibronectin</mark> to <mark style="background-color:orange;">influence</mark> osteoblast responses to <mark style="background-color:lightblue;" id="24456">tricalcium phosphate</mark> scaffolds.
18704653-198	To explore the possibility of controlling cell interaction with biomaterials, <mark style="background-color:lightblue;" id="24456">tricalcium phosphate</mark> scaffolds were <mark style="background-color:orange;">modified</mark> <mark style="background-color:orange;">using</mark> the enzyme <mark style="background-color:lightgreen;" id="P08587,P21980,P21981,P51176,P52181,Q01841">tissue transglutaminase</mark> (tTgase) in conjunction with <mark style="background-color:lightgreen;" id="P07589,P11722,Q28275,Q28377,Q28749,Q91289,Q91400">fibronectin</mark> .
18702613-201	Prolonged L-<mark style="background-color:lightblue;" id="602,4580,5950,71080">alanine</mark> exposure <mark style="background-color:orange;">induces</mark> <mark style="background-color:orange;">changes</mark> in metabolism, <mark style="background-color:lightblue;" id="271">Ca(2</mark>+) handling and desensitization of <mark style="background-color:lightgreen;" id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">insulin</mark>  <mark style="background-color:yellow;" id="GO:0046903,biological_process">secretion</mark> in clonal pancreatic beta-cells.
18702613-203	Collectively, these results illustrate the phenomenon of beta-cell desensitization by amino acids, indicating that prolonged exposure to <mark style="background-color:lightblue;" id="602,4580,5950,71080">alanine</mark> can <mark style="background-color:orange;">induce</mark> reversible alterations to metabolic flux, <mark style="background-color:lightblue;" id="271">Ca(2</mark>+) handling and <mark style="background-color:lightgreen;" id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">insulin</mark>  <mark style="background-color:yellow;" id="GO:0046903,biological_process">secretion</mark> .
18671897-205	Western blotting showed that <mark style="background-color:lightblue;" id="21913,636403,5311038">carbenoxolone</mark> <mark style="background-color:orange;">down-regulated</mark> <mark style="background-color:lightgreen;" id="O57474,P08050,P14154,P16863,P17302,P18246,P23242,Q29101,Q6S9C0">Cx43</mark> protein expression in the BA, which in the SAH-only group was significantly higher than that of the normal group.
18624794-206	In addition to transporting <mark style="background-color:lightblue;" id="611,23327,33032">glutamate</mark>, <mark style="background-color:lightgreen;" id="P31597,P43005,Q95135">EAAC1</mark> plays other roles in <mark style="background-color:orange;">regulating</mark> <mark style="background-color:lightblue;" id="119">GABA</mark> synthesis, reducing oxidative stress in neurons, and is important in supporting neuron viability.
18563803-210	In conclusion, <mark style="background-color:lightblue;" id="124886,128225">TAD</mark>-A has sufficient bonding strength and comparatively low toxicity in clinical <mark style="background-color:orange;">use</mark> of 0.3 mmol or less of <mark style="background-color:lightblue;" id="124886,128225">TAD</mark> and 0.8 mL of 44 w/w % <mark style="background-color:lightgreen;" id="P24807,Q07490">HSA</mark> solution.
18680102-211	Inhibition of non-small cell lung cancer <mark style="background-color:yellow;" id="GO:0016477,biological_process">cell migration</mark> by grape seed <mark style="background-color:lightblue;" id="108065">proanthocyanidins</mark> is <mark style="background-color:orange;">mediated</mark> through the inhibition of <mark style="background-color:lightblue;" id="145068">nitric oxide</mark>, <mark style="background-color:lightblue;" id="6804">guanylate</mark> <mark style="background-color:lightgreen;" id="O94303,P33734,Q9P4P9,Q9SZ30">cyclase</mark> , and <mark style="background-color:lightgreen;" id="P27361,P28869,P42525,Q07176">ERK1</mark> /2.
18680102-216	<mark style="background-color:lightgreen;" id="P63092,P90518">GSPs</mark> <mark style="background-color:orange;">inhibited</mark> <mark style="background-color:lightblue;" id="6322">L-arginine</mark> and <mark style="background-color:lightblue;" id="104767">8-Br-cGMP</mark>-induced activation of <mark style="background-color:lightgreen;" id="P27361,P28869,P42525,Q07176">ERK1</mark> /2 in A549 cells.
18622759-218	The deduced amino acid sequence of Ai <mark style="background-color:lightblue;" id="90220,102416">Lec</mark> was highly similar to those of the C-type <mark style="background-color:lightgreen;" id="P02871,P02873,P02874,P02875,P07386,P16108,P16349,P16351,P16352,P33888,P38662,P42088,P83410,P83511,P84987,Q41114">lectins</mark> from other animals and <mark style="background-color:orange;">contained</mark> a typical carbohydrate-recognition domain (CRD) of 131 residues, which has four conserved disulfide-bonded <mark style="background-color:lightblue;" id="594,5862,5360637">cysteine</mark> residues that define the CRD and two additional <mark style="background-color:lightblue;" id="594,5862,5360637">cysteine</mark> residues at the amino terminus.
18570631-224	A comparison of the inhibitory effect of <mark style="background-color:lightblue;" id="9395">paraoxon</mark> on soluble and <mark style="background-color:orange;">immobilized</mark> <mark style="background-color:lightgreen;" id="O42275,O62763,P04058,P07140,P07692,P21836,P22303,P23795,P36196,P37136,P56161,Q27677,Q29499,Q867X2,Q867X3,Q869C3,Q86GC8,Q86GC9,Q92035,Q92081,Q9DDE3">AChE</mark> showed that immobilization increased the linearity of the inhibition plot particularly in the range 0.1 nM-0.1 microM.
18676776-233	Inhibition of <mark style="background-color:lightgreen;" id="Q00859">mitogen-activated protein kinase</mark> ( <mark style="background-color:lightgreen;" id="O42781,P27638,Q00859">MAPK</mark> ) and <mark style="background-color:lightgreen;" id="P31750,Q8INB9">Akt</mark> <mark style="background-color:orange;">prevented</mark> the antiapoptotic <mark style="background-color:orange;">effects</mark> of <mark style="background-color:lightblue;" id="942,89594,157672">nicotine</mark> and decreased chemotherapy-induced <mark style="background-color:yellow;" id="GO:0006915,biological_process">apoptosis</mark> .
18676776-235	<mark style="background-color:lightblue;" id="942,89594,157672">Nicotine</mark> <mark style="background-color:orange;">up-regulated</mark> <mark style="background-color:lightgreen;" id="P31750,Q8INB9">Akt</mark> -mediated antiapoptotic X-linked <mark style="background-color:lightgreen;" id="Q90660">inhibitor of apoptosis protein</mark> and <mark style="background-color:orange;">phosphorylated</mark> proapoptotic <mark style="background-color:lightgreen;" id="O35147,Q61337,Q92934">Bcl2-antagonist of cell death</mark> .
18704095-238	These data confirm that endogenous miR-<mark style="background-color:lightblue;" id="7248">34a</mark> <mark style="background-color:orange;">regulates</mark> <mark style="background-color:lightgreen;" id="Q14831,Q5RDQ8">GRM7</mark> <mark style="background-color:orange;">levels</mark> and supports the notion that miR-<mark style="background-color:lightblue;" id="7248">34a</mark> contributes to the <mark style="background-color:orange;">effects</mark> of <mark style="background-color:lightblue;" id="28486,3028194">lithium</mark> and VPA on <mark style="background-color:lightgreen;" id="Q14831,Q5RDQ8">GRM7</mark> .
18606396-239	Two major groups of ligand-activated nuclear receptors/xenosensors evolved: the <mark style="background-color:lightgreen;" id="O02747,P30561,P35869,P41738,Q8R4S2,Q8R4S4,Q8R4S5,Q8R4S6,Q8R4S7,Q95LD9">Ah receptor</mark> (activated by aryl hydrocarbons and drugs such as <mark style="background-color:lightblue;" id="4594,9579578">omeprazole</mark>) and type 2 steroid receptors such as <mark style="background-color:lightgreen;" id="O75469,Q8SQ01">PXR</mark> and <mark style="background-color:yellow;" id="GO:0030480,cellular_component">CAR</mark> , <mark style="background-color:orange;">activated</mark> by drugs such as <mark style="background-color:lightblue;" id="5381226,5388984,5458213,6243627,6842115,6913622,16043998,17753751,25141428,45356263,56947149">rifampicin</mark>, carbamazepin and <mark style="background-color:lightblue;" id="1775">phenytoin</mark>.
18710606-241	The purpose of this study was to investigate the effect of dietary supplementation with <mark style="background-color:lightblue;" id="65064">EGCG</mark> on <mark style="background-color:lightgreen;" id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">insulin</mark> resistance and <mark style="background-color:orange;">associated</mark> metabolic risk factors in <mark style="background-color:lightblue;" id="185698">man</mark>.
18712288-246	Rapid determination of <mark style="background-color:lightblue;" id="5961,145815">L-glutamine</mark> <mark style="background-color:orange;">using</mark> engineered Escherichia coli overexpressing <mark style="background-color:lightgreen;" id="O00088,O04867,O08467,O27612,O29313,O58097,O59648,O66514,P00964,P04773,P07804,P09606,P0A039,P0A040,P0A1P6,P0A1P7,P0A9C5,P0A9C6,P0A9C7,P0A9C8,P10583,P10656,P11600,P12424,P12425,P13499,P15103,P15104,P15105,P15106,P15124,P15623,P16580,P19064,P19904,P20479,P21154,P22248,P23712,P23794,P25821,P28605,P28786,P32288,P33035,P36205,P43386,P43518,P43794,P45627,P46410,P51120,P51121,P60890,P77961,P94126,P94845,P99095,Q04831,Q05650,Q05907,Q06378,Q09179,Q12613,Q4R7U3,Q5HGC3,Q5HPN2,Q60182,Q6B4U7,Q6C3E0,Q6FMT6,Q6G9Q4,Q6GHC6,Q75BT9,Q86ZF9,Q86ZU6,Q874T6,Q8CSR8,Q8HZM5,Q8J1R3,Q8X169,Q96UG9,Q96UV5,Q96V52,Q9C2U9,Q9CDL9,Q9CLP2,Q9HH09,Q9HNI2,Q9HU65,Q9KNJ2,Q9QY94,Q9UUN6,Q9UY99,Q9ZLW5">glutamine synthetase</mark> .
18618694-248	The planar angle between the <mark style="background-color:lightblue;" id="278">carbamoyl phosphate</mark> and <mark style="background-color:lightblue;" id="5960">aspartate</mark> domains of the catalytic chain is more <mark style="background-color:orange;">open</mark> at pH 8.5 than in <mark style="background-color:lightgreen;" id="O25716,O27464,O30130,O58451,O66726,P05654,P0A1Z4,P0A1Z5,P0A786,P0A787,P0A788,P0A789,P19910,P41008,P49077,P56585,P57450,P65611,P65612,P65613,P65614,P65615,P65616,P65617,P65618,P65619,P65620,P65621,P74163,P77883,P77918,P96079,P96111,P96174,Q04595,Q2W156,Q55338,Q58976,Q59653,Q59711,Q5E7U5,Q5FGW9,Q5FJB7,Q5FRG8,Q5H2Z0,Q5HBA3,Q5HGN2,Q5HPZ1,Q5HU06,Q5JHM9,Q5L0U6,Q5LX75,Q5M0X1,Q5M5F8,Q5N3S1,Q5NPE5,Q5P6I4,Q5PAN5,Q5PJB2,Q5SK66,Q5V2T3,Q5WFI9,Q5WYW3,Q5X7G7,Q5XCR9,Q5YTM0,Q5ZXZ2,Q60252,Q605F1,Q62I89,Q636D7,Q63RI2,Q64U74,Q65JV0,Q665I6,Q67Q01,Q6A917,Q6AF88,Q6AS40,Q6DA73,Q6FCR5,Q6FZS5,Q6G3F3,Q6GA13,Q6GHN5,Q6HES5,Q6L0F2,Q6LUX0,Q6LWQ0,Q6N565,Q6NH13,Q71YH8,Q727F4,Q72KU0,Q72NJ5,Q732I0,Q73GP1,Q741H5,Q74DP5,Q74J31,Q7M9Y9,Q7MHF1,Q7MX58,Q7MZ16,Q7NCV1,Q7P145,Q7U9G2,Q7UNR3,Q7V355,Q7V4X7,Q7VDV6,Q7VIT3,Q7W044,Q7W3U7,Q7WF77,Q819S0,Q81WE9,Q827R1,Q82U44,Q83A16,Q87C22,Q87LF8,Q87V99,Q88D30,Q89K19,Q8A9S3,Q8CPJ7,Q8D293,Q8DCF6,Q8DIM4,Q8DPH9,Q8DUP5,Q8DZQ5,Q8E5F3,Q8ER38,Q8EUX9,Q8F812,Q8FT39,Q8G655,Q8K9H9,Q8KBI7,Q8NQ38,Q8P1G1,Q8P767,Q8PII1,Q8PXK5,Q8R9R5,Q8RG89,Q8THL2,Q8TVB2,Q8U373,Q8UFT9,Q8XL59,Q8Y1L2,Q8Y662,Q8YWD2,Q8ZB39,Q8ZYH7,Q92AH0,Q92QL5,Q934T0,Q970X2,Q97B29,Q97FS3,Q97QE2,Q98M86,Q9A5K4,Q9CCR5,Q9CF79,Q9HHN4,Q9HKM2,Q9K9V6,Q9KP66,Q9KXR2,Q9L4N6,Q9L4T8,Q9PBB8,Q9PNJ6,Q9RVC0,Q9UX08,Q9YBD4,Q9ZM81">ATCase</mark> structures determined at lower pH values.
18618700-254	At 0.15 microM <mark style="background-color:lightblue;" id="271">Ca(2</mark>+), [(35)S] <mark style="background-color:lightgreen;" id="O02367,O16305,O60041,O82018,O94739,O96102,O97341,P02594,P02595,P02598,P02599,P04352,P04353,P04464,P05933,P05934,P05935,P06787,P07463,P11118,P11120,P11121,P15094,P17928,P18061,P21251,P23286,P24044,P27161,P27165,P27166,P41040,P41041,P48976,P60204,P60205,P60206,P61859,P61860,P61861,P62144,P62145,P62149,P62151,P62152,P62154,P62155,P62156,P62157,P62158,P62160,P62161,P62162,P62184,P62201,P62202,P62203,P62204,P69097,P69098,P84339,P93087,P93171,Q00168,Q05055,Q39752,Q40302,Q5EHV7,Q5RAD2,Q6IT78,Q6PI52,Q6R520,Q6YNX6,Q71UH5,Q71UH6,Q7T3T2,Q7Y052,Q8STF0,Q8X187,Q95NI4,Q95NR9,Q9GRJ1,Q9HFY6,Q9U6D3,Q9UWF0">CaM</mark> <mark style="background-color:orange;">bound</mark> to <mark style="background-color:lightgreen;" id="P30957,Q92736">RyR2</mark> with <mark style="background-color:orange;">decreased</mark> affinity and <mark style="background-color:yellow;" id="GO:0005488,molecular_function">binding</mark> enthalpy compared with <mark style="background-color:lightgreen;" id="P11716,P16960,P21817">RyR1</mark> .
18618700-255	The rates of [(35)S] <mark style="background-color:lightgreen;" id="O02367,O16305,O60041,O82018,O94739,O96102,O97341,P02594,P02595,P02598,P02599,P04352,P04353,P04464,P05933,P05934,P05935,P06787,P07463,P11118,P11120,P11121,P15094,P17928,P18061,P21251,P23286,P24044,P27161,P27165,P27166,P41040,P41041,P48976,P60204,P60205,P60206,P61859,P61860,P61861,P62144,P62145,P62149,P62151,P62152,P62154,P62155,P62156,P62157,P62158,P62160,P62161,P62162,P62184,P62201,P62202,P62203,P62204,P69097,P69098,P84339,P93087,P93171,Q00168,Q05055,Q39752,Q40302,Q5EHV7,Q5RAD2,Q6IT78,Q6PI52,Q6R520,Q6YNX6,Q71UH5,Q71UH6,Q7T3T2,Q7Y052,Q8STF0,Q8X187,Q95NI4,Q95NR9,Q9GRJ1,Q9HFY6,Q9U6D3,Q9UWF0">CaM</mark> dissociation from <mark style="background-color:lightgreen;" id="P11716,P16960,P21817">RyR1</mark> <mark style="background-color:orange;">increased</mark> as the temperature was raised, whereas at 0.15 microM <mark style="background-color:lightblue;" id="271">Ca(2</mark>+) the rate from <mark style="background-color:lightgreen;" id="P30957,Q92736">RyR2</mark> was little affected.
18594129-259	Expression of <mark style="background-color:lightgreen;" id="P0AG38,P0AG39,Q8Z3B3,Q9L6N7">rhtC</mark> <mark style="background-color:orange;">reduced</mark> the <mark style="background-color:yellow;" id="GO:0005622,cellular_component">intracellular</mark> <mark style="background-color:lightblue;" id="6288">L-threonine</mark> concentration from 140 to 11 mM and resulted in maximal <mark style="background-color:yellow;" id="GO:0007588,biological_process">excretion</mark> rates of 11.2 nmol min(-1) mg(-1) as compared to 2.3 nmol min(-1) mg(-1) obtained without <mark style="background-color:lightgreen;" id="P0AG38,P0AG39,Q8Z3B3,Q9L6N7">rhtC</mark> expression.
18594129-260	In combination with an <mark style="background-color:lightgreen;" id="P04968,P20506,P37946,P46493,P53607,P66897,P66898,Q02145,Q04513,Q2FF63,Q2YUE8,Q3V7T4,Q3V7T5,Q49Z16,Q4L7U4,Q5HEE0,Q5HMF5,Q7A4H2,Q8CNK9,Q8NVI8,Q99SJ1,Q9CKJ2,Q9KC63,Q9X7F1">ilvA</mark> mutation <mark style="background-color:orange;">generated</mark> and introduced into the <mark style="background-color:yellow;" id="GO:0005694,cellular_component">chromosome</mark> , an accumulation of up to 54 mM <mark style="background-color:lightblue;" id="6288">L-threonine</mark> was achieved as compared to 21 mM obtained with the ancestor strain.
18702682-263	Acylation-stimulating protein ( <mark style="background-color:lightgreen;" id="P32765,P42127,P45381,P79407,Q03288,Q16937,Q1XGU5,Q1XGU6,Q1XGU7,Q1XGU8,Q1XGU9,Q1XGV0,Q1XGV1,Q1XGV2,Q1XGV3,Q1XGV4,Q1XGV5,Q1XGV6,Q1XGV7,Q29414,Q5UK76,Q6ZYM3,Q865F0,Q95MP2,Q99JA2,Q9H1Y0,Q9NQ94">ASP</mark> ) has been shown to positively <mark style="background-color:orange;">stimulate</mark> fatty acid esterification and <mark style="background-color:lightblue;" id="206,5793,64689,79025">glucose</mark> uptake in adipocytes.
18680156-264	Immunoblot analysis of signaling molecules, including cyclic- <mark style="background-color:lightgreen;" id="O24006">AMP</mark> response element <mark style="background-color:yellow;" id="GO:0005488,molecular_function">binding</mark> protein ( <mark style="background-color:lightgreen;" id="P15337,P16220,P27925,P51984,P51985,Q01147">CREB</mark> ), <mark style="background-color:lightgreen;" id="Q00859">mitogen-activated protein kinases</mark> (MAPKp44/42; <mark style="background-color:lightgreen;" id="P27361,P28869,P42525,Q07176">ERK1</mark> /2), in area <mark style="background-color:lightgreen;" id="P00915,P00916,P00917,P07452,P20507,P27140,P35217,P48282,P53461,P54087,P54088,P54089,P54090,P54209,Q1LZA1,Q7M316,Q7M317,Q8HY33,Q99153">CA1</mark> revealed that <mark style="background-color:lightblue;" id="5819">thyroxin</mark> treatment <mark style="background-color:orange;">reversed</mark> hypothyroidism-induced reduction of signaling molecules essential for <mark style="background-color:yellow;" id="GO:0007612,biological_process">learning</mark> and <mark style="background-color:yellow;" id="GO:0007613,biological_process">memory</mark> , and L- <mark style="background-color:lightgreen;" id="O04004,O04404,O23758,O24418,O65888,P0C088,P10976,P13865,P19656,P20145,P23096,P23802,P24296,P26912,P26913,P27631,P29420,P43217,P80450,P82007,P84160,P84161,Q39794,Q39950,Q40905,Q41073,Q42762,Q43129,Q43681,Q43748,Q9M5X6,Q9M5X7,Q9M5X8,Q9SW93">LTP</mark> .
18567517-267	<mark style="background-color:lightblue;" id="5311081">Endomorphin-2</mark> vector injection also <mark style="background-color:orange;">reduced</mark> spontaneous pain-related <mark style="background-color:yellow;" id="GO:0007610,biological_process">behaviors</mark> in the <mark style="background-color:orange;">delayed</mark> phase of the <mark style="background-color:lightblue;" id="712">formalin</mark> test and in both <mark style="background-color:lightgreen;" id="O04350,O75347,P48427,P48428,P48606,P80584,P80585,Q9Y703">CFA</mark> and <mark style="background-color:lightblue;" id="712">formalin</mark> models <mark style="background-color:orange;">suppressed</mark> spinal c- <mark style="background-color:lightgreen;" id="P01101,P12841,Q56415">fos</mark> expression.
18637152-268	Results showed that <mark style="background-color:lightblue;" id="19582,9838899">MENT</mark> treatments <mark style="background-color:orange;">increased</mark> <mark style="background-color:lightgreen;" id="P07288,P10658,P33619,P55786,Q11011,Q6DT45,Q9Y617">PSA</mark>  <mark style="background-color:yellow;" id="GO:0046903,biological_process">secretion</mark> and proliferation rate with a potency ranged between T and <mark style="background-color:lightblue;" id="10635">DHT</mark>.
18637152-269	The studies with <mark style="background-color:lightblue;" id="57363">finasteride</mark> showed that in BPH and CaP cells, the conversion of T into <mark style="background-color:lightblue;" id="10635">DHT</mark> significantly contributes to its <mark style="background-color:orange;">effect</mark> on the proliferation and <mark style="background-color:lightgreen;" id="P07288,P10658,P33619,P55786,Q11011,Q6DT45,Q9Y617">PSA</mark>  <mark style="background-color:yellow;" id="GO:0046903,biological_process">secretion</mark> , and corroborated the resistance of <mark style="background-color:lightblue;" id="19582,9838899">MENT</mark> to the 5-AR.
18637154-273	Pregnant Sprague-Dawley female rats were treated once with <mark style="background-color:lightblue;" id="15625">TCDD</mark> (0, 0.3 or 1 microg/kg) by gavage on <mark style="background-color:lightgreen;" id="P02301">embryonic</mark> day (ED) 11 and the expression <mark style="background-color:orange;">levels</mark> of androgen (AR) and <mark style="background-color:lightgreen;" id="O42132,P03372,P06211,P06212,P16058,P19785,P49884,P49885,P49886,P50240,P50241,P50242,P57717,P57753,P81559,Q29040,Q53AD2,Q91250,Q91424,Q9PVZ9,Q9QZJ5,Q9TV98,Q9YH33,Q9YHT3,Q9YHZ7">estrogen receptors</mark> ( <mark style="background-color:yellow;" id="GO:0005783,cellular_component">ER</mark> ), steroidogenic enzymes (P450scc and <mark style="background-color:lightgreen;" id="O46516,O57245,P14893,P21097,P26670,P27365,Q5IFP1,Q67477,Q9N119">3beta-HSD</mark> ) and four regulatory factors ( <mark style="background-color:lightgreen;" id="O46689,P49675,P51557,P58864,P70114,P79245,P97826,Q28918,Q28996,Q9DE06,Q9DEB4,Q9DG08,Q9DG09,Q9DG10">StAR</mark> , <mark style="background-color:lightgreen;" id="P33242,P50569,P79387,Q04752,Q13285,Q95L87,Q9GKL2">SF-1</mark> , <mark style="background-color:lightgreen;" id="P49604">GATA</mark> -4 and Insl-3) involved in foetal Leydig cell and adrenal function were analysed on ED 19.5.
18637154-274	In utero exposure to <mark style="background-color:lightblue;" id="15625">TCDD</mark> <mark style="background-color:orange;">reduced</mark> intratesticular T of foetal males (significant at 0.3 microg/kg <mark style="background-color:lightblue;" id="15625">TCDD</mark>) and tended to <mark style="background-color:orange;">reduce</mark> the protein expression of <mark style="background-color:lightgreen;" id="O42132,P03372,P06211,P06212,P16058,P19785,P49884,P49885,P49886,P50240,P50241,P50242,P57717,P57753,P81559,Q29040,Q53AD2,Q91250,Q91424,Q9PVZ9,Q9QZJ5,Q9TV98,Q9YH33,Q9YHT3,Q9YHZ7">ERalpha</mark> and AR of foetal male rat testis.
18637154-275	mRNA expression of developmental regulatory factors was not influenced by foetal <mark style="background-color:lightblue;" id="15625">TCDD</mark> exposure, except for significantly <mark style="background-color:orange;">reduced</mark> adrenal <mark style="background-color:lightgreen;" id="P33242,P50569,P79387,Q04752,Q13285,Q95L87,Q9GKL2">SF-1</mark> .
18596195-276	Here, we assessed the regulation of pancreatic <mark style="background-color:lightgreen;" id="O07091,O13393,O22642,O93863,P00002,P00003,P00004,P00007,P00008,P00011,P00012,P00013,P00014,P00017,P00018,P00019,P00020,P00021,P00022,P00024,P00025,P00027,P00028,P00029,P00030,P00031,P00032,P00035,P00036,P00037,P00038,P00039,P00040,P00041,P00042,P00043,P00046,P00047,P00048,P00049,P00051,P00052,P00053,P00054,P00055,P00056,P00057,P00058,P00059,P00060,P00061,P00062,P00063,P00064,P00065,P00066,P00067,P00068,P00069,P00070,P00071,P00072,P00073,P00074,P00075,P00076,P00077,P00078,P00079,P12831,P15451,P18822,P19681,P19974,P21665,P22342,P25400,P29380,P32556,P38091,P53698,P56205,P59218,P62772,P62773,P62894,P62895,P62896,P67881,P67882,P68096,P68097,P68098,P68099,P68100,P68517,P68518,P68519,P81280,P81459,P99998,P99999,Q41346,Q4HVX7,Q52V08,Q52V09,Q52V10,Q5RFH4,Q640U4,Q6C9Q0,Q6IQM2,Q6Q4H8,Q6QLW4,Q6WUX8,Q753F4,Q7YR71,Q96VP3">cytochrome c</mark> <mark style="background-color:orange;">release</mark> by <mark style="background-color:lightblue;" id="271">Ca(2</mark>+), <mark style="background-color:yellow;" id="GO:0005740,cellular_component">mitochondrial membrane</mark> potential (Delta <mark style="background-color:lightgreen;" id="P14801,Q09912">Psi</mark> m), and reactive <mark style="background-color:lightblue;" id="977">oxygen</mark> species (ROS), the signals involved in acute pancreatitis.
18573668-277	Inhibition of <mark style="background-color:lightgreen;" id="O02768,O19183,O62698,O62725,P27607,P35354,P35355,P70682,P79208,Q05769">cyclooxygenase 2</mark> expression by <mark style="background-color:lightblue;" id="11617">diallyl sulfide</mark> on joint inflammation <mark style="background-color:orange;">induced</mark> by urate crystal and <mark style="background-color:lightgreen;" id="P01584,P09428,P10749,P14628,P21621,P26889,P41687,P46648,P48090,P51493,P51745,P79162,P79182,Q28292,Q28386,Q2HZH0,Q2MH07,Q63264,Q6PUD2,Q6R2X3,Q865X8,Q8WNR2,Q9WVG1,Q9XS77">IL-1beta</mark> .
18626658-281	<mark style="background-color:lightgreen;" id="O97562,P55851,Q9N2J1,Q9W725">UCP2</mark> is <mark style="background-color:orange;">expressed</mark> in pancreatic beta cells where its postulated uncoupling activity will <mark style="background-color:orange;">modulate</mark> <mark style="background-color:lightblue;" id="206,5793,64689,79025">glucose</mark>-induced <mark style="background-color:orange;">changes</mark> in <mark style="background-color:lightblue;" id="5957">ATP</mark>/ <mark style="background-color:lightgreen;" id="P02783">ADP</mark> ratio and <mark style="background-color:lightgreen;" id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">insulin</mark>  <mark style="background-color:yellow;" id="GO:0046903,biological_process">secretion</mark> .
18626658-282	The consequences of <mark style="background-color:lightgreen;" id="O97562,P55851,Q9N2J1,Q9W725">UCP2</mark> over/underexpression on beta-cell function has mainly been studied in the basal state; however, a <mark style="background-color:lightgreen;" id="P04575,P10861,P14271,P25874">UCP</mark> has no uncoupling activity unless <mark style="background-color:orange;">stimulated</mark> by fatty acids and/or reactive <mark style="background-color:lightblue;" id="977">oxygen</mark> species.
18640679-288	Meanwhile, both the enhanced expression of <mark style="background-color:lightgreen;" id="P19320,P29533,P29534,Q28260">VCAM-1</mark> and <mark style="background-color:orange;">increased</mark> <mark style="background-color:yellow;" id="GO:0051092,biological_process">activation of NF-kappaB</mark> <mark style="background-color:orange;">induced</mark> by <mark style="background-color:lightgreen;" id="P01142,P06296,P06850,P49926,Q95MI6,Q9PTS1">CRH</mark> in aortas of LDLr-/- mice were also largely <mark style="background-color:orange;">suppressed</mark> by <mark style="background-color:lightblue;" id="176157">NBI27914</mark>, whereas these inhibitory effects were not observed in anti-Svg-30 group.
18665052-290	In contrast, the degree of (1) spinal cord inflammation and tissue injury (histological score), (2) nitrotyrosine and poly(<mark style="background-color:lightblue;" id="6022">adenosine diphosphate</mark> [ <mark style="background-color:lightgreen;" id="P02783">ADP</mark> ] ribose) formation, (3) <mark style="background-color:lightgreen;" id="O19114,O46660,O54705,O62699,P29477,P35228,P79290,Q06518,Q27995,Q28314,Q90703,Q92037,Q92091">iNOS</mark> expression, (4) nuclear factor-kappaB activation, and (5) <mark style="background-color:yellow;" id="GO:0006915,biological_process">apoptosis</mark> ( <mark style="background-color:lightgreen;" id="O02789,O57486,P04053,P06526,P09838,P36195,P42118,Q92089">terminal deoxynucleotidyltransferase</mark> -mediated <mark style="background-color:lightblue;" id="65070">dUTP</mark>-<mark style="background-color:lightblue;" id="253,171548">biotin</mark> end labeling, <mark style="background-color:lightgreen;" id="P27297,Q07813,Q63690">Bax</mark> , and <mark style="background-color:lightgreen;" id="P10417,P49950">Bcl-2</mark> ) was markedly <mark style="background-color:orange;">reduced</mark> in spinal cord tissue obtained from mice treated with <mark style="background-color:lightblue;" id="3495,14982,128229,44260118,45358130,46878350">glycyrrhizin</mark> extract (10 mg/kg, i.p., 30 min before and 1 and 6 h after SCI).
18704762-296	<mark style="background-color:lightgreen;" id="Q865F8,Q9NZD4">AHSP</mark> <mark style="background-color:orange;">inhibits</mark> cellular production of the reactive <mark style="background-color:lightblue;" id="977">oxygen</mark> species.
18704766-304	Hence, <mark style="background-color:lightgreen;" id="Q06180">MPTP</mark> lesion, <mark style="background-color:lightblue;" id="6047">L-DOPA</mark> treatment and prevention of LID with CI-1041 and <mark style="background-color:lightblue;" id="54746">cabergoline</mark>, or reduction with <mark style="background-color:lightblue;" id="5282337">Ro 61-8048</mark> were <mark style="background-color:orange;">associated</mark> with modulation of <mark style="background-color:lightgreen;" id="Q00960,Q01097,Q13224">NR2B</mark> /<mark style="background-color:lightblue;" id="22880">NMDA</mark> <mark style="background-color:lightblue;" id="611,23327,33032">glutamate</mark> receptors.
18616717-310	We investigated whether several different inflammatory markers including C-reactive protein ( <mark style="background-color:lightgreen;" id="O19062,P02741,P02742,P08462,P18151,P21291,P41964,P47875,P49254,P49262,P52753,P67966,P67967,P97315,Q07203">CRP</mark> ) and <mark style="background-color:lightgreen;" id="P22775,P81070">fibrinogen</mark> and white blood cells (WBCs) count, are <mark style="background-color:orange;">associated</mark> with maximal <mark style="background-color:lightblue;" id="977">oxygen</mark> consumption (VO(2 max)) in women with polycystic ovary syndrome (PCOS).
18639629-311	Peripheral administration of the <mark style="background-color:lightgreen;" id="Q867X2,Q867X3,Q86GC9,Q92081">acetylcholinesterase</mark> inhibitor <mark style="background-color:lightblue;" id="9651">galantamine</mark> significantly <mark style="background-color:orange;">reduced</mark> serum <mark style="background-color:lightgreen;" id="O35734,O77510,O77764,P01375,P04924,P13296,P19101,P23383,P23563,P29553,P33620,P36939,P48094,P51435,P51742,P51743,P59684,P59693,P59694,P59695,P79337,P79374,Q06599,Q19LH4,Q1G1A2,Q1WM27,Q2MH05,Q539C2,Q75N23,Q8HZD9,Q8JFG3,Q8MKG8,Q8WNR1,Q9BEA1">TNF</mark> levels through vagus nerve signaling, and protected against lethality during murine endotoxemia.
18639629-312	Administration of a centrally-acting muscarinic receptor antagonist abolished the suppression of <mark style="background-color:lightgreen;" id="O35734,O77510,O77764,P01375,P04924,P13296,P19101,P23383,P23563,P29553,P33620,P36939,P48094,P51435,P51742,P51743,P59684,P59693,P59694,P59695,P79337,P79374,Q06599,Q19LH4,Q1G1A2,Q1WM27,Q2MH05,Q539C2,Q75N23,Q8HZD9,Q8JFG3,Q8MKG8,Q8WNR1,Q9BEA1">TNF</mark> by <mark style="background-color:lightblue;" id="9651">galantamine</mark>, <mark style="background-color:orange;">indicating</mark> that <mark style="background-color:orange;">suppressing</mark> <mark style="background-color:lightgreen;" id="Q867X2,Q867X3,Q86GC9,Q92081">acetylcholinesterase</mark> activity, coupled with central muscarinic receptors, controls peripheral cytokine responses.
18698648-318	Escherichia coli strain PC09 (DeltaxylB, <mark style="background-color:lightblue;" id="6076">cAMP</mark>-independent <mark style="background-color:lightgreen;" id="O19062,P02741,P02742,P08462,P18151,P21291,P41964,P47875,P49254,P49262,P52753,P67966,P67967,P97315,Q07203">CRP</mark> ( <mark style="background-color:lightgreen;" id="O05689,P0A2T6,P0A2T7,P0ACJ8,P0ACJ9,P0ACK0,P0ACK1,P14847,P29281,P34117,P48199,Q07203">crp</mark> *) mutant) <mark style="background-color:orange;">expressing</mark> an <mark style="background-color:lightblue;" id="5884">NADPH</mark>-dependent <mark style="background-color:lightgreen;" id="P38715">xylose reductase</mark> from Candida boidinii (CbXR) was previously reported to <mark style="background-color:orange;">produce</mark> <mark style="background-color:lightblue;" id="6912">xylitol</mark> from xylose while <mark style="background-color:orange;">metabolizing</mark> <mark style="background-color:lightblue;" id="206,5793,64689,79025">glucose</mark> [Cirino et al.
18698648-319	Studies in which the expression of CbXR or a <mark style="background-color:lightgreen;" id="P96792">xylose transporter</mark> was <mark style="background-color:orange;">increased</mark> suggest that enzyme activity and xylose <mark style="background-color:yellow;" id="GO:0006810,biological_process">transport</mark> are not <mark style="background-color:orange;">limiting</mark> <mark style="background-color:lightblue;" id="6912">xylitol</mark> production in PC09.
18698648-321	For the case of xylose-proton symport, omitting the <mark style="background-color:lightgreen;" id="O51581,O54537,O68282,O83491,O84188,P0A584,P0A585,P0A586,P0A587,P0AC53,P0AC54,P11411,P21907,P29686,P37986,P44311,P48848,P48992,P54547,P56110,P57405,P73411,P77809,Q89AI7,Q8K9M2,Q8XCJ6,Q9PKK8,Q9X0N9,Q9Z3S2,Q9Z8U6,Q9ZKB2">Zwf</mark> (<mark style="background-color:lightblue;" id="5958,439284,439427,439958">glucose-6-phosphate</mark> dehydrogenase) or <mark style="background-color:lightgreen;" id="P0C187,P51995,Q2RSB3">PntAB</mark> ( <mark style="background-color:yellow;" id="GO:0016020,cellular_component">membrane</mark> -bound transhydrogenase) reactions or <mark style="background-color:lightgreen;" id="P56626">TCA</mark> cycle activity from the model <mark style="background-color:orange;">reduces</mark> the theoretical maximum <mark style="background-color:orange;">yield</mark> from 9.2 to 8.8, 3.6, and 8.0 mol <mark style="background-color:lightblue;" id="6912">xylitol</mark> (mol <mark style="background-color:lightblue;" id="206,5793,64689,79025">glucose</mark>)(-1), respectively.
18698648-322	Experimentally, deleting <mark style="background-color:lightgreen;" id="O25781,O51672,O83488,O84382,O88015,P0A0T0,P0A0T1,P0A6T1,P0A6T2,P28718,P44312,P47357,P52029,P52030,P52031,P52983,P57636,P64192,P64193,P64194,P64195,P64196,P77877,P78033,P80860,P81181,P96803,P99078,Q0TA36,Q0VR14,Q11MA0,Q13Z07,Q165T7,Q18FQ4,Q1ASN4,Q1BH79,Q1CSA0,Q1CX51,Q1GAY0,Q1GJQ5,Q1GTU1,Q1H1P4,Q1IYT4,Q1J8N2,Q1JDQ8,Q1JIS1,Q1JNM4,Q1LM68,Q1LU73,Q1MM06,Q1QEK1,Q1R3R3,Q1WUR2,Q21M11,Q21ZD5,Q24VW9,Q255I6,Q28QX4,Q2A2C5,Q2FIB3,Q2FZU0,Q2G7C4,Q2IE39,Q2JH03,Q2JHU0,Q2JX86,Q2KCY8,Q2KYE9,Q2LRD0,Q2NJ38,Q2NR04,Q2P380,Q2RQ51,Q2S8W1,Q2SS24,Q2SWP6,Q2VYV7,Q2YBU4,Q2YPF3,Q2YWS3,Q31AX5,Q31I19,Q31LL0,Q31TX1,Q328X7,Q38WF1,Q39FF4,Q39SU1,Q3A201,Q3AFH3,Q3AJU7,Q3ASZ0,Q3AXV8,Q3B3Q8,Q3BUL3,Q3IKH4,Q3IMS0,Q3J2U4,Q3JCN1,Q3JRE2,Q3K2Y2,Q3K6Q4,Q3KLX6,Q3M6S3,Q3YUW0,Q46L16,Q47IJ3,Q48N88,Q48VF9,Q491V0,Q49WA1,Q4A5S9,Q4A7J2,Q4A9F3,Q4FVH5,Q4JX51,Q4K5Y1,Q4L4X8,Q4QL07,Q4UTV8,Q4ZY88,Q57F73,Q57H06,Q59000,Q59088,Q5E847,Q5FL04,Q5H0A7,Q5HHC2,Q5HQJ9,Q5KVS7,Q5L5E1,Q5L9E3,Q5LRS9,Q5M1N9,Q5N0B4,Q5NFC4,Q5P0T4,Q5PL07,Q5QWW0,Q5SLL6,Q5UXU0,Q5WDX0,Q5WYE0,Q5X6Y8,Q5XE09,Q5YPP1,Q5ZXH2,Q600A8,Q609I7,Q62JL8,Q632G4,Q63V31,Q64PM7,Q65FL6,Q65TC2,Q660E3,Q664W9,Q67QQ0,Q6A5X5,Q6AQ48,Q6D022,Q6F1L2,Q6G0T9,Q6GAW4,Q6GIC6,Q6HC08,Q6KH90,Q6LM51,Q6LXQ4,Q6MD44,Q6MTA3,Q6NIE5,Q6YQU0,Q71X61,Q72GY6,Q72MT7,Q72YI4,Q73K18,Q742E4,Q74DK5,Q74K31,Q7MH97,Q7MUV9,Q7MZB4,Q7NJY9,Q7U6T0,Q7V1I1,Q7V7M6,Q7VBZ6,Q7VNR9,Q7VRI4,Q7VUF4,Q7W197,Q7WP01,Q816G0,Q81K75,Q822E7,Q82SP4,Q835G1,Q83D91,Q83XM3,Q848I4,Q87EV7,Q87L81,Q888Q7,Q88UI4,Q891H2,Q89A35,Q8A5W2,Q8CT80,Q8D1V8,Q8DCK7,Q8DKY2,Q8DN74,Q8EBH1,Q8ENY8,Q8EVU1,Q8EZG6,Q8FB44,Q8FR39,Q8G2N3,Q8G7I6,Q8K8Q6,Q8K910,Q8KDQ7,Q8L1Z9,Q8NS31,Q8NXF1,Q8P2R3,Q8P9S7,Q8R924,Q8RHH5,Q8UI94,Q8VVB7,Q8XI54,Q8XYN9,Q8Y4R7,Q8YF86,Q8YY05,Q8Z1U7,Q8ZAS2,Q8ZKI4,Q928R6,Q92SC4,Q97FP8,Q97NG0,Q98BV5,Q98R79,Q9A1L1,Q9ABK5,Q9CD75,Q9CNL2,Q9HNQ6,Q9HV67,Q9K7L8,Q9KUY4,Q9KX58,Q9PGR6,Q9PK16,Q9PMD4,Q9RDY2,Q9RMC1,Q9RTL8,Q9X1A5,Q9X670,Q9Z6N4,Q9ZK49">pgi</mark> (encoding <mark style="background-color:lightgreen;" id="O25781,O51672,O59618,O66954,O82059,O83488,O84382,P06744,P06745,P08059,P0A0T0,P0A0T1,P0A6T1,P0A6T2,P12341,P12709,P13377,P18240,P28718,P29333,P34795,P34796,P34797,P42861,P44312,P46479,P47357,P49105,P50309,P52029,P52030,P52031,P52983,P54234,P54235,P54236,P54237,P54238,P54239,P54240,P54241,P54242,P54243,P57636,P64192,P64193,P64194,P64195,P64196,P77877,P78033,P78917,P80860,P81181,P83194,P83780,P84140,P96803,P99078,Q0TA36,Q0VR14,Q11MA0,Q13Z07,Q165T7,Q18FQ4,Q1ASN4,Q1BH79,Q1CSA0,Q1CX51,Q1GAY0,Q1GJQ5,Q1GTU1,Q1H1P4,Q1IYT4,Q1J8N2,Q1JDQ8,Q1JIS1,Q1JNM4,Q1LM68,Q1LU73,Q1MM06,Q1QEK1,Q1R3R3,Q1WUR2,Q21M11,Q21ZD5,Q24VW9,Q255I6,Q28QX4,Q2A2C5,Q2FIB3,Q2FZU0,Q2G7C4,Q2IE39,Q2JH03,Q2JHU0,Q2JX86,Q2KCY8,Q2KYE9,Q2LRD0,Q2NJ38,Q2NR04,Q2P380,Q2RQ51,Q2S8W1,Q2SS24,Q2SWP6,Q2VYV7,Q2YBU4,Q2YPF3,Q2YWS3,Q31AX5,Q31I19,Q31LL0,Q31TX1,Q328X7,Q38WF1,Q39FF4,Q39SU1,Q3A201,Q3AFH3,Q3AJU7,Q3ASZ0,Q3AXV8,Q3B3Q8,Q3BUL3,Q3IKH4,Q3IMS0,Q3J2U4,Q3JCN1,Q3JRE2,Q3K2Y2,Q3K6Q4,Q3KLX6,Q3M6S3,Q3YUW0,Q3ZBD7,Q44407,Q46L16,Q47IJ3,Q48N88,Q48VF9,Q491V0,Q49WA1,Q4A5S9,Q4A7J2,Q4A9F3,Q4FVH5,Q4JCA7,Q4JX51,Q4K5Y1,Q4L4X8,Q4QL07,Q4R591,Q4UTV8,Q4ZY88,Q57F73,Q57H06,Q59000,Q59088,Q5E847,Q5FL04,Q5H0A7,Q5HHC2,Q5HQJ9,Q5JE38,Q5KVS7,Q5L5E1,Q5L9E3,Q5LRS9,Q5M1N9,Q5N0B4,Q5NFC4,Q5P0T4,Q5PL07,Q5QWW0,Q5R4E3,Q5SLL6,Q5UXU0,Q5WDX0,Q5WYE0,Q5X6Y8,Q5XE09,Q5YPP1,Q5ZXH2,Q600A8,Q609I7,Q62JL8,Q632G4,Q63V31,Q64PM7,Q65FL6,Q65TC2,Q660E3,Q664W9,Q67QQ0,Q6A5X5,Q6AQ48,Q6D022,Q6F1L2,Q6FRW1,Q6G0T9,Q6GAW4,Q6GIC6,Q6HC08,Q6KH90,Q6LM51,Q6LXQ4,Q6MD44,Q6MTA3,Q6NIE5,Q6YQU0,Q711G1,Q71X61,Q72GY6,Q72MT7,Q72YI4,Q73K18,Q742E4,Q74DK5,Q74K31,Q758L0,Q7MH97,Q7MUV9,Q7MZB4,Q7NJY9,Q7S986,Q7U6T0,Q7V1I1,Q7V7M6,Q7VBZ6,Q7VNR9,Q7VRI4,Q7VUF4,Q7W197,Q7WP01,Q816G0,Q81K75,Q822E7,Q82SP4,Q835G1,Q83D91,Q83XM3,Q848I4,Q87EV7,Q87L81,Q888Q7,Q88UI4,Q891H2,Q89A35,Q8A5W2,Q8CT80,Q8D1V8,Q8DCK7,Q8DKY2,Q8DN74,Q8EBH1,Q8ENY8,Q8EVU1,Q8EZG6,Q8FB44,Q8FR39,Q8G2N3,Q8G7I6,Q8K8Q6,Q8K910,Q8KDQ7,Q8L1Z9,Q8NS31,Q8NXF1,Q8P2R3,Q8P9S7,Q8R924,Q8RHH5,Q8SRY1,Q8UI94,Q8VVB7,Q8XI54,Q8XYN9,Q8Y4R7,Q8YF86,Q8YY05,Q8Z1U7,Q8ZAS2,Q8ZKI4,Q8ZWV0,Q928R6,Q92SC4,Q96YC2,Q978F3,Q97FP8,Q97NG0,Q97WE5,Q98BV5,Q98R79,Q9A1L1,Q9ABK5,Q9CD75,Q9CNL2,Q9FXM4,Q9FXM5,Q9HGZ2,Q9HIC2,Q9HNQ6,Q9HV67,Q9K7L8,Q9KUY4,Q9KX58,Q9N1E2,Q9PGR6,Q9PK16,Q9PMD4,Q9RDY2,Q9RMC1,Q9RTL8,Q9UXW3,Q9X1A5,Q9X670,Q9YE01,Q9Z6N4,Q9ZK49">phosphoglucose isomerase</mark> ) from strain PC09 <mark style="background-color:orange;">improves</mark> the <mark style="background-color:orange;">yield</mark> from 3.4 to 4.0 mol <mark style="background-color:lightblue;" id="6912">xylitol</mark> (mol <mark style="background-color:lightblue;" id="206,5793,64689,79025">glucose</mark>)(-1), while deleting either or both E. coli transhydrogenases ( <mark style="background-color:lightgreen;" id="O05139,P27306,P50529,P57112,P66006,P66007,P66008,P66009,P71317,Q0TA96,Q1CBU5,Q1CNP4,Q1QX78,Q1R3U7,Q2NQZ3,Q2SIP2,Q3K9F5,Q48A14,Q48KI8,Q4KFA6,Q4ZV77,Q57H91,Q5E212,Q5PK71,Q66G61,Q6CZB1,Q6LLT9,Q7MBG9,Q7MQ83,Q83MI1,Q87KN5,Q884I6,Q88KY8,Q8DD46,Q8FB93,Q8X727,Q8ZA97,Q9XBQ9">sthA</mark> and <mark style="background-color:lightgreen;" id="P07001,P43842">pntA</mark> ) has no significant effect on the measured yield.
18698648-323	Deleting either <mark style="background-color:lightgreen;" id="O51581,O54537,O68282,O83491,O84188,P0A584,P0A585,P0A586,P0A587,P0AC53,P0AC54,P11411,P21907,P29686,P37986,P44311,P48848,P48992,P54547,P56110,P57405,P73411,P77809,Q89AI7,Q8K9M2,Q8XCJ6,Q9PKK8,Q9X0N9,Q9Z3S2,Q9Z8U6,Q9ZKB2">zwf</mark> or <mark style="background-color:lightgreen;" id="O05966,O27115,O67546,O84828,O87840,P0A836,P0A837,P0A838,P0A839,P25126,P45101,P53592,P53593,P66867,P66868,P66869,P66870,P66871,P66872,P71559,P80886,P99071,Q49X32,Q4L5U8,Q4ULQ7,Q57663,Q57RL3,Q5HGI7,Q5HPU5,Q5PBI8,Q5PCM7,Q66DA0,Q68WU5,Q6F8L4,Q6G9W8,Q6GHJ0,Q72PA2,Q7MMN3,Q7U0Z1,Q7UKI3,Q822A1,Q87A98,Q87RE8,Q8CPH5,Q8DFQ1,Q8EFN8,Q8F746,Q8KFE7,Q8NMK7,Q8P676,Q8PHL5,Q8UC60,Q8Y1Y3,Q8ZH00,Q8ZVF3,Q92I21,Q98EC5,Q9AB94,Q9CNZ0,Q9EYG9,Q9HPP1,Q9JUT0,Q9JZP4,Q9KA20,Q9KQB5,Q9PAH1,Q9PHY1,Q9PL99,Q9RUY3,Q9Z5H8,Q9Z6T6">sucC</mark> ( <mark style="background-color:lightgreen;" id="P56626">TCA</mark> cycle) significantly <mark style="background-color:orange;">reduces</mark> the <mark style="background-color:orange;">yield</mark> from 3.4 to 2.0 and 2.3 mol <mark style="background-color:lightblue;" id="6912">xylitol</mark> (mol <mark style="background-color:lightblue;" id="206,5793,64689,79025">glucose</mark>)(-1), respectively.
18698649-324	In the process studied, the enzyme cellobiose dehydrogenase ( <mark style="background-color:lightgreen;" id="P17444,P54223,P60336,P60337,Q01738,Q0TKW1,Q13NG7,Q1BQE2,Q1C932,Q1CFR7,Q1MJU4,Q1QXE1,Q1RFM3,Q2FDP9,Q2FV11,Q2KB43,Q2T6D0,Q2YWJ5,Q39A44,Q3BXK8,Q3JLL7,Q3K5H3,Q48CM7,Q4A0Q1,Q4K4K7,Q4L9D7,Q4UYN5,Q4ZM63,Q5HCU1,Q5HL11,Q62CH8,Q63KK7,Q66D54,Q6D6D9,Q6FDF9,Q6G664,Q6GDJ1,Q6LGH5,Q7MF12,Q88AE7,Q88CW6,Q8BJ64,Q8CMY2,Q8D3K2,Q8FKI9,Q8G1Z8,Q8NE62,Q8NUM0,Q8P5D7,Q8PPG8,Q8UH55,Q8X6C6,Q8YFY2,Q8ZGW0,Q985M5,Q9HTJ2,Q9L4K0,Q9RA05,Q9X2M2">CDH</mark> ) <mark style="background-color:orange;">oxidizes</mark> <mark style="background-color:lightblue;" id="294,6134,84571,440995">lactose</mark> at the C-1 position of the <mark style="background-color:orange;">reducing</mark> sugar moiety to lactobionolactone, which spontaneously <mark style="background-color:orange;">hydrolyzes</mark> to <mark style="background-color:lightblue;" id="7314">lactobionic acid</mark>.
18698649-325	2,2'-Azino- <mark style="background-color:lightgreen;" id="Q9JLV1">bis</mark> (3-ethylbenzothiazoline-6-<mark style="background-color:lightblue;" id="104748">sulfonic acid</mark>) diammonium salt was <mark style="background-color:orange;">used</mark> as electron acceptor for <mark style="background-color:lightgreen;" id="P17444,P54223,P60336,P60337,Q01738,Q0TKW1,Q13NG7,Q1BQE2,Q1C932,Q1CFR7,Q1MJU4,Q1QXE1,Q1RFM3,Q2FDP9,Q2FV11,Q2KB43,Q2T6D0,Q2YWJ5,Q39A44,Q3BXK8,Q3JLL7,Q3K5H3,Q48CM7,Q4A0Q1,Q4K4K7,Q4L9D7,Q4UYN5,Q4ZM63,Q5HCU1,Q5HL11,Q62CH8,Q63KK7,Q66D54,Q6D6D9,Q6FDF9,Q6G664,Q6GDJ1,Q6LGH5,Q7MF12,Q88AE7,Q88CW6,Q8BJ64,Q8CMY2,Q8D3K2,Q8FKI9,Q8G1Z8,Q8NE62,Q8NUM0,Q8P5D7,Q8PPG8,Q8UH55,Q8X6C6,Q8YFY2,Q8ZGW0,Q985M5,Q9HTJ2,Q9L4K0,Q9RA05,Q9X2M2">CDH</mark> and was continuously <mark style="background-color:orange;">regenerated</mark> (reoxidized) by <mark style="background-color:lightgreen;" id="Q12570">laccase</mark> , a blue multi-<mark style="background-color:lightblue;" id="23978">copper</mark> oxidase.
18698649-326	<mark style="background-color:lightblue;" id="977">Oxygen</mark> served as the terminal electron acceptor of the reaction and was fully <mark style="background-color:orange;">reduced</mark> to water by <mark style="background-color:lightgreen;" id="Q12570">laccase</mark> .
18696261-327	<mark style="background-color:lightblue;" id="750">A D-amino acid</mark> oxidase gene ( <mark style="background-color:lightgreen;" id="O35078,P18894">dao</mark> ) was <mark style="background-color:orange;">ligated</mark> with the P(Hase) and cloned into pGEMKT to constitutively <mark style="background-color:orange;">express</mark> protein of <mark style="background-color:lightgreen;" id="O01739,O35078,P00371,P14920,P18894,P22942,P24552,P80324,Q19564,Q99042,Q9Z1M5,Q9Z302">DAAO</mark> without the <mark style="background-color:orange;">use</mark> of any inducer such as <mark style="background-color:lightblue;" id="656894">isopropyl beta-D-1-thiogalactopyranoside</mark> which is poisonous to the cells and environment.
18706848-328	The interaction between bovine <mark style="background-color:lightgreen;" id="P21847,P83517">serum albumin</mark> ( <mark style="background-color:lightgreen;" id="P02769">BSA</mark> (5-)) as well as the <mark style="background-color:orange;">damage</mark> of <mark style="background-color:lightgreen;" id="P02769">BSA</mark> in the presence of <mark style="background-color:lightblue;" id="29936">Fe(III</mark>)-<mark style="background-color:lightblue;" id="875,439655,444305">tartrate</mark> complexes under ultrasonic irradiation was studied by UV-vis and fluorescence spectra.
18706848-329	In addition, the influences of ultrasonic irradiation time, <mark style="background-color:lightblue;" id="29936">Fe(III</mark>)-<mark style="background-color:lightblue;" id="875,439655,444305">tartrate</mark> complex concentration, ionic strength and solution acidity (pH value) were also examined on the <mark style="background-color:orange;">damage</mark> of <mark style="background-color:lightgreen;" id="P02769">BSA</mark> .
18706848-330	Otherwise, under ultrasonic irradiation the <mark style="background-color:lightgreen;" id="P02769">BSA</mark> molecules were obviously <mark style="background-color:orange;">damaged</mark> by the <mark style="background-color:lightblue;" id="29936">Fe(III</mark>)-<mark style="background-color:lightblue;" id="875,439655,444305">tartrate</mark> complexes.
18584306-333	Site-directed mutation test and <mark style="background-color:lightblue;" id="29051,163659,230076,6326719">mithramycin A</mark> treatment demonstrated that the <mark style="background-color:lightgreen;" id="Q8WVD5,Q9UIE0">ZNF230</mark> promoter <mark style="background-color:orange;">contained</mark> a functional <mark style="background-color:lightgreen;" id="O14300,O89090,P17379,Q01714,Q85439,Q85449,Q85451">Sp1</mark> site.
18563517-342	Only the <mark style="background-color:yellow;" id="GO:0005622,cellular_component">intracellular</mark>  <mark style="background-color:lightgreen;" id="O62641,O77620,O97513,P04351,P05016,P17108,P19114,P26891,P36835,P37997,P46649,P51747,P60568,P60569,P68290,P68291,Q07885,Q08081,Q08867,Q1WM29,Q25BC3,Q29416,Q29615,Q2PE47,Q2PE78,Q4U313,Q5MBA8,Q5PXD0,Q7JFM2,Q7JFM3,Q7JFM4,Q7JFM5,Q865X2,Q865Y1,Q8MKH2,Q95KP3,Q9XS38,Q9XT83,Q9XT84">IL-2</mark> response in the <mark style="background-color:orange;">lower</mark> tertile of <mark style="background-color:lightgreen;" id="O62641,O77620,O97513,P04351,P05016,P17108,P19114,P26891,P36835,P37997,P46649,P51747,P60568,P60569,P68290,P68291,Q07885,Q08081,Q08867,Q1WM29,Q25BC3,Q29416,Q29615,Q2PE47,Q2PE78,Q4U313,Q5MBA8,Q5PXD0,Q7JFM2,Q7JFM3,Q7JFM4,Q7JFM5,Q865X2,Q865Y1,Q8MKH2,Q95KP3,Q9XS38,Q9XT83,Q9XT84">IL-2</mark> production was <mark style="background-color:orange;">improved</mark> with <mark style="background-color:lightblue;" id="738,5961">glutamine</mark> indicating a small influence.
18563517-343	The elevation of <mark style="background-color:lightblue;" id="738,5961">glutamine</mark> plasma <mark style="background-color:orange;">levels</mark> by a perioperative intravenous infusion of L-alanyl-<mark style="background-color:lightblue;" id="5961,145815">L-glutamine</mark> <mark style="background-color:orange;">influenced</mark> the <mark style="background-color:yellow;" id="GO:0005622,cellular_component">intracellular</mark> expression of <mark style="background-color:lightgreen;" id="O62641,O77620,O97513,P04351,P05016,P17108,P19114,P26891,P36835,P37997,P46649,P51747,P60568,P60569,P68290,P68291,Q07885,Q08081,Q08867,Q1WM29,Q25BC3,Q29416,Q29615,Q2PE47,Q2PE78,Q4U313,Q5MBA8,Q5PXD0,Q7JFM2,Q7JFM3,Q7JFM4,Q7JFM5,Q865X2,Q865Y1,Q8MKH2,Q95KP3,Q9XS38,Q9XT83,Q9XT84">IL-2</mark> in the lower tertile only slightly.
18627006-344	We found that the acetylated <mark style="background-color:lightgreen;" id="P02299,P07041,P08437,P08898,P22843,P23753,P40285,P50564,P61830,P61831,P61832,P61833,P61834,P61835,P61836,P80553,P83864,P84235,P84236,P84237,P84238,P84239,P90543,Q06196,Q2UCQ0,Q5DWI3,Q757N1,Q7XYZ0,Q98RY4,Q9HDN1,Q9P427,Q9U7D1">histone H3</mark> at <mark style="background-color:lightblue;" id="866,5962">lysine</mark> 9 and <mark style="background-color:lightblue;" id="866,5962">lysine</mark> 14 (H3K9/K14ac) is <mark style="background-color:orange;">reduced</mark> in both the <mark style="background-color:lightgreen;" id="P02686,P02687,P04370,P06906,P15720,P20939,P25188,P25274,P81558,P83487,P87346,P98190,Q91325,Q91439">myelin basic protein</mark> ( <mark style="background-color:lightgreen;" id="P02686,P02687,P04370,P06906,P13727,P15720,P20939,P25188,P25274,P25336,P81558,P83487,P87346,P98190,Q61878,Q63189,Q91325,Q91439,Q9SAV1">MBP</mark> ) and proteolipid protein ( <mark style="background-color:lightgreen;" id="P04116,P13085,P22858,P23289,P23294,P30044,P47789,P47790,P60201,P60202,P60203,P79826,P80145,P99029,Q8HXW7,Q96GD0,Q9R063">PLP</mark> ) genes of maturing oligodendroglial OL-1 cells, and furthermore, this temporally correlates with <mark style="background-color:orange;">increases</mark> in <mark style="background-color:lightgreen;" id="P02686,P02687,P04370,P06906,P13727,P15720,P20939,P25188,P25274,P25336,P81558,P83487,P87346,P98190,Q61878,Q63189,Q91325,Q91439,Q9SAV1">MBP</mark> , <mark style="background-color:lightgreen;" id="P04116,P13085,P22858,P23289,P23294,P30044,P47789,P47790,P60201,P60202,P60203,P79826,P80145,P99029,Q8HXW7,Q96GD0,Q9R063">PLP</mark> , and <mark style="background-color:lightgreen;" id="O22446">histone deacetylase</mark> (HDAC) 11 expression.
18565581-348	<mark style="background-color:lightblue;" id="3017">Diazinon</mark> <mark style="background-color:orange;">diminished</mark> the plasma <mark style="background-color:lightgreen;" id="Q867X2,Q867X3,Q86GC9,Q92081">acetylcholinesterase</mark> activity on day 1 post-treatment, although <mark style="background-color:lightblue;" id="6013">testosterone</mark> levels remained unaffected.
18565581-349	<mark style="background-color:lightblue;" id="896">Melatonin</mark> pretreatment <mark style="background-color:orange;">prevented</mark> every alteration <mark style="background-color:orange;">induced</mark> by <mark style="background-color:lightblue;" id="3017">diazinon</mark>, except the diminution of <mark style="background-color:lightgreen;" id="Q867X2,Q867X3,Q86GC9,Q92081">acetylcholinesterase</mark> plasmatic activity.
18577871-351	These data provide evidence that CMEC express <mark style="background-color:lightgreen;" id="O62714,P35384,P41180,P48442,Q9QY96">CaSR</mark> , which is able to <mark style="background-color:orange;">respond</mark> to physiological agonists by <mark style="background-color:orange;">mobilizing</mark> <mark style="background-color:lightblue;" id="271">Ca(2</mark>+) from <mark style="background-color:yellow;" id="GO:0005622,cellular_component">intracellular</mark> InsP(3)-sensitive stores.
18563542-358	Determination of bioactive matter by affinity adsorption solid substrate-room temperature phosphorimetry based on <mark style="background-color:lightgreen;" id="P02871,P02873,P02874,P02875,P07386,P16108,P16349,P16351,P16352,P33888,P38662,P42088,P83410,P83511,P84987,Q41114">lectin</mark> <mark style="background-color:orange;">labeled</mark> with self-ordered ring of <mark style="background-color:lightblue;" id="11049,27020">eosin Y</mark>.
18563560-376	With supplementation of <mark style="background-color:lightblue;" id="1123">taurine</mark> in diet, <mark style="background-color:orange;">lower</mark> expression of <mark style="background-color:lightgreen;" id="P03995,P14136,P47819,Q28115">GFAP</mark> and <mark style="background-color:lightgreen;" id="P15691,P15692,P26617,P49151,P50412,P67964,P67965,Q99PS1,Q9GKR0,Q9MYV3">VEGF</mark> while higher expression of <mark style="background-color:lightgreen;" id="P24942,P56564">GLAST</mark> , GS and <mark style="background-color:lightgreen;" id="P20228,P54767,Q04792,Q07346,Q42521,Q99259,Q9CG20">GAD</mark> in retina of diabetic rats were determinated by RT- <mark style="background-color:lightgreen;" id="O66148,O80333,P15904,Q01289,Q39617,Q41249,Q59987,Q9SDT1">PCR</mark> 0.05).
18592327-379	11beta-<mark style="background-color:lightblue;" id="235496">Hydroxysteroid</mark> dehydrogenase type 1 ( <mark style="background-color:lightgreen;" id="P16232,P28845,P50172,P51975,Q29608,Q6QLL4,Q6R0J2,Q7M3I4">11beta-HSD1</mark> ) enzyme <mark style="background-color:orange;">catalyzes</mark> interconversion of inactive <mark style="background-color:lightblue;" id="222786">cortisone</mark> to active <mark style="background-color:lightblue;" id="5754">cortisol</mark>.
18639339-380	The enzyme <mark style="background-color:lightgreen;" id="P14902,P28776">indoleamine 2,3-dioxygenase</mark> ( <mark style="background-color:lightgreen;" id="P14902,P28776">IDO</mark> ) <mark style="background-color:orange;">converts</mark> <mark style="background-color:lightblue;" id="1148,6305,9060,5460840">tryptophan</mark> to <mark style="background-color:lightblue;" id="846">kynurenine</mark>, blocking <mark style="background-color:yellow;" id="GO:0042110,biological_process">T-cell activation</mark> and inducing immunosuppression.
18677478-391	Induction of NY-<mark style="background-color:lightblue;" id="445419">ESO</mark>-1 expression on tumor <mark style="background-color:orange;">targets</mark> <mark style="background-color:orange;">using</mark> the <mark style="background-color:orange;">demethylating</mark> agent <mark style="background-color:lightblue;" id="451668">5-aza-2'-deoxycytidine</mark> (alone or in combination with the <mark style="background-color:lightgreen;" id="O22446">histone deacetylase</mark> inhibitor <mark style="background-color:lightblue;" id="5352062">depsipeptide</mark>) resulted in <mark style="background-color:orange;">enhanced</mark> <mark style="background-color:lightgreen;" id="Q9TTB0">interferon-gamma</mark>  <mark style="background-color:yellow;" id="GO:0046903,biological_process">secretion</mark> by the <mark style="background-color:yellow;" id="GO:0042101,cellular_component">TCR</mark> -transduced PBL on culture with treated targets.
18692599-393	<mark style="background-color:lightgreen;" id="O88480,Q9Y6J0">Calcineurin inhibitors</mark> (CsA, <mark style="background-color:lightblue;" id="6436007">FK-506</mark> and <mark style="background-color:lightblue;" id="6447131,6509979,17753757,24847863,53394893,53486290">pimecrolimus</mark>) <mark style="background-color:orange;">inhibited</mark> NO production and <mark style="background-color:lightgreen;" id="O19114,O46660,O54705,O62699,P29477,P35228,P79290,Q06518,Q27995,Q28314,Q90703,Q92037,Q92091">iNOS</mark> expression in a concentration-dependent manner, CsA being more potent than <mark style="background-color:lightblue;" id="6436007">FK-506</mark> and <mark style="background-color:lightblue;" id="6447131,6509979,17753757,24847863,53394893,53486290">pimecrolimus</mark>.
18692599-395	In conclusion, the results suggest that <mark style="background-color:lightgreen;" id="O88480,Q9Y6J0">calcineurin inhibitors</mark> <mark style="background-color:lightblue;" id="2909,5280754,5284373,5458585,5497195,6435893,24883466,49867938">cyclosporin A</mark>, <mark style="background-color:lightblue;" id="5372,445643,445647,6426916,6436007,6473866,6536850,9940643,23581796,54611630">tacrolimus</mark> (<mark style="background-color:lightblue;" id="6436007">FK-506</mark>) and <mark style="background-color:lightblue;" id="6447131,6509979,17753757,24847863,53394893,53486290">pimecrolimus</mark> <mark style="background-color:orange;">inhibit</mark> <mark style="background-color:lightgreen;" id="O19114,O46660,O54705,O62699,P29477,P35228,P79290,Q06518,Q27995,Q28314,Q90703,Q92037,Q92091">iNOS</mark> expression and NO production in response to inflammatory stimuli by enhancing the decay of <mark style="background-color:lightgreen;" id="O19114,O46660,O54705,O62699,P29477,P35228,P79290,Q06518,Q27995,Q28314,Q90703,Q92037,Q92091">iNOS</mark> mRNA by a 3'UTR-dependent manner.
18660796-396	<mark style="background-color:lightblue;" id="145068">Nitric oxide</mark> is a free radical molecule <mark style="background-color:orange;">synthesized</mark> from <mark style="background-color:lightblue;" id="6322">L-arginine</mark> by <mark style="background-color:lightgreen;" id="O61309,O61608,Q27571,Q9I9M2">nitric oxide synthases</mark> that plays a critical role in various physiological and pathological processes, including tumor growth and <mark style="background-color:yellow;" id="GO:0001525,biological_process">angiogenesis</mark> .
18635261-398	In absence of stretch, we could activate <mark style="background-color:lightgreen;" id="P64267,P64268">Gns</mark> and <mark style="background-color:orange;">deactivate</mark> <mark style="background-color:lightgreen;" id="Q9GTW9">GK1</mark> by <mark style="background-color:lightblue;" id="1394,5353264,6437055">1-oleoyl-2-acetyl-sn-glycerol</mark> (<mark style="background-color:lightblue;" id="5353264">OAG</mark>) and other amphipaths.
18600448-401	<mark style="background-color:lightblue;" id="750">Glycine</mark> <mark style="background-color:orange;">release</mark> was <mark style="background-color:orange;">potentiated</mark> by the activation of <mark style="background-color:lightgreen;" id="P13678,Q25378">protein kinase C</mark> and <mark style="background-color:orange;">diminished</mark> by <mark style="background-color:orange;">increasing</mark> <mark style="background-color:lightblue;" id="24316">cyclic guanosine monophosphate</mark> <mark style="background-color:orange;">levels</mark> with a phosphodiesterase inhibitor, <mark style="background-color:lightblue;" id="5722">zaprinast</mark>.
18686165-403	Four different molecules contain galactofuranose in A. fumigatus: (i) the <mark style="background-color:lightblue;" id="439336">galactomannan</mark> present in the alkali soluble and <mark style="background-color:yellow;" id="GO:0005626,cellular_component">insoluble fraction</mark> of the <mark style="background-color:yellow;" id="GO:0009275,GO:0009505,GO:0009277,GO:0009276,GO:0009274,GO:0005618,cellular_component">cell wall</mark> (ii) N- and O <mark style="background-color:lightblue;" id="871">glycan</mark> moieties of <mark style="background-color:orange;">secreted</mark> <mark style="background-color:lightgreen;" id="P08163">glycoproteins</mark> (iii) a <mark style="background-color:lightgreen;" id="O25781,O51672,O59618,O66954,O82059,O83488,O84382,P06744,P06745,P08059,P0A0T0,P0A0T1,P0A6T1,P0A6T2,P12341,P12709,P13377,P18240,P28718,P29333,P34795,P34796,P34797,P42861,P44312,P46479,P47357,P49105,P50309,P52029,P52030,P52031,P52983,P54234,P54235,P54236,P54237,P54238,P54239,P54240,P54241,P54242,P54243,P57636,P64192,P64193,P64194,P64195,P64196,P77877,P78033,P78917,P80860,P81181,P83194,P83780,P84140,P99078,Q0TA36,Q0VR14,Q11MA0,Q13Z07,Q165T7,Q18FQ4,Q1ASN4,Q1BH79,Q1CSA0,Q1CX51,Q1GAY0,Q1GJQ5,Q1GTU1,Q1H1P4,Q1IYT4,Q1J8N2,Q1JDQ8,Q1JIS1,Q1JNM4,Q1LM68,Q1LU73,Q1MM06,Q1QEK1,Q1R3R3,Q1WUR2,Q21M11,Q21ZD5,Q24VW9,Q255I6,Q28QX4,Q2A2C5,Q2FIB3,Q2FZU0,Q2G7C4,Q2IE39,Q2JH03,Q2JHU0,Q2JX86,Q2KCY8,Q2KYE9,Q2LRD0,Q2NJ38,Q2NR04,Q2P380,Q2RQ51,Q2S8W1,Q2SS24,Q2SWP6,Q2VYV7,Q2YBU4,Q2YPF3,Q2YWS3,Q31AX5,Q31I19,Q31LL0,Q31TX1,Q328X7,Q38WF1,Q39FF4,Q39SU1,Q3A201,Q3AFH3,Q3AJU7,Q3ASZ0,Q3AXV8,Q3B3Q8,Q3BUL3,Q3IKH4,Q3IMS0,Q3J2U4,Q3JCN1,Q3JRE2,Q3K2Y2,Q3K6Q4,Q3KLX6,Q3M6S3,Q3YUW0,Q3ZBD7,Q44407,Q46L16,Q47IJ3,Q48N88,Q48VF9,Q491V0,Q49WA1,Q4A5S9,Q4A7J2,Q4A9F3,Q4FVH5,Q4JCA7,Q4JX51,Q4K5Y1,Q4L4X8,Q4QL07,Q4R591,Q4UTV8,Q4ZY88,Q57F73,Q57H06,Q59000,Q59088,Q5E847,Q5FL04,Q5H0A7,Q5HHC2,Q5HQJ9,Q5JE38,Q5KVS7,Q5L5E1,Q5L9E3,Q5LRS9,Q5M1N9,Q5N0B4,Q5NFC4,Q5P0T4,Q5PL07,Q5QWW0,Q5R4E3,Q5SLL6,Q5UXU0,Q5WDX0,Q5WYE0,Q5X6Y8,Q5XE09,Q5YPP1,Q5ZXH2,Q600A8,Q609I7,Q62JL8,Q632G4,Q63V31,Q64PM7,Q65FL6,Q65TC2,Q660E3,Q664W9,Q67QQ0,Q6A5X5,Q6AQ48,Q6D022,Q6F1L2,Q6FRW1,Q6G0T9,Q6GAW4,Q6GIC6,Q6HC08,Q6KH90,Q6LM51,Q6LXQ4,Q6MD44,Q6MTA3,Q6NIE5,Q6YQU0,Q711G1,Q71X61,Q72GY6,Q72MT7,Q72YI4,Q73K18,Q742E4,Q74DK5,Q74K31,Q758L0,Q7MH97,Q7MUV9,Q7MZB4,Q7NJY9,Q7S986,Q7U6T0,Q7V1I1,Q7V7M6,Q7VBZ6,Q7VNR9,Q7VRI4,Q7VUF4,Q7W197,Q7WP01,Q816G0,Q81K75,Q822E7,Q82SP4,Q835G1,Q83D91,Q83XM3,Q848I4,Q87EV7,Q87L81,Q888Q7,Q88UI4,Q891H2,Q89A35,Q8A5W2,Q8CT80,Q8D1V8,Q8DCK7,Q8DKY2,Q8DN74,Q8EBH1,Q8ENY8,Q8EVU1,Q8EZG6,Q8FB44,Q8FR39,Q8G2N3,Q8G7I6,Q8K8Q6,Q8K910,Q8KDQ7,Q8L1Z9,Q8NS31,Q8NXF1,Q8P2R3,Q8P9S7,Q8R924,Q8RHH5,Q8SRY1,Q8UI94,Q8VVB7,Q8XI54,Q8XYN9,Q8Y4R7,Q8YF86,Q8YY05,Q8Z1U7,Q8ZAS2,Q8ZKI4,Q8ZWV0,Q928R6,Q92SC4,Q96YC2,Q978F3,Q97FP8,Q97NG0,Q97WE5,Q98BV5,Q98R79,Q9A1L1,Q9ABK5,Q9CD75,Q9CNL2,Q9FXM4,Q9FXM5,Q9HGZ2,Q9HIC2,Q9HNQ6,Q9HV67,Q9K7L8,Q9KUY4,Q9KX58,Q9N1E2,Q9PGR6,Q9PK16,Q9PMD4,Q9RDY2,Q9RMC1,Q9RTL8,Q9UXW3,Q9X1A5,Q9X670,Q9YE01,Q9Z6N4,Q9ZK49">GPI</mark> - anchored lipophosphogalactomannan and (iv) several sphingolipids also anchored to the <mark style="background-color:yellow;" id="GO:0016020,cellular_component">membrane</mark> by an <mark style="background-color:lightblue;" id="57339182">inositol phosphoceramide</mark>.
18600455-406	Our study demonstrates that <mark style="background-color:lightblue;" id="6675">taurocholate</mark> causes evident <mark style="background-color:orange;">damage</mark> to acinar cells, <mark style="background-color:orange;">impairing</mark> both calcium <mark style="background-color:yellow;" id="GO:0042592,biological_process">homeostasis</mark> and secretory response to <mark style="background-color:lightgreen;" id="O57312,O93464,P01355,P01356,P06307,P09240,P0C229,P23362,P41520,P50144,P50145,P68125,P68126,P80344,P80345,Q9PU29,Q9PU41">CCK</mark> .
18600456-407	Enteric neuronal <mark style="background-color:lightblue;" id="681">dopamine</mark> (DA) <mark style="background-color:orange;">inhibits</mark> <mark style="background-color:lightblue;" id="187">acetylcholine</mark> <mark style="background-color:orange;">release</mark> and gastric motility; this has been thought to be <mark style="background-color:orange;">mediated</mark> via neuronal <mark style="background-color:lightblue;" id="681">dopamine</mark>-2 receptor ( <mark style="background-color:lightgreen;" id="Q8IS44">D2R</mark> ).
18592271-409	The activities of <mark style="background-color:lightgreen;" id="O51891,O67031,O83281,P03304,P0A295,P0A296,P0AG30,P0AG31,P0AG32,P0AG33,P15409,P17593,P17594,P20350,P29403,P33561,P35359,P38527,P44619,P45835,P51489,P52152,P52153,P52154,P52155,P52156,P52157,P52158,P56466,P57652,P66028,P66029,Q03222,Q06447,Q89A22,Q9ZD24,Q9ZLS9">Rho</mark> GTPases are predominantly controlled by <mark style="background-color:lightblue;" id="764">guanine</mark> nucleotide exchange factors ( <mark style="background-color:lightgreen;" id="Q9NR83">GEFs</mark> ), which <mark style="background-color:orange;">activate</mark> GTPases by <mark style="background-color:orange;">catalyzing</mark> the exchange of <mark style="background-color:orange;">bound</mark> <mark style="background-color:lightblue;" id="8977">GDP</mark> for <mark style="background-color:lightblue;" id="6830">GTP</mark>.
18700818-411	While bass in all <mark style="background-color:lightblue;" id="3017">diazinon</mark> treatment groups had significantly <mark style="background-color:orange;">inhibited</mark> brain <mark style="background-color:lightgreen;" id="O42275,O62763,P04058,P07140,P07692,P21836,P22303,P23795,P36196,P37136,P56161,Q27677,Q29499,Q867X2,Q867X3,Q869C3,Q86GC8,Q86GC9,Q92035,Q92081,Q9DDE3">AChE</mark> activity, only the medium and high treatment groups showed a dose- and time-dependent increase in time to capture prey.
18571801-413	<mark style="background-color:yellow;" id="GO:0005576,cellular_component">Extracellular</mark>  <mark style="background-color:lightgreen;" id="Q7M4U7">lipase</mark>  <mark style="background-color:lightgreen;" id="O59952,P21764,P49081,Q06383,Q96Q15">LIP</mark> prepared in our lab from the yeast Yarrowia lipolytica was <mark style="background-color:orange;">used</mark> for the resolution of racemic <mark style="background-color:lightblue;" id="3672,39912">ibuprofen</mark>.
18571801-414	The high purity (<mark style="background-color:lightblue;" id="39912">S)-ibuprofen</mark> (ee = 0.98) was obtained <mark style="background-color:orange;">using</mark> <mark style="background-color:lightgreen;" id="Q7M4U7">lipase</mark>  <mark style="background-color:lightgreen;" id="O59952,P21764,P49081,Q06383,Q96Q15">LIP</mark> to <mark style="background-color:orange;">catalyze</mark> hydrolysis of (S)-ester in 0.1 M <mark style="background-color:lightblue;" id="1061,167704,644102">phosphate</mark> buffer (pH = 8).
18563616-418	<mark style="background-color:lightgreen;" id="O23970,P00435,P04041,P07203,P11352,P11909,P36014,Q4AEI1,Q4AEI2,Q4AEI3,Q865R2,Q8MJ14">Glutathione peroxidase 1</mark> ( <mark style="background-color:lightgreen;" id="O48646,P00435,P07203,P11909,P36014,P52032,Q00277,Q4AEI1,Q4AEI2,Q4AEI3,Q865R2,Q8MJ14">GPX1</mark> ) is a ubiquitously <mark style="background-color:orange;">expressed</mark> <mark style="background-color:lightblue;" id="6326970">selenium</mark>-dependent enzyme that <mark style="background-color:orange;">protects</mark> cells against oxidative <mark style="background-color:orange;">damage</mark> by <mark style="background-color:orange;">reducing</mark> <mark style="background-color:lightblue;" id="784">hydrogen peroxide</mark> and a wide range of organic peroxides.
18612777-425	Type I <mark style="background-color:lightgreen;" id="P40746,P52183,P81453,Q819L3,Q81MS1,Q8GR90,Q9K5W7">transglutaminase</mark> (<mark style="background-color:lightblue;" id="446378">TG1</mark>), an enzyme that <mark style="background-color:orange;">catalyzes</mark> the formation of <mark style="background-color:lightgreen;" id="P05463">epsilon</mark> -(gamma-glutamyl)<mark style="background-color:lightblue;" id="866,5962">lysine</mark> bonds, is the key protein responsible for generation of the crosslinks.
18704940-430	<mark style="background-color:lightgreen;" id="O06222,O07108,O07669,O25236,O51532,O67852,O83873,O84763,P0A089,P0A090,P0A091,P0C0D7,P0C0D8,P14900,P45063,P57313,P57995,P73668,Q03522,Q0SHR9,Q0SQ91,Q0TLQ1,Q0TMJ3,Q0VS04,Q11GS3,Q11RH3,Q12EL7,Q13TZ0,Q14J05,Q163I6,Q182Y7,Q1AVX1,Q1BZG5,Q1C212,Q1CMM9,Q1CU35,Q1D0S8,Q1GAT6,Q1GIV4,Q1GRX7,Q1GYZ9,Q1IKG8,Q1J147,Q1J5S5,Q1JAT4,Q1JG10,Q1JKY4,Q1LIM4,Q1LSW4,Q1ME31,Q1MPC1,Q1Q883,Q1QNU5,Q1QVG5,Q1RGA7,Q1RI52,Q1WT99,Q216E0,Q21MH1,Q21SW7,Q24TE4,Q255W7,Q28NN2,Q2A1Z9,Q2FHQ4,Q2FZ92,Q2G997,Q2IG29,Q2IYL0,Q2JD52,Q2JHP5,Q2JVR9,Q2K6B9,Q2KVF5,Q2LR50,Q2NVV3,Q2P5V2,Q2RK81,Q2RVU2,Q2S530,Q2S9Z0,Q2SZI5,Q2W0H5,Q2Y636,Q2YM69,Q2YXD9,Q313Q5,Q319C4,Q31I61,Q31MM2,Q326E7,Q32K04,Q38XM9,Q39JX2,Q39YM1,Q3A2G4,Q3AAE4,Q3AHP0,Q3ANV5,Q3AZI5,Q3B127,Q3BR29,Q3IG02,Q3J4M6,Q3J787,Q3JND6,Q3K2P4,Q3K742,Q3KKT4,Q3MF19,Q3SMH5,Q3STT0,Q3Z5S1,Q46JA8,Q46WZ2,Q47AA2,Q47QX1,Q47VQ7,Q48EF6,Q48SK8,Q493Q3,Q49WW5,Q4FQ21,Q4JW97,Q4K6J1,Q4L5N4,Q4QLG0,Q4ULT8,Q4UWX9,Q4ZNY8,Q52953,Q57C76,Q57TD2,Q5E2P8,Q5F6L6,Q5FKV3,Q5FUJ7,Q5GSC8,Q5H2Y1,Q5HGP8,Q5HQ09,Q5HW34,Q5L0X7,Q5L521,Q5LIJ5,Q5LU71,Q5M0D5,Q5M4Y2,Q5MZA8,Q5NHK3,Q5NPA7,Q5P6Z4,Q5PBH9,Q5PDC2,Q5R0M3,Q5SJD2,Q5WFG8,Q5WTI5,Q5X1S4,Q5XB04,Q5YYY1,Q5ZSA3,Q604V5,Q62GS5,Q636B4,Q63QJ5,Q64ZL9,Q65JY2,Q65RY4,Q66EK7,Q67QM7,Q68WW9,Q6A9Q4,Q6AE62,Q6AJ52,Q6D0I1,Q6FFC2,Q6G122,Q6G2Q3,Q6GA29,Q6GHQ2,Q6HEQ2,Q6LMF4,Q6MBS4,Q6MIF8,Q6N409,Q6NGC6,Q71XX7,Q728U6,Q72JQ1,Q72NP4,Q732F6,Q73GT3,Q73YQ6,Q748D4,Q74JY5,Q7MNV3,Q7MWM5,Q7N145,Q7NEZ5,Q7NPZ7,Q7U8T1,Q7V0A5,Q7V5V5,Q7VAM1,Q7VEP7,Q7VP56,Q7VQI9,Q7VUQ1,Q7W4B2,Q7WFS0,Q819Q2,Q81WC9,Q821S1,Q82AD8,Q82VS5,Q83F20,Q83GN2,Q83HK0,Q83MF9,Q879A1,Q87EA7,Q87SG6,Q87WY3,Q88N78,Q88V80,Q899G5,Q89AQ2,Q89FU5,Q8A256,Q8CSX6,Q8D2Z4,Q8DEK8,Q8DMN8,Q8DQM2,Q8DVE3,Q8E186,Q8E6P1,Q8E9P6,Q8ER50,Q8F7V4,Q8FL65,Q8FNT8,Q8FZP2,Q8G4Q6,Q8K9T2,Q8KGD2,Q8NX35,Q8P063,Q8P775,Q8PII9,Q8R9G4,Q8RDQ1,Q8UDM6,Q8X9Y9,Q8XHM4,Q8XVI5,Q8Y5M1,Q8YI68,Q8YPS9,Q8Z9H0,Q8ZIF1,Q8ZRU4,Q929Y1,Q92I60,Q97EB9,Q97RU8,Q98KB1,Q9A597,Q9CF91,Q9CPB0,Q9F1N2,Q9HVZ9,Q9JSZ5,Q9K0Y4,Q9K9S8,Q9KPG5,Q9PEB0,Q9PI73,Q9PLG5,Q9RRJ4,Q9S2W9,Q9WY76,Q9Z705,Q9ZDC2,Q9ZLY0">MurD</mark> (<mark style="background-color:lightblue;" id="11006912">UDP-N-acetylmuramoyl</mark>-<mark style="background-color:lightblue;" id="14534790">L-alanine:D-glutamate</mark> ligase), a three-domain bacterial protein, <mark style="background-color:orange;">catalyses</mark> a highly specific incorporation of <mark style="background-color:lightblue;" id="23327">D-glutamate</mark> to the cytoplasmic intermediate UDP-N-acetyl-muramoyl-L-<mark style="background-color:lightblue;" id="602,4580,5950,71080">alanine</mark> (<mark style="background-color:lightblue;" id="5496796">UMA</mark>) <mark style="background-color:orange;">utilizing</mark> <mark style="background-color:yellow;" id="GO:0006200,biological_process">ATP hydrolysis</mark> to <mark style="background-color:lightgreen;" id="P02783">ADP</mark> and P(i).
18704940-431	On the basis of structural studies of <mark style="background-color:lightgreen;" id="O06222,O07108,O07669,O25236,O51532,O67852,O83873,O84763,P0A089,P0A090,P0A091,P0C0D7,P0C0D8,P14900,P45063,P57313,P57995,P73668,Q03522,Q0SHR9,Q0SQ91,Q0TLQ1,Q0TMJ3,Q0VS04,Q11GS3,Q11RH3,Q12EL7,Q13TZ0,Q14J05,Q163I6,Q182Y7,Q1AVX1,Q1BZG5,Q1C212,Q1CMM9,Q1CU35,Q1D0S8,Q1GAT6,Q1GIV4,Q1GRX7,Q1GYZ9,Q1IKG8,Q1J147,Q1J5S5,Q1JAT4,Q1JG10,Q1JKY4,Q1LIM4,Q1LSW4,Q1ME31,Q1MPC1,Q1Q883,Q1QNU5,Q1QVG5,Q1RGA7,Q1RI52,Q1WT99,Q216E0,Q21MH1,Q21SW7,Q24TE4,Q255W7,Q28NN2,Q2A1Z9,Q2FHQ4,Q2FZ92,Q2G997,Q2IG29,Q2IYL0,Q2JD52,Q2JHP5,Q2JVR9,Q2K6B9,Q2KVF5,Q2LR50,Q2NVV3,Q2P5V2,Q2RK81,Q2RVU2,Q2S530,Q2S9Z0,Q2SZI5,Q2W0H5,Q2Y636,Q2YM69,Q2YXD9,Q313Q5,Q319C4,Q31I61,Q31MM2,Q326E7,Q32K04,Q38XM9,Q39JX2,Q39YM1,Q3A2G4,Q3AAE4,Q3AHP0,Q3ANV5,Q3AZI5,Q3B127,Q3BR29,Q3IG02,Q3J4M6,Q3J787,Q3JND6,Q3K2P4,Q3K742,Q3KKT4,Q3MF19,Q3SMH5,Q3STT0,Q3Z5S1,Q46JA8,Q46WZ2,Q47AA2,Q47QX1,Q47VQ7,Q48EF6,Q48SK8,Q493Q3,Q49WW5,Q4FQ21,Q4JW97,Q4K6J1,Q4L5N4,Q4QLG0,Q4ULT8,Q4UWX9,Q4ZNY8,Q52953,Q57C76,Q57TD2,Q5E2P8,Q5F6L6,Q5FKV3,Q5FUJ7,Q5GSC8,Q5H2Y1,Q5HGP8,Q5HQ09,Q5HW34,Q5L0X7,Q5L521,Q5LIJ5,Q5LU71,Q5M0D5,Q5M4Y2,Q5MZA8,Q5NHK3,Q5NPA7,Q5P6Z4,Q5PBH9,Q5PDC2,Q5R0M3,Q5SJD2,Q5WFG8,Q5WTI5,Q5X1S4,Q5XB04,Q5YYY1,Q5ZSA3,Q604V5,Q62GS5,Q636B4,Q63QJ5,Q64ZL9,Q65JY2,Q65RY4,Q66EK7,Q67QM7,Q68WW9,Q6A9Q4,Q6AE62,Q6AJ52,Q6D0I1,Q6FFC2,Q6G122,Q6G2Q3,Q6GA29,Q6GHQ2,Q6HEQ2,Q6LMF4,Q6MBS4,Q6MIF8,Q6N409,Q6NGC6,Q71XX7,Q728U6,Q72JQ1,Q72NP4,Q732F6,Q73GT3,Q73YQ6,Q748D4,Q74JY5,Q7MNV3,Q7MWM5,Q7N145,Q7NEZ5,Q7NPZ7,Q7U8T1,Q7V0A5,Q7V5V5,Q7VAM1,Q7VEP7,Q7VP56,Q7VQI9,Q7VUQ1,Q7W4B2,Q7WFS0,Q819Q2,Q81WC9,Q821S1,Q82AD8,Q82VS5,Q83F20,Q83GN2,Q83HK0,Q83MF9,Q879A1,Q87EA7,Q87SG6,Q87WY3,Q88N78,Q88V80,Q899G5,Q89AQ2,Q89FU5,Q8A256,Q8CSX6,Q8D2Z4,Q8DEK8,Q8DMN8,Q8DQM2,Q8DVE3,Q8E186,Q8E6P1,Q8E9P6,Q8ER50,Q8F7V4,Q8FL65,Q8FNT8,Q8FZP2,Q8G4Q6,Q8K9T2,Q8KGD2,Q8NX35,Q8P063,Q8P775,Q8PII9,Q8R9G4,Q8RDQ1,Q8UDM6,Q8X9Y9,Q8XHM4,Q8XVI5,Q8Y5M1,Q8YI68,Q8YPS9,Q8Z9H0,Q8ZIF1,Q8ZRU4,Q929Y1,Q92I60,Q97EB9,Q97RU8,Q98KB1,Q9A597,Q9CF91,Q9CPB0,Q9F1N2,Q9HVZ9,Q9JSZ5,Q9K0Y4,Q9K9S8,Q9KPG5,Q9PEB0,Q9PI73,Q9PLG5,Q9RRJ4,Q9S2W9,Q9WY76,Q9Z705,Q9ZDC2,Q9ZLY0">MurD</mark> complexes, a stepwise catalytic mechanism was proposed that commences with a formation of the acyl-<mark style="background-color:lightblue;" id="1061,167704,644102">phosphate</mark> intermediate, followed by a nucleophilic <mark style="background-color:orange;">attack</mark> of <mark style="background-color:lightblue;" id="23327">D-glutamate</mark> that, through the formation of a tetrahedral reaction intermediate and subsequent <mark style="background-color:lightblue;" id="1061,167704,644102">phosphate</mark> dissociation, affords the final product, UDP-N-acetyl-muramoyl-<mark style="background-color:lightblue;" id="14534790">L-alanine-D-glutamate</mark> (UMAG).
18684339-438	A 3-fold increase in the expression of the <mark style="background-color:lightgreen;" id="P00448,P66828,P66829,Q8Z2V9,Q9RUV2">MnSOD</mark> gene was <mark style="background-color:orange;">associated</mark> with <mark style="background-color:orange;">decreased</mark> <mark style="background-color:lightblue;" id="6804">CpG</mark> methylation of the analysed promoter region in the vegetarian group compared with the age-matched omnivores group.
18655797-440	We found that <mark style="background-color:lightgreen;" id="P01101,P12841,Q56415">Fos</mark> expression in LH orexin neurons <mark style="background-color:orange;">varied</mark> in proportion to preference for <mark style="background-color:lightblue;" id="5288826,5479215">morphine</mark>, <mark style="background-color:lightblue;" id="2826,5760,439497,446220,644017,54613779">cocaine</mark> or food.
18655797-441	Recent studies showed that LH orexin neurons that project to ventral tegmental area (VTA) have greater <mark style="background-color:lightgreen;" id="P01101,P12841,Q56415">Fos</mark> induction in association with <mark style="background-color:orange;">elevated</mark> <mark style="background-color:lightblue;" id="5288826,5479215">morphine</mark> preference during protracted withdrawal than non-VTA-projecting orexin neurons, indicating that the VTA is an important site of action for orexin's role in reward processing.
18604600-443	<mark style="background-color:lightgreen;" id="P21917,P30729,P51436,Q6TLJ0">Dopamine D4 receptor</mark> involvement in the discriminative stimulus <mark style="background-color:orange;">effects</mark> in rats of <mark style="background-color:lightblue;" id="5761">LSD</mark>, but not the <mark style="background-color:lightblue;" id="1001,31016">phenethylamine</mark> <mark style="background-color:lightblue;" id="31374">hallucinogen</mark> <mark style="background-color:lightblue;" id="1229,6603801,9840090">DOI</mark>.
18655808-447	<mark style="background-color:lightgreen;" id="O07091,O13393,O22642,O93863,P00002,P00003,P00004,P00007,P00008,P00011,P00012,P00013,P00014,P00017,P00018,P00019,P00020,P00021,P00022,P00024,P00025,P00027,P00028,P00029,P00030,P00031,P00032,P00035,P00036,P00037,P00038,P00039,P00040,P00041,P00042,P00043,P00046,P00047,P00048,P00049,P00051,P00052,P00053,P00054,P00055,P00056,P00057,P00058,P00059,P00060,P00061,P00062,P00063,P00064,P00065,P00066,P00067,P00068,P00069,P00070,P00071,P00072,P00073,P00074,P00075,P00076,P00077,P00078,P00079,P12831,P15451,P18822,P19681,P19974,P21665,P22342,P25400,P29380,P32556,P38091,P53698,P56205,P59218,P62772,P62773,P62894,P62895,P62896,P67881,P67882,P68096,P68097,P68098,P68099,P68100,P68517,P68518,P68519,P81280,P81459,P99998,P99999,Q41346,Q4HVX7,Q52V08,Q52V09,Q52V10,Q5RFH4,Q640U4,Q6C9Q0,Q6IQM2,Q6Q4H8,Q6QLW4,Q6WUX8,Q753F4,Q7YR71,Q96VP3">Cytochromes c</mark> are metalloproteins that function in <mark style="background-color:yellow;" id="GO:0006118,biological_process">electron transfer</mark> reactions and <mark style="background-color:orange;">contain</mark> a <mark style="background-color:lightblue;" id="4971">heme</mark> moiety covalently attached via thioether linkages between the co-factor and a CXXCH motif in the protein.
18615734-449	These mRNAs no longer encode the <mark style="background-color:lightgreen;" id="P08567,Q4KM33,Q6Q308,Q9JHK5">pleckstrin</mark> homology (PH) domain of <mark style="background-color:lightgreen;" id="O43307,Q3UTH8,Q58DL7,Q5RDK0,Q9QX73">collybistin</mark> , which we now show <mark style="background-color:orange;">binds</mark> <mark style="background-color:lightblue;" id="6857403,9776841">phosphatidylinositol-3-phosphate</mark> (PI3P/<mark style="background-color:lightblue;" id="643964,24755494">PtdIns-3-P</mark>), a <mark style="background-color:lightblue;" id="16738692">phosphoinositide</mark> with an emerging role in <mark style="background-color:yellow;" id="GO:0016020,cellular_component">membrane</mark> trafficking and signal <mark style="background-color:yellow;" id="GO:0009293,biological_process">transduction</mark> , rather than <mark style="background-color:lightblue;" id="643963">phosphatidylinositol 3,4,5-trisphosphate</mark> ( <mark style="background-color:lightgreen;" id="P53044,P93004,Q02574">PIP3</mark> /<mark style="background-color:lightblue;" id="643963">PtdIns-3,4,5-P</mark>) as previously suggested in the " <mark style="background-color:yellow;" id="GO:0016020,cellular_component">membrane</mark> activation model" of <mark style="background-color:lightgreen;" id="Q03555,Q9NQX3">gephyrin</mark> clustering.
18635336-453	Using enzyme-linked immunosorbent assays, we showed <mark style="background-color:lightblue;" id="9881652">DHMEQ</mark> to <mark style="background-color:orange;">inhibit</mark> LPS-induced <mark style="background-color:yellow;" id="GO:0046903,biological_process">secretion</mark> of <mark style="background-color:lightgreen;" id="O35736,P05231,P08505,P20607,P26892,P26893,P29455,P41323,P41683,P41693,P46650,P51494,P79341,Q25BC2,Q28319,Q28747,Q28819,Q2MH06,Q5I6E3,Q6V919,Q865W7,Q865X6,Q8MKH0,Q95181,Q9MZR1,Q9XT80">IL-6</mark> and <mark style="background-color:lightgreen;" id="O35734,O77510,O77764,P01375,P04924,P06804,P13296,P16599,P19101,P23383,P23563,P29553,P33620,P36939,P48094,P51435,P51742,P51743,P59684,P59693,P59694,P59695,P79337,P79374,Q06599,Q19LH4,Q1G1A2,Q1WM27,Q2MH05,Q539C2,Q75N23,Q8HZD9,Q8JFG3,Q8MKG8,Q8WNR1,Q9BEA1">TNF-alpha</mark> .
18612811-461	<mark style="background-color:lightgreen;" id="P01108,P09416,P52160">Myc</mark> -oncogene <mark style="background-color:orange;">inactivating</mark> <mark style="background-color:orange;">effect</mark> by <mark style="background-color:lightblue;" id="614,8988,145742">proline</mark> rich polypeptide ( <mark style="background-color:lightgreen;" id="P11670">PRP-1</mark> ) in chondrosarcoma JJ012 cells.
18631247-468	<mark style="background-color:lightblue;" id="65064">Green tea extract</mark> <mark style="background-color:orange;">reduces</mark> induction of <mark style="background-color:lightgreen;" id="O09185,O12946,O57538,O93379,P02340,P04637,P10361,P19558,P19559,P56423,P56424,P61260,P79820,P79892,Q29537,Q42578,Q8SPZ3,Q92143,Q9TTA1,Q9TUB2,Q9W678,Q9W679">p53</mark> and <mark style="background-color:yellow;" id="GO:0006915,biological_process">apoptosis</mark> in UVB-irradiated human skin independent of transcriptional controls.
18612819-471	Like <mark style="background-color:lightblue;" id="5289212">PSC</mark>, DSL6A cells <mark style="background-color:orange;">secrete</mark> less <mark style="background-color:lightgreen;" id="P05305,P09558,P13206,P17322,P22387,P22388,P29560,P97740,Q28469,Q5NRP9,Q5NRQ1,Q9BG76">ET-1</mark> when cultured with <mark style="background-color:lightblue;" id="104865">bosentan</mark>.
18575957-472	Aim The present study sought insight into the effects of <mark style="background-color:lightblue;" id="60815">remifentanyl</mark> and <mark style="background-color:lightblue;" id="3345">fentanyl</mark> on LPS-induced <mark style="background-color:orange;">release</mark> of <mark style="background-color:lightgreen;" id="P41693">interleukin-6</mark> ( <mark style="background-color:lightgreen;" id="O35736,P05231,P08505,P20607,P26892,P26893,P29455,P41323,P41683,P41693,P46650,P51494,P79341,Q25BC2,Q28319,Q28747,Q28819,Q2MH06,Q5I6E3,Q6V919,Q865W7,Q865X6,Q8MKH0,Q95181,Q9MZR1,Q9XT80">IL-6</mark> ), <mark style="background-color:lightgreen;" id="Q8JFG3">tumor necrosis factor</mark> -alpha ( <mark style="background-color:lightgreen;" id="O35734,O77510,O77764,P01375,P04924,P06804,P13296,P16599,P19101,P23383,P23563,P29553,P33620,P36939,P48094,P51435,P51742,P51743,P59684,P59693,P59694,P59695,P79337,P79374,Q06599,Q19LH4,Q1G1A2,Q1WM27,Q2MH05,Q539C2,Q75N23,Q8HZD9,Q8JFG3,Q8MKG8,Q8WNR1,Q9BEA1">TNF-alpha</mark> ) and <mark style="background-color:lightgreen;" id="O46673,O97798,P18893,P22301,P29456,P43480,P46651,P47965,P48411,P51496,P51497,P51746,P55029,P79338,Q0Z972,Q25BC1,Q28374,Q29055,Q29408,Q2PE73,Q5Q0V6,Q865X4,Q8MKG9,Q9JHK7,Q9TSJ4,Q9Z1Y5">IL-10</mark> in human whole blood.
18575957-475	<mark style="background-color:lightblue;" id="60815">Remifentanyl</mark> and <mark style="background-color:lightblue;" id="3345">fentanyl</mark> could <mark style="background-color:orange;">inhibit</mark> the expressions of <mark style="background-color:lightgreen;" id="O35736,P05231,P08505,P20607,P26892,P26893,P29455,P41323,P41683,P41693,P46650,P51494,P79341,Q25BC2,Q28319,Q28747,Q28819,Q2MH06,Q5I6E3,Q6V919,Q865W7,Q865X6,Q8MKH0,Q95181,Q9MZR1,Q9XT80">IL-6</mark> , <mark style="background-color:lightgreen;" id="O35734,O77510,O77764,P01375,P04924,P06804,P13296,P16599,P19101,P23383,P23563,P29553,P33620,P36939,P48094,P51435,P51742,P51743,P59684,P59693,P59694,P59695,P79337,P79374,Q06599,Q19LH4,Q1G1A2,Q1WM27,Q2MH05,Q539C2,Q75N23,Q8HZD9,Q8JFG3,Q8MKG8,Q8WNR1,Q9BEA1">TNF-alpha</mark> and <mark style="background-color:lightgreen;" id="O46673,O97798,P18893,P22301,P29456,P43480,P46651,P47965,P48411,P51496,P51497,P51746,P55029,P79338,Q0Z972,Q25BC1,Q28374,Q29055,Q29408,Q2PE73,Q5Q0V6,Q865X4,Q8MKG9,Q9JHK7,Q9TSJ4,Q9Z1Y5">IL-10</mark> induced by LPS.
18608743-488	Design and synthesis of substituted <mark style="background-color:lightblue;" id="795">imidazole</mark> and <mark style="background-color:lightblue;" id="67516">triazole</mark> N-phenylbenzo[d]oxazolamine inhibitors of <mark style="background-color:lightblue;" id="444795">retinoic acid</mark> <mark style="background-color:orange;">metabolizing</mark> enzyme <mark style="background-color:lightgreen;" id="O43174,Q9PUB4">CYP26</mark> .
18592367-499	Parents (N = 19) of children with autism spectrum disorders ( <mark style="background-color:lightgreen;" id="P51689">ASD</mark> ) and adult controls (N = 17) underwent positron emission tomography (PET) <mark style="background-color:orange;">using</mark> [(18)F]<mark style="background-color:lightblue;" id="68604">setoperone</mark> to image cortical <mark style="background-color:lightblue;" id="5202">serotonin</mark> type-2 ( <mark style="background-color:lightgreen;" id="O46635,P14842,P18599,P28223,P35363,P35382,P50128,P50129,Q5R4Q6,Q75Z89">5-HT2</mark> ) receptors.
18608754-503	The enzyme <mark style="background-color:lightgreen;" id="O25536,O30931,O41033,O48500,O52597,O54134,O66592,O68992,O83855,O84294,P03195,P03370,P06968,P09254,P0A552,P0A553,P10234,P14597,P16088,P16824,P16901,P17374,P19028,P23426,P23427,P28892,P28893,P30007,P31625,P31822,P32208,P32518,P33317,P33826,P35956,P43058,P43792,P52341,P52541,P57623,P57914,P59408,P61906,P61907,P61908,P61909,P61910,P61911,P61912,P61913,P64004,P64005,P64006,P64007,P64008,P64009,P68634,P68635,P70583,P87630,Q00030,Q01034,Q06095,Q07275,Q2Y742,Q2YRG4,Q31EC7,Q31UY6,Q329L7,Q39DM5,Q39V99,Q3A499,Q3AQ75,Q3B304,Q3BNA6,Q3J0B2,Q3J6W1,Q3JV72,Q3K4M6,Q3KM70,Q3SFR7,Q3SWM9,Q3YRU2,Q3YW02,Q45920,Q47BB1,Q47NK1,Q48Q06,Q491W8,Q49992,Q4FU67,Q4JVB1,Q4K3S2,Q4QLV3,Q4ULV2,Q4UPP2,Q4ZZX9,Q57BK5,Q57IA2,Q58502,Q5F9E0,Q5FN20,Q5GST1,Q5H5L9,Q5L6D8,Q5LIH9,Q5LWD3,Q5NHX4,Q5P7Z9,Q5PAE6,Q5PC28,Q5QZB6,Q5WTW6,Q5X242,Q5YT90,Q5ZSN0,Q603M1,Q62HL1,Q63WI6,Q64ZK3,Q65R66,Q66GD8,Q68WX8,Q69151,Q6A8W1,Q6AFE0,Q6AJZ0,Q6BRN7,Q6C141,Q6CQN7,Q6DAV9,Q6E4Q0,Q6FDR0,Q6FKQ6,Q6FYR2,Q6G202,Q6MEK7,Q6MVL2,Q6RZR1,Q6TUZ4,Q74ZF0,Q76RE7,Q775Z7,Q7M9N1,Q7MAX3,Q7MBE8,Q7MVT6,Q7NKL2,Q7VJU0,Q7VN49,Q7VRK0,Q7VVR1,Q7W8Z8,Q7WKE3,Q823Q9,Q82KK4,Q82UM1,Q83G43,Q83I22,Q83PN3,Q87F19,Q88BD3,Q88C95,Q895R1,Q89662,Q8A245,Q8D2F3,Q8E9M0,Q8F729,Q8FPH9,Q8G4E8,Q8K921,Q8NPA9,Q8P458,Q8PFR5,Q8RA46,Q8RER7,Q8SRS0,Q8UII1,Q8V2Y0,Q8XWL1,Q8ZJP5,Q90030,Q92I74,Q92SM6,Q97J61,Q98C10,Q9A253,Q9CJ30,Q9F7S4,Q9HTN3,Q9J5G5,Q9JUW1,Q9JZU7,Q9PGZ6,Q9PKA2,Q9X3X5,Q9YYS0,Q9Z9C2,Q9ZDD2,Q9ZKY3">deoxyuridine 5'-triphosphate nucleotidohydrolase</mark> ( <mark style="background-color:lightgreen;" id="O25536,O27642,O29157,O30931,O41033,O48500,O52597,O54134,O66592,O68992,O83855,O84294,P03195,P03370,P06968,P09254,P0A552,P0A553,P10234,P14597,P16088,P16824,P16901,P17374,P19028,P23426,P23427,P28892,P28893,P30007,P31625,P31822,P32208,P32518,P33316,P33317,P33826,P35956,P43058,P43792,P52341,P52541,P57623,P57914,P59408,P61906,P61907,P61908,P61909,P61910,P61911,P61912,P61913,P64004,P64005,P64006,P64007,P64008,P64009,P68634,P68635,P70583,P87630,Q00030,Q01034,Q06095,Q07275,Q2Y742,Q2YRG4,Q31EC7,Q31UY6,Q329L7,Q39DM5,Q39V99,Q3A499,Q3AQ75,Q3B304,Q3BNA6,Q3J0B2,Q3J6W1,Q3JV72,Q3K4M6,Q3KM70,Q3SFR7,Q3SWM9,Q3YRU2,Q3YW02,Q45920,Q47BB1,Q47NK1,Q48Q06,Q491W8,Q49992,Q4FU67,Q4JVB1,Q4K3S2,Q4QLV3,Q4ULV2,Q4UPP2,Q4ZZX9,Q57BK5,Q57IA2,Q58502,Q5F9E0,Q5FN20,Q5GST1,Q5H5L9,Q5L6D8,Q5LIH9,Q5LWD3,Q5NHX4,Q5P7Z9,Q5PAE6,Q5PC28,Q5QZB6,Q5WTW6,Q5X242,Q5YT90,Q5ZSN0,Q603M1,Q62HL1,Q63WI6,Q64ZK3,Q65R66,Q66GD8,Q68WX8,Q69151,Q6A8W1,Q6AFE0,Q6AJZ0,Q6BRN7,Q6C141,Q6CQN7,Q6DAV9,Q6E4Q0,Q6FDR0,Q6FKQ6,Q6FYR2,Q6G202,Q6MEK7,Q6MVL2,Q6RZR1,Q6TUZ4,Q74ZF0,Q76RE7,Q775Z7,Q7M9N1,Q7MAX3,Q7MBE8,Q7MVT6,Q7NKL2,Q7VJU0,Q7VN49,Q7VRK0,Q7VVR1,Q7W8Z8,Q7WKE3,Q823Q9,Q82KK4,Q82UM1,Q83G43,Q83I22,Q83PN3,Q87F19,Q88BD3,Q88C95,Q895R1,Q89662,Q8A245,Q8D2F3,Q8E9M0,Q8F729,Q8FPH9,Q8G4E8,Q8K921,Q8NPA9,Q8P458,Q8PFR5,Q8PWG1,Q8RA46,Q8RER7,Q8SRS0,Q8TGX9,Q8TV34,Q8UII1,Q8V2Y0,Q8XWL1,Q8ZJP5,Q90030,Q92I74,Q92SM6,Q97J61,Q98C10,Q9A253,Q9CJ30,Q9F7S4,Q9HMF3,Q9HTN3,Q9J5G5,Q9JUW1,Q9JZU7,Q9P6Q5,Q9PGZ6,Q9PKA2,Q9X3X5,Q9YG32,Q9YYS0,Q9Z9C2,Q9ZDD2,Q9ZKY3">dUTPase</mark> ) <mark style="background-color:orange;">catalyses</mark> the hydrolysis of <mark style="background-color:lightblue;" id="65070">dUTP</mark> to dUMP and PPi thus controlling the incorporation of <mark style="background-color:lightblue;" id="1174">uracil</mark> into DNA genomes.
18608754-504	In the present study we perform a kinetic analysis of Campylobacter <mark style="background-color:lightgreen;" id="O25536,O27642,O29157,O30931,O41033,O48500,O52597,O54134,O66592,O68992,O83855,O84294,P03195,P03370,P06968,P09254,P0A552,P0A553,P10234,P14597,P16088,P16824,P16901,P17374,P19028,P23426,P23427,P28892,P28893,P30007,P31625,P31822,P32208,P32518,P33316,P33317,P33826,P35956,P43058,P43792,P52341,P52541,P57623,P57914,P59408,P61906,P61907,P61908,P61909,P61910,P61911,P61912,P61913,P64004,P64005,P64006,P64007,P64008,P64009,P68634,P68635,P70583,P87630,Q00030,Q01034,Q06095,Q07275,Q2Y742,Q2YRG4,Q31EC7,Q31UY6,Q329L7,Q39DM5,Q39V99,Q3A499,Q3AQ75,Q3B304,Q3BNA6,Q3J0B2,Q3J6W1,Q3JV72,Q3K4M6,Q3KM70,Q3SFR7,Q3SWM9,Q3YRU2,Q3YW02,Q45920,Q47BB1,Q47NK1,Q48Q06,Q491W8,Q49992,Q4FU67,Q4JVB1,Q4K3S2,Q4QLV3,Q4ULV2,Q4UPP2,Q4ZZX9,Q57BK5,Q57IA2,Q58502,Q5F9E0,Q5FN20,Q5GST1,Q5H5L9,Q5L6D8,Q5LIH9,Q5LWD3,Q5NHX4,Q5P7Z9,Q5PAE6,Q5PC28,Q5QZB6,Q5WTW6,Q5X242,Q5YT90,Q5ZSN0,Q603M1,Q62HL1,Q63WI6,Q64ZK3,Q65R66,Q66GD8,Q68WX8,Q69151,Q6A8W1,Q6AFE0,Q6AJZ0,Q6BRN7,Q6C141,Q6CQN7,Q6DAV9,Q6E4Q0,Q6FDR0,Q6FKQ6,Q6FYR2,Q6G202,Q6MEK7,Q6MVL2,Q6RZR1,Q6TUZ4,Q74ZF0,Q76RE7,Q775Z7,Q7M9N1,Q7MAX3,Q7MBE8,Q7MVT6,Q7NKL2,Q7VJU0,Q7VN49,Q7VRK0,Q7VVR1,Q7W8Z8,Q7WKE3,Q823Q9,Q82KK4,Q82UM1,Q83G43,Q83I22,Q83PN3,Q87F19,Q88BD3,Q88C95,Q895R1,Q89662,Q8A245,Q8D2F3,Q8E9M0,Q8F729,Q8FPH9,Q8G4E8,Q8K921,Q8NPA9,Q8P458,Q8PFR5,Q8PWG1,Q8RA46,Q8RER7,Q8SRS0,Q8TGX9,Q8TV34,Q8UII1,Q8V2Y0,Q8XWL1,Q8ZJP5,Q90030,Q92I74,Q92SM6,Q97J61,Q98C10,Q9A253,Q9CJ30,Q9F7S4,Q9HMF3,Q9HTN3,Q9J5G5,Q9JUW1,Q9JZU7,Q9P6Q5,Q9PGZ6,Q9PKA2,Q9X3X5,Q9YG32,Q9YYS0,Q9Z9C2,Q9ZDD2,Q9ZKY3">dUTPase</mark> <mark style="background-color:orange;">using</mark> the continuous spectrophotometric method and show that the enzyme is highly specific for <mark style="background-color:lightblue;" id="13712">deoxyuridine</mark> nucleotides.
18608755-505	<mark style="background-color:lightgreen;" id="O07674,O30971,P0A853,P0A854,P21643,P28796,P48775,P48776,Q09474,Q2KIQ5,Q59342,Q5EBG2,Q5U4U6,Q7MCR1,Q7N8C9,Q7NYV9,Q7SY53,Q87JQ6,Q894M8,Q8D5Q4,Q8FBV2,Q8R9K5,Q8XB34,Q9CL27,Q9KN05,Q9ZNA8">Tryptophanase</mark> (<mark style="background-color:lightblue;" id="1148,6305,9060,5460840">tryptophan</mark> <mark style="background-color:lightblue;" id="798">indole</mark>-lyase, Tnase, EC 4.1.99.1), a bacterial enzyme with no counterpart in eukaryotic cells, <mark style="background-color:orange;">produces</mark> from <mark style="background-color:lightblue;" id="4802,6305,5460850">L-tryptophan</mark> <mark style="background-color:lightblue;" id="1060">pyruvate</mark>, <mark style="background-color:lightblue;" id="222">ammonia</mark> and <mark style="background-color:lightblue;" id="798">indole</mark>.
18563708-512	<mark style="background-color:lightblue;" id="145068">Nitric oxide</mark> (NO), which is <mark style="background-color:orange;">produced</mark> by <mark style="background-color:lightgreen;" id="O61309,O61608,Q27571,Q9I9M2">nitric oxide synthase</mark> ( <mark style="background-color:lightgreen;" id="O54705,O61309,O61608,Q26240,Q28969,Q9I9M2">NOS</mark> ), may play a role in the <mark style="background-color:yellow;" id="GO:0007275,biological_process">development</mark> of <mark style="background-color:lightgreen;" id="P51689">ASD</mark> .
18608765-513	Activity assays with <mark style="background-color:lightgreen;" id="P12614,P15885,P27034,P29091,P40740,Q03506,Q46684">beta-glucosidase</mark> <mark style="background-color:orange;">indicated</mark> that <mark style="background-color:lightblue;" id="5858639">compound 3</mark> was much more stable than the corresponding pentasaccharide.
18608766-514	<mark style="background-color:lightgreen;" id="O00084,O13465,P07374,P08298,Q5KCQ6,Q6A3P9">Urease</mark> allows soil microorganisms to <mark style="background-color:orange;">use</mark> <mark style="background-color:lightblue;" id="1176,265993">urea</mark> as a source of <mark style="background-color:lightblue;" id="947,123329">nitrogen</mark> and aid in the rapid break down of <mark style="background-color:lightblue;" id="1176,265993">urea</mark>-based fertilizers resulting in phytopathicity.
18636565-515	Mutations in <mark style="background-color:lightgreen;" id="P36021">MCT8</mark> are <mark style="background-color:orange;">associated</mark> with severe psychomotor retardation, high serum T3 and low <mark style="background-color:lightblue;" id="5920,644280">3,3',5'-triiodothyronine</mark> (<mark style="background-color:lightblue;" id="644280">rT3</mark>) levels.
18682988-518	Over-expression of <mark style="background-color:lightgreen;" id="O52310,O59650,O74024,O95479,P00366,P00367,P00368,P0AES2,P0AES3,P10860,P13443,P26443,P28270,P36234,P42174,P42206,P42238,P49448,P52596,P54385,P56201,P80319,P82264,P93541,P94598,P96110,Q09115,Q43260,Q47950,Q47951,Q53199,Q56304,Q59516,Q64HZ8,Q64HZ9,Q64I00,Q64I01,Q9HFR6,Q9HGU3,Q9HGU4,Q9RDE9,Q9URS1,Q9YC65">GDH</mark> <mark style="background-color:orange;">decreased</mark> the <mark style="background-color:orange;">yield</mark> of <mark style="background-color:lightblue;" id="702">ethanol</mark> and <mark style="background-color:lightblue;" id="262,225936">2,3-butanediol</mark>, meanwhile it <mark style="background-color:orange;">increased</mark> the concentration of <mark style="background-color:lightblue;" id="176,286,291512">acetic acid</mark>.
18586252-521	High <mark style="background-color:lightblue;" id="206,5793,64689,79025">glucose</mark> and <mark style="background-color:lightgreen;" id="Q9TTB0">interferon gamma</mark> synergistically <mark style="background-color:orange;">stimulate</mark> <mark style="background-color:lightgreen;" id="P03956,P13943,P21692,P28053,P81563,Q11133,Q9XSZ5">MMP-1</mark> expression in U937 macrophages by <mark style="background-color:orange;">increasing</mark> <mark style="background-color:yellow;" id="GO:0006350,biological_process">transcription</mark> factor <mark style="background-color:lightgreen;" id="P42224,Q764M5">STAT1</mark> activity.
18586252-523	Results showed that high <mark style="background-color:lightblue;" id="206,5793,64689,79025">glucose</mark> and <mark style="background-color:lightgreen;" id="O35497,O35735,O57571,O57603,O57608,O73915,O77763,P01579,P01580,P01581,P07353,P17773,P17803,P28333,P28341,P30123,P42160,P42161,P42162,P46402,P49708,P63309,P63310,P63311,P79154,Q1WM28,Q25BC0,Q2PE75,Q4ZH68,Q5CCK0,Q5I6S9,Q62574,Q647G2,Q7TSP4,Q865W6,Q865X1,Q865Y4,Q866Y6,Q8MKF5,Q8SPW9,Q9QXX2,Q9TTB0,Q9TV67,Q9YGB9">IFN gamma</mark> had a synergistic <mark style="background-color:orange;">effect</mark> on the expression of <mark style="background-color:lightgreen;" id="P03956,P13943,P21692,P28053,P81563,Q11133,Q9XSZ5">MMP-1</mark> , <mark style="background-color:lightgreen;" id="O18733,P14780,P41245,P41246,P50282,P52176">MMP-9</mark> and <mark style="background-color:lightgreen;" id="P01584,P09428,P10749,P14628,P21621,P26889,P41687,P46648,P48090,P51493,P51745,P79162,P79182,Q28292,Q28386,Q2HZH0,Q2MH07,Q63264,Q6PUD2,Q6R2X3,Q865X8,Q8WNR2,Q9WVG1,Q9XS77">IL-1 beta</mark> .
18586252-525	Furthermore, high <mark style="background-color:lightblue;" id="206,5793,64689,79025">glucose</mark> and <mark style="background-color:lightgreen;" id="O35497,O35735,O57571,O57603,O57608,O73915,O77763,P01579,P01580,P01581,P07353,P17773,P17803,P28333,P28341,P30123,P42160,P42161,P42162,P46402,P49708,P63309,P63310,P63311,P79154,Q1WM28,Q25BC0,Q2PE75,Q4ZH68,Q5CCK0,Q5I6S9,Q62574,Q647G2,Q7TSP4,Q865W6,Q865X1,Q865Y4,Q866Y6,Q8MKF5,Q8SPW9,Q9QXX2,Q9TTB0,Q9TV67,Q9YGB9">IFN gamma</mark> exert the synergistic <mark style="background-color:orange;">effect</mark> on <mark style="background-color:lightgreen;" id="P03956,P13943,P21692,P28053,P81563,Q11133,Q9XSZ5">MMP-1</mark> expression by <mark style="background-color:orange;">enhancing</mark> <mark style="background-color:lightgreen;" id="P42224,Q764M5">STAT1</mark>  <mark style="background-color:yellow;" id="GO:0016310,biological_process">phosphorylation</mark> and <mark style="background-color:lightgreen;" id="P42224,Q764M5">STAT1</mark> transcriptional activity.
18608782-527	<mark style="background-color:lightgreen;" id="O83085,P00813,P03958,P22333,P53909,P53984,P56658,P63907,P63908,P63909,P63910,Q2TZN9,Q4IMJ1,Q4X1Q4,Q59ZB1,Q5ZKP6,Q63ZU0,Q6CM42,Q6DG22,Q6FP78,Q6GP70,Q7M9R5,Q7MDL6,Q7N4H5,Q7VNV1,Q7WBG5,Q7WMY6,Q839J4,Q83RC0,Q889J2,Q88QA3,Q8D6Q8,Q8DTN8,Q8E8D4,Q8FH99,Q8UJ05,Q8X1T6,Q8X661,Q8XHH8,Q8XXL5,Q8Z6R2,Q8ZPL9,Q920P6,Q92T48,Q97EV1,Q98GV2,Q9A3M3,Q9CCL9,Q9CIR9,Q9I6Y4,Q9KNI7,Q9P6I7">Adenosine deaminase</mark> ( <mark style="background-color:lightgreen;" id="P00813,P56658,Q5ZKP6">ADA</mark> ), an enzyme involved in <mark style="background-color:lightblue;" id="1044">purine</mark> metabolism, <mark style="background-color:orange;">catalyzes</mark> the hydrolytic breakdown of <mark style="background-color:lightblue;" id="60961">adenosine</mark> into <mark style="background-color:lightblue;" id="6021">inosine</mark> and free <mark style="background-color:lightblue;" id="222">ammonia</mark>.
18700057-534	The effects of <mark style="background-color:lightgreen;" id="P0A3L5,P0A3L6,P15653,P25018,P46376,Q04590,Q47851,Q80UN9">Ipt</mark> were <mark style="background-color:orange;">reversed</mark> by the mitochondrial <mark style="background-color:lightblue;" id="5957">KATP</mark> blocker, <mark style="background-color:lightblue;" id="1825">5-hydroxydecanoate</mark>, indicating that mitochondrial <mark style="background-color:lightblue;" id="5957">KATP</mark> channels participate in the regulation of <mark style="background-color:yellow;" id="GO:0048143,biological_process">astrocyte activation</mark> .
18592408-535	Natural <mark style="background-color:lightblue;" id="167551">anacardic acid</mark> was enzymatically <mark style="background-color:orange;">polymerized</mark> <mark style="background-color:orange;">using</mark> soybean <mark style="background-color:lightgreen;" id="P15984,P16147,P84714">peroxidase</mark> .
18616988-540	Microelectrode array recordings revealed that <mark style="background-color:lightblue;" id="977">oxygen</mark>-<mark style="background-color:lightblue;" id="206,5793,64689,79025">glucose</mark> deprivation <mark style="background-color:orange;">enhances</mark> hippocampal network firing rates, which <mark style="background-color:orange;">induces</mark> c- <mark style="background-color:lightgreen;" id="P01101,P12841,Q56415">fos</mark>  <mark style="background-color:yellow;" id="GO:0006350,biological_process">transcription</mark> through a signaling pathway that, in contrast to Clca1, is activated by synaptic but not extrasynaptic <mark style="background-color:yellow;" id="GO:0004972,molecular_function">NMDA receptors</mark> .
18592416-542	Vesicle mobilization requires <mark style="background-color:lightblue;" id="271">Ca(2</mark>+)-induced <mark style="background-color:lightgreen;" id="P00920,P27139">Ca2</mark> + <mark style="background-color:orange;">release</mark> by presynaptic <mark style="background-color:yellow;" id="GO:0005783,cellular_component">endoplasmic reticulum</mark> ( <mark style="background-color:yellow;" id="GO:0005783,cellular_component">ER</mark> ) <mark style="background-color:lightblue;" id="5114,27439,441753,6326656,11317883">ryanodine</mark> receptors ( <mark style="background-color:lightgreen;" id="Q24498">RyRs</mark> ) that in turn <mark style="background-color:orange;">stimulates</mark> <mark style="background-color:lightgreen;" id="P00920,P27139">Ca2</mark> +/ <mark style="background-color:lightgreen;" id="O02367,O16305,O60041,O82018,O94739,O96102,O97341,P02594,P02595,P02598,P02599,P04352,P04353,P04464,P05933,P05934,P05935,P06787,P07463,P11118,P11120,P11121,P15094,P17928,P18061,P21251,P23286,P24044,P27161,P27165,P27166,P41040,P41041,P48976,P60204,P60205,P60206,P61859,P61860,P61861,P62144,P62145,P62149,P62151,P62152,P62154,P62155,P62156,P62157,P62158,P62160,P62161,P62162,P62184,P62201,P62202,P62203,P62204,P69097,P69098,P84339,P93087,P93171,Q05055,Q39752,Q40302,Q5EHV7,Q5RAD2,Q6IT78,Q6PI52,Q6R520,Q6YNX6,Q71UH5,Q71UH6,Q7T3T2,Q7Y052,Q8STF0,Q8X187,Q95NI4,Q95NR9,Q9GRJ1,Q9HFY6,Q9U6D3,Q9UWF0">calmodulin</mark> -dependent kinase II (CamKII).
18621093-545	Recent findings indicate that the <mark style="background-color:yellow;" id="GO:0008187,molecular_function">polypyrimidine tract-binding</mark> protein ( <mark style="background-color:lightgreen;" id="P17225,P26599,Q00438,Q29099,Q8WN55,Q9MAC5,Q9UKA9">PTB</mark> ), also named <mark style="background-color:lightgreen;" id="P17225,P26599,Q00438,Q29099">hnRNP I</mark> , by <mark style="background-color:yellow;" id="GO:0005488,molecular_function">binding</mark> to the 3'-UTR (untranslated region) of the preproinsulin mRNA molecule, <mark style="background-color:orange;">stabilizes</mark> the messenger, thereby participating in the <mark style="background-color:lightblue;" id="206,5793,64689,79025">glucose</mark>-induced increase in preproinsulin mRNA.
18571954-554	<mark style="background-color:lightblue;" id="311">Citric acid</mark> perfusion marginally <mark style="background-color:orange;">increased</mark> <mark style="background-color:lightgreen;" id="P21617,P34129,Q6YBR5,Q90W38">NGF</mark> levels to 7.3 fg/microg/ml on average in the upper arm and control axilla.
18571954-555	In contrast, perfusion of the inflamed axilla with <mark style="background-color:lightblue;" id="311">citric acid</mark> significantly <mark style="background-color:orange;">enhanced</mark> the <mark style="background-color:orange;">release</mark> of both <mark style="background-color:lightgreen;" id="P21617,P34129,Q6YBR5,Q90W38">NGF</mark> and <mark style="background-color:lightgreen;" id="O18752,O18753,O18755,O70183,O97759,P14082,P21237,P23363,P23560,P25429,P25430,P25431,P25432,Q02193,Q06225,Q3SAT7,Q4L0Y3,Q5IS78,Q6LCI5,Q7YRB4,Q90322,Q95106,Q9TST3">BDNF</mark> .
18688696-558	We here show that calumenin in the presence of <mark style="background-color:lightblue;" id="271">Ca(2</mark>+) <mark style="background-color:orange;">binds</mark> to <mark style="background-color:lightgreen;" id="P07996,P54000,Q28178">TSP1</mark> with a dissociation constant K (d) around 0.4 muM.
18694845-560	E(2) increased the expression of <mark style="background-color:lightgreen;" id="P33724,P35431,P41350,P49817,P79132,Q03135,Q07DV9,Q07DX1,Q07DY2,Q07DZ2,Q07E02,Q07E25,Q07E38,Q07E49,Q09YH8,Q09YK1,Q09YN6,Q108U7,Q2IBA5,Q2IBC1,Q2IBD7,Q2IBF0,Q2IBG8,Q2QL79,Q2QL90,Q2QLB0,Q2QLC1,Q2QLF2,Q2QLG6,Q2QLH7,Q6B3Y2,Q6RVA9,Q94051,Q9YGM8">caveolin-1</mark> and <mark style="background-color:lightgreen;" id="O46550,P51636,Q07DW0,Q07DX2,Q07DZ3,Q07E26,Q07E39,Q07E50,Q09YH9,Q09YJ1,Q09YK2,Q09YL4,Q09YN7,Q108U8,Q18879,Q2IBA4,Q2IBC2,Q2IBD6,Q2IBF3,Q2IBG9,Q2QL80,Q2QL91,Q2QLB1,Q2QLC2,Q2QLD3,Q2QLE2,Q2QLF3,Q2QLG7,Q2QLH8,Q66WT7,Q9WVC3,Q9YGM9">caveolin-2</mark> mRNA and proteins, but pre-treatment with <mark style="background-color:lightblue;" id="104741">ICI 182,780</mark> [an <mark style="background-color:lightgreen;" id="O42132,P03372,P06211,P06212,P16058,P19785,P49884,P49885,P49886,P50240,P50241,P50242,P57717,P57753,P81559,Q29040,Q53AD2,Q91250,Q91424,Q9PVZ9,Q9QZJ5,Q9TV98,Q9YH33,Q9YHT3,Q9YHZ7">estrogen receptor</mark> ( <mark style="background-color:yellow;" id="GO:0005783,cellular_component">ER</mark> ) antagonist] inhibited E(2)-induced <mark style="background-color:orange;">increase</mark> in <mark style="background-color:lightgreen;" id="P33724,P35431,P41350,P49817,P79132,Q03135,Q07DV9,Q07DX1,Q07DY2,Q07DZ2,Q07E02,Q07E25,Q07E38,Q07E49,Q09YH8,Q09YK1,Q09YN6,Q108U7,Q2IBA5,Q2IBC1,Q2IBD7,Q2IBF0,Q2IBG8,Q2QL79,Q2QL90,Q2QLB0,Q2QLC1,Q2QLF2,Q2QLG6,Q2QLH7,Q6B3Y2,Q6RVA9,Q94051,Q9YGM8">caveolin-1</mark> and <mark style="background-color:lightgreen;" id="O46550,P51636,Q07DW0,Q07DX2,Q07DZ3,Q07E26,Q07E39,Q07E50,Q09YH9,Q09YJ1,Q09YK2,Q09YL4,Q09YN7,Q108U8,Q18879,Q2IBA4,Q2IBC2,Q2IBD6,Q2IBF3,Q2IBG9,Q2QL80,Q2QL91,Q2QLB1,Q2QLC2,Q2QLD3,Q2QLE2,Q2QLF3,Q2QLG7,Q2QLH8,Q66WT7,Q9WVC3,Q9YGM9">caveolin-2</mark> proteins expression.
18694845-561	Phospho- <mark style="background-color:lightgreen;" id="P33724,P35431,P41350,P49817,P79132,Q03135,Q07DV9,Q07DX1,Q07DY2,Q07DZ2,Q07E02,Q07E25,Q07E38,Q07E49,Q09YH8,Q09YK1,Q09YN6,Q108U7,Q2IBA5,Q2IBC1,Q2IBD7,Q2IBF0,Q2IBG8,Q2QL79,Q2QL90,Q2QLB0,Q2QLC1,Q2QLF2,Q2QLG6,Q2QLH7,Q6B3Y2,Q6RVA9,Q94051,Q9YGM8">caveolin-1</mark> was significantly <mark style="background-color:orange;">blocked</mark> by <mark style="background-color:lightblue;" id="104741">ICI 182,780</mark> or <mark style="background-color:lightblue;" id="15077741,21083976">pyrazolopyrimidine</mark> 2 ( <mark style="background-color:lightgreen;" id="P80073,Q61212">PP2</mark> ; a <mark style="background-color:lightgreen;" id="P05480,Q9WUD9">Src</mark> -kinase inhibitor).
18694845-562	<mark style="background-color:lightblue;" id="3973">LY 294002</mark> (a <mark style="background-color:lightgreen;" id="O00329,O02697,O35904,P23727,P26450,P27986,P32871,P42336,P42337,P42338,P42347,P42348,P48736,P54673,P54674,P54675,P54676,Q63787,Q8BTI9,Q8UUU2,Q9JHG7,Q9Z1L0">PI3K</mark> inhibitor) or <mark style="background-color:lightblue;" id="4713">PD 98059</mark> (an <mark style="background-color:lightgreen;" id="P27361,P28869,P42525,Q07176">ERK1</mark> /2 inhibitor) <mark style="background-color:orange;">prevented</mark> E(2)-induced <mark style="background-color:orange;">increase</mark> in <mark style="background-color:lightgreen;" id="P33724,P35431,P41350,P49817,P79132,Q03135,Q07DV9,Q07DX1,Q07DY2,Q07DZ2,Q07E02,Q07E25,Q07E38,Q07E49,Q09YH8,Q09YK1,Q09YN6,Q108U7,Q2IBA5,Q2IBC1,Q2IBD7,Q2IBF0,Q2IBG8,Q2QL79,Q2QL90,Q2QLB0,Q2QLC1,Q2QLF2,Q2QLG6,Q2QLH7,Q6B3Y2,Q6RVA9,Q94051,Q9YGM8">caveolin-1</mark> expression and the accompanying [(3)H]-<mark style="background-color:lightblue;" id="5789">thymidine</mark> incorporation.
18651838-564	<mark style="background-color:lightgreen;" id="O46540,P01160,P01161,P05125,P07499,P07500,P07501,P09196,P18144,P18908,P18909,P24259,P27104,P27596,P83964,Q805D8,Q805E9,Q9GLD0">ANP</mark> ( <mark style="background-color:lightgreen;" id="O46540,P01160,P01161,P05125,P07499,P07500,P07501,P09196,P18144,P18908,P18909,P24259,P27104,P27596,P83964,Q805D8,Q805E9,Q9GLD0">atrial natriuretic peptide</mark> ) exerts its biological <mark style="background-color:orange;">effects</mark> by <mark style="background-color:yellow;" id="GO:0005488,molecular_function">binding</mark> to GC (<mark style="background-color:lightblue;" id="6804">guanylate</mark> <mark style="background-color:lightgreen;" id="O94303,P33734,Q9P4P9,Q9SZ30">cyclase</mark> )-A/ <mark style="background-color:lightgreen;" id="P20910,Q41249">NPR</mark> ( <mark style="background-color:lightgreen;" id="P28374">natriuretic peptide</mark> receptor)-A, which <mark style="background-color:orange;">generates</mark> the second messenger <mark style="background-color:lightblue;" id="24316">cGMP</mark>.
18651838-565	Overexpression of <mark style="background-color:lightgreen;" id="P27577,P41156">Ets-1</mark> <mark style="background-color:orange;">enhanced</mark> significantly <mark style="background-color:lightgreen;" id="P18293,P18910">Npr1</mark> mRNA levels, protein expression, GC activity and <mark style="background-color:lightgreen;" id="O46540,P01160,P01161,P05125,P07499,P07500,P07501,P09196,P18144,P18908,P18909,P24259,P27104,P27596,P83964,Q805D8,Q805E9,Q9GLD0">ANP</mark> -stimulated <mark style="background-color:yellow;" id="GO:0005622,cellular_component">intracellular</mark> accumulation of <mark style="background-color:lightblue;" id="24316">cGMP</mark> in transfected cells.
18602691-569	<mark style="background-color:lightgreen;" id="P04279">SEMG</mark> I expression is <mark style="background-color:orange;">upregulated</mark> by <mark style="background-color:lightgreen;" id="O77762,P05112,P07750,P20096,P30367,P30368,P42202,P46652,P47966,P51492,P51744,P55030,P79155,P79339,Q04745,Q2PE74,Q3S4V6,Q58M18,Q60440,Q7YS71,Q865X5,Q865Y0,Q8HYB1,Q9MZR8,Q9XS58">IL-4</mark> , <mark style="background-color:lightgreen;" id="O35736,P05231,P08505,P20607,P26892,P26893,P29455,P41323,P41683,P41693,P46650,P51494,P79341,Q25BC2,Q28319,Q28747,Q28819,Q2MH06,Q5I6E3,Q6V919,Q865W7,Q865X6,Q8MKH0,Q95181,Q9MZR1,Q9XT80">IL-6</mark> and <mark style="background-color:lightblue;" id="9444">5-azacytidine</mark>.
18692155-571	<mark style="background-color:lightblue;" id="10635">DHT</mark> and <mark style="background-color:lightgreen;" id="P01132,P01133,P07522,P26224,Q00968,Q95ND4,Q9BEA0">EGF</mark> <mark style="background-color:orange;">up-regulated</mark> cyclinD1 ( <mark style="background-color:lightgreen;" id="P23043">CD1</mark> ) at both mRNA and protein levels in A549 cells, while in LNCaP cells each mitogen increased only <mark style="background-color:lightgreen;" id="P23043">CD1</mark> protein expression.
18574025-577	Genetic variants of <mark style="background-color:lightgreen;" id="P11712">cytochrome P450 2C9</mark> ( <mark style="background-color:lightgreen;" id="P11712">CYP2C9</mark> ) and <mark style="background-color:lightblue;" id="5280845">vitamin K epoxide</mark> reductase ( <mark style="background-color:lightgreen;" id="Q6B4J2,Q9BQB6">VKORC1</mark> ) are known to <mark style="background-color:orange;">influence</mark> <mark style="background-color:lightblue;" id="54678486">warfarin</mark> dose, but the effect of other genes has not been fully elucidated.
18574025-578	In conclusion, <mark style="background-color:lightgreen;" id="P11712">CYP2C9</mark> and <mark style="background-color:lightgreen;" id="Q6B4J2,Q9BQB6">VKORC1</mark> significantly <mark style="background-color:orange;">influenced</mark> <mark style="background-color:lightblue;" id="54678486">warfarin</mark> dose and predicted individuals predisposed to unstable anticoagulation.
18668243-580	Role of <mark style="background-color:lightgreen;" id="Q05823,Q05921">RNase L</mark> in <mark style="background-color:yellow;" id="GO:0006915,biological_process">apoptosis</mark> <mark style="background-color:orange;">induced</mark> by <mark style="background-color:lightblue;" id="56841052">1-(3-C-ethynyl-beta-D-ribo-pentofuranosyl)cytosine</mark>.
18672341-581	Hepatocytes exposed to resistin, but only in the presence of <mark style="background-color:lightgreen;" id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">insulin</mark> , show a <mark style="background-color:orange;">decrease</mark> in <mark style="background-color:lightgreen;" id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">insulin</mark> -stimulated <mark style="background-color:lightblue;" id="439177">glycogen</mark> content.
18612687-586	However, <mark style="background-color:lightblue;" id="23976">CR</mark>-ME had a little <mark style="background-color:orange;">effect</mark> on the <mark style="background-color:orange;">levels</mark> of reactive <mark style="background-color:lightblue;" id="977">oxygen</mark> species, interleukin-1 and <mark style="background-color:lightgreen;" id="O35497,O35735,O57571,O57603,O57608,O73915,O77763,P01579,P01580,P01581,P07353,P17773,P17803,P28333,P28341,P30123,P42160,P42161,P42162,P46402,P49708,P63309,P63310,P63311,P79154,Q1WM28,Q25BC0,Q2PE75,Q4ZH68,Q5CCK0,Q5I6S9,Q62574,Q647G2,Q7TSP4,Q865W6,Q865X1,Q865Y4,Q866Y6,Q8MKF5,Q8SPW9,Q9QXX2,Q9TTB0,Q9TV67,Q9YGB9">IFN-gamma</mark> in <mark style="background-color:lightblue;" id="23976">CR</mark>-ME-treated macrophages.
18612687-587	Thus, the tumoricidal effect of <mark style="background-color:lightblue;" id="23976">CR</mark>-ME appeared to be mainly <mark style="background-color:orange;">mediated</mark> by NO and <mark style="background-color:lightgreen;" id="O35734,O77510,O77764,P01375,P04924,P06804,P13296,P16599,P19101,P23383,P23563,P29553,P33620,P36939,P48094,P51435,P51742,P51743,P59684,P59693,P59694,P59695,P79337,P79374,Q06599,Q19LH4,Q1G1A2,Q1WM27,Q2MH05,Q539C2,Q75N23,Q8HZD9,Q8JFG3,Q8MKG8,Q8WNR1,Q9BEA1">TNF-alpha</mark> production from macrophages.
18612687-589	These results suggest that <mark style="background-color:lightblue;" id="23976">CR</mark>-ME <mark style="background-color:orange;">induces</mark> the tumoricidal activity via the <mark style="background-color:lightgreen;" id="O62618">p38 MAPK</mark> -dependent pathway.
18584284-591	<mark style="background-color:lightgreen;" id="P08587,P21980,P21981,P51176,P52181,Q01841">Transglutaminase 2</mark> (TG2) is an inducible transamidating <mark style="background-color:lightgreen;" id="P05521,P19197,P21309,P23148,P41302,Q06878,Q7N576,Q9AJA7,Q9S3Z2">acyltransferase</mark> that <mark style="background-color:orange;">catalyzes</mark> <mark style="background-color:lightblue;" id="271">Ca(2</mark>+)-dependent <mark style="background-color:yellow;" id="GO:0006464,biological_process">protein modifications</mark> .
18584285-592	<mark style="background-color:lightgreen;" id="P40746,P52183,P81453,Q819L3,Q81MS1,Q8GR90,Q9K5W7">Transglutaminases</mark> <mark style="background-color:orange;">catalyze</mark> a calcium-dependent transamidation reaction that <mark style="background-color:orange;">produces</mark> covalent cross-linking of available substrate <mark style="background-color:lightblue;" id="738,5961">glutamine</mark> residues and modifies the <mark style="background-color:yellow;" id="GO:0005578,GO:0048196,cellular_component">extracellular matrix</mark> .
18615011-598	<mark style="background-color:lightgreen;" id="P30531,P36148,P43574">GAT1</mark> blockade resulted in significant <mark style="background-color:orange;">increases</mark> in mean (+/- SD) [(11)C]<mark style="background-color:lightblue;" id="3373">flumazenil</mark>- <mark style="background-color:yellow;" id="GO:0005488,molecular_function">binding</mark> potential (BP(ND)) over baseline in brain regions representing the major functional domains of the cerebral cortex: association cortex +15.2+/-20.2% (p=0.05), sensory cortex +13.5+/-15.5% (p=0.03) and limbic (medial temporal lobe, MTL) +16.4+/-20.2% (p=0.03).
18704103-600	Here, we found that the addition of glucocorticoids, such as <mark style="background-color:lightblue;" id="5743">dexamethasone</mark> and <mark style="background-color:lightblue;" id="5754">cortisol</mark>, to cultured human keratinocytes <mark style="background-color:orange;">increased</mark> their <mark style="background-color:lightgreen;" id="O60603,Q2V897,Q689D1,Q95LA9,Q95M53,Q9R1F8">TLR2</mark> gene expression.
18704103-601	Gene expression of <mark style="background-color:lightgreen;" id="Q00859">mitogen-activated protein kinase</mark> ( <mark style="background-color:lightgreen;" id="O42781,P27638,Q00859">MAPK</mark> ) <mark style="background-color:lightgreen;" id="P06961,P45269,Q57JQ5,Q5E2K7,Q5F8K9,Q5P3T0,Q5PC82,Q5WT58,Q5X1E5,Q5ZRX9,Q60CQ4,Q62EU1,Q63YC3,Q65Q41,Q665U9,Q6D160,Q6FA38,Q6LV05,Q7M7K5,Q7MAZ9,Q7MBF4,Q821A6,Q82U82,Q87DS9,Q87SK9,Q88A53,Q88QU2,Q8CWL6,Q8CXX6,Q8P5D4,Q8PPG9,Q8XBL4,Q8Y395,Q8Z3M9,Q8ZI64,Q8ZLY4,Q9CP21,Q9I5V3,Q9JUB2,Q9JZ88,Q9KPC6,Q9L7A3,Q9PDL7">phosphatase</mark> -1 was also <mark style="background-color:orange;">increased</mark> by the addition of <mark style="background-color:lightblue;" id="5743">dexamethasone</mark>.
18623211-610	The purpose of this study was to investigate the solid-state properties of lyophilized formulations of protein ( <mark style="background-color:lightgreen;" id="P27043">ribonuclease A</mark> ) <mark style="background-color:orange;">containing</mark> <mark style="background-color:lightblue;" id="5988">sucrose</mark> or <mark style="background-color:lightblue;" id="7427">trehalose</mark> across a wide range of compositions, both in the presence or absence of hydroxyethylstarch (HES).
18642386-611	<mark style="background-color:lightblue;" id="97663">SD4</mark> in anionic <mark style="background-color:lightgreen;" id="Q01129">DSPG</mark> liposomes <mark style="background-color:orange;">stimulated</mark> murine <mark style="background-color:lightgreen;" id="O35736,P05231,P08505,P20607,P26892,P26893,P29455,P41323,P41683,P41693,P46650,P51494,P79341,Q25BC2,Q28319,Q28747,Q28819,Q2MH06,Q5I6E3,Q6V919,Q865W7,Q865X6,Q8MKH0,Q95181,Q9MZR1,Q9XT80">IL-6</mark> production in RAW 264 cells at concentrations 25- to 30-fold lower than free drug.
18692849-615	An increased activity of <mark style="background-color:yellow;" id="GO:0005524,molecular_function">ATP-binding</mark> cassette transporter A1 ( <mark style="background-color:lightgreen;" id="O95477">ABCA1</mark> ) and <mark style="background-color:lightgreen;" id="Q9H222">ABCG5</mark> /G8 heterodimer has been proposed as a mechanism underlying the hypocholesterolaemic <mark style="background-color:orange;">effect</mark> of <mark style="background-color:lightblue;" id="12303662">phytosterols</mark>.
18679593-620	With covalent method, <mark style="background-color:lightblue;" id="3485">glutaraldehyde</mark> was introduced to <mark style="background-color:orange;">immobilize</mark> <mark style="background-color:lightgreen;" id="O33843,P06835,P07337,P10482,P12614,P14002,P15885,P16084,P22073,P22505,P22506,P22507,P26208,P27034,P29090,P29091,P33363,P38645,P40740,P42403,P48825,P49235,Q03506,Q08638,Q46684,Q56078">cellobiase</mark> .
18703100-623	Using a set of experiments aimed at manipulate a putative <mark style="background-color:lightblue;" id="33032">l-glutamate</mark>/<mark style="background-color:lightblue;" id="22880">NMDA</mark>/NO signal <mark style="background-color:yellow;" id="GO:0009293,biological_process">transduction</mark> pathway, we have demonstrated, by quantitative real-time <mark style="background-color:lightgreen;" id="O66148,O80333,P15904,Q01289,Q39617,Q41249,Q59987,Q9SDT1">PCR</mark> , that <mark style="background-color:lightblue;" id="22880">NMDA</mark> <mark style="background-color:orange;">enhances</mark> the expression of <mark style="background-color:lightgreen;" id="P27429">GnRH</mark> mRNA in a dose-response manner.
18584320-630	<mark style="background-color:lightblue;" id="5994">Progesterone</mark> <mark style="background-color:orange;">effects</mark> on neuronal ultrastructure and expression of <mark style="background-color:lightgreen;" id="P11137,P15146,P20357">microtubule-associated protein 2</mark> ( <mark style="background-color:lightgreen;" id="P11137,P38174,Q5Z859,Q6XMH6,Q6XMH7,Q8SR45">MAP2</mark> ) in rats with acute spinal cord injury.
18584320-631	(4) Our data indicated that <mark style="background-color:lightblue;" id="5994">progesterone</mark> <mark style="background-color:orange;">maintained</mark> in part neuronal ultrastructure, attenuated chromatolysis, and preclude the loss of <mark style="background-color:lightgreen;" id="P11137,P38174,Q5Z859,Q6XMH6,Q6XMH7,Q8SR45">MAP2</mark> , suggesting a protective effect during the early phases of spinal cord injury.
18619522-636	In rats, infusion of <mark style="background-color:lightgreen;" id="P01015,P01016,P01017,P01019,P11859,P20757,P67885,P67886,Q9GLN8,Q9GLP6,Q9TSZ0">angiotensin II</mark> <mark style="background-color:orange;">increases</mark> <mark style="background-color:lightgreen;" id="Q26061">ferritin</mark> <mark style="background-color:orange;">levels</mark> and arterial thickness which are <mark style="background-color:orange;">reversed</mark> by treatment with the iron chelator <mark style="background-color:lightblue;" id="2973">deferoxamine</mark>.
18625298-639	We found that <mark style="background-color:lightblue;" id="3386">fluoxetine</mark> <mark style="background-color:orange;">restored</mark> <mark style="background-color:yellow;" id="GO:0042098,biological_process">T cell proliferation</mark> and interleukin-2, <mark style="background-color:lightgreen;" id="Q9TTB0">interferon-gamma</mark> and <mark style="background-color:lightgreen;" id="Q8JFG3">tumor necrosis factor</mark> -alpha production by compensatory mechanisms.
18675966-641	To compare expression of endometrial estrogen ( <mark style="background-color:yellow;" id="GO:0005783,cellular_component">ER</mark> ) and <mark style="background-color:lightblue;" id="5994">progesterone</mark> (PR) receptors, beta(3)-integrin subunit, leukemia inhibitory factor ( <mark style="background-color:lightgreen;" id="O62728,P09056,P15018,P17777,Q27956">LIF</mark> ), <mark style="background-color:lightgreen;" id="P41693">interleukin-6</mark> ( <mark style="background-color:lightgreen;" id="O35736,P05231,P08505,P20607,P26892,P26893,P29455,P41323,P41683,P41693,P46650,P51494,P79341,Q25BC2,Q28319,Q28747,Q28819,Q2MH06,Q5I6E3,Q6V919,Q865W7,Q865X6,Q8MKH0,Q95181,Q9MZR1,Q9XT80">IL-6</mark> ), and pinopodes in Indian women <mark style="background-color:orange;">using</mark> <mark style="background-color:lightblue;" id="35805,154413">ormeloxifene</mark> as a contraceptive with fertile and infertile subjects during the window of implantation.
18692896-648	In sum, <mark style="background-color:lightblue;" id="23978">copper</mark> exposure <mark style="background-color:orange;">lowered</mark> TOSC, a result that at least in part can be related to <mark style="background-color:orange;">lowering</mark> of antioxidant enzymes like <mark style="background-color:lightgreen;" id="O62839,O97492,P00432,P00485,P00486,P00487,P04040,P06135,P07641,P11504,P20074,P22782,P25309,P25819,P26825,P26826,P32796,P36882,P36883,P43155,P47934,P49417,P52826,P58777,P62577,P62578,P62579,P62580,P90682,Q00614,Q02736,Q03058,Q5RF10,Q64405,Q704S8,Q9M5L6,Q9PWF7">CAT</mark> .
18684712-650	<mark style="background-color:lightgreen;" id="Q9Y758">ALK2</mark> (R206H) with <mark style="background-color:lightgreen;" id="P70340,P97588,Q9I8V2">Smad1</mark> or <mark style="background-color:lightgreen;" id="P97454,Q99717,Q9R1V3,Q9W7E7">Smad5</mark> <mark style="background-color:orange;">induced</mark> osteoblastic differentiation that could be <mark style="background-color:orange;">inhibited</mark> by <mark style="background-color:lightgreen;" id="O15105,O35253,O88406">Smad7</mark> or <mark style="background-color:lightblue;" id="11524144">dorsomorphin</mark>.
18602794-652	<mark style="background-color:lightblue;" id="444732">Trichostatin A</mark> <mark style="background-color:orange;">down-regulates</mark> <mark style="background-color:lightgreen;" id="O46512,P11511,P19098,P46194,P70091,P79690,P79699,Q29605,Q29624,Q5QQX7,Q69FB6,Q6QHT9,Q6YI21,Q92087,Q92111,Q92112,Q95M61,Q9XS28">CYP19</mark> transcript and protein levels in MCF-7 breast cancer cells.
18658095-656	Previous studies have shown that wounding of human corneal epithelial cells (HCECs) results in the release of G-protein-coupled receptor ligands such as <mark style="background-color:lightblue;" id="5957">ATP</mark> and <mark style="background-color:lightblue;" id="3988,5311263,5497152">lysophosphatidic acid</mark> ( <mark style="background-color:lightgreen;" id="P08519,P14417">LPA</mark> ), which in turn <mark style="background-color:orange;">transactivate</mark> <mark style="background-color:lightgreen;" id="P01132,P01133,P07522,Q00968,Q95ND4,Q9BEA0">epidermal growth factor</mark> ( <mark style="background-color:lightgreen;" id="P01132,P01133,P07522,P26224,Q00968,Q95ND4,Q9BEA0">EGF</mark> ) receptor ( <mark style="background-color:lightgreen;" id="P00533,P13387,P55245">EGFR</mark> ) through ectodomain shedding of <mark style="background-color:yellow;" id="GO:0008201,molecular_function">heparin-binding</mark>  <mark style="background-color:lightgreen;" id="P01132,P01133,P07522,P26224,Q00968,Q95ND4,Q9BEA0">EGF</mark> -like growth factor ( <mark style="background-color:lightgreen;" id="Q01580,Q06175,Q06186,Q09118,Q99075">HB-EGF</mark> ).
18688816-657	It represents transition in <mark style="background-color:lightblue;" id="402">sulfur</mark>-deprived conditions, known to lead to H2 production in Chlamydomonas reinhardtii, and the two main <mark style="background-color:orange;">processes</mark> then <mark style="background-color:orange;">induced</mark> which are an over-accumulation of <mark style="background-color:yellow;" id="GO:0005622,cellular_component">intracellular</mark> starch and a progressive reduction of <mark style="background-color:lightgreen;" id="O47040,O78462,O96813,P12185,P12186,P12187,P13165,P17227,P17228,P28251,P30980,P48116,P49159,P49484,P51387,P52768,P56768,P58214,P69396,P69397,P69398,Q31909,Q5QA78,Q5SCW1,Q68RZ6,Q6B8K8,Q6ENG4,Q6ENV4,Q6EW69,Q6L390,Q6L603,Q6QBN9,Q70XZ3,Q7FNS8,Q7YJW3,Q85CI4,Q85FL2,Q85X26,Q8M9X5,Q8WI10,Q9BBS0,Q9GDV2,Q9MTL2,Q9MUQ4,Q9TL12,Q9TM24">PSII</mark> activity for anoxia achievement.
18680626-658	We hypothesised that <mark style="background-color:lightgreen;" id="P04181,Q07805,Q4XWV5,Q6LFH8,Q7RT90">OAT</mark> could be a <mark style="background-color:orange;">limiting</mark> step in <mark style="background-color:lightblue;" id="738,5961">glutamine</mark>-<mark style="background-color:lightblue;" id="232,4367,6322">arginine</mark> interconversion.
18680626-659	<mark style="background-color:lightgreen;" id="P04181,Q07805,Q4XWV5,Q6LFH8,Q7RT90">OAT</mark> overexpression <mark style="background-color:orange;">decreased</mark> plasma and liver <mark style="background-color:lightblue;" id="389,6262,71082">ornithine</mark> concentrations but did not <mark style="background-color:orange;">affect</mark> <mark style="background-color:lightblue;" id="738,5961">glutamine</mark> or <mark style="background-color:lightblue;" id="232,4367,6322">arginine</mark> <mark style="background-color:yellow;" id="GO:0042592,biological_process">homeostasis</mark> .
18680626-660	There was an inverse relationship between <mark style="background-color:lightblue;" id="389,6262,71082">ornithine</mark> <mark style="background-color:orange;">levels</mark> and <mark style="background-color:lightgreen;" id="P04181,Q07805,Q4XWV5,Q6LFH8,Q7RT90">OAT</mark> activity.
18602807-667	Consumption of the <mark style="background-color:lightblue;" id="104763">trichothecene</mark> mycotoxin <mark style="background-color:lightblue;" id="40024,430147,442408,6321385,6432495,49868109">deoxynivalenol</mark> (DON) <mark style="background-color:orange;">induces</mark> <mark style="background-color:lightgreen;" id="P41693">interleukin-6</mark> ( <mark style="background-color:lightgreen;" id="O35736,P05231,P08505,P20607,P26892,P26893,P29455,P41323,P41683,P41693,P46650,P51494,P79341,Q25BC2,Q28319,Q28747,Q28819,Q2MH06,Q5I6E3,Q6V919,Q865W7,Q865X6,Q8MKH0,Q95181,Q9MZR1,Q9XT80">IL-6</mark> )-dependent IgA nephropathy (IgAN) in mice.
18602807-668	The purpose of this study was to identify the signal <mark style="background-color:yellow;" id="GO:0009293,biological_process">transduction</mark> pathways by which DON up-regulates <mark style="background-color:lightgreen;" id="O35736,P05231,P08505,P20607,P26892,P26893,P29455,P41323,P41683,P41693,P46650,P51494,P79341,Q25BC2,Q28319,Q28747,Q28819,Q2MH06,Q5I6E3,Q6V919,Q865W7,Q865X6,Q8MKH0,Q95181,Q9MZR1,Q9XT80">IL-6</mark> in the peritoneal macrophage and how consumption of fish oil <mark style="background-color:orange;">enriched</mark> with the <mark style="background-color:lightgreen;" id="P25225">n-3</mark> PUFA <mark style="background-color:lightblue;" id="445580">docosahexaenoic acid</mark> (DHA) suppresses these processes.
18651191-669	Functional analysis demonstrated that elkj encoded a <mark style="background-color:lightgreen;" id="Q9SDN0">C20</mark> -elongase that <mark style="background-color:orange;">mediated</mark> the elongation of <mark style="background-color:lightgreen;" id="P01033,P12032">EPA</mark> into <mark style="background-color:lightblue;" id="3145,5497182,6441454">docosapentaenoic acid</mark> (22:5n-3), confirming the two-step conversion from <mark style="background-color:lightgreen;" id="P01033,P12032">EPA</mark> to DHA in marine microalga.
18602811-670	<mark style="background-color:lightblue;" id="5282349,53394606">gamma-Tocotrienol</mark> <mark style="background-color:orange;">induced</mark> activation of caspase-3 and <mark style="background-color:orange;">increased</mark> the cleavage of the downstream substrate poly( <mark style="background-color:lightgreen;" id="P02783">ADP</mark> -ribose) polymerase.
18602814-672	The aim of the present study was to determine the effects of <mark style="background-color:lightblue;" id="938">niacin</mark> and <mark style="background-color:lightblue;" id="23976">chromium</mark> on HDL formation by <mark style="background-color:orange;">investigating</mark> the <mark style="background-color:orange;">changes</mark> in <mark style="background-color:lightgreen;" id="O95477">ABCA1</mark> and ApoA-1 <mark style="background-color:yellow;" id="GO:0006350,biological_process">transcription</mark> in the human hepatoblastoma cell line (HepG2 cells).
18602814-674	<mark style="background-color:lightblue;" id="938">Niacin</mark> and <mark style="background-color:lightblue;" id="23976">chromium</mark> cotreatment significantly <mark style="background-color:orange;">induced</mark> the expression of <mark style="background-color:lightgreen;" id="O35507,P23204,P37230,P37232,Q07869,Q8HYL6,Q95N78">peroxisome proliferator-activated receptor-alpha</mark> ( <mark style="background-color:lightgreen;" id="O35507,P23204,P37230,P37232,Q07869,Q8HYL6,Q95N78">PPARalpha</mark> ) mRNA by approximately 1.3-1.8-fold.
18602814-675	A combination of <mark style="background-color:lightblue;" id="938">niacin</mark> and <mark style="background-color:lightblue;" id="24808,24871">chromium chloride</mark> did not significantly <mark style="background-color:orange;">increase</mark> (3+1 mM) but instead <mark style="background-color:orange;">reduced</mark> (1+3 mM) <mark style="background-color:lightgreen;" id="O95477">ABCA1</mark> gene expression.
18602814-676	We hypothesize that the stimulation of <mark style="background-color:lightgreen;" id="O95477">ABCA1</mark> gene expression causes an <mark style="background-color:orange;">enhanced</mark> <mark style="background-color:lightblue;" id="304,5997,6432564,11025495">cholesterol</mark> efflux, perhaps <mark style="background-color:orange;">mediated</mark> by <mark style="background-color:lightgreen;" id="O35507,P23204,P37230,P37232,Q07869,Q8HYL6,Q95N78">PPARalpha</mark> pathway(s).
18602822-681	<mark style="background-color:lightblue;" id="104815">Cu</mark> deficiency <mark style="background-color:orange;">disrupts</mark> the architecture of mitochondria, <mark style="background-color:orange;">impairs</mark> respiration, and <mark style="background-color:orange;">inhibits</mark> the activity of <mark style="background-color:lightgreen;" id="O07091,O13393,O22642,O93863,P00002,P00003,P00004,P00007,P00008,P00011,P00012,P00013,P00014,P00017,P00018,P00019,P00020,P00021,P00022,P00024,P00025,P00027,P00028,P00029,P00030,P00031,P00032,P00035,P00036,P00037,P00038,P00039,P00040,P00041,P00042,P00043,P00046,P00047,P00048,P00049,P00051,P00052,P00053,P00054,P00055,P00056,P00057,P00058,P00059,P00060,P00061,P00062,P00063,P00064,P00065,P00066,P00067,P00068,P00069,P00070,P00071,P00072,P00073,P00074,P00075,P00076,P00077,P00078,P00079,P12831,P15451,P18822,P19681,P19974,P21665,P22342,P25400,P29380,P32556,P38091,P53698,P56205,P59218,P62772,P62773,P62894,P62895,P62896,P67881,P67882,P68096,P68097,P68098,P68099,P68100,P68517,P68518,P68519,P81280,P81459,P99998,P99999,Q41346,Q4HVX7,Q52V08,Q52V09,Q52V10,Q5RFH4,Q640U4,Q6C9Q0,Q6IQM2,Q6Q4H8,Q6QLW4,Q6WUX8,Q753F4,Q7YR71,Q96VP3">cytochrome c</mark> oxidase - the terminal, <mark style="background-color:lightblue;" id="104815">Cu</mark>-dependent respiratory complex (Complex IV) of the <mark style="background-color:yellow;" id="GO:0006118,biological_process">electron transport</mark> chain.
18602823-684	<mark style="background-color:lightblue;" id="5350">Sulforaphane</mark> <mark style="background-color:orange;">inhibited</mark> <mark style="background-color:yellow;" id="GO:0008283,biological_process">cell proliferation</mark> with IC(50) values at 24 and 48 h of 12.5 and 7.5 muM doses, respectively, and <mark style="background-color:orange;">decreased</mark> <mark style="background-color:lightgreen;" id="O42132,P03372,P06211,P06212,P16058,P19785,P49884,P49885,P49886,P50240,P50241,P50242,P57717,P57753,P81559,Q29040,Q53AD2,Q91250,Q91424,Q9PVZ9,Q9QZJ5,Q9TV98,Q9YH33,Q9YHT3,Q9YHZ7">ERalpha</mark> protein expression at concentrations between 2.5 and 30 muM.
18602823-685	30 muM, the SUL-induced suppression of <mark style="background-color:lightgreen;" id="O42132,P03372,P06211,P06212,P16058,P19785,P49884,P49885,P49886,P50240,P50241,P50242,P57717,P57753,P81559,Q29040,Q53AD2,Q91250,Q91424,Q9PVZ9,Q9QZJ5,Q9TV98,Q9YH33,Q9YHT3,Q9YHZ7">ERalpha</mark> protein was <mark style="background-color:orange;">reversed</mark> by preincubation with the proteasome inhibitor <mark style="background-color:lightblue;" id="462382">MG132</mark> and was accompanied by an <mark style="background-color:orange;">increase</mark> in protein <mark style="background-color:orange;">levels</mark> of the <mark style="background-color:lightblue;" id="10412331">20S</mark> catalytic core subunit <mark style="background-color:lightgreen;" id="P28074,P34065">PSMB5</mark> .
18668366-689	<mark style="background-color:lightblue;" id="1548943">Capsaicin</mark> is known to have regulatory <mark style="background-color:orange;">effects</mark> on gastrointestinal functions via the vanilloid receptor ( <mark style="background-color:lightgreen;" id="Q8NER1">VR1</mark> ).
18596687-690	Here, we report the efficacy of <mark style="background-color:lightblue;" id="2369,60657">betaxolol</mark> in <mark style="background-color:orange;">reducing</mark> <mark style="background-color:orange;">increases</mark> in gene expression of amygdalar <mark style="background-color:lightgreen;" id="P01142,P01143,P06296,P06850,P49188,P49926,Q8CIT0,Q95MI6,Q9PTS1">corticotropin-releasing factor</mark> ( <mark style="background-color:lightgreen;" id="O75973,P01142,P01143,P06296,P06850,P49188,P49926,Q8CIT0,Q95MI6,Q9PTS1">CRF</mark> ), a peptide known to be involved in <mark style="background-color:orange;">mediating</mark> 'anxiety-like' <mark style="background-color:yellow;" id="GO:0007610,biological_process">behaviors</mark> during initial phases of <mark style="background-color:lightblue;" id="2826,5760,439497,446220,644017,54613779">cocaine</mark> abstinence.
18596687-691	Results showed that <mark style="background-color:lightblue;" id="2369,60657">betaxolol</mark> treatment during early <mark style="background-color:lightblue;" id="2826,5760,439497,446220,644017,54613779">cocaine</mark> withdrawal attenuated <mark style="background-color:orange;">increases</mark> in amygdalar <mark style="background-color:lightgreen;" id="O75973,P01142,P01143,P06296,P06850,P49188,P49926,Q8CIT0,Q95MI6,Q9PTS1">CRF</mark> gene expression and <mark style="background-color:lightblue;" id="188955">cyclic adenosine monophosphate</mark>-dependent <mark style="background-color:lightgreen;" id="P00513,P25848">protein kinase</mark> regulatory and catalytic subunit (nuclear fraction) protein expression.
18596687-692	The present findings suggest that the efficacy of <mark style="background-color:lightblue;" id="2369,60657">betaxolol</mark> treatment on <mark style="background-color:lightblue;" id="2826,5760,439497,446220,644017,54613779">cocaine</mark> withdrawal-induced anxiety may be related, in part, to its <mark style="background-color:orange;">effect</mark> on amygdalar beta(1)- <mark style="background-color:yellow;" id="GO:0004935,molecular_function">adrenergic receptor</mark> , modulation of its downstream cell-signaling elements and <mark style="background-color:lightgreen;" id="O75973,P01142,P01143,P06296,P06850,P49188,P49926,Q8CIT0,Q95MI6,Q9PTS1">CRF</mark> gene expression.
18677561-697	Elevated beta1,4- <mark style="background-color:lightgreen;" id="P14769,P23336,P50127">galactosyltransferase</mark> -I <mark style="background-color:orange;">induced</mark> by the intraspinal injection of <mark style="background-color:lightblue;" id="11970143">lipopolysaccharide</mark>.
18627421-707	However, <mark style="background-color:lightgreen;" id="P10451,P14287,P31096,Q9XSY9">OPN</mark> -(/-) mice showed <mark style="background-color:orange;">increased</mark> serum <mark style="background-color:orange;">levels</mark> of tumour necrosis factor ( <mark style="background-color:lightgreen;" id="O35734,O77510,O77764,P01375,P04924,P13296,P19101,P23383,P23563,P29553,P33620,P36939,P48094,P51435,P51742,P51743,P59684,P59693,P59694,P59695,P79337,P79374,Q06599,Q19LH4,Q1G1A2,Q1WM27,Q2MH05,Q539C2,Q75N23,Q8HZD9,Q8JFG3,Q8MKG8,Q8WNR1,Q9BEA1">TNF</mark> )-alpha, which could be due to systemically present <mark style="background-color:lightblue;" id="11970143">lipopolysaccharide</mark> translocated to the gut.
18588512-710	In patients with hypertension and diabetes, <mark style="background-color:lightblue;" id="439764">ARB</mark>, ACEi and diuretic treatment <mark style="background-color:orange;">increased</mark> <mark style="background-color:lightgreen;" id="P03967,P22126,Q07152">Ras</mark> activation only during the first week.
18656400-713	These results indicate that <mark style="background-color:lightblue;" id="5202">5-HT</mark> <mark style="background-color:orange;">released</mark> into peripheral tissue and its receptors, <mark style="background-color:lightgreen;" id="P50129">5-HT2A</mark> as well as <mark style="background-color:lightgreen;" id="P08909,P28335,P34968,Q5IS66,Q60F97">5-HT2C</mark> , at the periphery have an important role in pain-related <mark style="background-color:yellow;" id="GO:0007610,biological_process">behaviors</mark> during acute peripheral inflammation.
18709649-718	Whereas <mark style="background-color:lightblue;" id="32051">Zn2</mark>+-dependent upregulation of <mark style="background-color:lightgreen;" id="O02033,O13257,O18842,O42152,O93571,P02807,P04358,P07216,P08002,P23038,P25127,P25128,P30331,P30565,P51902,P52723,P52725,P52726,P52728,P55945,P55946,P55948,P55951,P55952,P55953,P68494,P68495,P68497,P68498,P68499,P80367,P80593,P84865,Q05890,Q6J1T3,Q6S4N8,Q6XUW5,Q708T3,Q7ZZP9,Q800D3,Q8UVY1,Q94550,Q9IB50,Q9U568">metallothionein</mark> may help to <mark style="background-color:orange;">counteract</mark> excessive astrocyte swelling and production of reactive <mark style="background-color:lightblue;" id="977">oxygen</mark> and <mark style="background-color:lightblue;" id="945,948,25352,61526,160954,3609161">nitrogen oxide</mark> species, stimulation of <mark style="background-color:lightgreen;" id="P16257,P30535,P30536,P50637">PBR</mark> expression may augment HE <mark style="background-color:yellow;" id="GO:0007275,biological_process">development</mark> .
18657194-724	Androgenic action correlates inversely with a polymorphic <mark style="background-color:lightgreen;" id="Q00398">CAG</mark> repeat region in the AR gene encoding for <mark style="background-color:lightblue;" id="738,5961">glutamine</mark> residues the length of which appears to <mark style="background-color:orange;">influence</mark> <mark style="background-color:lightgreen;" id="P81182">high density lipoprotein</mark> (HDL) <mark style="background-color:lightblue;" id="304,5997,6432564,11025495">cholesterol</mark> levels.
18679731-726	As metabolic flux for the operation of the <mark style="background-color:lightblue;" id="10251">flavonoid</mark> pathway is <mark style="background-color:orange;">maintained</mark> through the activities of <mark style="background-color:lightgreen;" id="O03979,O04058,O93967,P10248,P10731,P11544,P14166,P14717,P14925,P19021,P26600,P35511,P35512,P45726,P45727,P45730,P45731,P45735,P52777,P83388,P91268,P97467,Q42609,Q43210,Q9P2V4,Q9PSN0">PAL</mark> and <mark style="background-color:lightgreen;" id="O24312,O81928,P37114,P37115,P48522,P92994,Q04468,Q42797,Q43033,Q43054,Q43067,Q43240,Q96423,Q9AR74">C4H</mark> , thus, catechins <mark style="background-color:yellow;" id="GO:0009058,biological_process">biosynthesis</mark> in tea is critically dependent on the products of these enzymes.
18590587-733	NOPE-<mark style="background-color:lightblue;" id="65064">EGCG</mark> treatment <mark style="background-color:orange;">improved</mark> <mark style="background-color:lightgreen;" id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">insulin</mark> 0.0001).
18590597-739	A 23.5-fold increase in <mark style="background-color:lightblue;" id="130779">7-ethoxy-4-trifluoromethylcoumarin</mark> O-deethylation activity suggested that metabolic resistance through <mark style="background-color:orange;">elevated</mark> <mark style="background-color:orange;">levels</mark> of <mark style="background-color:lightgreen;" id="O08469">cytochrome P450</mark> dependent <mark style="background-color:yellow;" id="GO:0004497,molecular_function">monooxygenase-activity</mark> is a possible resistance mechanism.However, synergism studies with different metabolic inhibitors revealed some contrasting resistance mechanisms between the METI-acaricides.
18637708-746	<mark style="background-color:lightblue;" id="947,123329">Nitrogen</mark>-containing bisphosphonates were found to <mark style="background-color:orange;">inhibit</mark> <mark style="background-color:lightgreen;" id="O66126,O66952,P22939,P45204,P54383,P55539,P57537,Q08291,Q45220,Q8K9A0">farnesyl diphosphate synthase</mark> - an essential enzyme in the <mark style="background-color:yellow;" id="GO:0006695,biological_process">cholesterol biosynthesis</mark> pathway, but their effect on <mark style="background-color:lightblue;" id="304,5997,6432564,11025495">cholesterol</mark> synthesis per se in the central nervous system (CNS) remains unknown.
18572174-747	<mark style="background-color:lightblue;" id="5282452">Pitavastatin</mark> <mark style="background-color:orange;">induces</mark> <mark style="background-color:lightgreen;" id="P27169,P27170">PON1</mark> expression through <mark style="background-color:lightgreen;" id="P16342,P19751,Q66198,Q8TCB0,Q8V439,Q8V6W7,Q91A29,Q93V93,Q9PYA3">p44</mark> /42 mitogen-activated <mark style="background-color:lightgreen;" id="P00513,P25848">protein kinase</mark> signaling cascade in Huh7 cells.
18572174-748	Both <mark style="background-color:lightgreen;" id="P27169,P27170">PON1</mark> gene promoter activity and <mark style="background-color:lightgreen;" id="P27169,P27170">PON1</mark> protein expression were <mark style="background-color:orange;">elevated</mark> by <mark style="background-color:lightblue;" id="5282452">pitavastatin</mark> stimulation.
18572174-749	<mark style="background-color:lightblue;" id="5282452">Pitavastatin</mark> <mark style="background-color:orange;">phosphorylated</mark> <mark style="background-color:lightgreen;" id="P16342,P19751,Q66198,Q8TCB0,Q8V439,Q8V6W7,Q91A29,Q93V93,Q9PYA3">p44</mark> /42 MAP kinase.
18572174-751	<mark style="background-color:lightblue;" id="5282452">Pitavastatin</mark> <mark style="background-color:orange;">increased</mark> the <mark style="background-color:lightgreen;" id="O14300,O89090,P17379,Q01714,Q85439,Q85449,Q85451">Sp1</mark> - <mark style="background-color:lightgreen;" id="P27169,P27170">PON1</mark> DNA complex and this <mark style="background-color:orange;">effect</mark> was attenuated by <mark style="background-color:lightblue;" id="4713">PD98059</mark>.
18572174-752	These observations suggest that <mark style="background-color:lightblue;" id="5282452">pitavastatin</mark> <mark style="background-color:orange;">phosphorylates</mark> <mark style="background-color:lightgreen;" id="P16342,P19751,Q66198,Q8TCB0,Q8V439,Q8V6W7,Q91A29,Q93V93,Q9PYA3">p44</mark> /42 MAP kinase and then <mark style="background-color:orange;">activates</mark> the <mark style="background-color:yellow;" id="GO:0006350,biological_process">transcription</mark> of <mark style="background-color:lightgreen;" id="P27169,P27170">PON1</mark> gene and increases the <mark style="background-color:lightgreen;" id="P27169,P27170">PON1</mark> protein expression in Huh7 cells.
18572174-753	Furthermore, we speculate that <mark style="background-color:lightblue;" id="5282452">pitavastatin</mark> <mark style="background-color:orange;">affects</mark> both the <mark style="background-color:yellow;" id="GO:0016310,biological_process">phosphorylation</mark> of <mark style="background-color:lightgreen;" id="Q12772,Q60429">SREBP-2</mark> and the <mark style="background-color:lightgreen;" id="O14300,O89090,P17379,Q01714,Q85439,Q85449,Q85451">Sp1</mark>  <mark style="background-color:yellow;" id="GO:0005488,molecular_function">binding</mark> to <mark style="background-color:lightgreen;" id="P27169,P27170">PON1</mark> DNA through the activation of <mark style="background-color:lightgreen;" id="P16342,P19751,Q66198,Q8TCB0,Q8V439,Q8V6W7,Q91A29,Q93V93,Q9PYA3">p44</mark> /42 MAP kinase signaling cascade.
18637712-756	hsBAFF-upregulated <mark style="background-color:yellow;" id="GO:0005622,cellular_component">intracellular</mark> free <mark style="background-color:lightblue;" id="271">Ca(2</mark>+) <mark style="background-color:yellow;" id="GO:0042592,biological_process">homeostasis</mark> <mark style="background-color:orange;">regulates</mark> <mark style="background-color:lightgreen;" id="P27361,P28869,P42525,Q07176">ERK1</mark> /2 activity and <mark style="background-color:yellow;" id="GO:0008283,biological_process">cell proliferation</mark> in B cells in vitro.
18637712-757	Using immunocytochemistry and Western blot analysis, we found that the activation of <mark style="background-color:lightgreen;" id="P27361,P28869,P42525,Q07176">ERK1</mark> /2 due to hsBAFF was <mark style="background-color:orange;">triggered</mark> by a [<mark style="background-color:lightblue;" id="271">Ca(2</mark>+)](i) -dependent pathway, leading to elevation of <mark style="background-color:yellow;" id="GO:0042100,biological_process">B cell proliferation</mark> .
18637712-758	This is supported by the findings that <mark style="background-color:yellow;" id="GO:0005622,cellular_component">intracellular</mark> <mark style="background-color:lightblue;" id="271">Ca(2</mark>+) chelator <mark style="background-color:lightblue;" id="2293">BAPTA/AM</mark> attenuated <mark style="background-color:orange;">phosphorylated</mark> <mark style="background-color:lightgreen;" id="P27361,P28869,P42525,Q07176">ERK1</mark> /2 expression and <mark style="background-color:yellow;" id="GO:0008283,biological_process">cell proliferation</mark> in hsBAFF-stimulated B cells.
18637712-759	Taken together, the main finding of this study is that hsBAFF elicits higher but homeostatic [<mark style="background-color:lightblue;" id="271">Ca(2</mark>+)](i) levels, which <mark style="background-color:orange;">regulates</mark> <mark style="background-color:lightgreen;" id="P27361,P28869,P42525,Q07176">ERK1</mark> /2 activity and <mark style="background-color:yellow;" id="GO:0008283,biological_process">cell proliferation</mark> in in vitro B cells.
18609042-761	Diastolic function and <mark style="background-color:lightgreen;" id="P40753,P83965,Q805D7,Q805E8,Q9GLK4">BNP</mark> <mark style="background-color:orange;">changes</mark> during exercise predict <mark style="background-color:lightblue;" id="977">oxygen</mark> consumption in chronic heart failure patients.
18627475-762	The expression of the <mark style="background-color:lightgreen;" id="O08703,O08962,O13306,O35219,P32476,Q12809,Q14534,Q75F69,Q7GC09,Q86QT3,Q86QU1,Q86QU6,Q86QV0,Q86QV3,Q86QV6,Q8WNY2,Q92206,Q9PT84,Q9TSZ3,Q9TUI4">ERG1</mark> , <mark style="background-color:lightgreen;" id="O13597,O93875,P32353,P50860,P78575,Q754B9,Q7F9X0,Q86QT9,Q86QU4,Q86QU8,Q86QV1,Q86QV4,Q86QV9,Q8J207,Q8NJ57,Q9NS40">ERG3</mark> , <mark style="background-color:lightgreen;" id="P38604,Q04782,Q96WJ0">ERG7</mark> , <mark style="background-color:lightgreen;" id="O74165,P29704,P78589,Q752X9,Q92459,Q9HGZ6">ERG9</mark> , <mark style="background-color:lightgreen;" id="P10613,P10614,P14263,P49602,P50859,Q759W0">ERG11</mark> and <mark style="background-color:lightgreen;" id="O59933,P53045,Q15800">ERG25</mark> genes in response to incubation with <mark style="background-color:lightblue;" id="3365">fluconazole</mark> and <mark style="background-color:yellow;" id="GO:0042710,biological_process">biofilm formation</mark> was <mark style="background-color:orange;">investigated</mark> <mark style="background-color:orange;">using</mark> <mark style="background-color:yellow;" id="GO:0006410,biological_process">reverse-transcription</mark>  <mark style="background-color:lightgreen;" id="O66148,O80333,P15904,Q01289,Q39617,Q41249,Q59987,Q9SDT1">PCR</mark> and real-time <mark style="background-color:lightgreen;" id="O66148,O80333,P15904,Q01289,Q39617,Q41249,Q59987,Q9SDT1">PCR</mark> in Candida albicans and Candida dubliniensis clinical isolates.
18627475-763	Expression of the <mark style="background-color:lightgreen;" id="P10613,P10614,P14263,P49602,P50859,Q759W0">ERG11</mark> gene was found to be low or <mark style="background-color:orange;">moderate</mark> and it was <mark style="background-color:orange;">regulated</mark> by <mark style="background-color:lightblue;" id="3365">fluconazole</mark> addition more so than by <mark style="background-color:yellow;" id="GO:0042710,biological_process">biofilm formation</mark> .
18627475-764	The expression of the <mark style="background-color:lightgreen;" id="O74165,P29704,P78589,Q752X9,Q92459,Q9HGZ6">ERG9</mark> <mark style="background-color:orange;">increased</mark> in the presence of <mark style="background-color:lightblue;" id="3365">fluconazole</mark> in some isolates.
18599066-769	<mark style="background-color:lightblue;" id="985">Palmitate</mark> <mark style="background-color:orange;">phosphorylated</mark> <mark style="background-color:lightgreen;" id="O24473,O75791,O95433,O97628,P46108,P80350,P82869,Q01552,Q04929,Q63768,Q64010,Q9LDA4,Q9Y2S7">p38</mark> and <mark style="background-color:lightgreen;" id="P92208,Q966Y3">JNK</mark> kinases, and blocking of these kinases with specific inhibitors diminished the <mark style="background-color:lightblue;" id="985">palmitate</mark>-induced <mark style="background-color:yellow;" id="GO:0050663,biological_process">cytokine secretion</mark> .
18599066-770	<mark style="background-color:lightblue;" id="985">Palmitate</mark> also <mark style="background-color:orange;">activated</mark> the <mark style="background-color:lightgreen;" id="P21525">AP-1</mark> (c- <mark style="background-color:lightgreen;" id="P05627,P17325,P18289">Jun</mark> ) <mark style="background-color:yellow;" id="GO:0006350,biological_process">transcription</mark> factor.
18635693-781	<mark style="background-color:lightblue;" id="681">Dopamine</mark> <mark style="background-color:orange;">release</mark> and direct stimulation of <mark style="background-color:lightblue;" id="681">dopamine</mark> D2 and <mark style="background-color:lightblue;" id="5202">serotonin</mark> <mark style="background-color:lightgreen;" id="P50129">5-HT2A</mark> receptors also contributes to the overall action of <mark style="background-color:lightblue;" id="1615">MDMA</mark>.
18602931-788	A-804598 was tritiated ([<mark style="background-color:lightblue;" id="45481830">3H]A-804598</mark>; 8.1Ci/mmol) and <mark style="background-color:orange;">utilized</mark> to study recombinant rat <mark style="background-color:lightgreen;" id="Q64663,Q99572,Q9Z1M0">P2X7</mark> receptors expressed in 1321N1 cells.
18586549-790	We systematically investigated whether PD-related stresses including <mark style="background-color:lightblue;" id="462382">MG132</mark> and epoxomicin (proteasomal impairment), tunicamycin (unfolded protein stress), and <mark style="background-color:lightblue;" id="6758">rotenone</mark> (mitochondrial dysfunction) resulted in expressional <mark style="background-color:orange;">changes</mark> of <mark style="background-color:lightblue;" id="3290">parkin</mark> and other E3 <mark style="background-color:lightgreen;" id="O46543,P08565,P08618,P0C014,P0C072,P13117,P14624,P14792,P15174,P19848,P20685,P22589,P23324,P23398,P42739,P42740,P46574,P49634,P49635,P59263,P59669,P61862,P61863,P61864,P62972,P62973,P62974,P62975,P62976,P62977,P62988,P62989,P62990,P62991,P63049,P63051,P68195,P68196,P68197,P68198,P68199,P68201,P68204,P69308,P69309,P69310,P69311,P69312,P69313,P69314,P69315,P69316,P69317,P69318,P69319,P69320,P69321,P69322,P69323,P69324,P69325,P69326,P84589,Q05550,Q865C5,Q867C2,Q867C3,Q867C4,Q8MKD1,Q9Y848">ubiquitin</mark> ligases ( <mark style="background-color:lightgreen;" id="Q9NV58">dorfin</mark> , SIAH-1).
18693051-793	Accumulation of <mark style="background-color:lightblue;" id="206,5793,64689,79025">glucose</mark> in PA was <mark style="background-color:orange;">increased</mark> by <mark style="background-color:lightgreen;" id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">insulin</mark> at 10nM and by <mark style="background-color:lightgreen;" id="P05017,P07455,P08025,P10763,P16545,P17085,P17647,P18254,P33712,P51457,P51458,P51462,Q02815,Q28933,Q68LC0,Q6GUL6,Q6IVA5,Q6JLX1,Q95222">IGF-I</mark> at 1 nM and 10nM.
18621373-794	Pretreatment with <mark style="background-color:yellow;" id="GO:0005576,cellular_component">extracellular</mark> signal-regulated kinase ( <mark style="background-color:lightgreen;" id="P29323">ERK</mark> ) and <mark style="background-color:lightgreen;" id="P05627,P17325,P18289">Jun</mark> N-terminal kinase ( <mark style="background-color:lightgreen;" id="P92208,Q966Y3">JNK</mark> ) inhibitors, but not <mark style="background-color:lightgreen;" id="O24473,O75791,O95433,O97628,P46108,P80350,P82869,Q01552,Q04929,Q63768,Q64010,Q9LDA4,Q9Y2S7">p38</mark>  <mark style="background-color:lightgreen;" id="Q00859">mitogen-activated protein kinase</mark> ( <mark style="background-color:lightgreen;" id="O62618">p38MAPK</mark> ) significantly <mark style="background-color:orange;">decreased</mark> <mark style="background-color:lightgreen;" id="O19062,P02741,P02742,P08462,P18151,P21291,P41964,P47875,P49254,P49262,P52753,P67966,P67967,P97315,Q07203">CRP</mark> -induced <mark style="background-color:lightblue;" id="5359597">superoxide</mark> anion release from macrophages in vivo.
18690549-796	Rat <mark style="background-color:lightblue;" id="867">dicarboxylate</mark> transporter ( <mark style="background-color:lightgreen;" id="Q13183,Q28615">SDCT1</mark> ), <mark style="background-color:orange;">expressed</mark> in renal tubular epithelial cells, plays a key role in <mark style="background-color:orange;">regulating</mark> blood and urinary <mark style="background-color:lightblue;" id="311,2733526">citrate</mark> level by reabsorbing <mark style="background-color:lightblue;" id="311,2733526">citrate</mark> from the lumen.
18676199-799	Exposure of erythrocytes to <mark style="background-color:lightgreen;" id="Q9UQ90">PGNs</mark> <mark style="background-color:orange;">increased</mark> cytosolic <mark style="background-color:lightblue;" id="271">Ca(2</mark>+) concentration, increased ceramide formation, <mark style="background-color:orange;">enhanced</mark> the percentage of <mark style="background-color:lightgreen;" id="P08758,P14668,P17153,P48036,P70075,P81287,Q4R4H7,Q5R1W0">annexin V</mark> - <mark style="background-color:yellow;" id="GO:0005488,molecular_function">binding</mark> erythrocytes, <mark style="background-color:orange;">decreased</mark> erythrocyte forward scatter, and <mark style="background-color:orange;">lowered</mark> the <mark style="background-color:yellow;" id="GO:0005622,cellular_component">intracellular</mark> <mark style="background-color:lightblue;" id="5957">ATP</mark> concentration.
18643908-800	<mark style="background-color:lightgreen;" id="O16005,O16017,O16018,O16019,O16020,O18312,O18315,O18481,O18485,O18486,O18766,O42268,O42294,O42300,O42301,O42307,O42327,O42328,O42330,O42427,O42431,O42451,O42452,O42466,O42604,O62791,O62792,O62793,O62794,O62795,O62796,O62798,O93441,O93459,P02699,P02700,P08100,P09241,P15409,P22328,P22671,P24603,P28681,P29403,P31355,P31356,P32308,P32309,P35356,P35359,P35362,P35403,P41590,P41591,P49912,P51470,P51488,P51489,P52202,P56514,P56515,P56516,P79756,P79798,P79807,P79808,P79809,P79812,P79848,P79863,P79898,P79901,P79902,P79903,P79911,P79914,P87369,Q17094,Q17292,Q17296,Q28886,Q68J47,Q6W3E1,Q769E8,Q8HY69,Q90245,Q90305,Q90373,Q95KU1,Q98980,Q9DGG4,Q9YGY9,Q9YGZ0,Q9YGZ1,Q9YGZ2,Q9YGZ3,Q9YGZ4,Q9YGZ5,Q9YGZ6,Q9YGZ7,Q9YGZ8,Q9YGZ9,Q9YH00,Q9YH01,Q9YH02,Q9YH03,Q9YH04,Q9YH05">Rhodopsin</mark> is one of the members of the G protein-coupled receptor family that can <mark style="background-color:orange;">catalyze</mark> a <mark style="background-color:lightblue;" id="8977">GDP</mark>-<mark style="background-color:lightblue;" id="6830">GTP</mark> exchange reaction on the retinal G protein <mark style="background-color:lightgreen;" id="P49177">transducin</mark> (Gt) upon photon absorption.
18564056-810	In the present study we explored the possibility of using genetic engineering to increase the <mark style="background-color:lightblue;" id="2240,68827,452191,641602,5458876,9838675,11836791,23757058,44266427,49796325">artemisinin</mark> content of A. annua by <mark style="background-color:orange;">suppressing</mark> the expression of <mark style="background-color:lightgreen;" id="O74165,P29704,P36596,P37268,P53798,P53799,P53800,P78589,Q02769,Q752X9,Q7S4Z6,Q92459,Q9HGZ6,Q9Y753">SQS</mark> ( <mark style="background-color:yellow;" id="GO:0004310,molecular_function">squalene synthase</mark> ), a key enzyme of sterol pathway (a pathway competitive with that of <mark style="background-color:lightblue;" id="2240,68827,452191,641602,5458876,9838675,11836791,23757058,44266427,49796325">artemisinin</mark> <mark style="background-color:yellow;" id="GO:0009058,biological_process">biosynthesis</mark> ) by means of a hairpin-RNA-mediated <mark style="background-color:yellow;" id="GO:0016246,biological_process">RNAi</mark> ( <mark style="background-color:yellow;" id="GO:0016246,biological_process">RNA interference</mark> ) technique.
18650080-815	Determination of reactive <mark style="background-color:lightblue;" id="977">oxygen</mark> species <mark style="background-color:orange;">generated</mark> in <mark style="background-color:lightgreen;" id="Q12570">laccase</mark> <mark style="background-color:orange;">catalyzed</mark> oxidation of wood fibers from Chinese <mark style="background-color:lightblue;" id="449156">fir</mark> (Cunninghamia lanceolata) by electron spin resonance spectrometry.
18621413-823	The free radicals produced are thought to be generated during the production of <mark style="background-color:lightblue;" id="1175">uric acid</mark>, a reaction <mark style="background-color:orange;">catalyzed</mark> by <mark style="background-color:lightgreen;" id="P22985,P47989,P47990,P80457,Q00519,Q9MYW6">xanthine oxidase</mark> .
18615280-830	<mark style="background-color:lightgreen;" id="O33830,O43451,O59645,P21517,P43473,Q02751">alpha-Glucosidase</mark> inhibitory activity of <mark style="background-color:lightblue;" id="44256700">cyanidin-3-galactoside</mark> and synergistic <mark style="background-color:orange;">effect</mark> with <mark style="background-color:lightblue;" id="41774,441184,444254,445421,4432690">acarbose</mark>.
18615280-831	<mark style="background-color:lightblue;" id="44256700">Cyanidin-3-galactoside</mark>, a natural <mark style="background-color:lightblue;" id="145858">anthocyanin</mark>, was <mark style="background-color:orange;">investigated</mark> for its <mark style="background-color:lightgreen;" id="O33830,O43451,O59645,P21517,P43473,Q02751">alpha-glucosidase</mark> inhibitory activity.
18692592-835	High <mark style="background-color:lightblue;" id="206,5793,64689,79025">glucose</mark> <mark style="background-color:orange;">induced</mark> endothelial cell growth inhibition is <mark style="background-color:orange;">associated</mark> with an <mark style="background-color:orange;">increase</mark> in <mark style="background-color:lightgreen;" id="O19011,O93449,P01137,P04202,P07200,P09531,P09533,P16176,P17246,P18341,P50414,P54831,Q38HS2,Q9PTQ2,Q9Z1Y6">TGFbeta1</mark>  <mark style="background-color:yellow;" id="GO:0046903,biological_process">secretion</mark> and inhibition of <mark style="background-color:lightgreen;" id="P03967,P22126,Q07152">Ras</mark> prenylation via suppression of the <mark style="background-color:yellow;" id="GO:0010142,biological_process">mevalonate pathway</mark> .
18692592-836	The influence of the prenylation status of <mark style="background-color:lightgreen;" id="P03967,P22126,Q07152">Ras</mark> on the observed <mark style="background-color:orange;">changes</mark> in endothelial cell growth under high <mark style="background-color:lightblue;" id="206,5793,64689,79025">glucose</mark> conditions has not previously been examined.
18615288-840	A series of systematically modified vanadyl-beta-<mark style="background-color:lightblue;" id="167775">diketone</mark> complexes, VO(beta-<mark style="background-color:lightblue;" id="167775">diketone</mark>)(2), bearing substituent groups with different electron inductive properties were <mark style="background-color:orange;">synthesized</mark> and evaluated as inhibitors against calf-intestine <mark style="background-color:lightgreen;" id="O60109,P81800,P83456">alkaline phosphatase</mark> ( <mark style="background-color:lightgreen;" id="P00634,P19147,P21948">APase</mark> ).
18641920-846	<mark style="background-color:lightblue;" id="151194">PTK787/ZK222584</mark>, a potent orally active <mark style="background-color:yellow;" id="GO:0001525,biological_process">angiogenesis</mark> inhibitor capable of <mark style="background-color:orange;">inhibiting</mark> all known isoforms of Vascular Endothelial Growth Factor ( <mark style="background-color:lightgreen;" id="P15691,P15692,P26617,P49151,P50412,P67964,P67965,Q99PS1,Q9GKR0,Q9MYV3">VEGF</mark> ) receptor, belongs to the class of aminophthalazines.
18594817-848	Furthermore, the CD3(+) T cells co-cultured with <mark style="background-color:lightblue;" id="60700">topotecan</mark> treated U-87 and autologous GBM tumor cells showed a significant <mark style="background-color:orange;">increase</mark> in expression in <mark style="background-color:lightgreen;" id="O35497,O35735,O57571,O57603,O57608,O73915,O77763,P01579,P01580,P01581,P07353,P17773,P17803,P28333,P28341,P30123,P42160,P42161,P42162,P46402,P49708,P63309,P63310,P63311,P79154,Q1WM28,Q25BC0,Q2PE75,Q4ZH68,Q5CCK0,Q5I6S9,Q62574,Q647G2,Q7TSP4,Q865W6,Q865X1,Q865Y4,Q866Y6,Q8MKF5,Q8SPW9,Q9QXX2,Q9TTB0,Q9TV67,Q9YGB9">IFN-gamma</mark> , a key cytokine produced by activated T cells, and accordingly enhanced tumor cytotoxicity.
18629637-851	<mark style="background-color:lightblue;" id="107647">Fluorocitrate</mark>, an inhibitor of glial metabolism, <mark style="background-color:orange;">inhibits</mark> the up-regulation of <mark style="background-color:lightgreen;" id="O54705,O61309,O61608,Q26240,Q28969,Q9I9M2">NOS</mark> expression, activity and NO production in the spinal cord <mark style="background-color:orange;">induced</mark> by <mark style="background-color:lightblue;" id="712">formalin</mark> test in rats.
18629637-852	In order to explore the involvement of glia in the NO-mediated nociceptive transmission, the present study was undertaken to investigate the effect of <mark style="background-color:lightblue;" id="107647">fluorocitrate</mark> (FC), an inhibitor of glial metabolism, on <mark style="background-color:lightgreen;" id="O54705,O61309,O61608,Q26240,Q28969,Q9I9M2">NOS</mark> expression and activity and NO production in the spinal cord during the <mark style="background-color:orange;">process</mark> of peripheral inflammatory pain and hyperalgesia <mark style="background-color:orange;">induced</mark> by <mark style="background-color:lightblue;" id="712">formalin</mark> test in rats.
18656273-863	<mark style="background-color:lightblue;" id="445154">Resveratrol</mark> <mark style="background-color:orange;">reverses</mark> <mark style="background-color:lightgreen;" id="P05305,P09558,P13206,P17322,P22387,P22388,P29560,P97740,Q28469,Q5NRP9,Q5NRQ1,Q9BG76">ET-1</mark> -evoked mitogenic <mark style="background-color:orange;">effects</mark> in human coronary arterial cells by <mark style="background-color:orange;">activating</mark> the kinase-G to <mark style="background-color:orange;">inhibit</mark> <mark style="background-color:lightgreen;" id="P29323">ERK</mark> -enzymes.
18656273-864	Pretreatment with the <mark style="background-color:lightblue;" id="6569">MEK</mark>- <mark style="background-color:lightgreen;" id="P29323">ERK</mark> inhibitor (<mark style="background-color:lightblue;" id="4713">PD98059</mark>) appreciably <mark style="background-color:orange;">reversed</mark> the mitogenic <mark style="background-color:orange;">effects</mark> of <mark style="background-color:lightgreen;" id="P05305,P09558,P13206,P17322,P22387,P22388,P29560,P97740,Q28469,Q5NRP9,Q5NRQ1,Q9BG76">ET-1</mark> .
18656273-865	On the other hand, pretreatment with the polyphenolic <mark style="background-color:lightblue;" id="638088">stilbene</mark> <mark style="background-color:lightblue;" id="445154">resveratrol</mark> (RSVL, 1-100 microM) <mark style="background-color:orange;">triggered</mark> more prominent inhibition of <mark style="background-color:lightgreen;" id="P05305,P09558,P13206,P17322,P22387,P22388,P29560,P97740,Q28469,Q5NRP9,Q5NRQ1,Q9BG76">ET-1</mark> -evoked <mark style="background-color:yellow;" id="GO:0008283,biological_process">cell proliferation</mark> and <mark style="background-color:lightgreen;" id="P27361,P28869,P42525,Q07176">ERK1</mark> /2 activation.
18656273-866	Further, pretreatment with the specific <mark style="background-color:lightblue;" id="24316">cGMP</mark>-phosphodiesterase inhibitor, <mark style="background-color:lightblue;" id="5722">zaprinast</mark> (10 microM) appreciably <mark style="background-color:orange;">augmented</mark> RSVL-evoked <mark style="background-color:lightblue;" id="24316">cGMP</mark> formation, <mark style="background-color:lightgreen;" id="P29323">ERK</mark> inhibition, and cytostatic response.
18656273-867	Moreover, the RSVL-induced <mark style="background-color:lightgreen;" id="P29323">ERK</mark> -inhibitory <mark style="background-color:orange;">effects</mark> were significantly <mark style="background-color:orange;">reversed</mark> by the kinase-G inhibitor, <mark style="background-color:lightblue;" id="108152">KT-5823</mark> (10 microM; 69%), but not by the <mark style="background-color:lightgreen;" id="P60495">kinase-A inhibitor</mark> (<mark style="background-color:lightblue;" id="3844,454202,16219545">KT-5720</mark>).
18693294-868	The activity of guanylyl <mark style="background-color:lightgreen;" id="O94303,P33734,Q9P4P9,Q9SZ30">cyclase</mark> was determined by the amount of <mark style="background-color:lightblue;" id="24316">cGMP</mark> <mark style="background-color:orange;">generated</mark> in responses to sodium nitroprusside (SNP) or <mark style="background-color:lightgreen;" id="O46540,P01160,P01161,P05125,P07499,P07500,P07501,P09196,P18144,P18908,P18909,P24259,P27104,P27596,P83964,Q805D8,Q805E9,Q9GLD0">ANP</mark> .
18635814-879	<mark style="background-color:lightblue;" id="5641">Urethane</mark> is a chemical carcinogen found in tobacco smoke that causes <mark style="background-color:orange;">activating</mark> mutations in <mark style="background-color:lightgreen;" id="P08644,P32883,Q05147">Kras</mark> and induces lung tumors in mice.
18594856-883	Hypergravity also induced a transient reorganization of <mark style="background-color:lightgreen;" id="O00937,O13419,O16808,O17320,O65314,O65315,O65316,O74258,O81221,P02577,P10365,P10989,P11426,P13363,P14235,P17128,P20904,P24902,P26182,P26183,P30161,P45520,P45521,P48465,P50138,P51775,P53455,P53476,P53477,P53491,P53498,P53499,P53500,P53502,P53689,P60009,P60010,P60011,P68555,P78711,P80709,P81085,P90689,P91754,Q05214,Q11212,Q24733,Q2U7A3,Q39596,Q39758,Q6TCF2,Q75D00,Q8SWN8,Q8X119,Q92192,Q92193,Q99023,Q9P4D1,Q9UVF3,Q9UVX4,Q9UVZ8">actin</mark> fibers in 3 min, which was <mark style="background-color:orange;">inhibited</mark> by <mark style="background-color:lightgreen;" id="O51891,O67031,O83281,P03304,P0A295,P0A296,P0AG30,P0AG31,P0AG32,P0AG33,P15409,P17593,P17594,P20350,P29403,P33561,P35359,P38527,P44619,P45835,P51489,P52152,P52153,P52154,P52155,P52156,P52157,P52158,P56466,P57652,P66028,P66029,Q03222,Q06447,Q89A22,Q9ZD24,Q9ZLS9">Rho</mark> -kinase inhibitor (<mark style="background-color:lightblue;" id="448042">Y27632</mark>) and <mark style="background-color:lightblue;" id="1153,6057,5460803">tyrosine</mark> kinase inhibitors (<mark style="background-color:lightblue;" id="3591,5311102,6436247">herbimycin A</mark> and <mark style="background-color:lightblue;" id="5328768">tyrphostin 46</mark>).
18594856-886	Collectively, these results indicate that hypergravity induces <mark style="background-color:lightblue;" id="5957">ATP</mark> <mark style="background-color:orange;">release</mark> and <mark style="background-color:lightgreen;" id="O00937,O13419,O16808,O17320,O65314,O65315,O65316,O74258,O81221,P02577,P10365,P10989,P11426,P13363,P14235,P17128,P20904,P24902,P26182,P26183,P30161,P45520,P45521,P48465,P50138,P51775,P53455,P53476,P53477,P53491,P53498,P53499,P53500,P53502,P53689,P60009,P60010,P60011,P68555,P78711,P80709,P81085,P90689,P91754,Q05214,Q11212,Q24733,Q2U7A3,Q39596,Q39758,Q6TCF2,Q75D00,Q8SWN8,Q8X119,Q92192,Q92193,Q99023,Q9P4D1,Q9UVF3,Q9UVX4,Q9UVZ8">actin</mark> reorganization via <mark style="background-color:lightgreen;" id="Q9C3Y4">RhoA</mark> activation and <mark style="background-color:lightgreen;" id="Q00944,Q05397">FAK</mark>  <mark style="background-color:yellow;" id="GO:0016310,biological_process">phosphorylation</mark> , thereby activating <mark style="background-color:yellow;" id="GO:0008283,biological_process">cell proliferation</mark> and migration in BAECs.
18686047-887	In an effort to identify agents which enhance the activity of oligos and which possess less toxicity than traditionally employed chemotherapeutics, <mark style="background-color:lightblue;" id="5040,478951,5284616,5358081,5374464,5460439,5497196,6436030,16760631,17753749,44295234,53627520,54600319">Rapamycin</mark>, an immunosuppressive agent known to <mark style="background-color:orange;">regulate</mark> tumor growth and signal <mark style="background-color:yellow;" id="GO:0009293,biological_process">transduction</mark> <mark style="background-color:orange;">mediated</mark> by the <mark style="background-color:lightgreen;" id="P42345,P42346,Q9JLN9">mTOR</mark> receptor, is compared to <mark style="background-color:lightblue;" id="4666,36314,441276,5352019,6713921,6915727,44155032,53313247">paclitaxel</mark> in combination therapy employing monospecific or bispecific oligos.
18700809-895	The <mark style="background-color:yellow;" id="GO:0008283,biological_process">cell proliferation</mark> , the up-regulation of <mark style="background-color:lightblue;" id="16040252">pS2</mark>, and the down-regulation of <mark style="background-color:lightgreen;" id="O42132,P03372,P06211,P06212,P16058,P19785,P49884,P49885,P49886,P50240,P50241,P50242,P57717,P57753,P81559,Q29040,Q53AD2,Q91250,Q91424,Q9PVZ9,Q9QZJ5,Q9TV98,Q9YH33,Q9YHT3,Q9YHZ7">ERalpha</mark> and <mark style="background-color:lightgreen;" id="O08537,O13012,O93511,P57781,P57782,Q62986,Q92731,Q95171,Q9IAK1,Q9PTU5,Q9PVE2,Q9TTE5,Q9TU15,Q9W6M2,Q9XSB5,Q9XSW2,Q9YH32">ERbeta</mark> gene expressions <mark style="background-color:orange;">induced</mark> by the racemate and enantiomers of o,p'- <mark style="background-color:lightgreen;" id="P30046">DDT</mark> were all <mark style="background-color:orange;">reversed</mark> by cotreatment with 10(-6) mol/L <mark style="background-color:lightblue;" id="104741">ICI 182,780</mark>.
18639930-897	The involvement of <mark style="background-color:lightblue;" id="5359597">superoxide</mark> and <mark style="background-color:lightblue;" id="145068">nitric oxide</mark> was verified by the <mark style="background-color:orange;">block</mark> of <mark style="background-color:lightgreen;" id="O60682">MSC</mark> <mark style="background-color:orange;">using</mark> specific scavengers (<mark style="background-color:lightblue;" id="9002">tiron</mark> and PTIO, respectively).
18639930-898	Accordingly, <mark style="background-color:lightgreen;" id="O60682">MSC</mark> were <mark style="background-color:orange;">blocked</mark> by the <mark style="background-color:lightblue;" id="104806">peroxynitrite</mark> scavenger <mark style="background-color:lightblue;" id="1175">uric acid</mark> and could be <mark style="background-color:orange;">mimicked</mark> by application of exogenous <mark style="background-color:lightblue;" id="104806">peroxynitrite</mark>.
18639930-899	This conclusion is supported by our findings that <mark style="background-color:lightgreen;" id="O60682">MSC</mark> were <mark style="background-color:orange;">suppressed</mark> by inhibitors of phospholipases but could be <mark style="background-color:orange;">mimicked</mark> by exogenous phospholipases or by amphipaths (<mark style="background-color:lightblue;" id="445639">oleic acid</mark>, <mark style="background-color:lightblue;" id="5590">Triton X-100</mark>).
18704755-900	A special rigid planar structural octupolar molecule titled 2,4,6-tris(p-methylstyryl)-<mark style="background-color:lightblue;" id="9262,20437">s-triazine</mark> ( <mark style="background-color:lightgreen;" id="Q9NRR2">TMT</mark> ) was <mark style="background-color:orange;">synthesized</mark> and its interaction with bovine <mark style="background-color:lightgreen;" id="P21847,P83517">serum albumin</mark> ( <mark style="background-color:lightgreen;" id="P02769">BSA</mark> ) were studied by molecular spectroscopy.
18570309-903	The enantioselective interaction between penicillium expansum alkaline <mark style="background-color:lightgreen;" id="Q7M4U7">lipase</mark> and chiral <mark style="background-color:lightblue;" id="13658">phenoxypropionic acid</mark> herbicide <mark style="background-color:lightblue;" id="8427,119435">dichlorprop</mark> was studied by <mark style="background-color:orange;">using</mark> UV differential spectrophotometry and fluorescence spectrophotometry in the presence of a pH 8, <mark style="background-color:lightblue;" id="1061,167704,644102">phosphate</mark> buffer solution.
18656335-913	Adding <mark style="background-color:lightblue;" id="5280489">beta-carotene</mark> to the diet of the mice during the period of irradiation <mark style="background-color:orange;">suppressed</mark> the activity and expression of <mark style="background-color:lightgreen;" id="O18733,P14780,P41245,P41246,P50282,P52176">MMP-9</mark> as well as the wrinkling and sagging formation.
18656335-914	Dietary <mark style="background-color:lightblue;" id="5280489">beta-carotene</mark> <mark style="background-color:orange;">prevents</mark> the expression of <mark style="background-color:lightgreen;" id="O18733,P14780,P41245,P41246,P50282,P52176">MMP-9</mark> , at least partly, by inhibiting photodynamic action involved in the formation of Chol-OOHs.
18564176-915	<mark style="background-color:lightblue;" id="3476">Glimepiride</mark> <mark style="background-color:orange;">upregulates</mark> <mark style="background-color:lightgreen;" id="P29473,P29474,P70313,P79209,P97270,Q28969,Q62600">eNOS</mark> activity and <mark style="background-color:orange;">inhibits</mark> cytokine-induced NF-kappaB activation through a phosphoinoside 3-kinase- <mark style="background-color:lightgreen;" id="P31750,Q8INB9">Akt</mark> -dependent pathway.
18656337-916	Exposure to <mark style="background-color:lightblue;" id="5280450">linoleic acid</mark> for 6 h <mark style="background-color:orange;">induced</mark> expression of both <mark style="background-color:lightgreen;" id="P33724,P35431,P41350,P49817,P79132,Q03135,Q07DV9,Q07DX1,Q07DY2,Q07DZ2,Q07E02,Q07E25,Q07E38,Q07E49,Q09YH8,Q09YK1,Q09YN6,Q108U7,Q2IBA5,Q2IBC1,Q2IBD7,Q2IBF0,Q2IBG8,Q2QL79,Q2QL90,Q2QLB0,Q2QLC1,Q2QLF2,Q2QLG6,Q2QLH7,Q6B3Y2,Q6RVA9,Q94051,Q9YGM8">caveolin-1</mark> and cyclooxygenase ( <mark style="background-color:lightgreen;" id="P11353,P36551,P36552,Q9UTE2,Q9V3D2">COX</mark> )-2.
18656337-917	Pretreatment with <mark style="background-color:lightblue;" id="65064">EGCG</mark> <mark style="background-color:orange;">blocked</mark> fatty-acid-induced <mark style="background-color:lightgreen;" id="P33724,P35431,P41350,P49817,P79132,Q03135,Q07DV9,Q07DX1,Q07DY2,Q07DZ2,Q07E02,Q07E25,Q07E38,Q07E49,Q09YH8,Q09YK1,Q09YN6,Q108U7,Q2IBA5,Q2IBC1,Q2IBD7,Q2IBF0,Q2IBG8,Q2QL79,Q2QL90,Q2QLB0,Q2QLC1,Q2QLF2,Q2QLG6,Q2QLH7,Q6B3Y2,Q6RVA9,Q94051,Q9YGM8">caveolin-1</mark> and <mark style="background-color:lightgreen;" id="O02768,O19183,O62698,O62725,P27607,P35354,P35355,P70682,P79208,Q05769">COX-2</mark> expression in a time- and concentration-dependent manner.
18656337-918	Exposure to <mark style="background-color:lightblue;" id="5280450">linoleic acid</mark> rapidly <mark style="background-color:orange;">increased</mark> <mark style="background-color:yellow;" id="GO:0016310,biological_process">phosphorylation</mark> of several kinases, <mark style="background-color:orange;">including</mark> <mark style="background-color:lightgreen;" id="O62618">p38 MAPK</mark> , <mark style="background-color:lightgreen;" id="P21708,P27361,P28869,P42525,Q63844">extracellular signal regulated kinase 1</mark> /2 ( <mark style="background-color:lightgreen;" id="P27361,P28869,P42525,Q07176">ERK1</mark> /2) and amino kinase terminal ( <mark style="background-color:lightgreen;" id="P31750,Q8INB9">Akt</mark> ), with maximal induction at about 10 min.
18656337-919	Inhibitors of <mark style="background-color:lightgreen;" id="P27361,P28869,P42525,Q07176">ERK1</mark> /2 and <mark style="background-color:lightgreen;" id="P31750,Q8INB9">Akt</mark> <mark style="background-color:orange;">down-regulated</mark> the <mark style="background-color:lightblue;" id="5280450">linoleic-acid</mark>-induced <mark style="background-color:orange;">increase</mark> in <mark style="background-color:lightgreen;" id="O02768,O19183,O62698,O62725,P27607,P35354,P35355,P70682,P79208,Q05769">COX-2</mark> protein, which also occurred after pretreatment with <mark style="background-color:lightblue;" id="65064">EGCG</mark>.
18656337-920	<mark style="background-color:lightgreen;" id="P33724,P35431,P41350,P49817,P79132,Q03135,Q07DV9,Q07DX1,Q07DY2,Q07DZ2,Q07E02,Q07E25,Q07E38,Q07E49,Q09YH8,Q09YK1,Q09YN6,Q108U7,Q2IBA5,Q2IBC1,Q2IBD7,Q2IBF0,Q2IBG8,Q2QL79,Q2QL90,Q2QLB0,Q2QLC1,Q2QLF2,Q2QLG6,Q2QLH7,Q6B3Y2,Q6RVA9,Q94051,Q9YGM8">Caveolin-1</mark> silencing <mark style="background-color:orange;">blocked</mark> <mark style="background-color:lightblue;" id="5280450">linoleic-acid</mark>-induced <mark style="background-color:yellow;" id="GO:0016310,biological_process">phosphorylation</mark> of <mark style="background-color:lightgreen;" id="P27361,P28869,P42525,Q07176">ERK1</mark> /2 and protein expression of <mark style="background-color:lightgreen;" id="O02768,O19183,O62698,O62725,P27607,P35354,P35355,P70682,P79208,Q05769">COX-2</mark> , suggesting that specific <mark style="background-color:lightgreen;" id="O42781,P27638,Q00859">MAPK</mark> signaling is <mark style="background-color:yellow;" id="GO:0005901,cellular_component">caveolae</mark> dependent.
18656338-921	<mark style="background-color:lightblue;" id="5280443">Apigenin</mark> causes G(2)/M arrest <mark style="background-color:orange;">associated</mark> with the modulation of <mark style="background-color:lightgreen;" id="O19002,O39927,O39928,O39929,O91936,O92529,O92530,O92531,O92532,P26660,P26661,P26662,P26663,P26664,P27954,P27955,P27956,P27957,P27958,P27959,P27960,P27961,P29846,P38936,P39689,P61585,P63028,Q00269,Q01403,Q01404,Q07828,Q11118,Q42580,Q5EG65,Q5I2N3,Q62092,Q68749,Q68798,Q68801,Q81258,Q81487,Q81495,Q81754,Q913D4,Q99IB8,Q9DHD6,Q9QAX1,Q9WMX2">p21</mark> ( <mark style="background-color:lightgreen;" id="O42923,P39689">Cip1</mark> ) and <mark style="background-color:lightgreen;" id="P04551,P11440,P23572,P39951">Cdc2</mark> and <mark style="background-color:orange;">activates</mark> <mark style="background-color:lightgreen;" id="O09185,O12946,O57538,O93379,P02340,P04637,P10361,P19558,P19559,P56423,P56424,P61260,P79820,P79892,Q29537,Q42578,Q8SPZ3,Q92143,Q9TTA1,Q9TUB2,Q9W678,Q9W679">p53</mark> -dependent <mark style="background-color:yellow;" id="GO:0006915,biological_process">apoptosis</mark> pathway in human breast cancer SK-BR-3 cells.
18656338-922	To investigate the regulatory proteins of <mark style="background-color:yellow;" id="GO:0007050,biological_process">cell cycle arrest</mark> affected by <mark style="background-color:lightblue;" id="5280443">apigenin</mark>, we treated cells with 50 and 100 microM <mark style="background-color:lightblue;" id="5280443">apigenin</mark> for 72 h. <mark style="background-color:lightblue;" id="5280443">Apigenin</mark> caused a slight <mark style="background-color:orange;">decrease</mark> in <mark style="background-color:lightgreen;" id="Q5SCB5">cyclin D</mark> and <mark style="background-color:lightgreen;" id="O01377,O16852,P04961,P12004,P17070,P17917,P17918,P18248,P22177,P24314,P31008,P53358,P61074,Q00265,Q00268">cyclin</mark> E expression, with no <mark style="background-color:orange;">change</mark> in <mark style="background-color:lightgreen;" id="O55076,P24941,P43450,P48963,Q5E9Y0">CDK2</mark> and <mark style="background-color:lightgreen;" id="P11802,P79432">CDK4</mark> .
18656338-923	In addition, the <mark style="background-color:lightblue;" id="5280443">apigenin</mark>-induced accumulation of the cell population in the G(2)/ <mark style="background-color:yellow;" id="GO:0000279,biological_process">M phase</mark> resulted in a <mark style="background-color:orange;">decrease</mark> in <mark style="background-color:lightgreen;" id="P00546,P06493,P11440,P13863,P39951,P43063,P48734,P51958,Q5RCH1,Q9DG98,Q9DGA2,Q9DGA5,Q9DGD3">CDK1</mark> together with <mark style="background-color:lightgreen;" id="P20248,P30274,P37881,P43449,P51943,Q92161">cyclin A</mark> and <mark style="background-color:lightgreen;" id="O01377,O16852,P04961,P12004,P17070,P17917,P17918,P18248,P22177,P24314,P31008,P53358,P61074,Q00265,Q00268">cyclin</mark> B.
18656338-924	In an additional study, <mark style="background-color:lightblue;" id="5280443">apigenin</mark> also <mark style="background-color:orange;">increased</mark> the accumulation of <mark style="background-color:lightgreen;" id="O09185,O12946,O57538,O93379,P02340,P04637,P10361,P19558,P19559,P56423,P56424,P61260,P79820,P79892,Q29537,Q42578,Q8SPZ3,Q92143,Q9TTA1,Q9TUB2,Q9W678,Q9W679">p53</mark> and further <mark style="background-color:orange;">enhanced</mark> the <mark style="background-color:orange;">level</mark> of <mark style="background-color:lightgreen;" id="O19002,O39927,O39928,O39929,O91936,O92529,O92530,O92531,O92532,P26660,P26661,P26662,P26663,P26664,P27954,P27955,P27956,P27957,P27958,P27959,P27960,P27961,P29846,P38936,P39689,P61585,P63028,Q00269,Q01403,Q01404,Q07828,Q11118,Q42580,Q5EG65,Q5I2N3,Q62092,Q68749,Q68798,Q68801,Q81258,Q81487,Q81495,Q81754,Q913D4,Q99IB8,Q9DHD6,Q9QAX1,Q9WMX2">p21</mark> ( <mark style="background-color:lightgreen;" id="O42923,P39689">Cip1</mark> ), with no <mark style="background-color:orange;">change</mark> in <mark style="background-color:lightgreen;" id="O11451,O11452,O11453,O39927,O39928,O39929,O91936,O92529,O92530,O92531,O92532,P06934,P16342,P19751,P25880,P25881,P25882,P25884,P25989,P26660,P26661,P26662,P26663,P26664,P27958,P29833,P29846,P29996,P29997,P40305,P68763,P68764,P68765,P69180,P69181,P69182,P69183,P69184,P69618,P69619,Q00269,Q43735,Q5I2N3,Q66198,Q68749,Q68798,Q68801,Q81258,Q81487,Q81495,Q81754,Q81835,Q81842,Q8V439,Q8V6W7,Q913D4,Q91A29,Q91DH7,Q91DH8,Q91DH9,Q99IB8,Q9DHD6,Q9E925,Q9PYA3,Q9QAX1,Q9WMX2">p27</mark> (Kip1).
18656338-925	The expression of <mark style="background-color:lightgreen;" id="P27297,Q07813,Q63690">Bax</mark> and <mark style="background-color:lightgreen;" id="O07091,O13393,O22642,O93863,P00002,P00003,P00004,P00007,P00008,P00011,P00012,P00013,P00014,P00017,P00018,P00019,P00020,P00021,P00022,P00024,P00025,P00027,P00028,P00029,P00030,P00031,P00032,P00035,P00036,P00037,P00038,P00039,P00040,P00041,P00042,P00043,P00046,P00047,P00048,P00049,P00051,P00052,P00053,P00054,P00055,P00056,P00057,P00058,P00059,P00060,P00061,P00062,P00063,P00064,P00065,P00066,P00067,P00068,P00069,P00070,P00071,P00072,P00073,P00074,P00075,P00076,P00077,P00078,P00079,P12831,P15451,P18822,P19681,P19974,P21665,P22342,P25400,P29380,P32556,P38091,P53698,P56205,P59218,P62772,P62773,P62894,P62895,P62896,P67881,P67882,P68096,P68097,P68098,P68099,P68100,P68517,P68518,P68519,P81280,P81459,P99998,P99999,Q41346,Q4HVX7,Q52V08,Q52V09,Q52V10,Q5RFH4,Q640U4,Q6C9Q0,Q6IQM2,Q6Q4H8,Q6QLW4,Q6WUX8,Q753F4,Q7YR71,Q96VP3">cytochrome c</mark> of <mark style="background-color:lightgreen;" id="O09185,O12946,O57538,O93379,P02340,P04637,P10361,P19558,P19559,P56423,P56424,P61260,P79820,P79892,Q29537,Q42578,Q8SPZ3,Q92143,Q9TTA1,Q9TUB2,Q9W678,Q9W679">p53</mark> downstream <mark style="background-color:orange;">target</mark> was <mark style="background-color:orange;">increased</mark> markedly at high concentration treatment over 50 microM <mark style="background-color:lightblue;" id="5280443">apigenin</mark>.
18691156-926	Two related polytopic <mark style="background-color:lightgreen;" id="P16629,P24266,P28991,Q04565,Q07252">membrane proteins</mark> of the major facilitator family, <mark style="background-color:lightgreen;" id="P10903,P46907">NarK</mark> and <mark style="background-color:lightgreen;" id="P37593,P37758">NarU</mark> , <mark style="background-color:orange;">catalyse</mark> <mark style="background-color:lightblue;" id="943">nitrate</mark> uptake, nitrite export and nitrite uptake across the Escherichia coli <mark style="background-color:yellow;" id="GO:0005886,cellular_component">cytoplasmic membrane</mark> by an unknown mechanism.
18695937-929	During the incubation of <mark style="background-color:lightblue;" id="6140">L-phenylalanine</mark> with para-hydroquinones <mark style="background-color:orange;">using</mark> <mark style="background-color:lightgreen;" id="Q12570">laccase</mark> as biocatalyst, one or two main products were formed.
18595002-930	<mark style="background-color:lightgreen;" id="O77220,P14944,P30814,P55845,P56687,P59685,P81032,P83800,Q25588,Q25589,Q25683,Q26181">CHH</mark> <mark style="background-color:orange;">elevates</mark> <mark style="background-color:lightblue;" id="206,5793,64689,79025">glucose</mark> levels in the hemolymph by stimulating glycogenolysis in target tissues.
18640059-934	To investigate the role of <mark style="background-color:lightblue;" id="60961">adenosine</mark> analogs and electromagnetic field (<mark style="background-color:lightblue;" id="23644574">EMF</mark>) stimulation on prostaglandin E(2) ( <mark style="background-color:lightgreen;" id="Q29458">PGE</mark> (2)) <mark style="background-color:orange;">release</mark> and <mark style="background-color:lightgreen;" id="O02768,O19183,O62698,O62725,P27607,P35354,P35355,P70682,P79208,Q05769">cyclooxygenase-2</mark> ( <mark style="background-color:lightgreen;" id="O02768,O19183,O62698,O62725,P27607,P35354,P35355,P70682,P79208,Q05769">COX-2</mark> ) expression in bovine synovial fibroblasts (SFs).
18564211-943	It has been reported that <mark style="background-color:lightblue;" id="2733526">tamoxifen</mark> may <mark style="background-color:orange;">affect</mark> hepatoma cell growth in vitro by <mark style="background-color:orange;">suppressing</mark> <mark style="background-color:orange;">transforming</mark> growth factor beta-1 ( <mark style="background-color:lightgreen;" id="O19011,O93449,P01137,P04202,P07200,P09531,P09533,P16176,P17246,P18341,P50414,P54831,Q38HS2,Q9PTQ2,Q9Z1Y6">TGF-beta1</mark> ) expression, suggesting that <mark style="background-color:lightblue;" id="2733526">tamoxifen</mark> might also retard fibrogenesis.
18564211-944	Thus, we examined whether <mark style="background-color:lightblue;" id="2733526">tamoxifen</mark> might <mark style="background-color:orange;">suppress</mark> <mark style="background-color:lightgreen;" id="O19011,O93449,P01137,P04202,P07200,P09531,P09533,P16176,P17246,P18341,P50414,P54831,Q38HS2,Q9PTQ2,Q9Z1Y6">TGF-beta1</mark> expression and consequently inhibit the process of hepatic fibrosis in vivo.
18621563-947	The immunomodulatory effects of <mark style="background-color:lightblue;" id="5426,75792,92142">thalidomide</mark> are at least partially <mark style="background-color:orange;">mediated</mark> through its ability to <mark style="background-color:orange;">down-regulate</mark> the pathogenic over-production of <mark style="background-color:lightgreen;" id="Q8JFG3">tumor necrosis factor</mark> -alpha ( <mark style="background-color:lightgreen;" id="O35734,O77510,O77764,P01375,P04924,P06804,P13296,P16599,P19101,P23383,P23563,P29553,P33620,P36939,P48094,P51435,P51742,P51743,P59684,P59693,P59694,P59695,P79337,P79374,Q06599,Q19LH4,Q1G1A2,Q1WM27,Q2MH05,Q539C2,Q75N23,Q8HZD9,Q8JFG3,Q8MKG8,Q8WNR1,Q9BEA1">TNF-alpha</mark> ).
18621563-948	In the central nervous system, <mark style="background-color:lightgreen;" id="O35734,O77510,O77764,P01375,P04924,P06804,P13296,P16599,P19101,P23383,P23563,P29553,P33620,P36939,P48094,P51435,P51742,P51743,P59684,P59693,P59694,P59695,P79337,P79374,Q06599,Q19LH4,Q1G1A2,Q1WM27,Q2MH05,Q539C2,Q75N23,Q8HZD9,Q8JFG3,Q8MKG8,Q8WNR1,Q9BEA1">TNF-alpha</mark> is involved in induction of a <mark style="background-color:yellow;" id="GO:0001660,biological_process">fever</mark> response and <mark style="background-color:orange;">triggers</mark> the <mark style="background-color:orange;">release</mark> of other cytokines, and may also <mark style="background-color:orange;">influence</mark> <mark style="background-color:yellow;" id="GO:0006810,biological_process">transport</mark> of compounds into the brain, leading to cerebrospinal fluid leukocytosis, <mark style="background-color:orange;">increased</mark> protein influx, and <mark style="background-color:lightblue;" id="612">lactate</mark> accumulation.
18621563-949	<mark style="background-color:lightblue;" id="5426,75792,92142">Thalidomide</mark> has been shown to <mark style="background-color:orange;">down-regulate</mark> the production of <mark style="background-color:lightgreen;" id="O35734,O77510,O77764,P01375,P04924,P06804,P13296,P16599,P19101,P23383,P23563,P29553,P33620,P36939,P48094,P51435,P51742,P51743,P59684,P59693,P59694,P59695,P79337,P79374,Q06599,Q19LH4,Q1G1A2,Q1WM27,Q2MH05,Q539C2,Q75N23,Q8HZD9,Q8JFG3,Q8MKG8,Q8WNR1,Q9BEA1">TNF-alpha</mark> .
18594946-953	Cell exposure to 250 microM <mark style="background-color:lightblue;" id="778">homocysteine</mark> was able to <mark style="background-color:orange;">induce</mark> <mark style="background-color:lightgreen;" id="P08587,P21980,P21981,P51176,P52181,Q01841">transglutaminase 2</mark> up-regulation and <mark style="background-color:orange;">increased</mark> in situ <mark style="background-color:lightgreen;" id="P40746,P52183,P81453,Q819L3,Q81MS1,Q8GR90,Q9K5W7">transglutaminase</mark> activity.
18594946-954	<mark style="background-color:lightblue;" id="778">Homocysteine</mark> also <mark style="background-color:orange;">induced</mark> NF-kappaB activation that seemed <mark style="background-color:orange;">associated</mark> with <mark style="background-color:lightgreen;" id="P08587,P21980,P21981,P51176,P52181,Q01841">transglutaminase 2</mark> up-regulation since the specific NF-kappaB inhibition by SN50 was able to <mark style="background-color:orange;">reduce</mark> <mark style="background-color:lightgreen;" id="P40746,P52183,P81453,Q819L3,Q81MS1,Q8GR90,Q9K5W7">transglutaminase</mark> expression and activity levels.
18711746-961	Our previous studies have shown that <mark style="background-color:lightblue;" id="5202">serotonin</mark> (<mark style="background-color:lightblue;" id="5202">5-HT</mark>) <mark style="background-color:orange;">altered</mark> under diabetic condition was accompanied by alterations of <mark style="background-color:lightgreen;" id="P13678,Q25378">protein kinase C</mark> -alpha ( <mark style="background-color:lightgreen;" id="P04409,P05696,P10102,P17252,P20444">PKC-alpha</mark> ) and <mark style="background-color:lightgreen;" id="Q00168">CaMKII</mark> , and those alterations were <mark style="background-color:orange;">reversed</mark> after <mark style="background-color:lightgreen;" id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">insulin</mark> administration.
18711746-964	In contrast, the in vitro study has shown that the <mark style="background-color:lightblue;" id="5202">5-HT</mark> <mark style="background-color:orange;">levels</mark> correlated with <mark style="background-color:lightgreen;" id="P04409,P05696,P10102,P17252,P20444">PKC-alpha</mark> expressions as well as <mark style="background-color:lightgreen;" id="P05130,P13677,P13678,P34722">PKC</mark> 0.05), implying a regulatory role for <mark style="background-color:lightgreen;" id="P04409,P05696,P10102,P17252,P20444">PKC-alpha</mark> only in ST, MB, and CB.
18609294-966	Although incubation with <mark style="background-color:lightgreen;" id="P10765,P22393,P33089,P33090,P33091,P43001">prolactin</mark> ( <mark style="background-color:lightgreen;" id="O62781,O62819,O93337,P01236,P01237,P01238,P01239,P01240,P06879,P09585,P10765,P12420,P14676,P17572,P21993,P22393,P29234,P29235,P33089,P33090,P33091,P33096,P34181,P35395,P37884,P40424,P43001,P43299,P46403,P48096,P48249,P51904,P55151,P87495,Q28318,Q28632,Q3Y4G6,Q6UC74,Q7ZZV3,Q8HXS1,Q9QZL1,Q9YGV6">PRL</mark> ) and/or adrenocorticotrophic hormone ( <mark style="background-color:lightgreen;" id="P01189,P01190,P01191,P01192,P01193,P01194,P01196,P01197,P01201,P06297,P06298,P06299,P10000,P11280,P11885,P19402,P21252,P22923,P68000,P68001,P87352,Q04617,Q04618,Q91082,Q9YGK2,Q9YGK4,Q9YGK5">ACTH</mark> ) resulted in a dose-dependent <mark style="background-color:orange;">increase</mark> of <mark style="background-color:lightblue;" id="5753">corticosterone</mark> and <mark style="background-color:lightblue;" id="5994">progesterone</mark> <mark style="background-color:orange;">release</mark> by adrenal cells from both <mark style="background-color:lightblue;" id="547">HAA</mark> and LAA male rats, the responses were markedly increased for adrenal cells from LAA rats as compared with <mark style="background-color:lightblue;" id="547">HAA</mark> rats.
18709647-968	Both 17alpha- and <mark style="background-color:lightblue;" id="5757">17beta-estradiol</mark> <mark style="background-color:orange;">elicited</mark> rapid <mark style="background-color:yellow;" id="GO:0016310,biological_process">phosphorylation</mark> of <mark style="background-color:lightgreen;" id="P46672,Q27272,Q8NFH3,Q9SB81">p42</mark> /44MAPK, <mark style="background-color:lightgreen;" id="P31750,Q8INB9">Akt</mark> , and <mark style="background-color:lightgreen;" id="P18266,P49841,Q5YJC2,Q9WV60">GSK-3beta</mark> within 8 min.
18680106-970	Enhancement of <mark style="background-color:lightgreen;" id="O09185,O12946,O57538,O93379,P02340,P04637,P10361,P19558,P19559,P56423,P56424,P61260,P79820,P79892,Q29537,Q42578,Q8SPZ3,Q92143,Q9TTA1,Q9TUB2,Q9W678,Q9W679">p53</mark> expression in keratinocytes by the <mark style="background-color:lightblue;" id="5280805">bioflavonoid</mark> <mark style="background-color:lightblue;" id="5280443">apigenin</mark> is <mark style="background-color:orange;">associated</mark> with <mark style="background-color:lightgreen;" id="P03526,P04487,P07940,P12002,P56958,P82866">RNA-binding protein</mark>  <mark style="background-color:lightgreen;" id="P70372,Q15717">HuR</mark> .
18680106-971	We have reported previously that <mark style="background-color:lightblue;" id="5280443">apigenin</mark>, a naturally occurring nonmutagenic <mark style="background-color:lightblue;" id="10251">flavonoid</mark>, <mark style="background-color:orange;">increased</mark> wild-type <mark style="background-color:lightgreen;" id="O09185,O12946,O57538,O93379,P02340,P04637,P10361,P19558,P19559,P56423,P56424,P61260,P79820,P79892,Q29537,Q42578,Q8SPZ3,Q92143,Q9TTA1,Q9TUB2,Q9W678,Q9W679">p53</mark> protein expression in the mouse keratinocyte 308 cell line by a mechanism involving <mark style="background-color:lightgreen;" id="O09185,O12946,O57538,O93379,P02340,P04637,P10361,P19558,P19559,P56423,P56424,P61260,P79820,P79892,Q29537,Q42578,Q8SPZ3,Q92143,Q9TTA1,Q9TUB2,Q9W678,Q9W679">p53</mark>  <mark style="background-color:yellow;" id="GO:0050821,biological_process">protein stabilization</mark> .
18680106-973	Instead, biosynthetic labeling showed that <mark style="background-color:lightblue;" id="5280443">apigenin</mark> <mark style="background-color:orange;">increased</mark> nascent <mark style="background-color:lightgreen;" id="O09185,O12946,O57538,O93379,P02340,P04637,P10361,P19558,P19559,P56423,P56424,P61260,P79820,P79892,Q29537,Q42578,Q8SPZ3,Q92143,Q9TTA1,Q9TUB2,Q9W678,Q9W679">p53</mark> protein synthesis by enhancing <mark style="background-color:lightgreen;" id="O09185,O12946,O57538,O93379,P02340,P04637,P10361,P19558,P19559,P56423,P56424,P61260,P79820,P79892,Q29537,Q42578,Q8SPZ3,Q92143,Q9TTA1,Q9TUB2,Q9W678,Q9W679">p53</mark>  <mark style="background-color:yellow;" id="GO:0043037,biological_process">translation</mark> .
18680106-975	Furthermore, <mark style="background-color:lightblue;" id="5280443">apigenin</mark> treatment <mark style="background-color:orange;">increased</mark> the <mark style="background-color:orange;">level</mark> of association of the <mark style="background-color:lightgreen;" id="P03526,P04487,P07940,P12002,P56958,P82866">RNA binding protein</mark>  <mark style="background-color:lightgreen;" id="P70372,Q15717">HuR</mark> with endogenous <mark style="background-color:lightgreen;" id="O09185,O12946,O57538,O93379,P02340,P04637,P10361,P19558,P19559,P56423,P56424,P61260,P79820,P79892,Q29537,Q42578,Q8SPZ3,Q92143,Q9TTA1,Q9TUB2,Q9W678,Q9W679">p53</mark> mRNA.
18680106-976	<mark style="background-color:lightblue;" id="5280443">Apigenin</mark> treatment also <mark style="background-color:orange;">augmented</mark> <mark style="background-color:lightgreen;" id="P70372,Q15717">HuR</mark> translocation into the <mark style="background-color:yellow;" id="GO:0005737,cellular_component">cytoplasm</mark> .
18680106-979	Overall, these findings indicate that, in addition to modulating <mark style="background-color:lightgreen;" id="O09185,O12946,O57538,O93379,P02340,P04637,P10361,P19558,P19559,P56423,P56424,P61260,P79820,P79892,Q29537,Q42578,Q8SPZ3,Q92143,Q9TTA1,Q9TUB2,Q9W678,Q9W679">p53</mark> protein stability, one of the mechanisms by which <mark style="background-color:lightblue;" id="5280443">apigenin</mark> <mark style="background-color:orange;">induces</mark> <mark style="background-color:lightgreen;" id="O09185,O12946,O57538,O93379,P02340,P04637,P10361,P19558,P19559,P56423,P56424,P61260,P79820,P79892,Q29537,Q42578,Q8SPZ3,Q92143,Q9TTA1,Q9TUB2,Q9W678,Q9W679">p53</mark> protein expression is enhancement of <mark style="background-color:yellow;" id="GO:0043037,biological_process">translation</mark> through the <mark style="background-color:lightgreen;" id="P03526,P04487,P07940,P12002,P56958,P82866">RNA binding protein</mark>  <mark style="background-color:lightgreen;" id="P70372,Q15717">HuR</mark> .
18594965-980	<mark style="background-color:lightblue;" id="3988,5311263,5497152">Lysophosphatidic acid</mark> can support the formation of membranous structures and an <mark style="background-color:orange;">increase</mark> in <mark style="background-color:lightgreen;" id="P02686,P02687,P04370,P06906,P13727,P15720,P20939,P25188,P25274,P25336,P81558,P83487,P87346,P98190,Q61878,Q63189,Q91325,Q91439,Q9SAV1">MBP</mark> mRNA levels in differentiating oligodendrocytes.
18600473-984	As compared with parental <mark style="background-color:lightgreen;" id="P34087,Q8VXV4">B16</mark> cells, the inhibitory <mark style="background-color:orange;">effects</mark> of <mark style="background-color:lightgreen;" id="O19011,O93449,P01137,P04202,P07200,P09531,P09533,P16176,P17246,P18341,P50414,P54831,Q38HS2,Q9PTQ2,Q9Z1Y6">TGF-beta1</mark> and activin A on <mark style="background-color:lightblue;" id="6325610">melanin</mark> content were relative smaller in <mark style="background-color:lightgreen;" id="P34087,Q8VXV4">B16</mark>  <mark style="background-color:lightgreen;" id="O19045,O88947,P00742,P00743,P13396,P25155,P29887,P68547,P68609,Q4QXT9,Q63207">F10</mark> cells, a subline of <mark style="background-color:lightgreen;" id="P34087,Q8VXV4">B16</mark> cells that contain more pigment.
18574490-986	BMI and <mark style="background-color:lightblue;" id="6013">testosterone</mark> <mark style="background-color:orange;">levels</mark> were evaluated for their ability to predict overall survival (OS) and prostate-specific antigen ( <mark style="background-color:lightgreen;" id="P07288,P10658,P33619,P55786,Q11011,Q6DT45,Q9Y617">PSA</mark> ) <mark style="background-color:orange;">declines</mark> in the TAX327 clinical trial, an international phase III randomized trial of one of the two schedules of <mark style="background-color:lightblue;" id="148124">docetaxel</mark> and <mark style="background-color:lightblue;" id="5865">prednisone</mark> compared with <mark style="background-color:lightblue;" id="4212">mitoxantrone</mark> and <mark style="background-color:lightblue;" id="5865">prednisone</mark>.
18709661-989	Accordingly, the <mark style="background-color:lightgreen;" id="O15455,Q0PV50,Q5TJ59">TLR3</mark> agonist <mark style="background-color:lightblue;" id="32744,213546,274740">poly(I:C</mark>) (<mark style="background-color:lightblue;" id="1854">PIC</mark>) <mark style="background-color:orange;">induced</mark> higher <mark style="background-color:orange;">release</mark> of <mark style="background-color:lightgreen;" id="O77812,P01574,P01575,P05012,P70499,Q6XZW6,Q9N2J0">IFN-beta</mark> in primary and purified astroglia than in microglia.
18709661-990	As siRNA, <mark style="background-color:lightblue;" id="1854">PIC</mark> <mark style="background-color:orange;">induced</mark> <mark style="background-color:lightgreen;" id="P02778,P17515,P48973">IP-10</mark> , <mark style="background-color:lightgreen;" id="P42225">Stat1</mark> , <mark style="background-color:lightgreen;" id="P19320,P29533,P29534,Q28260">VCAM-1</mark> , and <mark style="background-color:lightgreen;" id="P00411,P24894,P35355,Q05769,Q8HEC3,Q8SEM9">Cox-2</mark> and <mark style="background-color:orange;">increased</mark> <mark style="background-color:lightgreen;" id="O15455,Q0PV50,Q5TJ59">TLR3</mark> mRNA expression.
18643838-993	To elucidate the mechanism by which <mark style="background-color:lightblue;" id="77999">rosiglitazone</mark> <mark style="background-color:orange;">regulates</mark> adipose triglyceride <mark style="background-color:lightgreen;" id="Q7M4U7">lipase</mark> (ATGL).
18568363-998	<mark style="background-color:lightblue;" id="145068">Nitric oxide</mark> <mark style="background-color:orange;">decreases</mark> expression of osmoprotective genes via direct inhibition of <mark style="background-color:lightgreen;" id="O94916">TonEBP</mark> transcriptional activity.
18568363-999	Because <mark style="background-color:lightblue;" id="145068">nitric oxide</mark> (NO) is abundantly <mark style="background-color:orange;">produced</mark> in the renal medulla, the present studies <mark style="background-color:orange;">addressed</mark> the <mark style="background-color:orange;">effect</mark> of NO on expression of osmoprotective genes and <mark style="background-color:lightgreen;" id="O94916">TonEBP</mark> activation in MDCK cells.
18646192-1003	In our earlier method, <mark style="background-color:lightblue;" id="65359">glutathione disulfide</mark> (<mark style="background-color:lightblue;" id="65359">GSSG</mark>) was measured by first <mark style="background-color:orange;">reducing</mark> it to <mark style="background-color:lightblue;" id="124886">GSH</mark> with <mark style="background-color:lightgreen;" id="O15770,P06715,P11804,P23189,P41921,P43783,P48638,P48639,P70619,P78965,Q60151,Q6BPI1,Q6C5H4,Q6FRV2,Q6HA23,Q74ZK4,Q873E8,Q94655">glutathione reductase</mark> (GR) in the presence of <mark style="background-color:lightblue;" id="5884">NADPH</mark>.
18599093-1004	Characterisation of <mark style="background-color:lightblue;" id="5957">ATP</mark> analogues to cross-link and <mark style="background-color:orange;">label</mark> <mark style="background-color:lightgreen;" id="P13900,P16604">P2X</mark> receptors.
18599093-1005	In this study we determined whether the UV light-reactive <mark style="background-color:lightblue;" id="5957">ATP</mark> analogues <mark style="background-color:lightblue;" id="123645,189791">2-azido ATP</mark>, <mark style="background-color:lightblue;" id="5957">ATP</mark> azidoanilide (<mark style="background-color:lightblue;" id="5957">ATP</mark>-AA) and 2',<mark style="background-color:lightblue;" id="115205">3'-O-(4-benzoylbenzoyl)-ATP</mark> (<mark style="background-color:lightblue;" id="115205">BzATP</mark>) can be <mark style="background-color:orange;">used</mark> to <mark style="background-color:orange;">label</mark> the <mark style="background-color:yellow;" id="GO:0005524,molecular_function">ATP binding</mark> site of <mark style="background-color:lightgreen;" id="P47824,P51575,P51576">P2X1</mark> receptors.
18599093-1006	cross-linked to <mark style="background-color:lightgreen;" id="P47824,P51575,P51576">P2X1</mark> receptors and this <mark style="background-color:yellow;" id="GO:0005488,molecular_function">binding</mark> was <mark style="background-color:orange;">reduced</mark> by co-incubation with <mark style="background-color:lightblue;" id="5957">ATP</mark>.
18599093-1007	These studies demonstrate that photo-reactive <mark style="background-color:lightblue;" id="5957">ATP</mark> analogues can be <mark style="background-color:orange;">used</mark> to <mark style="background-color:orange;">label</mark> <mark style="background-color:lightgreen;" id="P13900,P16604">P2X</mark> receptor and may prove useful in elucidating the <mark style="background-color:yellow;" id="GO:0005524,molecular_function">ATP binding</mark> site at this novel class of <mark style="background-color:yellow;" id="GO:0005524,molecular_function">ATP binding</mark> proteins.
18564281-1010	We also explored the effect of <mark style="background-color:lightgreen;" id="P01289,P06767,P19850,P20366,P28498,P28499,P41333,P41539,P41540,P67932,P67933,Q60541">substance P</mark> <mark style="background-color:orange;">released</mark> by <mark style="background-color:lightblue;" id="1548943">capsaicin</mark> because this <mark style="background-color:lightgreen;" id="P21259">neuropeptide</mark> is known to affect the microvasculature environment.
18652909-1018	Lecithin:<mark style="background-color:lightblue;" id="445354">retinol</mark> <mark style="background-color:lightgreen;" id="P05521,P19197,P21309,P23148,P41302,Q06878,Q7N576,Q9AJA7,Q9S3Z2">acyltransferase</mark> ( <mark style="background-color:lightgreen;" id="O95237,Q9BGL2">LRAT</mark> ) <mark style="background-color:orange;">catalyzes</mark> the esterification of <mark style="background-color:lightblue;" id="445354">retinol</mark> (<mark style="background-color:lightblue;" id="445354">vitamin A</mark>).
18652909-1019	<mark style="background-color:lightblue;" id="444795">Retinoic acid</mark> (RA) treatment <mark style="background-color:orange;">increased</mark> this <mark style="background-color:lightgreen;" id="O95237,Q9BGL2">LRAT</mark> promoter- <mark style="background-color:lightgreen;" id="P08659,P13129,Q01158,Q26304,Q27757">luciferase</mark> activity in PrEC cells, but not in PC-3 cells.
18711749-1020	We tested the hypothesis that a <mark style="background-color:lightblue;" id="145068">nitric oxide</mark> donor, <mark style="background-color:lightblue;" id="1606">DETA-NONOate</mark>, <mark style="background-color:orange;">up-regulates</mark> stromal cell-derived factor-1 ( <mark style="background-color:lightgreen;" id="O62657,P48061">SDF1</mark> ) and angiopoietin 1 ( <mark style="background-color:lightgreen;" id="P21570">Ang1</mark> ) in the ischemic brain and their respective receptors chemokine CXC motif receptor 4 ( <mark style="background-color:lightgreen;" id="O62747,P25930,P56491,P56498,P61072,P61073,P79394,Q28474,Q28553,Q3LSL6,Q764M9,Q7YS92,Q8HZU0,Q8HZU1,Q9TSQ8">CXCR4</mark> ) and <mark style="background-color:lightgreen;" id="O73791,Q02858">Tie2</mark> in the subventricular zone (SVZ) and thereby promote SVZ neuroblast <mark style="background-color:yellow;" id="GO:0016477,biological_process">cell migration</mark> after stroke.
18711749-1021	To elucidate whether <mark style="background-color:lightgreen;" id="O62657,P48061">SDF1</mark> / <mark style="background-color:lightgreen;" id="O62747,P25930,P56491,P56498,P61072,P61073,P79394,Q28474,Q28553,Q3LSL6,Q764M9,Q7YS92,Q8HZU0,Q8HZU1,Q9TSQ8">CXCR4</mark> and <mark style="background-color:lightgreen;" id="P21570">Ang1</mark> / <mark style="background-color:lightgreen;" id="O73791,Q02858">Tie2</mark> pathways <mark style="background-color:orange;">mediate</mark> <mark style="background-color:lightblue;" id="1606">DETA-NONOate</mark>-induced SVZ migration after stroke, SDF1alpha, <mark style="background-color:lightgreen;" id="P21570">Ang1</mark> <mark style="background-color:lightblue;" id="52944803">peptide, a</mark> specific antagonist of <mark style="background-color:lightgreen;" id="O62747,P25930,P56491,P56498,P61072,P61073,P79394,Q28474,Q28553,Q3LSL6,Q764M9,Q7YS92,Q8HZU0,Q8HZU1,Q9TSQ8">CXCR4</mark> (<mark style="background-color:lightblue;" id="65015">AMD3100</mark>), and a neutralizing antibody of <mark style="background-color:lightgreen;" id="O73791,Q02858">Tie2</mark> (anti- <mark style="background-color:lightgreen;" id="O73791,Q02858">Tie2</mark> ) were used in vitro.
18711749-1023	<mark style="background-color:lightblue;" id="1606">DETA-NONOate</mark> significantly <mark style="background-color:orange;">increased</mark> the expression of <mark style="background-color:lightgreen;" id="O62657,P48061">SDF1</mark> and <mark style="background-color:lightgreen;" id="P21570">Ang1</mark> in the ischemic border and <mark style="background-color:orange;">up-regulated</mark> <mark style="background-color:lightgreen;" id="O62747,P25930,P56491,P56498,P61072,P61073,P79394,Q28474,Q28553,Q3LSL6,Q764M9,Q7YS92,Q8HZU0,Q8HZU1,Q9TSQ8">CXCR4</mark> and <mark style="background-color:lightgreen;" id="O73791,Q02858">Tie2</mark> in the SVZ compared with MCAo control.
18711749-1025	Our data indicate that treatment of stroke with a <mark style="background-color:lightblue;" id="145068">nitric oxide</mark> donor <mark style="background-color:orange;">up-regulates</mark> <mark style="background-color:lightgreen;" id="O62657,P48061">SDF1</mark> / <mark style="background-color:lightgreen;" id="O62747,P25930,P56491,P56498,P61072,P61073,P79394,Q28474,Q28553,Q3LSL6,Q764M9,Q7YS92,Q8HZU0,Q8HZU1,Q9TSQ8">CXCR4</mark> and <mark style="background-color:lightgreen;" id="P21570">Ang1</mark> / <mark style="background-color:lightgreen;" id="O73791,Q02858">Tie2</mark> pathways and thereby likely increases SVZ neuroblast <mark style="background-color:yellow;" id="GO:0016477,biological_process">cell migration</mark> .
18708284-1027	Islets from <mark style="background-color:lightblue;" id="1123">taurine</mark>-supplemented mice had: (i) significantly higher <mark style="background-color:lightgreen;" id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">insulin</mark> content, (ii) <mark style="background-color:orange;">increased</mark> <mark style="background-color:lightgreen;" id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">insulin</mark>  <mark style="background-color:yellow;" id="GO:0046903,biological_process">secretion</mark> at stimulatory <mark style="background-color:lightblue;" id="206,5793,64689,79025">glucose</mark> concentrations, (iii) significantly <mark style="background-color:orange;">displaced</mark> the dose-response curve for <mark style="background-color:lightblue;" id="206,5793,64689,79025">glucose</mark>-induced <mark style="background-color:lightgreen;" id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">insulin</mark> <mark style="background-color:orange;">release</mark> to the left, (iv) increased <mark style="background-color:yellow;" id="GO:0006006,biological_process">glucose metabolism</mark> at 5.6 and 11.1-mmol/L concentrations; (v) <mark style="background-color:orange;">slowed</mark> cytosolic <mark style="background-color:lightgreen;" id="P00920,P27139">Ca2</mark> + concentration ([ <mark style="background-color:lightgreen;" id="P00920,P27139">Ca2</mark> +]i) oscillations in response to stimulatory <mark style="background-color:lightblue;" id="206,5793,64689,79025">glucose</mark> concentrations; (vi) increased <mark style="background-color:lightgreen;" id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">insulin</mark> , <mark style="background-color:lightgreen;" id="Q09427,Q09428,Q09429">sulfonylurea receptor-1</mark> , <mark style="background-color:lightgreen;" id="O25731,P0A4E1,P0A4E2,P0A6V8,P0A6V9,P17712,P21908,P35557,P52792,P54495,P58616,P58617,P58618,P58619,P64253,P64254,P82680,Q55855,Q56198,Q59171,Q668N7,Q6D7C4,Q7N6Y0,Q83K86,Q87EG6,Q8FFD4,Q8FV09,Q8P8U7,Q8PKU2,Q8UIV7,Q8YDC6,Q92407,Q92T27,Q93IM5,Q98DM2,Q9A6N3,Q9HZ46,Q9KCZ4,Q9PEG4,Q9ZKB0">glucokinase</mark> , <mark style="background-color:lightgreen;" id="P12336,P14246">Glut-2</mark> , proconvertase and <mark style="background-color:lightgreen;" id="P52945,P52946">pancreas duodenum homeobox-1</mark> ( <mark style="background-color:lightgreen;" id="P52945">PDX-1</mark> ) gene expression and (vii) increased <mark style="background-color:lightgreen;" id="P52945">PDX-1</mark> expression in the <mark style="background-color:yellow;" id="GO:0005634,cellular_component">nucleus</mark> .
18708284-1028	Moreover, <mark style="background-color:lightblue;" id="1123">taurine</mark> supplementation significantly <mark style="background-color:orange;">increased</mark> both basal and <mark style="background-color:lightgreen;" id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">insulin</mark> <mark style="background-color:orange;">stimulated</mark> <mark style="background-color:lightblue;" id="1153,6057,5460803">tyrosine</mark> <mark style="background-color:yellow;" id="GO:0016310,biological_process">phosphorylation</mark> of the <mark style="background-color:lightgreen;" id="Q28516">insulin receptor</mark> in skeletal muscle and liver tissues.
18708284-1029	These results indicate that <mark style="background-color:lightblue;" id="1123">taurine</mark> controls <mark style="background-color:yellow;" id="GO:0042593,biological_process">glucose homeostasis</mark> by <mark style="background-color:orange;">regulating</mark> the expression of genes required for <mark style="background-color:lightblue;" id="206,5793,64689,79025">glucose</mark>-stimulated <mark style="background-color:lightgreen;" id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">insulin</mark>  <mark style="background-color:yellow;" id="GO:0046903,biological_process">secretion</mark> .
18708284-1030	In addition, <mark style="background-color:lightblue;" id="1123">taurine</mark> <mark style="background-color:orange;">enhances</mark> peripheral <mark style="background-color:lightgreen;" id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">insulin</mark> sensitivity.
18597073-1033	<mark style="background-color:lightgreen;" id="O04437,O18598,P0A9D2,P0A9D3,P30116,P44521,P46088,P46419,P46423,P46426,P46428,P46437,P48438,P80894,P81065,P82996,P82997,P82998,P82999,P83000,P83001,P83246,Q04522,Q08392,Q08393,Q0ZS46,Q7REH6,Q8ILQ7,Q8MU52,Q96324">Glutathione S-transferase</mark> ( <mark style="background-color:lightgreen;" id="P20432,P30104,P30106,P30107,P30108,Q04522,Q0ZS46,Q7REH6,Q8ILQ7,Q8MU52">GST</mark> ) isozymes <mark style="background-color:orange;">catalyze</mark> nucleophilic <mark style="background-color:orange;">attack</mark> by <mark style="background-color:lightblue;" id="124886">reduced Glutathione</mark> (<mark style="background-color:lightblue;" id="124886">GSH</mark>) on a variety of electrophilic compounds and play a central role in biotransformation of xenobiotics (Hayes et al., Annu Rev Pharmacol Toxicol 45:51-88, 2005).
18670810-1039	Both expression of tac and <mark style="background-color:lightgreen;" id="P06767,P08435,P41539,P55099">tac2</mark> were <mark style="background-color:orange;">induced</mark> by 2% <mark style="background-color:lightblue;" id="5988">sucrose</mark>.
18708285-1040	Furthermore, treatment of <mark style="background-color:lightblue;" id="446925">lycopene</mark> and <mark style="background-color:lightgreen;" id="P01033,P12032">EPA</mark> also synergistically <mark style="background-color:orange;">blocked</mark> the activation of downstream <mark style="background-color:lightgreen;" id="P42345,P42346,Q9JLN9">mTOR</mark> molecule.
18708285-1041	Immunocytochemical staining results revealed that <mark style="background-color:lightblue;" id="446925">lycopene</mark> and <mark style="background-color:lightgreen;" id="P01033,P12032">EPA</mark> could also <mark style="background-color:orange;">up-regulate</mark> the expression of apoptotic proteins such as <mark style="background-color:lightgreen;" id="P27297,Q07813,Q63690">Bax</mark> and <mark style="background-color:lightgreen;" id="P36940,P41047,P48023,P63306,P63307,P63308,Q861W5,Q9BDN1,Q9BEA8">Fas ligand</mark> to suppress cell survival.
18568422-1042	Ran GTPase <mark style="background-color:lightblue;" id="764">guanine</mark> nucleotide exchange factor <mark style="background-color:lightgreen;" id="P18754,P23800,P52499">RCC1</mark> is <mark style="background-color:orange;">phosphorylated</mark> on <mark style="background-color:lightblue;" id="5951">serine</mark> 11 by <mark style="background-color:lightgreen;" id="P04551,P11440,P23572,P39951">cdc2</mark> kinase in vitro.
18568422-1043	An <mark style="background-color:lightgreen;" id="P18754,P23800,P52499">RCC1</mark> mutant in which all N-terminal <mark style="background-color:lightblue;" id="5951">serine</mark> and <mark style="background-color:lightblue;" id="6288">threonine</mark> residues were <mark style="background-color:orange;">substituted</mark> with <mark style="background-color:lightblue;" id="611,23327,33032">glutamate</mark> residues to <mark style="background-color:orange;">mimic</mark> <mark style="background-color:yellow;" id="GO:0016310,biological_process">phosphorylation</mark> at these residues showed <mark style="background-color:orange;">decreased</mark> <mark style="background-color:yellow;" id="GO:0005488,molecular_function">binding</mark> to the karyopherin, <mark style="background-color:lightgreen;" id="O00629">KPNA4</mark> , compared with wild type <mark style="background-color:lightgreen;" id="P18754,P23800,P52499">RCC1</mark> .
18568426-1046	<mark style="background-color:lightblue;" id="5957">ATP</mark>, <mark style="background-color:orange;">acting</mark> on <mark style="background-color:lightgreen;" id="P13900,P16604">P2X</mark> (7) receptors, <mark style="background-color:orange;">stimulates</mark> <mark style="background-color:orange;">changes</mark> in <mark style="background-color:yellow;" id="GO:0005622,cellular_component">intracellular</mark> calcium concentrations, maturation, and <mark style="background-color:orange;">release</mark> of interleukin-1beta ( <mark style="background-color:lightgreen;" id="P01584,P09428,P10749,P14628,P21621,P26889,P41687,P46648,P48090,P51493,P51745,P79162,P79182,Q28292,Q28386,Q2HZH0,Q2MH07,Q63264,Q6PUD2,Q6R2X3,Q865X8,Q8WNR2,Q9WVG1,Q9XS77">IL-1beta</mark> ), and following prolonged agonist exposure, <mark style="background-color:yellow;" id="GO:0008219,biological_process">cell death</mark> .
18612775-1047	<mark style="background-color:lightgreen;" id="P14902,P28776">Indoleamine 2,3-dioxygenase</mark> ( <mark style="background-color:lightgreen;" id="P14902,P28776">IDO</mark> ) <mark style="background-color:orange;">catalyzes</mark> the first and rate-limiting step of <mark style="background-color:lightblue;" id="846">Kynurenine</mark> pathway along the major route of <mark style="background-color:yellow;" id="GO:0006569,biological_process">Tryptophan catabolism</mark> .
18599154-1053	<mark style="background-color:lightgreen;" id="O19011,O93449,P01137,P04202,P07200,P09531,P09533,P16176,P17246,P18341,P50414,P54831,Q38HS2,Q9PTQ2,Q9Z1Y6">TGF-beta1</mark> treatment for 72 h also <mark style="background-color:orange;">induced</mark> <mark style="background-color:lightgreen;" id="O75751,Q08881">EMT</mark> in the A549 cells and this <mark style="background-color:orange;">transition</mark> led to resistance to <mark style="background-color:lightblue;" id="123631">gefitinib</mark>.
18603252-1055	Of importance, treatment with <mark style="background-color:lightblue;" id="150311">ezetimibe</mark> significantly <mark style="background-color:orange;">improved</mark> endothelial dysfunction as assessed by the vasodilator response to <mark style="background-color:lightblue;" id="187">acetylcholine</mark>, accompanied by inhibition of <mark style="background-color:lightgreen;" id="P41693">interleukin-6</mark> mRNA and an <mark style="background-color:orange;">increase</mark> in endothelial <mark style="background-color:lightgreen;" id="O61309,O61608,Q27571,Q9I9M2">nitric oxide synthase</mark> ( <mark style="background-color:lightgreen;" id="P29473,P29474,P70313,P79209,P97270,Q28969,Q62600">eNOS</mark> ) mRNA in the aorta.
18603252-1056	Furthermore, <mark style="background-color:lightblue;" id="150311">ezetimibe</mark> <mark style="background-color:orange;">increased</mark> the mRNA expression of 3-hydroxy-3-methylglutaryl <mark style="background-color:lightblue;" id="87642">co-enzyme A</mark> ( <mark style="background-color:lightgreen;" id="O74164,P40625,Q05153,Q39601">HMG</mark> -CoA) synthase as a counteraction in the liver, but not in the aorta.
18618472-1060	Due to the absence of hydrophobic solute-material interactions, which limit the scope of microstructures fabricated from poly(dimethylsiloxane) for biocatalytic applications, the new microreactor was fully compatible with the alternate enzyme substrate 2-nitro-<mark style="background-color:lightblue;" id="16218547">phenyl-beta-D-galactoside</mark> and the <mark style="background-color:lightblue;" id="6947">2-nitro-phenol</mark> product resulting from its hydrolysis <mark style="background-color:orange;">catalyzed</mark> by <mark style="background-color:lightgreen;" id="P04956,P06565,P06963,P10474,P17334,P18126,P22698,P23550,P23661,P26222,P37701,P38569,P46317,Q45400">CelB</mark> .
18633600-1063	By contrast, treatment of <mark style="background-color:lightblue;" id="46174174">N2a</mark> cells with 1-10 microM <mark style="background-color:lightblue;" id="6419789">DZO</mark> resulted in <mark style="background-color:orange;">marked</mark> reductions in the expression of the <mark style="background-color:yellow;" id="GO:0030424,cellular_component">axon</mark> growth-associated protein <mark style="background-color:lightgreen;" id="P09851,P20936,P50904,P74851,P74873,Q5PEA9,Q92211,Q92263">GAP</mark> -43.
18633600-1064	<mark style="background-color:lightblue;" id="6419789">DZO</mark>-treated cells also showed an <mark style="background-color:orange;">increased</mark> expression of the heat shock protein <mark style="background-color:lightgreen;" id="P27894">HSP-70</mark> compared to controls.
18704946-1065	Although the overall amino acid identity between <mark style="background-color:lightgreen;" id="P31645,Q9XT49">SERTs</mark> and the LeuT(Aa) is only 17%, it <mark style="background-color:orange;">increases</mark> to above 50% in the first shell of the putative <mark style="background-color:lightblue;" id="5202">5-HT</mark> <mark style="background-color:yellow;" id="GO:0005488,molecular_function">binding</mark> site, allowing de novo computational <mark style="background-color:orange;">docking</mark> of <mark style="background-color:lightblue;" id="1150">tryptamine</mark> derivatives in atomic detail.
18624726-1067	The stimulatory effects of stearic, palmitic and palmitoleic acids on resistin <mark style="background-color:yellow;" id="GO:0046903,biological_process">secretion</mark> and the stimulatory effect of <mark style="background-color:lightblue;" id="5281">stearic acid</mark> on <mark style="background-color:lightgreen;" id="P10148,P13500,P14844,P28291,P28292,P42831,P52203,P61274,P61275,Q08782,Q9TTQ3">MCP-1</mark>  <mark style="background-color:yellow;" id="GO:0046903,biological_process">secretion</mark> are <mark style="background-color:orange;">mediated</mark> via <mark style="background-color:lightgreen;" id="P23799">TLR</mark> -4.
18636040-1069	Furthermore, <mark style="background-color:lightgreen;" id="P08263,Q08863">GSTA1-1</mark> levels did not correlate with <mark style="background-color:lightgreen;" id="O35736,P05231,P08505,P20607,P26892,P26893,P29455,P41323,P41683,P41693,P46650,P51494,P79341,Q25BC2,Q28319,Q28747,Q28819,Q2MH06,Q5I6E3,Q6V919,Q865W7,Q865X6,Q8MKH0,Q95181,Q9MZR1,Q9XT80">IL-6</mark> <mark style="background-color:orange;">levels</mark> but did with <mark style="background-color:lightblue;" id="36811">dobutamine</mark> infusion rate (Spearman r = 0.94; P = 0.02), suggesting that the extent of hemodynamic instability and not the degree of inflammation could be of importance for the occurrence of liver damage.
18636044-1070	<mark style="background-color:lightblue;" id="402,108196">Hydrogen sulfide</mark> (<mark style="background-color:lightblue;" id="6857678">H2S</mark>) is a novel gaseous mediator <mark style="background-color:orange;">produced</mark> by <mark style="background-color:lightgreen;" id="P32232,P32582,P35520,P46794,Q58H57,Q91WT9,Q9N0V7,Q9YBL2">cystathionine-beta-synthase</mark> and <mark style="background-color:lightgreen;" id="P18757,P31373,P32929,Q58DW2,Q60HG7,Q8VCN5">cystathionine-gamma-lyase</mark> in the cardiovascular system, including the heart.
18691343-1073	<mark style="background-color:yellow;" id="GO:0005622,cellular_component">Intracellular</mark> interleukin-4 (Th2 cytokine) and <mark style="background-color:lightgreen;" id="Q9TTB0">interferon-gamma</mark> ( <mark style="background-color:lightgreen;" id="Q64279,Q922L6">Th1</mark> cytokine) production was assessed in <mark style="background-color:lightgreen;" id="P01730,P05542,P16003,P16004,P33705,P46630,P79184,P79185,Q08336,Q08338,Q08339,Q08340,Q29037,Q9XS78">CD4</mark> + T lymphocytes <mark style="background-color:orange;">activated</mark> by <mark style="background-color:lightblue;" id="4792,27924,122634,22833501">phorbol 12-myristate 13-acetate</mark> and <mark style="background-color:lightblue;" id="3733,6434517,6912226,25134244">ionomycin</mark> using flow cytometry.
18602447-1075	The rise in [<mark style="background-color:lightblue;" id="271">Ca(2</mark>+)](i) <mark style="background-color:orange;">elicited</mark> by hGH is <mark style="background-color:orange;">associated</mark> with an <mark style="background-color:orange;">enhanced</mark> <mark style="background-color:lightgreen;" id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">insulin</mark>  <mark style="background-color:yellow;" id="GO:0046903,biological_process">secretion</mark> , <mark style="background-color:orange;">effects</mark> that are <mark style="background-color:orange;">mediated</mark> mainly through the <mark style="background-color:lightgreen;" id="P10765,P22393,P33089,P33090,P33091,P43001">prolactin</mark> receptor.
18602447-1076	These mechanisms indicate that a rise in [<mark style="background-color:lightblue;" id="271">Ca(2</mark>+)](i) <mark style="background-color:orange;">elicited</mark> by activation of <mark style="background-color:lightgreen;" id="O46561,P14787,P16471,Q04594,Q28172,Q28235,Q6JTA8,Q90374,Q91094,Q91513">PRLR</mark> is <mark style="background-color:lightgreen;" id="O60674">JAK2</mark> -dependent and is <mark style="background-color:orange;">associated</mark> with <mark style="background-color:orange;">enhanced</mark> <mark style="background-color:lightgreen;" id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">insulin</mark>  <mark style="background-color:yellow;" id="GO:0046903,biological_process">secretion</mark> .
18602447-1077	In contrast, <mark style="background-color:lightgreen;" id="O46600,P10912,P16310,P16882,P19756,P19941,P79108,P79194,Q02092,Q28575,Q90375,Q95JF2,Q95ML5,Q9JI97,Q9TU69,Q9XSZ1">GH receptor</mark> -mediated <mark style="background-color:orange;">increase</mark> in [<mark style="background-color:lightblue;" id="271">Ca(2</mark>+)](i) is <mark style="background-color:lightgreen;" id="O60674">JAK2</mark> -independent and is <mark style="background-color:orange;">dissociated</mark> from <mark style="background-color:lightgreen;" id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">insulin</mark>  <mark style="background-color:yellow;" id="GO:0046903,biological_process">secretion</mark> .
18599191-1078	<mark style="background-color:lightgreen;" id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">Insulin</mark> -antagonistic <mark style="background-color:orange;">effects</mark> of hormones, cytokines and excess metabolic substrates such as <mark style="background-color:lightblue;" id="206,5793,64689,79025">glucose</mark> and fatty acids may be exerted via common mechanisms involving for example reactive <mark style="background-color:lightblue;" id="977">oxygen</mark> species (ROS) accumulation and associated <mark style="background-color:yellow;" id="GO:0006954,biological_process">inflammatory responses</mark> .
18609433-1079	<mark style="background-color:lightblue;" id="5324346">Fluvoxamine</mark>, a SSRI, is mainly <mark style="background-color:orange;">metabolized</mark> by <mark style="background-color:lightgreen;" id="O08469">cytochrome P450</mark> ( <mark style="background-color:lightgreen;" id="P21568,P21569,P24525,P34887,Q26551">CYP</mark> ) 2D6 and <mark style="background-color:lightblue;" id="24941259">1A2</mark>.
18670880-1082	Contaminants of current high use in the LRGV, such as <mark style="background-color:lightblue;" id="2256">atrazine</mark>, and some of the highly persistent organochlorines, such as <mark style="background-color:lightblue;" id="5284469">toxaphene</mark> and <mark style="background-color:lightblue;" id="3035">DDE</mark>, could be potentially <mark style="background-color:orange;">associated</mark> with modulation of <mark style="background-color:lightgreen;" id="O42145,O46512,P11511,P19098,P22443,P28649,P46194,P70091,P79304,P79430,P79699,Q29605,Q29624,Q5QQX7,Q69FB6,Q6QHT9,Q6YI21,Q92087,Q92111,Q92112,Q95M61,Q9XS28">aromatase</mark> activity in avian tissues.
18599210-1087	Optimization of decolorization of <mark style="background-color:lightblue;" id="4139">methylene blue</mark> (MB) <mark style="background-color:orange;">dye</mark> by <mark style="background-color:lightgreen;" id="P06181,P11542,P11543,P20010,P20011,P20012,P20013,P21764,P31837,P31838,P49012,P50622">lignin peroxidase</mark> (LiP) enzyme <mark style="background-color:orange;">produced</mark> by white-rot fungus Phanerochaete chrysosporium <mark style="background-color:orange;">using</mark> sewage treatment plant ( <mark style="background-color:lightgreen;" id="P18347,P50225,P50227,P52846,Q15642">STP</mark> ) sludge as a major substrate was carried out in the laboratory.
18670896-1090	<mark style="background-color:lightblue;" id="6599">Ziram</mark> exposures that caused a loss of <mark style="background-color:yellow;" id="GO:0005488,molecular_function">binding</mark> function were examined for <mark style="background-color:orange;">effects</mark> on expression of key NK cell- <mark style="background-color:lightgreen;" id="O12164,O41803,O42043,O56861,O70902,O71037,O89292,O91086,P03374,P03375,P03377,P03378,P03379,P03380,P03381,P03383,P03385,P03386,P03387,P03388,P03390,P03391,P03392,P03395,P03396,P03397,P03399,P04027,P04502,P04577,P04578,P04579,P04580,P04581,P04582,P04583,P04624,P05877,P05878,P05879,P05880,P05881,P05882,P05883,P05884,P05885,P05886,P06445,P06751,P06752,P07575,P08359,P08360,P08810,P0C212,P10259,P10267,P10269,P11261,P11267,P11268,P11306,P12449,P12487,P12488,P12489,P12492,P14075,P14351,P15073,P15831,P16082,P16090,P16899,P17281,P17755,P18040,P18094,P18799,P19030,P19503,P19549,P19550,P19551,P19556,P19557,P20871,P20872,P20888,P21412,P21415,P21436,P21443,P21444,P21445,P22380,P22427,P22428,P22429,P22430,P23064,P23073,P23422,P23423,P24105,P25057,P25504,P25505,P25506,P25507,P26803,P26804,P27399,P27757,P27977,P31621,P31626,P31627,P31789,P31791,P31794,P31796,P31819,P31872,P32536,P32541,P33498,P35954,P35961,P51515,P51519,P51520,P60507,P60508,P60608,P61549,P61550,P61552,P61553,P61554,P61555,P61556,P61557,P61558,P61559,P61561,P61562,P61563,P61564,P61565,P61566,P61567,P61570,Q02076,Q02077,Q02282,Q02837,Q03804,Q03816,Q03817,Q04993,Q04995,Q05312,Q09SZ7,Q0R5Q9,Q14264,Q1A243,Q1A261,Q69384,Q70626,Q73372,Q74126,Q75008,Q76638,Q77377,Q79670,Q85646,Q89607,Q8AIH5,Q8MIB6,Q902F8,Q902F9,Q96L62,Q9IDV2,Q9N2J8,Q9N2J9,Q9N2K0,Q9NX77,Q9Q714,Q9QBY2,Q9QBZ0,Q9QBZ4,Q9QBZ8,Q9QSQ7,Q9TTC0,Q9UKH3,Q9UQF0,Q9WC60,Q9WC69">surface proteins</mark> needed for <mark style="background-color:yellow;" id="GO:0005488,molecular_function">binding</mark> to targets.
18683188-1093	Furthermore, HA induced dose-dependent elevation of reactive <mark style="background-color:lightblue;" id="977">oxygen</mark> species (ROS) <mark style="background-color:orange;">level</mark> in SMCs, and antioxidant <mark style="background-color:lightblue;" id="54670067">vitamin C</mark> and <mark style="background-color:lightblue;" id="40634">Trolox</mark> effectively <mark style="background-color:orange;">suppressed</mark> HA-induced DNA <mark style="background-color:orange;">damage</mark> and dysregulation of <mark style="background-color:lightgreen;" id="P10417,P49950">Bcl-2</mark> / <mark style="background-color:lightgreen;" id="P27297,Q07813,Q63690">Bax</mark> .
18619705-1094	Furthermore, <mark style="background-color:lightblue;" id="3213">ellipticine</mark> <mark style="background-color:orange;">regulated</mark> endogenous survival signaling by <mark style="background-color:orange;">up-regulating</mark> <mark style="background-color:orange;">phosphorylated</mark> <mark style="background-color:lightgreen;" id="P31750,Q8INB9">Akt</mark> that returned to its basal level later.
18619705-1095	Furthermore, <mark style="background-color:lightblue;" id="3213">ellipticine</mark> <mark style="background-color:orange;">induced</mark> <mark style="background-color:yellow;" id="GO:0005634,cellular_component">nucleus</mark> translocalization of <mark style="background-color:lightgreen;" id="O09185,O12946,O57538,O93379,P02340,P04637,P10361,P19558,P19559,P56423,P56424,P61260,P79820,P79892,Q29537,Q42578,Q8SPZ3,Q92143,Q9TTA1,Q9TUB2,Q9W678,Q9W679">p53</mark> and <mark style="background-color:lightgreen;" id="P31750,Q8INB9">Akt</mark> and recruitment of <mark style="background-color:yellow;" id="GO:0005776,cellular_component">autophagosomes</mark> .
18670906-1096	<mark style="background-color:lightgreen;" id="Q8IUC2">KAP8.1</mark> protein <mark style="background-color:orange;">contains</mark> high <mark style="background-color:lightblue;" id="750">glycine</mark> and <mark style="background-color:lightblue;" id="1153,6057,5460803">tyrosine</mark>, which concerns regulation and function of the matrix structure fiber.
18710402-1097	<mark style="background-color:yellow;" id="GO:0005622,cellular_component">Intracellular</mark> concentrations of <mark style="background-color:lightblue;" id="271">Ca(2</mark>+) <mark style="background-color:orange;">modulate</mark> the strength of signal and <mark style="background-color:orange;">alter</mark> the outcomes of cytotoxic T-lymphocyte <mark style="background-color:lightgreen;" id="P31522,Q26721,Q56982">antigen-4</mark> ( <mark style="background-color:lightgreen;" id="P16410">CD152</mark> )- <mark style="background-color:lightgreen;" id="P33681,P42070">CD80</mark> / <mark style="background-color:lightgreen;" id="P42071,P42081">CD86</mark> interactions in <mark style="background-color:lightgreen;" id="P01730,P05542,P16003,P16004,P33705,P46630,P79184,P79185,Q08336,Q08338,Q08339,Q08340,Q29037,Q9XS78">CD4</mark> (+) T lymphocytes.
18710402-1099	During activation with <mark style="background-color:lightblue;" id="27924,122634,22833501">PMA</mark> and low amounts of I, <mark style="background-color:yellow;" id="GO:0005622,cellular_component">intracellular</mark> concentrations of calcium ([<mark style="background-color:lightblue;" id="271">Ca(2</mark>+)](i)) were greatly <mark style="background-color:orange;">reduced</mark> upon <mark style="background-color:lightgreen;" id="P09793,P16410,P42072,Q9MYX7,Q9XSI1">CTLA-4</mark> - <mark style="background-color:lightgreen;" id="P33681,P42070">CD80</mark> / <mark style="background-color:lightgreen;" id="P42071,P42081">CD86</mark> blockade.
18710402-1100	Further experiments demonstrated that <mark style="background-color:lightgreen;" id="P09793,P16410,P42072,Q9MYX7,Q9XSI1">CTLA-4</mark> - <mark style="background-color:lightgreen;" id="P33681,P42070">CD80</mark> / <mark style="background-color:lightgreen;" id="P42071,P42081">CD86</mark> interactions <mark style="background-color:orange;">reduced</mark> cell cycling upon activation with <mark style="background-color:lightblue;" id="27924,122634,22833501">PMA</mark> and high amounts of I or TG (high <mark style="background-color:lightblue;" id="8885">SOS</mark>) but the opposite occurred with <mark style="background-color:lightblue;" id="27924,122634,22833501">PMA</mark> and low amounts of I or TG (low <mark style="background-color:lightblue;" id="8885">SOS</mark>).
18710402-1101	Also, <mark style="background-color:lightgreen;" id="P09793,P16410,P42072,Q9MYX7,Q9XSI1">CTLA-4</mark> - <mark style="background-color:lightgreen;" id="P33681,P42070">CD80</mark> / <mark style="background-color:lightgreen;" id="P42071,P42081">CD86</mark> interactions <mark style="background-color:orange;">enhanced</mark> the generation of reactive <mark style="background-color:lightblue;" id="977">oxygen</mark> species (ROS).
18584896-1102	For this purpose, on day 0, male Wistar rats received NTG (120 microg/kg, iv) with or without pre-administration of <mark style="background-color:lightgreen;" id="P05130,P13677,P13678,P34722">PKC</mark> inhibitor <mark style="background-color:lightblue;" id="2703,411938">chelerythrine</mark> (CHE), <mark style="background-color:lightblue;" id="1548943">capsaicin</mark> (CAP) to <mark style="background-color:orange;">deplete</mark> <mark style="background-color:lightgreen;" id="P10286,P30880,P30881,P31888,P80511">CGRP</mark> from sensory nerves or mK(<mark style="background-color:lightblue;" id="5957">ATP</mark>) channel blocker 5-hydroxydecaonic acid (<mark style="background-color:lightblue;" id="25058136">5HD</mark>).
18619713-1104	The ubiquitous enzyme <mark style="background-color:lightblue;" id="65070">dUTP</mark> nucleotidohydrolase ( <mark style="background-color:lightgreen;" id="O25536,O27642,O29157,O30931,O41033,O48500,O52597,O54134,O66592,O68992,O83855,O84294,P03195,P03370,P06968,P09254,P0A552,P0A553,P10234,P14597,P16088,P16824,P16901,P17374,P19028,P23426,P23427,P28892,P28893,P30007,P31625,P31822,P32208,P32518,P33316,P33317,P33826,P35956,P43058,P43792,P52341,P52541,P57623,P57914,P59408,P61906,P61907,P61908,P61909,P61910,P61911,P61912,P61913,P64004,P64005,P64006,P64007,P64008,P64009,P68634,P68635,P70583,P87630,Q00030,Q01034,Q06095,Q07275,Q2Y742,Q2YRG4,Q31EC7,Q31UY6,Q329L7,Q39DM5,Q39V99,Q3A499,Q3AQ75,Q3B304,Q3BNA6,Q3J0B2,Q3J6W1,Q3JV72,Q3K4M6,Q3KM70,Q3SFR7,Q3SWM9,Q3YRU2,Q3YW02,Q45920,Q47BB1,Q47NK1,Q48Q06,Q491W8,Q49992,Q4FU67,Q4JVB1,Q4K3S2,Q4QLV3,Q4ULV2,Q4UPP2,Q4ZZX9,Q57BK5,Q57IA2,Q58502,Q5F9E0,Q5FN20,Q5GST1,Q5H5L9,Q5L6D8,Q5LIH9,Q5LWD3,Q5NHX4,Q5P7Z9,Q5PAE6,Q5PC28,Q5QZB6,Q5WTW6,Q5X242,Q5YT90,Q5ZSN0,Q603M1,Q62HL1,Q63WI6,Q64ZK3,Q65R66,Q66GD8,Q68WX8,Q69151,Q6A8W1,Q6AFE0,Q6AJZ0,Q6BRN7,Q6C141,Q6CQN7,Q6DAV9,Q6E4Q0,Q6FDR0,Q6FKQ6,Q6FYR2,Q6G202,Q6MEK7,Q6MVL2,Q6RZR1,Q6TUZ4,Q74ZF0,Q76RE7,Q775Z7,Q7M9N1,Q7MAX3,Q7MBE8,Q7MVT6,Q7NKL2,Q7VJU0,Q7VN49,Q7VRK0,Q7VVR1,Q7W8Z8,Q7WKE3,Q823Q9,Q82KK4,Q82UM1,Q83G43,Q83I22,Q83PN3,Q87F19,Q88BD3,Q88C95,Q895R1,Q89662,Q8A245,Q8D2F3,Q8E9M0,Q8F729,Q8FPH9,Q8G4E8,Q8K921,Q8NPA9,Q8P458,Q8PFR5,Q8PWG1,Q8RA46,Q8RER7,Q8SRS0,Q8TGX9,Q8TV34,Q8UII1,Q8V2Y0,Q8XWL1,Q8ZJP5,Q90030,Q92I74,Q92SM6,Q97J61,Q98C10,Q9A253,Q9CJ30,Q9F7S4,Q9HMF3,Q9HTN3,Q9J5G5,Q9JUW1,Q9JZU7,Q9P6Q5,Q9PGZ6,Q9PKA2,Q9X3X5,Q9YG32,Q9YYS0,Q9Z9C2,Q9ZDD2,Q9ZKY3">dUTPase</mark> ) <mark style="background-color:orange;">catalyses</mark> the hydrolysis of <mark style="background-color:lightblue;" id="65070">dUTP</mark> to dUMP and can be considered as the first line of defence against incorporation of <mark style="background-color:lightblue;" id="1174">uracil</mark> into DNA.
18603333-1106	A series of <mark style="background-color:lightblue;" id="9238">adamantane</mark> derivatives of thiazolyl-N-substituted amides were <mark style="background-color:orange;">synthesized</mark> in a three-step reaction and tested for anti-inflammatory activity as well as <mark style="background-color:lightgreen;" id="P27481,P38414">lipoxygenase</mark> and cycloxygenase inhibitory actions.
18634065-1115	Affinity assays were performed to measure endogenous <mark style="background-color:lightblue;" id="6830">GTP</mark>-bound <mark style="background-color:lightgreen;" id="O51891,O67031,O83281,P03304,P0A295,P0A296,P0AG30,P0AG31,P0AG32,P0AG33,P15409,P17593,P17594,P20350,P29403,P33561,P35359,P38527,P44619,P45835,P51489,P52152,P52153,P52154,P52155,P52156,P52157,P52158,P56466,P57652,P66028,P66029,Q03222,Q06447,Q89A22,Q9ZD24,Q9ZLS9">Rho</mark> , and confocal microscopy was <mark style="background-color:orange;">used</mark> to assess <mark style="background-color:orange;">changes</mark> in organization of the <mark style="background-color:lightgreen;" id="O00937,O13419,O16808,O17320,O65314,O65315,O65316,O74258,O81221,P02577,P10365,P10989,P11426,P13363,P14235,P17128,P20904,P24902,P26182,P26183,P30161,P45520,P45521,P48465,P50138,P51775,P53455,P53476,P53477,P53491,P53498,P53499,P53500,P53502,P53689,P60009,P60010,P60011,P68555,P78711,P80709,P81085,P90689,P91754,Q05214,Q11212,Q24733,Q2U7A3,Q39596,Q39758,Q6TCF2,Q75D00,Q8SWN8,Q8X119,Q92192,Q92193,Q99023,Q9P4D1,Q9UVF3,Q9UVX4,Q9UVZ8">actin</mark>  <mark style="background-color:yellow;" id="GO:0005856,cellular_component">cytoskeleton</mark> .
18634065-1116	<mark style="background-color:lightgreen;" id="O46612,O46613,P01582,P01583,P04822,P08831,P16598,P18430,P46647,P48089,P79161,P79340,Q28385,Q28579,Q3HWU1,Q60480,Q865X7">IL-1alpha</mark> and RhoG14V <mark style="background-color:orange;">increased</mark> cytoplasmic <mark style="background-color:lightgreen;" id="O00937,O13419,O16808,O17320,O65314,O65315,O65316,O74258,O81221,P02577,P10365,P10989,P11426,P13363,P14235,P17128,P20904,P24902,P26182,P26183,P30161,P45520,P45521,P48465,P50138,P51775,P53455,P53476,P53477,P53491,P53498,P53499,P53500,P53502,P53689,P60009,P60010,P60011,P68555,P78711,P80709,P81085,P90689,P91754,Q05214,Q11212,Q24733,Q2U7A3,Q39596,Q39758,Q6TCF2,Q75D00,Q8SWN8,Q8X119,Q92192,Q92193,Q99023,Q9P4D1,Q9UVF3,Q9UVX4,Q9UVZ8">actin</mark>  <mark style="background-color:yellow;" id="GO:0001725,cellular_component">stress fiber</mark> formation, which was <mark style="background-color:orange;">blocked</mark> by C3 Transferase, and <mark style="background-color:lightblue;" id="448042">Y27632</mark>.
18634065-1118	Expression of RhoQ63L or RhoG14V resulted in increased <mark style="background-color:lightgreen;" id="O18927,O62806,O77656,P23097,P33435,P45452,Q10835">MMP-13</mark> expression; however, inhibition of <mark style="background-color:lightgreen;" id="O51891,O67031,O83281,P03304,P0A295,P0A296,P0AG30,P0AG31,P0AG32,P0AG33,P15409,P17593,P17594,P20350,P29403,P33561,P35359,P38527,P44619,P45835,P51489,P52152,P52153,P52154,P52155,P52156,P52157,P52158,P56466,P57652,P66028,P66029,Q03222,Q06447,Q89A22,Q9ZD24,Q9ZLS9">Rho</mark> with <mark style="background-color:lightblue;" id="448042">Y27632</mark> was unable to <mark style="background-color:orange;">inhibit</mark> <mark style="background-color:lightgreen;" id="O46612,O46613,P01582,P01583,P04822,P08831,P16598,P18430,P46647,P48089,P79161,P79340,Q28385,Q28579,Q3HWU1,Q60480,Q865X7">IL-1alpha</mark> -induced <mark style="background-color:lightgreen;" id="O18927,O62806,O77656,P23097,P33435,P45452,Q10835">MMP-13</mark> expression.
18617682-1119	CSE activated the <mark style="background-color:lightgreen;" id="P03956,P13943,P21692,P28053,P81563,Q11133,Q9XSZ5">MMP-1</mark> promoter, and this induction was <mark style="background-color:orange;">prevented</mark> by <mark style="background-color:lightblue;" id="4713">PD98059</mark> blockade of <mark style="background-color:lightgreen;" id="P27361,P28869,P42525,Q07176">ERK1</mark> /2 <mark style="background-color:yellow;" id="GO:0016310,biological_process">phosphorylation</mark> .
18683221-1122	The adsorption of ovine <mark style="background-color:lightgreen;" id="P22775,P81070">fibrinogen</mark> onto <mark style="background-color:lightblue;" id="27924,122634,22833501">PMA</mark>-modified surfaces was <mark style="background-color:orange;">reduced</mark> relative to unmodified surfaces, and in vitro ovine blood contact through a rocking test revealed <mark style="background-color:orange;">marked</mark> reductions in platelet deposition and bulk phase <mark style="background-color:yellow;" id="GO:0030168,biological_process">platelet activation</mark> relative to unmodified TiAl6V4 and <mark style="background-color:lightblue;" id="7501">polystyrene</mark> controls.
18683225-1127	When the <mark style="background-color:lightgreen;" id="P84122">thrombin</mark> concentration was higher than 15 U/mL, the gelation could be finished within 1 min and <mark style="background-color:orange;">yielded</mark> a composite with evenly suspended and distributed <mark style="background-color:lightblue;" id="36797">PLGA</mark> microspheres.
18704955-1137	Our findings suggest that <mark style="background-color:lightgreen;" id="O12956,P01272,P01273,P01274,P01275,P05110,P06883,P22890,P29794,P55095,P68259,Q06605,Q8MJ25">GLP-1</mark> <mark style="background-color:orange;">substituted</mark> with a <mark style="background-color:lightgreen;" id="P09466">PEG</mark> of an appropriate Mw at <mark style="background-color:lightgreen;" id="P05821,P10099,P13344,P13345,P15176,P23630,P51728,Q03709,Q9T1X2">Lys</mark> (34) could be <mark style="background-color:orange;">used</mark> as a promising type 2 anti-diabetic agent to timely control postprandial <mark style="background-color:lightblue;" id="206,5793,64689,79025">glucose</mark> levels.
18626791-1140	Following thermal denaturation, rabbit reticulocyte lysate and <mark style="background-color:lightblue;" id="5957">ATP</mark> were <mark style="background-color:orange;">added</mark> and <mark style="background-color:lightgreen;" id="P08659,P13129,Q01158,Q26304,Q27757">luciferase</mark> activity measured.
18683246-1143	<mark style="background-color:lightgreen;" id="P01282,P01283,P01284,P04566,P09684,P09685,P32648,P32649,P39089,P45644,P48142,P48143,P63289,P63290,P63291,P81016,P81401,P84488,P84771,P84772">Vasoactive intestinal peptide</mark> <mark style="background-color:orange;">inhibits</mark> toll-like receptor 3-induced <mark style="background-color:lightblue;" id="145068">nitric oxide</mark> production in Schwann cells and subsequent sensory neuronal <mark style="background-color:yellow;" id="GO:0008219,biological_process">cell death</mark> in vitro.
18634843-1147	The increase of mature <mark style="background-color:lightgreen;" id="O19073,P70380,P97636,Q14116,Q3ZT29,Q5I931,Q8QFQ8,Q95M33,Q9TU73,Q9XSQ7,Q9XSR0">IL-18</mark> by macrophages was <mark style="background-color:orange;">inhibited</mark> by <mark style="background-color:lightblue;" id="44134608">caspase-1 inhibitor</mark>: caspase-1 is known to cleave the proform of <mark style="background-color:lightgreen;" id="O19073,P70380,P97636,Q14116,Q3ZT29,Q5I931,Q8QFQ8,Q95M33,Q9TU73,Q9XSQ7,Q9XSR0">IL-18</mark> to produce active mature <mark style="background-color:lightgreen;" id="O19073,P70380,P97636,Q14116,Q3ZT29,Q5I931,Q8QFQ8,Q95M33,Q9TU73,Q9XSQ7,Q9XSR0">IL-18</mark> .
18633619-1153	Resistance of neoplastic cells to the alkylating drug <mark style="background-color:lightblue;" id="2578">BCNU</mark> [1,3- <mark style="background-color:lightgreen;" id="Q9JLV1">bis</mark> (2-<mark style="background-color:lightblue;" id="6338">chloroethyl</mark>)-<mark style="background-color:lightblue;" id="105035">1-nitrosourea</mark>] has been correlated with expression of <mark style="background-color:lightblue;" id="65275">O (6)-methylguanine</mark>-DNA <mark style="background-color:lightgreen;" id="O40976,P03588,P03589,P06011,P17769,P20122,P27752,P28726,P28931,Q00020,Q66121,Q83264,Q83270">methyltransferase</mark> , which <mark style="background-color:orange;">repairs</mark> the O (6)-<mark style="background-color:lightblue;" id="161383">chloroethylguanine</mark> produced by the drug.
18562423-1156	Patients under <mark style="background-color:lightblue;" id="2818">clozapine</mark>-<mark style="background-color:lightblue;" id="5073">risperidone</mark> therapy <mark style="background-color:orange;">developed</mark> a <mark style="background-color:orange;">rise</mark> of serum <mark style="background-color:lightgreen;" id="P10765,P22393,P33089,P33090,P33091,P43001">prolactin</mark> levels.
18683263-1164	The amplification of <mark style="background-color:lightgreen;" id="O33915,O34002,O68883,P09948,P0ABH7,P0ABH8,P14165,P18789,P20902,P20903,P21553,P26491,P39812,P42457,P51031,P51032,P51033,P51034,P51035,P51036,P51039,P51040,P51041,P51042,P51043,P51045,P56062,P80148,P94325,Q10530,Q53554,Q59136,Q59198,Q59258,Q59730,Q59732,Q59734,Q59741,Q59742,Q59748,Q59759,Q59768,Q59776,Q59778,Q59977,Q9RWB2,Q9ZN37">gltA</mark> gene encoding <mark style="background-color:lightgreen;" id="O33915,O34002,O68883,P09948,P0ABH7,P0ABH8,P14165,P18789,P20901,P20902,P20903,P21553,P26491,P27660,P42457,P51031,P51032,P51033,P51034,P51035,P51036,P51039,P51040,P51041,P51042,P51043,P51045,P56062,P80148,P84543,P94325,Q53554,Q59136,Q59198,Q59258,Q59730,Q59732,Q59734,Q59741,Q59742,Q59748,Q59759,Q59768,Q59776,Q59778,Q59939,Q59977,Q9RWB2,Q9ZN37">citrate synthase</mark> of <mark style="background-color:lightgreen;" id="P56626">TCA</mark> cycle was required for the efficient conversion of <mark style="background-color:lightgreen;" id="P07668">acetyl-CoA</mark> , <mark style="background-color:orange;">generated</mark> during <mark style="background-color:lightblue;" id="1183">vanillin</mark> production from <mark style="background-color:lightblue;" id="445858">ferulic acid</mark>, to CoA, which is essential for <mark style="background-color:lightblue;" id="1183">vanillin</mark> production.
18683263-1167	The <mark style="background-color:lightgreen;" id="O33915,O34002,O68883,P09948,P0ABH7,P0ABH8,P14165,P18789,P20902,P20903,P21553,P26491,P39812,P42457,P51031,P51032,P51033,P51034,P51035,P51036,P51039,P51040,P51041,P51042,P51043,P51045,P56062,P80148,P94325,Q10530,Q53554,Q59136,Q59198,Q59258,Q59730,Q59732,Q59734,Q59741,Q59742,Q59748,Q59759,Q59768,Q59776,Q59778,Q59977,Q9RWB2,Q9ZN37">gltA</mark> amplification of the <mark style="background-color:yellow;" id="GO:0006097,biological_process">glyoxylate bypass</mark> in the <mark style="background-color:lightgreen;" id="P08200,P79089">icdA</mark> null mutant remarkably <mark style="background-color:orange;">increased</mark> the production rate of <mark style="background-color:lightblue;" id="1183">vanillin</mark> with a little increase in the amount of <mark style="background-color:lightblue;" id="1183">vanillin</mark> production.
18570630-1172	Ischaemia and <mark style="background-color:lightgreen;" id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">insulin</mark> , but not ischaemia and contraction, <mark style="background-color:orange;">act</mark> synergistically in <mark style="background-color:orange;">stimulating</mark> muscle <mark style="background-color:lightblue;" id="206,5793,64689,79025">glucose</mark> uptake in vivo in humans.
18570630-1173	In summary, ischaemia and <mark style="background-color:lightgreen;" id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">insulin</mark> independently <mark style="background-color:orange;">stimulate</mark> skeletal muscle <mark style="background-color:lightblue;" id="206,5793,64689,79025">glucose</mark> uptake in vivo in humans, whereas ischaemia and contraction do not.
18580872-1175	Pre-synaptic <mark style="background-color:lightgreen;" id="P52451">CB1Rs</mark> <mark style="background-color:orange;">inhibit</mark> <mark style="background-color:yellow;" id="GO:0007269,biological_process">neurotransmitter release</mark> , suggesting that <mark style="background-color:lightgreen;" id="P52451">CB1R</mark> activation during extinction may <mark style="background-color:orange;">decrease</mark> <mark style="background-color:lightgreen;" id="O57312,O93464,P01355,P01356,P06307,P09240,P0C229,P23362,P41520,P50144,P50145,P68125,P68126,P80344,P80345,Q9PU29,Q9PU41">CCK</mark> peptide <mark style="background-color:orange;">release</mark> as well as <mark style="background-color:lightblue;" id="119">GABA</mark> release.
18580876-1179	Acute <mark style="background-color:lightblue;" id="2826,5760,439497,446220,644017,54613779">cocaine</mark>, through <mark style="background-color:lightgreen;" id="O73810,P14416,P20288,P52702,P60026,P61168,P61169,Q6TLI9,Q9GJU1">D(2) dopamine receptors</mark> , <mark style="background-color:orange;">induced</mark> a dose-response <mark style="background-color:orange;">increase</mark> in <mark style="background-color:lightgreen;" id="Q13158,Q61160">FADD protein</mark> in the cortex, with opposite <mark style="background-color:orange;">effects</mark> over pFADD (Ser191/194), and no induction of apoptotic <mark style="background-color:yellow;" id="GO:0008219,biological_process">cell death</mark> (poly-( <mark style="background-color:lightgreen;" id="P02783">ADP</mark> -ribose) polymerase cleavage).
18580876-1180	<mark style="background-color:lightgreen;" id="P46310,Q13158">FADD</mark> was <mark style="background-color:orange;">increased</mark> by <mark style="background-color:lightblue;" id="2826,5760,439497,446220,644017,54613779">cocaine</mark> in <mark style="background-color:yellow;" id="GO:0005829,cellular_component">cytosol</mark> (approximately 142%), <mark style="background-color:yellow;" id="GO:0016020,cellular_component">membranes</mark> (approximately 23%) and <mark style="background-color:yellow;" id="GO:0005634,cellular_component">nucleus</mark> (approximately 54%).
18654608-1184	As multidrug resistance (MDR) is a major problem in the chemotherapy of progressive breast cancer, the in vitro effects of Ad- <mark style="background-color:lightgreen;" id="Q9UBP4">REIC</mark> treatment were <mark style="background-color:orange;">investigated</mark> in terms of the sensitivity of multidrug-resistant MCF7/ <mark style="background-color:lightgreen;" id="P31107,P40471">ADR</mark> cells to <mark style="background-color:lightblue;" id="31703">doxorubicin</mark> and of the P- <mark style="background-color:lightgreen;" id="P08163">glycoprotein</mark> expression.
18654608-1185	Ad- <mark style="background-color:lightgreen;" id="Q9UBP4">REIC</mark> treatment in MCF7/ <mark style="background-color:lightgreen;" id="P31107,P40471">ADR</mark> cells also <mark style="background-color:orange;">downregulated</mark> P- <mark style="background-color:lightgreen;" id="P08163">glycoprotein</mark> expresssion through <mark style="background-color:lightgreen;" id="P92208,Q966Y3">JNK</mark> activation, and <mark style="background-color:orange;">sensitized</mark> its drug resistance against <mark style="background-color:lightblue;" id="31703">doxorubicin</mark>.
18689429-1187	We examined whether <mark style="background-color:lightblue;" id="5839">aldosterone</mark> <mark style="background-color:orange;">produced</mark> locally in the brain may contribute to the activation of <mark style="background-color:lightgreen;" id="P08235,P22199,P79404,Q29131,Q3YC04,Q4JM28,Q8QHI2,Q8VII8,Q91573,Q9BDJ7,Q9IAC6,Q9N0W8">mineralocorticoid receptors</mark> in the CNS.
18617751-1188	We have previously demonstrated that <mark style="background-color:lightblue;" id="5311181,6435378,6443959,53394043,53486260">iloprost</mark>, a stable <mark style="background-color:lightblue;" id="5280427,5282411,6434194">prostacyclin</mark> ( <mark style="background-color:lightgreen;" id="O25781,O51672,O59618,O66954,O82059,O83488,O84382,P06744,P06745,P08059,P0A0T0,P0A0T1,P0A6T1,P0A6T2,P12341,P12709,P13377,P18240,P28718,P29333,P34795,P34796,P34797,P42861,P44312,P46479,P47357,P49105,P50309,P52029,P52030,P52031,P52983,P54234,P54235,P54236,P54237,P54238,P54239,P54240,P54241,P54242,P54243,P57636,P64192,P64193,P64194,P64195,P64196,P77877,P78033,P78917,P80860,P81181,P83194,P83780,P84140,P96803,P99078,Q0TA36,Q0VR14,Q11MA0,Q13Z07,Q165T7,Q18FQ4,Q1ASN4,Q1BH79,Q1CSA0,Q1CX51,Q1GAY0,Q1GJQ5,Q1GTU1,Q1H1P4,Q1IYT4,Q1J8N2,Q1JDQ8,Q1JIS1,Q1JNM4,Q1LM68,Q1LU73,Q1MM06,Q1QEK1,Q1R3R3,Q1WUR2,Q21M11,Q21ZD5,Q24VW9,Q255I6,Q28QX4,Q2A2C5,Q2FIB3,Q2FZU0,Q2G7C4,Q2IE39,Q2JH03,Q2JHU0,Q2JX86,Q2KCY8,Q2KYE9,Q2LRD0,Q2NJ38,Q2NR04,Q2P380,Q2RQ51,Q2S8W1,Q2SS24,Q2SWP6,Q2VYV7,Q2YBU4,Q2YPF3,Q2YWS3,Q31AX5,Q31I19,Q31LL0,Q31TX1,Q328X7,Q38WF1,Q39FF4,Q39SU1,Q3A201,Q3AFH3,Q3AJU7,Q3ASZ0,Q3AXV8,Q3B3Q8,Q3BUL3,Q3IKH4,Q3IMS0,Q3J2U4,Q3JCN1,Q3JRE2,Q3K2Y2,Q3K6Q4,Q3KLX6,Q3M6S3,Q3YUW0,Q3ZBD7,Q44407,Q46L16,Q47IJ3,Q48N88,Q48VF9,Q491V0,Q49WA1,Q4A5S9,Q4A7J2,Q4A9F3,Q4FVH5,Q4JCA7,Q4JX51,Q4K5Y1,Q4L4X8,Q4QL07,Q4R591,Q4UTV8,Q4ZY88,Q57F73,Q57H06,Q59000,Q59088,Q5E847,Q5FL04,Q5H0A7,Q5HHC2,Q5HQJ9,Q5JE38,Q5KVS7,Q5L5E1,Q5L9E3,Q5LRS9,Q5M1N9,Q5N0B4,Q5NFC4,Q5P0T4,Q5PL07,Q5QWW0,Q5R4E3,Q5SLL6,Q5UXU0,Q5WDX0,Q5WYE0,Q5X6Y8,Q5XE09,Q5YPP1,Q5ZXH2,Q600A8,Q609I7,Q62JL8,Q632G4,Q63V31,Q64PM7,Q65FL6,Q65TC2,Q660E3,Q664W9,Q67QQ0,Q6A5X5,Q6AQ48,Q6D022,Q6F1L2,Q6FRW1,Q6G0T9,Q6GAW4,Q6GIC6,Q6HC08,Q6KH90,Q6LM51,Q6LXQ4,Q6MD44,Q6MTA3,Q6NIE5,Q6YQU0,Q711G1,Q71X61,Q72GY6,Q72MT7,Q72YI4,Q73K18,Q742E4,Q74DK5,Q74K31,Q758L0,Q7MH97,Q7MUV9,Q7MZB4,Q7NJY9,Q7S986,Q7U6T0,Q7V1I1,Q7V7M6,Q7VBZ6,Q7VNR9,Q7VRI4,Q7VUF4,Q7W197,Q7WP01,Q816G0,Q81K75,Q822E7,Q82SP4,Q835G1,Q83D91,Q83XM3,Q848I4,Q87EV7,Q87L81,Q888Q7,Q88UI4,Q891H2,Q89A35,Q8A5W2,Q8CT80,Q8D1V8,Q8DCK7,Q8DKY2,Q8DN74,Q8EBH1,Q8ENY8,Q8EVU1,Q8EZG6,Q8FB44,Q8FR39,Q8G2N3,Q8G7I6,Q8K8Q6,Q8K910,Q8KDQ7,Q8L1Z9,Q8NS31,Q8NXF1,Q8P2R3,Q8P9S7,Q8R924,Q8RHH5,Q8SRY1,Q8UI94,Q8VVB7,Q8XI54,Q8XYN9,Q8Y4R7,Q8YF86,Q8YY05,Q8Z1U7,Q8ZAS2,Q8ZKI4,Q8ZWV0,Q928R6,Q92SC4,Q96YC2,Q978F3,Q97FP8,Q97NG0,Q97WE5,Q98BV5,Q98R79,Q9A1L1,Q9ABK5,Q9CD75,Q9CNL2,Q9FXM4,Q9FXM5,Q9HGZ2,Q9HIC2,Q9HNQ6,Q9HV67,Q9K7L8,Q9KUY4,Q9KX58,Q9N1E2,Q9PGR6,Q9PK16,Q9PMD4,Q9RDY2,Q9RMC1,Q9RTL8,Q9UXW3,Q9X1A5,Q9X670,Q9YE01,Q9Z6N4,Q9ZK49">PGI</mark> (2)) analogue, <mark style="background-color:orange;">induces</mark> <mark style="background-color:yellow;" id="GO:0001525,biological_process">angiogenesis</mark> in vivo, through a vascular endothelial growth factor ( <mark style="background-color:lightgreen;" id="P15691,P15692,P26617,P49151,P50412,P67964,P67965,Q99PS1,Q9GKR0,Q9MYV3">VEGF</mark> )-dependent mechanism.
18617751-1189	In this study, we demonstrate that <mark style="background-color:lightblue;" id="5311181,6435378,6443959,53394043,53486260">iloprost</mark>-induced <mark style="background-color:yellow;" id="GO:0001525,biological_process">angiogenesis</mark> and <mark style="background-color:lightgreen;" id="P15691,P15692,P26617,P49151,P50412,P67964,P67965,Q99PS1,Q9GKR0,Q9MYV3">VEGF</mark> upregulation are <mark style="background-color:orange;">modulated</mark> by <mark style="background-color:lightgreen;" id="O35507,P23204,P37230,P37232,Q07869,Q8HYL6,Q95N78">peroxisome proliferator-activated receptor-alpha</mark> ( <mark style="background-color:lightgreen;" id="O35507,P23204,P37230,P37232,Q07869,Q8HYL6,Q95N78">PPARalpha</mark> ), a ligand-inducible <mark style="background-color:yellow;" id="GO:0006350,biological_process">transcription</mark> factor that belongs to the nuclear hormone receptor superfamily and plays multiple biological activities in the vascular system.
18617751-1191	In contrast, <mark style="background-color:lightblue;" id="5311181,6435378,6443959,53394043,53486260">iloprost</mark> <mark style="background-color:orange;">induces</mark> a robust angiogenic response in wild-type mice, along with local upregulation of <mark style="background-color:lightgreen;" id="P15691,P15692,P26617,P49151,P50412,P67964,P67965,Q99PS1,Q9GKR0,Q9MYV3">VEGF</mark> .
18615707-1194	<mark style="background-color:lightgreen;" id="O64362,O80288,O80292,P00720,P03706,P07540,P09963,P10439,P11187,P13656,P15057,P19385,P19386,P21270,P23472,P23473,P27359,P33486,P37715,P39046,P51771,P62692,P62693,P68920,P68921,P81241,P82174,P82175,P83673,Q27650,Q37875,Q37896,Q48603,Q7SID7,Q9CIT4,Q9T1X2,Q9ZXB7">Lysozymes</mark> <mark style="background-color:orange;">act</mark> as crucial bacteriolytic enzymes in insect immune system by <mark style="background-color:orange;">hydrolyzing</mark> the beta (1--&gt;4) bonds between <mark style="background-color:lightblue;" id="24139">N-acetylglucosamine</mark> and <mark style="background-color:lightblue;" id="440822,542212,5462244,6323218">N-acetylmuramic acid</mark> in the <mark style="background-color:lightblue;" id="9816401">peptidoglycan</mark> of prokaryotic <mark style="background-color:yellow;" id="GO:0009275,GO:0009505,GO:0009277,GO:0009276,GO:0009274,GO:0005618,cellular_component">cell walls</mark> .
18698130-1197	To confirm that mouse <mark style="background-color:lightgreen;" id="Q13316,Q95120">DMP1</mark> -PG possesses a single <mark style="background-color:lightgreen;" id="P01105,P32503">GAG</mark> chain attached to <mark style="background-color:lightgreen;" id="P18168">Ser</mark> (89), we <mark style="background-color:orange;">substituted</mark> <mark style="background-color:lightgreen;" id="P18168">Ser</mark> (89) by <mark style="background-color:lightblue;" id="750,5460845">Gly</mark>(89).
18607531-1203	The structure-activity relationship between <mark style="background-color:lightblue;" id="5281426">oxycoumarin</mark> derivatives showing inhibitory <mark style="background-color:orange;">effects</mark> on <mark style="background-color:lightgreen;" id="O19114,O46660,O54705,O62699,P29477,P35228,P79290,Q06518,Q27995,Q28314,Q90703,Q92037,Q92091">iNOS</mark> in mouse macrophage RAW264.7 cells.
18607531-1204	We have investigated the structure-activity relationship between 63 natural <mark style="background-color:lightblue;" id="5281426">oxycoumarin</mark> derivatives and their <mark style="background-color:orange;">effects</mark> on the expression of inducible- <mark style="background-color:lightgreen;" id="O61309,O61608,Q27571,Q9I9M2">nitric oxide synthase</mark> ( <mark style="background-color:lightgreen;" id="O19114,O46660,O54705,O62699,P29477,P35228,P79290,Q06518,Q27995,Q28314,Q90703,Q92037,Q92091">iNOS</mark> ) <mark style="background-color:orange;">induced</mark> by <mark style="background-color:lightblue;" id="11970143">lipopolysaccharide</mark>.
18703795-1210	In addition, treatment of primary mouse lung fibroblasts with <mark style="background-color:lightblue;" id="123831">ADMA</mark> <mark style="background-color:orange;">stimulated</mark> <mark style="background-color:lightgreen;" id="O49046,P00812,P0A2X9,P0A2Y0,P0A2Y1,P14012,P33280,P37818,P39138,P40906,P46637,P53608,P60086,P60087,P60088,Q10066,Q12611,Q1E180,Q6G7E9,Q6GER3,Q74ZW4,Q7M0Z3,Q8NVE3">arginase</mark> activity and <mark style="background-color:yellow;" id="GO:0005581,cellular_component">collagen</mark> formation in vitro.
18703795-1211	These data support the idea that <mark style="background-color:lightblue;" id="123831">ADMA</mark> may play a role in airway diseases, <mark style="background-color:orange;">including</mark> asthma and pulmonary fibrosis, through <mark style="background-color:lightgreen;" id="O54705,O61309,O61608,Q26240,Q28969,Q9I9M2">NOS</mark> inhibition and enhancement of <mark style="background-color:lightgreen;" id="O49046,P00812,P0A2X9,P0A2Y0,P0A2Y1,P14012,P33280,P37818,P39138,P40906,P46637,P53608,P60086,P60087,P60088,Q10066,Q12611,Q1E180,Q6G7E9,Q6GER3,Q74ZW4,Q7M0Z3,Q8NVE3">arginase</mark> activity.
18607542-1212	Inhibition of protein synthesis by <mark style="background-color:lightblue;" id="68791">imexon</mark> <mark style="background-color:orange;">reduces</mark> <mark style="background-color:lightgreen;" id="O35800,Q0PGG7,Q16665,Q309Z6,Q61221,Q98SW2,Q9I8A9,Q9XTA5,Q9YIB9">HIF-1alpha</mark> expression in normoxic and hypoxic pancreatic cancer cells.
18607542-1213	Western blot analyses of <mark style="background-color:lightblue;" id="68791">imexon</mark>-treated cells demonstrated that <mark style="background-color:lightblue;" id="68791">imexon</mark> <mark style="background-color:orange;">reduces</mark> <mark style="background-color:lightgreen;" id="O35800,Q0PGG7,Q16665,Q309Z6,Q61221,Q98SW2,Q9I8A9,Q9XTA5,Q9YIB9">HIF-1alpha</mark> protein levels in both normoxic and hypoxic conditions in a time- and concentration-dependant fashion.
18607542-1216	Concurrently, the half-life of existing <mark style="background-color:lightgreen;" id="O35800,Q0PGG7,Q16665,Q309Z6,Q61221,Q98SW2,Q9I8A9,Q9XTA5,Q9YIB9">HIF-1alpha</mark> protein was <mark style="background-color:orange;">increased</mark> by <mark style="background-color:lightblue;" id="68791">imexon</mark>, in association with a <mark style="background-color:orange;">marked</mark> inhibition of chymotryptic activity in the <mark style="background-color:lightblue;" id="10412331">20S</mark> proteasome.
18607542-1217	The inhibition of <mark style="background-color:lightgreen;" id="O35800,Q0PGG7,Q16665,Q309Z6,Q61221,Q98SW2,Q9I8A9,Q9XTA5,Q9YIB9">HIF-1alpha</mark>  <mark style="background-color:yellow;" id="GO:0043037,biological_process">translation</mark> was not specific, rather it was part of a general <mark style="background-color:orange;">decrease</mark> in protein <mark style="background-color:yellow;" id="GO:0043037,biological_process">translation</mark> caused by <mark style="background-color:lightblue;" id="68791">imexon</mark>.
18708191-1226	Intravenous <mark style="background-color:lightblue;" id="738,5961">glutamine</mark> <mark style="background-color:orange;">enhances</mark> <mark style="background-color:lightgreen;" id="O02768,O19183,O62698,O62725,P27607,P35354,P35355,P70682,P79208,Q05769">COX-2</mark> activity giving cardioprotection.
18708191-1227	We investigated whether acute intravenous <mark style="background-color:lightblue;" id="738,5961">glutamine</mark>, through an <mark style="background-color:orange;">effect</mark> on cyclooxygenase ( <mark style="background-color:lightgreen;" id="P11353,P36551,P36552,Q9UTE2,Q9V3D2">COX</mark> )-2 and heat shock protein ( <mark style="background-color:lightgreen;" id="P32590">HSP</mark> ) 72, might induce preconditioning.
18694847-1230	Almost all <mark style="background-color:lightgreen;" id="P31750,Q8INB9">Akt</mark> kinase that translocates to the <mark style="background-color:yellow;" id="GO:0005634,cellular_component">nucleus</mark> shows a <mark style="background-color:orange;">marked</mark> <mark style="background-color:yellow;" id="GO:0016310,biological_process">phosphorylation</mark> on <mark style="background-color:lightblue;" id="5951">serine</mark> 473.
18570695-1236	7,12-Dimethyl-benz[a]<mark style="background-color:lightblue;" id="8418">anthracene</mark> (<mark style="background-color:lightblue;" id="6001">DMBA</mark>) can <mark style="background-color:orange;">induce</mark> expressions of <mark style="background-color:lightgreen;" id="O42231,O42430,O42457,P00185,P04798,P05176,P33616,P56590,P56591,P79716,P98181,Q00557,Q06367,Q3LFU0,Q5KQT7,Q6GUR1,Q6JZS3,Q92039,Q92095,Q92100,Q92109,Q92110,Q92116,Q92148,Q9W683,Q9YH64">CYP1A1</mark> and <mark style="background-color:lightgreen;" id="Q16678">CYP1B1</mark> which are known to be responsive to <mark style="background-color:lightgreen;" id="P00439,P04176,P16331,P17276,P30967,P43334,P90925,Q8XU39,Q98D72,Q9A7V7,Q9KLB8">PAH</mark> .
18582992-1242	Therefore, <mark style="background-color:lightblue;" id="156419">cinacalcet</mark>, which <mark style="background-color:orange;">inhibit</mark> the production of <mark style="background-color:lightgreen;" id="P01270">parathormone</mark> by negative feedback, was considered a treatment option to control the evolution of calciphylaxis in a dialysed patient suffering from cholangiocarcinoma.
18636241-1244	Removal of <mark style="background-color:yellow;" id="GO:0005576,cellular_component">extracellular</mark>  <mark style="background-color:lightgreen;" id="P00920,P27139">Ca2</mark> + or inhibition of the <mark style="background-color:lightgreen;" id="P00920,P27139">Ca2</mark> +-permeable cation channels with <mark style="background-color:lightblue;" id="16231">amiloride</mark> blunted the <mark style="background-color:orange;">effects</mark> of arsenic on <mark style="background-color:lightgreen;" id="P08758,P14668,P17153,P48036,P70075,P81287,Q4R4H7,Q5R1W0">annexin V</mark> - <mark style="background-color:yellow;" id="GO:0005488,molecular_function">binding</mark> and cell shrinkage.
18701806-1254	The <mark style="background-color:lightblue;" id="614,8988,145742">proline</mark> mutation at amino acid location 164 significantly <mark style="background-color:orange;">reduced</mark> the initial hydrolysis of either the <mark style="background-color:lightgreen;" id="O97646,O97647,Q28462">amelogenins</mark> in solution or the proteins <mark style="background-color:orange;">bound</mark> on <mark style="background-color:lightgreen;" id="P10826,Q15424,Q99933">HAP</mark> , which was confirmed by <mark style="background-color:lightgreen;" id="O97646,O97647,Q28462">amelogenin</mark> oligopeptide assays.
18618621-1255	These findings suggest that multiple variations in the <mark style="background-color:lightgreen;" id="O35899,P31645,Q9MYX0,Q9XT49">SLC6A4</mark> gene are <mark style="background-color:orange;">associated</mark> with remission in white non-Hispanic <mark style="background-color:orange;">depressed</mark> adults treated with <mark style="background-color:lightblue;" id="2771,146570">citalopram</mark>.
18696104-1256	The effect on activation voltage but not that on amplitude was absent when expressing a <mark style="background-color:lightblue;" id="6076">cAMP</mark>-insensitive mutant (HCN2R/E), while a C-terminal truncated form of <mark style="background-color:lightgreen;" id="Q9UL51">HCN2</mark> (HCN2DeltaCx) exhibited only the voltage dependent but not the amplitude <mark style="background-color:orange;">effect</mark> of <mark style="background-color:lightblue;" id="5328552">erbstatin</mark>.
18696104-1257	Thus, the action of <mark style="background-color:lightblue;" id="5328552">erbstatin</mark> on the activation relation and current amplitude are distinct and separable in newborn myocytes, and the <mark style="background-color:orange;">effect</mark> on activation voltage depends on the <mark style="background-color:lightblue;" id="6076">cAMP</mark> status of <mark style="background-color:lightgreen;" id="Q9UL51">HCN2</mark> channels.
18703867-1272	Osteopontin ( <mark style="background-color:lightgreen;" id="P10451,P14287,P31096,Q9XSY9">OPN</mark> ) <mark style="background-color:orange;">inhibits</mark> the growth of <mark style="background-color:lightblue;" id="971">calcium oxalate monohydrate</mark> (COM) and other crystal phases in a <mark style="background-color:yellow;" id="GO:0016310,biological_process">phosphorylation</mark> -dependent manner.
18623061-1275	<mark style="background-color:lightgreen;" id="P05480,Q9WUD9">Src</mark> kinases can be <mark style="background-color:orange;">activated</mark> by trans- <mark style="background-color:yellow;" id="GO:0016310,biological_process">phosphorylation</mark> of a <mark style="background-color:lightblue;" id="1153,6057,5460803">tyrosine</mark> located in the central activation loop of the catalytic domain.
18704953-1278	Mal- <mark style="background-color:lightgreen;" id="P56862">sCT</mark> , prepared by <mark style="background-color:orange;">conjugating</mark> <mark style="background-color:lightgreen;" id="P56862">sCT</mark> via thio-<mark style="background-color:lightblue;" id="3283,5382654">ether</mark> bonds with aqueous-soluble <mark style="background-color:lightblue;" id="985">palmitic acid</mark> derivative at <mark style="background-color:lightgreen;" id="P23779,Q86GF7">Cys</mark> 1 and <mark style="background-color:lightgreen;" id="P23779,Q86GF7">Cys</mark> 7, was <mark style="background-color:orange;">reacted</mark> with <mark style="background-color:lightblue;" id="8019">mPEG</mark>-<mark style="background-color:lightblue;" id="11439">succinimide</mark> (<mark style="background-color:lightblue;" id="8019">mPEG</mark>-Suc, 5 kDa).
18662930-1285	<mark style="background-color:lightblue;" id="24759">Hyaluronan</mark> <mark style="background-color:orange;">inhibits</mark> expression of <mark style="background-color:lightgreen;" id="O75173,Q5RFQ8,Q9TT93">ADAMTS4</mark> ( <mark style="background-color:lightgreen;" id="O75173,Q5RFQ8,Q8BNJ2,Q9ESP7,Q9TT93">aggrecanase-1</mark> ) in human osteoarthritic chondrocytes.
18636311-1287	In the present study, we investigated the inhibitory effect of the known oxycoumarins poncitrin (3), <mark style="background-color:lightblue;" id="10228">osthol</mark> (4), and <mark style="background-color:lightblue;" id="66548">xanthoxyletin</mark> (5), newly isolated from Clausena guillauminii (Rutaceae), together with the known carbazoles <mark style="background-color:lightblue;" id="5318015">heptaphylline</mark> (1) and 7-methoxyheptaphylline (2) on inducible- <mark style="background-color:lightgreen;" id="O61309,O61608,Q27571,Q9I9M2">nitric oxide synthase</mark> ( <mark style="background-color:lightgreen;" id="O19114,O46660,O54705,O62699,P29477,P35228,P79290,Q06518,Q27995,Q28314,Q90703,Q92037,Q92091">iNOS</mark> ) expression <mark style="background-color:orange;">induced</mark> by <mark style="background-color:lightblue;" id="11970143">lipopolysaccharide</mark> (LPS) and the NO generation in RAW 264.7 mouse macrophages.
18654747-1289	<mark style="background-color:lightblue;" id="219023">Diflomotecan</mark>, a homocamptothecin, <mark style="background-color:orange;">targets</mark> <mark style="background-color:lightgreen;" id="O27661,O28469,O34204,O51768,O58356,O66893,O69548,O73954,O83409,P04786,P06612,P07799,P0A2I1,P0A2I2,P0A620,P0A621,P11387,P16472,P30181,P30189,P32989,P34184,P34185,P39814,P40114,P41511,P41512,P43012,P46155,P46799,P47368,P55991,P57371,P68697,P68698,P73810,P78032,P93119,Q00313,Q04750,Q07050,Q59046,Q76ZS7,Q7YR26,Q87AQ6,Q8K9P7,Q92IH1,Q9CG80,Q9CN30,Q9HM08,Q9HZJ5,Q9JN65,Q9KA23,Q9KRB2,Q9PEV8,Q9PLZ2,Q9UYS8,Q9WUL0,Q9X3X7,Q9X909,Q9YB01,Q9ZDK2,Q9ZMV7">DNA topoisomerase I</mark> .
18703622-1295	The <mark style="background-color:lightgreen;" id="P05017,P07455,P08025,P10763,P16545,P17085,P17647,P18254,P33712,P51457,P51458,P51462,Q02815,Q28933,Q68LC0,Q6GUL6,Q6IVA5,Q6JLX1,Q95222">IGF-I</mark> <mark style="background-color:orange;">effect</mark> was further demonstrated by showing that the <mark style="background-color:lightgreen;" id="P08069,P24062,Q05688,Q29000,Q60751">IGF-I receptor</mark> antagonist, <mark style="background-color:lightblue;" id="71455">JB-1</mark>, blocked the <mark style="background-color:lightgreen;" id="P05017,P07455,P08025,P10763,P16545,P17085,P17647,P18254,P33712,P51457,P51458,P51462,Q02815,Q28933,Q68LC0,Q6GUL6,Q6IVA5,Q6JLX1,Q95222">IGF-I</mark> -induced increase in KiSS-1 expression.
18706695-1298	<mark style="background-color:lightgreen;" id="P06961,P45269,Q57JQ5,Q5E2K7,Q5F8K9,Q5P3T0,Q5PC82,Q5WT58,Q5X1E5,Q5ZRX9,Q60CQ4,Q62EU1,Q63YC3,Q65Q41,Q665U9,Q6D160,Q6FA38,Q6LV05,Q7M7K5,Q7MAZ9,Q7MBF4,Q821A6,Q82U82,Q87DS9,Q87SK9,Q88A53,Q88QU2,Q8CWL6,Q8CXX6,Q8P5D4,Q8PPG9,Q8XBL4,Q8Y395,Q8Z3M9,Q8ZI64,Q8ZLY4,Q9CP21,Q9I5V3,Q9JUB2,Q9JZ88,Q9KPC6,Q9L7A3,Q9PDL7">Phosphatase</mark> activity was also <mark style="background-color:orange;">inhibited</mark> for all the soils treated with <mark style="background-color:lightblue;" id="5564">triclosan</mark> (from 0.1 to 50mg/kg dry soil), but a declining inhibition was observed after 2 days of incubation.
18674953-1307	<mark style="background-color:lightblue;" id="64947">Gyp</mark> <mark style="background-color:orange;">inhibited</mark> the <mark style="background-color:orange;">levels</mark> of the anti-apoptotic proteins <mark style="background-color:lightgreen;" id="P10417,P49950">Bcl-2</mark> and Bcl-xl, but <mark style="background-color:orange;">promoted</mark> the levels of the pro-apoptotic <mark style="background-color:lightgreen;" id="P27297">protein Bax</mark> .
18674953-1308	In conclusion, <mark style="background-color:lightblue;" id="64947">Gyp</mark> <mark style="background-color:orange;">induced</mark> <mark style="background-color:yellow;" id="GO:0005783,cellular_component">ER</mark> stress and production of reactive <mark style="background-color:lightblue;" id="977">oxygen</mark> species and <mark style="background-color:lightblue;" id="271">Ca(2</mark>+), <mark style="background-color:orange;">change</mark> the ratio of <mark style="background-color:lightgreen;" id="P10417,P49950">Bcl-2</mark> and <mark style="background-color:lightgreen;" id="P27297,Q07813,Q63690">Bax</mark> , followed by the dysfunction of mitochondria, caused <mark style="background-color:lightgreen;" id="O07091,O13393,O22642,O93863,P00002,P00003,P00004,P00007,P00008,P00011,P00012,P00013,P00014,P00017,P00018,P00019,P00020,P00021,P00022,P00024,P00025,P00027,P00028,P00029,P00030,P00031,P00032,P00035,P00036,P00037,P00038,P00039,P00040,P00041,P00042,P00043,P00046,P00047,P00048,P00049,P00051,P00052,P00053,P00054,P00055,P00056,P00057,P00058,P00059,P00060,P00061,P00062,P00063,P00064,P00065,P00066,P00067,P00068,P00069,P00070,P00071,P00072,P00073,P00074,P00075,P00076,P00077,P00078,P00079,P12831,P15451,P18822,P19681,P19974,P21665,P22342,P25400,P29380,P32556,P38091,P53698,P56205,P59218,P62772,P62773,P62894,P62895,P62896,P67881,P67882,P68096,P68097,P68098,P68099,P68100,P68517,P68518,P68519,P81280,P81459,P99998,P99999,Q41346,Q4HVX7,Q52V08,Q52V09,Q52V10,Q5RFH4,Q640U4,Q6C9Q0,Q6IQM2,Q6Q4H8,Q6QLW4,Q6WUX8,Q753F4,Q7YR71,Q96VP3">cytochrome c</mark> release, activation of caspase-3 before leading to <mark style="background-color:yellow;" id="GO:0006915,biological_process">apoptosis</mark> .
18688042-1313	The goal of this study was to determine the mechanisms by which <mark style="background-color:lightblue;" id="5757">17beta-estradiol</mark> <mark style="background-color:orange;">induces</mark> <mark style="background-color:lightgreen;" id="Q9HC84">MUC5B</mark> gene expression in airway epithelial cells.
18688042-1314	Pretreatment with <mark style="background-color:yellow;" id="GO:0005783,cellular_component">ER</mark> antagonist <mark style="background-color:lightblue;" id="104741">ICI 182,780</mark> <mark style="background-color:orange;">blocked</mark> both <mark style="background-color:yellow;" id="GO:0004840,molecular_function">E2</mark> -induced <mark style="background-color:lightgreen;" id="P27361,P28869,P42525,Q07176">ERK1</mark> /2- <mark style="background-color:lightgreen;" id="O42781,P27638,Q00859">MAPK</mark> activation and <mark style="background-color:lightgreen;" id="Q9HC84">MUC5B</mark> gene expression.
18665051-1321	Administration of <mark style="background-color:lightblue;" id="12041">ethyl pyruvate</mark> to <mark style="background-color:orange;">inhibit</mark> <mark style="background-color:lightgreen;" id="P07156,P09429,P10103,P12682,P36194,Q4R844,Q6YKA4">HMGB1</mark> or anti- <mark style="background-color:lightgreen;" id="Q15109,Q28173,Q9UQ07">RAGE</mark> antibody could significantly <mark style="background-color:orange;">decrease</mark> expression <mark style="background-color:orange;">levels</mark> of <mark style="background-color:lightgreen;" id="P09793,P16410,P42072,Q9MYX7,Q9XSI1">CTLA-4</mark> , <mark style="background-color:lightgreen;" id="Q99JB6">Foxp3</mark> on Tregs, and <mark style="background-color:lightgreen;" id="O46673,O97798,P18893,P22301,P29456,P43480,P46651,P47965,P48411,P51496,P51497,P51746,P55029,P79338,Q0Z972,Q25BC1,Q28374,Q29055,Q29408,Q2PE73,Q5Q0V6,Q865X4,Q8MKG9,Q9JHK7,Q9TSJ4,Q9Z1Y5">IL-10</mark> production after burns.
18607722-1327	The <mark style="background-color:lightgreen;" id="P01131,P20063,Q28832">low-density lipoprotein receptor</mark> (LDLr) <mark style="background-color:orange;">mediates</mark> the uptake of LDL particles <mark style="background-color:orange;">enriched</mark> with <mark style="background-color:lightblue;" id="304,5997,6432564,11025495">cholesterol</mark>, into several tissues.
18642106-1330	The <mark style="background-color:lightblue;" id="611,23327,33032">glutamate</mark> <mark style="background-color:orange;">induced</mark> <mark style="background-color:yellow;" id="GO:0006935,biological_process">chemotaxis</mark> was accompanied by polarization of the <mark style="background-color:lightgreen;" id="O00937,O13419,O16808,O17320,O65314,O65315,O65316,O74258,O81221,P02577,P10365,P10989,P11426,P13363,P14235,P17128,P20904,P24902,P26182,P26183,P30161,P45520,P45521,P48465,P50138,P51775,P53455,P53476,P53477,P53491,P53498,P53499,P53500,P53502,P53689,P60009,P60010,P60011,P68555,P78711,P80709,P81085,P90689,P91754,Q05214,Q11212,Q24733,Q2U7A3,Q39596,Q39758,Q6TCF2,Q75D00,Q8SWN8,Q8X119,Q92192,Q92193,Q99023,Q9P4D1,Q9UVF3,Q9UVX4,Q9UVZ8">actin</mark>  <mark style="background-color:yellow;" id="GO:0005856,cellular_component">cytoskeleton</mark> , and by polymerization of F- <mark style="background-color:lightgreen;" id="O00937,O13419,O16808,O17320,O65314,O65315,O65316,O74258,O81221,P02577,P10365,P10989,P11426,P13363,P14235,P17128,P20904,P24902,P26182,P26183,P30161,P45520,P45521,P48465,P50138,P51775,P53455,P53476,P53477,P53491,P53498,P53499,P53500,P53502,P53689,P60009,P60010,P60011,P68555,P78711,P80709,P81085,P90689,P91754,Q05214,Q11212,Q24733,Q2U7A3,Q39596,Q39758,Q6TCF2,Q75D00,Q8SWN8,Q8X119,Q92192,Q92193,Q99023,Q9P4D1,Q9UVF3,Q9UVX4,Q9UVZ8">actin</mark> .
18654835-1331	Both MudPIT and cDNA microarray analyses indicate that <mark style="background-color:lightblue;" id="784">H2O2</mark> treatment caused <mark style="background-color:orange;">elevated</mark> <mark style="background-color:orange;">levels</mark> of <mark style="background-color:lightgreen;" id="P29509,Q17745,Q39243">thioredoxin reductase 1</mark> .
18644606-1339	<mark style="background-color:lightblue;" id="4585">Olanzapine</mark> was <mark style="background-color:orange;">associated</mark> with a <mark style="background-color:orange;">lower</mark> frequency of extrapyramidal symptoms than other antipsychotics, fewer <mark style="background-color:lightgreen;" id="P10765,P22393,P33089,P33090,P33091,P43001">prolactin</mark> -related adverse events than <mark style="background-color:lightblue;" id="5073">risperidone</mark> and other atypical antipsychotics, but greater weight gain than typicals and <mark style="background-color:lightblue;" id="5073">risperidone</mark>.
18704001-1340	<mark style="background-color:lightblue;" id="206,5793,64689,79025">Glucose</mark> replacement to euglycemia causes hypoxia, acidosis, and <mark style="background-color:orange;">decreased</mark> <mark style="background-color:lightgreen;" id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">insulin</mark>  <mark style="background-color:yellow;" id="GO:0046903,biological_process">secretion</mark> in fetal sheep with intrauterine growth restriction.
18704001-1341	<mark style="background-color:lightblue;" id="206,5793,64689,79025">Glucose</mark> <mark style="background-color:orange;">stimulated</mark> <mark style="background-color:lightgreen;" id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">insulin</mark>  <mark style="background-color:yellow;" id="GO:0046903,biological_process">secretion</mark> (GSIS) was <mark style="background-color:orange;">lower</mark> in the <mark style="background-color:lightgreen;" id="P00864">Glu</mark> group.
18691715-1342	<mark style="background-color:lightblue;" id="778">Homocysteine</mark> <mark style="background-color:orange;">stimulates</mark> antioxidant response element-mediated expression of <mark style="background-color:lightgreen;" id="O68838,P0A6W9,P0A6X0,P32477,P57485,P58994,P61379,Q09768,Q20117,Q57KV3,Q5E7F8,Q5LYY5,Q5M3J8,Q5PF10,Q65RX0,Q66E64,Q6ANW2,Q6D1T4,Q6LMV1,Q71VZ1,Q72RD4,Q7MHS5,Q7N7A4,Q7W3F2,Q7WES2,Q82ZG8,Q87LS2,Q88AR1,Q88R90,Q88UW5,Q89AD8,Q8D2V5,Q8DC38,Q8DW15,Q8DXM9,Q8E399,Q8EBF9,Q8F4D5,Q8X0X0,Q8X900,Q8XK30,Q8Y3R3,Q8Z4D6,Q8ZBU2,Q926X7,Q97IV1,Q9CM00,Q9HF78,Q9HTY6,Q9KUG5,Q9NFN6,Q9W3K5">glutamate-cysteine ligase</mark> in mouse macrophages.
18691715-1343	The current study investigated whether <mark style="background-color:lightblue;" id="778">homocysteine</mark> <mark style="background-color:orange;">induces</mark> <mark style="background-color:yellow;" id="GO:0006350,biological_process">transcription</mark> of <mark style="background-color:lightgreen;" id="O68838,P0A6W9,P0A6X0,P32477,P57485,P58994,P61379,Q09768,Q20117,Q57KV3,Q5E7F8,Q5LYY5,Q5M3J8,Q5PF10,Q65RX0,Q66E64,Q6ANW2,Q6D1T4,Q6LMV1,Q71VZ1,Q72RD4,Q7MHS5,Q7N7A4,Q7W3F2,Q7WES2,Q82ZG8,Q87LS2,Q88AR1,Q88R90,Q88UW5,Q89AD8,Q8D2V5,Q8DC38,Q8DW15,Q8DXM9,Q8E399,Q8EBF9,Q8F4D5,Q8X0X0,Q8X900,Q8XK30,Q8Y3R3,Q8Z4D6,Q8ZBU2,Q926X7,Q97IV1,Q9CM00,Q9HF78,Q9HTY6,Q9KUG5,Q9NFN6,Q9W3K5">glutamate-cysteine ligase</mark> ( <mark style="background-color:lightgreen;" id="P0AEP7,P0AEP8,Q01820,Q920G9">Gcl</mark> ), via ARE driven gene expression in mouse macrophages.
18691715-1344	Treatment of mouse macrophages with d-/l-<mark style="background-color:lightblue;" id="778">homocysteine</mark> (50microM) <mark style="background-color:orange;">induced</mark> depletion of <mark style="background-color:yellow;" id="GO:0005622,cellular_component">intracellular</mark> <mark style="background-color:lightblue;" id="124886">glutathione</mark> and a compensatory <mark style="background-color:orange;">increase</mark> in <mark style="background-color:lightgreen;" id="P0AEP7,P0AEP8,Q01820,Q920G9">Gcl</mark> activity.
18691715-1345	Real-time RT- <mark style="background-color:lightgreen;" id="O66148,O80333,P15904,Q01289,Q39617,Q41249,Q59987,Q9SDT1">PCR</mark> revealed increased mRNA-expression of the catalytic subunit of <mark style="background-color:lightgreen;" id="P0AEP7,P0AEP8,Q01820,Q920G9">Gcl</mark> ( <mark style="background-color:lightgreen;" id="P19468,P97494,Q9W3K5">Gclc</mark> ) after treatment with <mark style="background-color:lightblue;" id="778">homocysteine</mark>, and this occurred via <mark style="background-color:orange;">increased</mark> <mark style="background-color:yellow;" id="GO:0006350,biological_process">transcription</mark> as demonstrated with <mark style="background-color:lightgreen;" id="P08659,P13129,Q01158,Q26304,Q27757">luciferase</mark> promoter reporter constructs for <mark style="background-color:lightgreen;" id="P19468,P97494,Q9W3K5">Gclc</mark> .
18695846-1364	During the early response in AR, <mark style="background-color:lightblue;" id="774">histamine</mark> has been found to be the most abundant mediator and it is <mark style="background-color:orange;">associated</mark> with many symptoms of this disease <mark style="background-color:orange;">mediated</mark> through the <mark style="background-color:lightgreen;" id="P30546,P31389,P31390,P35367,P70174,Q9N2B0,Q9N2B1,Q9N2B2">histamine H1 receptor</mark> .
18671273-1368	<mark style="background-color:lightblue;" id="6197">Cycloheximide</mark> <mark style="background-color:orange;">inhibited</mark> <mark style="background-color:lightgreen;" id="O61389,O96605,P19806,P55321,P55846,P55847,P55848,P83220,P83636,Q10987,Q27225">MIH</mark> <mark style="background-color:orange;">induced</mark> <mark style="background-color:lightgreen;" id="P00536,P00539,P12965">Mos</mark> expression and its <mark style="background-color:yellow;" id="GO:0016310,biological_process">phosphorylation</mark> , which in turn <mark style="background-color:orange;">reduced</mark> <mark style="background-color:lightgreen;" id="P70047,Q8CFC2,Q91618,Q9ESG9,Q9NI63">Myt1</mark>  <mark style="background-color:yellow;" id="GO:0016310,biological_process">phosphorylation</mark> and GVBD.
18648748-1370	Administration of <mark style="background-color:lightblue;" id="72281">hesperetin</mark> to <mark style="background-color:lightgreen;" id="O94833,Q03001,Q8WXK8">DMH</mark> treated rats significantly <mark style="background-color:orange;">decreased</mark> the tumor incidence, the number of aberrant crypt foci with simultaneous enhancement of tissue lipid peroxidation, <mark style="background-color:lightgreen;" id="P20432,P30104,P30106,P30107,P30108,Q04522,Q0ZS46,Q7REH6,Q8ILQ7,Q8MU52">GST</mark> , GPx, <mark style="background-color:lightgreen;" id="O12933,O22668,O75007,P24705,P51547,P93258,Q01137,Q27666,Q9SM64">SOD</mark> , and <mark style="background-color:lightgreen;" id="O62839,O97492,P00432,P00485,P00486,P00487,P04040,P06135,P07641,P11504,P20074,P22782,P25309,P25819,P26825,P26826,P32796,P36882,P36883,P43155,P47934,P49417,P52826,P58777,P62577,P62578,P62579,P62580,P90682,Q00614,Q02736,Q03058,Q5RF10,Q64405,Q704S8,Q9M5L6,Q9PWF7">CAT</mark> activities.
18650805-1377	Methylation of these <mark style="background-color:lightblue;" id="6804">CpG</mark> sites may lead to <mark style="background-color:orange;">reduced</mark> <mark style="background-color:lightgreen;" id="P35372,P79350,P97266,Q5IS39,Q5IS84,Q95247,Q95M54,Q9MYW9">OPRM1</mark> expression in the lymphocytes of these former <mark style="background-color:lightblue;" id="5462328">heroin</mark> addicts.
18655177-1378	We examined the effect of several different doses of <mark style="background-color:lightblue;" id="4004">malathion</mark> (25, 75, 200 microM), or <mark style="background-color:lightblue;" id="4004">malathion</mark> in combination with <mark style="background-color:lightblue;" id="54670067">vitamin C</mark> (VC; 10 microM) or <mark style="background-color:lightblue;" id="2116,14985,1548900,1742129">vitamin E</mark> (VE; 30 microM), on the <mark style="background-color:orange;">levels</mark> of <mark style="background-color:lightblue;" id="10964">malondialdehyde</mark> (MDA), and <mark style="background-color:lightgreen;" id="O50258">superoxide dismutase</mark> ( <mark style="background-color:lightgreen;" id="O12933,O22668,O75007,P24705,P51547,P93258,Q01137,Q27666,Q9SM64">SOD</mark> ), <mark style="background-color:lightgreen;" id="O24339,O52762,O62839,O68146,O77229,O93662,O97492,P00432,P04040,P04762,P07145,P0A323,P0A324,P0A325,P0A326,P0A327,P11934,P17336,P24168,P24270,P25890,P29422,P30265,P30266,P32290,P42321,P44390,P45737,P45739,P55304,P55306,P55310,P55311,P55313,P77872,P81138,P90682,Q27710,Q49XC1,Q4L643,Q59296,Q59337,Q59602,Q59714,Q5HG86,Q5HPK8,Q5RF10,Q64405,Q6G9M4,Q6GH72,Q7A5T2,Q8CPD0,Q8FWU0,Q8NWV5,Q8X1P0,Q8Y3P9,Q926X0,Q99UE2,Q9AXH0,Q9KW19,Q9L4S1,Q9M5L6,Q9PT92,Q9PWF7,Q9Z598,Q9ZKX5,Q9ZN99">catalase</mark> ( <mark style="background-color:lightgreen;" id="O62839,O97492,P00432,P00485,P00486,P00487,P04040,P06135,P07641,P11504,P20074,P22782,P25309,P25819,P26825,P26826,P32796,P36882,P36883,P43155,P47934,P49417,P52826,P58777,P62577,P62578,P62579,P62580,P90682,Q00614,Q02736,Q03058,Q5RF10,Q64405,Q704S8,Q9M5L6,Q9PWF7">CAT</mark> ), and <mark style="background-color:lightgreen;" id="O32770,O59858,Q00277,Q9CFV1">glutathione peroxidase</mark> (GPx) activities in human erythrocytes in vitro.
18655177-1379	Erythrocytes were incubated under various treatment conditions (<mark style="background-color:lightblue;" id="4004">malathion</mark> alone, vitamins alone, or <mark style="background-color:lightblue;" id="4004">malathion</mark> plus vitamin) at 37 degrees C for 60 min, and the <mark style="background-color:orange;">levels</mark> of MDA, and <mark style="background-color:lightgreen;" id="O12933,O22668,O75007,P24705,P51547,P93258,Q01137,Q27666,Q9SM64">SOD</mark> , <mark style="background-color:lightgreen;" id="O62839,O97492,P00432,P00485,P00486,P00487,P04040,P06135,P07641,P11504,P20074,P22782,P25309,P25819,P26825,P26826,P32796,P36882,P36883,P43155,P47934,P49417,P52826,P58777,P62577,P62578,P62579,P62580,P90682,Q00614,Q02736,Q03058,Q5RF10,Q64405,Q704S8,Q9M5L6,Q9PWF7">CAT</mark> and GPx activities, were determined.
18655177-1380	Treatment with <mark style="background-color:lightblue;" id="4004">malathion</mark> alone <mark style="background-color:orange;">increased</mark> the <mark style="background-color:orange;">levels</mark> of MDA and <mark style="background-color:orange;">decreased</mark> <mark style="background-color:lightgreen;" id="O12933,O22668,O75007,P24705,P51547,P93258,Q01137,Q27666,Q9SM64">SOD</mark> , <mark style="background-color:lightgreen;" id="O62839,O97492,P00432,P00485,P00486,P00487,P04040,P06135,P07641,P11504,P20074,P22782,P25309,P25819,P26825,P26826,P32796,P36882,P36883,P43155,P47934,P49417,P52826,P58777,P62577,P62578,P62579,P62580,P90682,Q00614,Q02736,Q03058,Q5RF10,Q64405,Q704S8,Q9M5L6,Q9PWF7">CAT</mark> 0.05).
18670196-1382	<mark style="background-color:lightgreen;" id="P25914">Cholesteryl ester transfer protein</mark> ( <mark style="background-color:lightgreen;" id="P11597,P22687,P25914,P47896">CETP</mark> ) is a plasma <mark style="background-color:lightgreen;" id="P08163">glycoprotein</mark> that facilitates the <mark style="background-color:orange;">transfer</mark> of neutral lipids and phospholipids between lipoproteins and contributes to the regulation of the plasma concentration of <mark style="background-color:lightgreen;" id="P81182">high density lipoprotein</mark> <mark style="background-color:lightblue;" id="304,5997,6432564,11025495">cholesterol</mark> (HDL-C).
18708157-1383	<mark style="background-color:lightblue;" id="104729">Co(2</mark>+) also <mark style="background-color:orange;">induces</mark> the <mark style="background-color:orange;">release</mark> of the pro-apoptotic factors, <mark style="background-color:lightgreen;" id="O07091,O13393,O22642,O93863,P00002,P00003,P00004,P00007,P00008,P00011,P00012,P00013,P00014,P00017,P00018,P00019,P00020,P00021,P00022,P00024,P00025,P00027,P00028,P00029,P00030,P00031,P00032,P00035,P00036,P00037,P00038,P00039,P00040,P00041,P00042,P00043,P00046,P00047,P00048,P00049,P00051,P00052,P00053,P00054,P00055,P00056,P00057,P00058,P00059,P00060,P00061,P00062,P00063,P00064,P00065,P00066,P00067,P00068,P00069,P00070,P00071,P00072,P00073,P00074,P00075,P00076,P00077,P00078,P00079,P12831,P15451,P18822,P19681,P19974,P21665,P22342,P25400,P29380,P32556,P38091,P53698,P56205,P59218,P62772,P62773,P62894,P62895,P62896,P67881,P67882,P68096,P68097,P68098,P68099,P68100,P68517,P68518,P68519,P81280,P81459,P99998,P99999,Q41346,Q4HVX7,Q52V08,Q52V09,Q52V10,Q5RFH4,Q640U4,Q6C9Q0,Q6IQM2,Q6Q4H8,Q6QLW4,Q6WUX8,Q753F4,Q7YR71,Q96VP3">cytochrome c</mark> and <mark style="background-color:lightgreen;" id="O95831">AIF</mark> .
18708157-1384	Incubation of rat hepatocyte primary cultures with <mark style="background-color:lightblue;" id="104729">Co(2</mark>+) results in <mark style="background-color:yellow;" id="GO:0006915,biological_process">apoptosis</mark> induction with <mark style="background-color:yellow;" id="GO:0006919,biological_process">caspase activation</mark> and <mark style="background-color:orange;">increased</mark> <mark style="background-color:orange;">level</mark> of expression of <mark style="background-color:lightgreen;" id="O35800,Q0PGG7,Q16665,Q309Z6,Q61221,Q98SW2,Q9I8A9,Q9XTA5,Q9YIB9">HIF-1alpha</mark> .
18708158-1386	<mark style="background-color:lightgreen;" id="P27297,Q07813,Q63690">Bax</mark> accumulated in mitochondria in response to <mark style="background-color:lightgreen;" id="P15636,P17979,Q95PP1">API</mark> -2, whereas <mark style="background-color:orange;">release</mark> of <mark style="background-color:lightgreen;" id="O07091,O13393,O22642,O93863,P00002,P00003,P00004,P00007,P00008,P00011,P00012,P00013,P00014,P00017,P00018,P00019,P00020,P00021,P00022,P00024,P00025,P00027,P00028,P00029,P00030,P00031,P00032,P00035,P00036,P00037,P00038,P00039,P00040,P00041,P00042,P00043,P00046,P00047,P00048,P00049,P00051,P00052,P00053,P00054,P00055,P00056,P00057,P00058,P00059,P00060,P00061,P00062,P00063,P00064,P00065,P00066,P00067,P00068,P00069,P00070,P00071,P00072,P00073,P00074,P00075,P00076,P00077,P00078,P00079,P12831,P15451,P18822,P19681,P19974,P21665,P22342,P25400,P29380,P32556,P38091,P53698,P56205,P59218,P62772,P62773,P62894,P62895,P62896,P67881,P67882,P68096,P68097,P68098,P68099,P68100,P68517,P68518,P68519,P81280,P81459,P99998,P99999,Q41346,Q4HVX7,Q52V08,Q52V09,Q52V10,Q5RFH4,Q640U4,Q6C9Q0,Q6IQM2,Q6Q4H8,Q6QLW4,Q6WUX8,Q753F4,Q7YR71,Q96VP3">cytochrome c</mark> from mitochondria required both <mark style="background-color:lightgreen;" id="P15636,P17979,Q95PP1">API</mark> -2 and <mark style="background-color:lightblue;" id="160355">roscovitine</mark>.
18708158-1387	We suggest that <mark style="background-color:lightblue;" id="160355">roscovitine</mark> <mark style="background-color:orange;">elicits</mark> events that <mark style="background-color:orange;">activate</mark> <mark style="background-color:lightgreen;" id="P27297,Q07813,Q63690">Bax</mark> once it translocates to mitochondria and that inactivation of <mark style="background-color:lightgreen;" id="Q641Z4,Q6GLD8,Q96WV9,Q99J95">cdk9</mark> signals these events and the down-regulation of <mark style="background-color:lightgreen;" id="P98170">XIAP</mark> .
18652864-1389	The <mark style="background-color:lightgreen;" id="P42559">allatostatins</mark> ( <mark style="background-color:lightgreen;" id="P0AE37,P0AE38,P80357,P80358,Q0TH83,Q1C8B0,Q1RB46,Q321N9,Q32G89,Q3Z294,Q5PHB9,Q66B20,Q7N2G8,Q83L52,Q8FH00,Q8Z6G0,Q8ZPV1,Q9NRA2,Q9ZC67">ASTs</mark> ), with a <mark style="background-color:lightgreen;" id="P11344">Tyr</mark> /Phe-Xaa-<mark style="background-color:lightblue;" id="98207">Phe-Gly</mark>-<mark style="background-color:lightblue;" id="857,6106">Leu</mark>/<mark style="background-color:lightblue;" id="791,6306">Ile</mark>-amide C-terminus, are <mark style="background-color:lightgreen;" id="P21259">neuropeptides</mark> that occur in many orders of insects, but are known to <mark style="background-color:orange;">inhibit</mark> <mark style="background-color:lightblue;" id="6439662">juvenile hormone</mark> (JH) synthesis by corpora allata (CA) only in cockroaches, crickets, and termites.
18672928-1390	To further test this hypothesis, we have measured the fluorescence quantum yield in solvents of different polarity for the following systems: <mark style="background-color:lightblue;" id="2003,94230">N-acetyl-L-tryptophanamide</mark> (NATA), an analogue for <mark style="background-color:lightgreen;" id="P19334,P55965,Q920J4">Trp</mark> in <mark style="background-color:lightgreen;" id="P03161,P03610,P03631,P03632,P07394,P15966,P25243,P25244,P35823,P98005">a protein</mark> ; <mark style="background-color:lightblue;" id="304749,2724382">N-acetyl-L-tryptophan ethyl ester</mark> (NATE), wherein the <mark style="background-color:lightgreen;" id="P19334,P55965,Q920J4">Trp</mark> amide is replaced by an ester group, <mark style="background-color:orange;">lowering</mark> the CT state energy; and <mark style="background-color:lightblue;" id="6736">3-methylindole</mark> (<mark style="background-color:lightblue;" id="11001318">3MI</mark>), a control wherein this quenching mechanism cannot take place.
18667202-1391	<mark style="background-color:lightgreen;" id="Q6BEG6,Q6BEG7,Q9BDJ6,Q9BEF8,Q9EQX0,Q9GKY5,Q9QYH7,Q9UBU3">Ghrelin</mark> <mark style="background-color:orange;">inhibits</mark> contraction and proliferation of human aortic smooth muscle cells by <mark style="background-color:lightblue;" id="6076">cAMP</mark>/ <mark style="background-color:yellow;" id="GO:0004691,molecular_function">PKA</mark> pathway activation.
18667202-1393	<mark style="background-color:lightgreen;" id="Q6BEG6,Q6BEG7,Q9BDJ6,Q9BEF8,Q9EQX0,Q9GKY5,Q9QYH7,Q9UBU3">Ghrelin</mark> was able to <mark style="background-color:orange;">inhibit</mark> <mark style="background-color:lightgreen;" id="P01015,P01016,P01017,P01019,P11859,P20757,P67885,P67886,Q9GLN8,Q9GLP6,Q9TSZ0">angiotensin II</mark> -induced proliferation and contraction in a dose-response fashion via the <mark style="background-color:lightblue;" id="6076">cAMP</mark>/ <mark style="background-color:yellow;" id="GO:0004691,molecular_function">PKA</mark> pathway.
18657228-1398	Moreover, similar to rFGF2, injection of the zebrafish form of <mark style="background-color:lightgreen;" id="P26617">vascular endothelial growth factor-A</mark> ( <mark style="background-color:lightgreen;" id="P15691,P15692,P16612,P26617,P49151,P50412,P67860,P67964,P67965,P83906,Q00731,Q99PS1,Q9GKR0,Q9MYV3">VEGF-A</mark> ) <mark style="background-color:orange;">induces</mark> a significant angiogenic response in the ZFYM assay that is <mark style="background-color:orange;">suppressed</mark> by the <mark style="background-color:lightgreen;" id="P15691,P15692,P26617,P49151,P50412,P67964,P67965,Q99PS1,Q9GKR0,Q9MYV3">VEGF</mark> receptor-2/ <mark style="background-color:lightgreen;" id="P35968,P52583">KDR</mark> TK inhibitor <mark style="background-color:lightblue;" id="5329098">SU5416</mark>.
18706130-1404	The antidepressant <mark style="background-color:lightblue;" id="82148">agomelatine</mark> <mark style="background-color:orange;">blocks</mark> the adverse <mark style="background-color:orange;">effects</mark> of stress on <mark style="background-color:yellow;" id="GO:0007613,biological_process">memory</mark> and <mark style="background-color:orange;">enables</mark> spatial <mark style="background-color:yellow;" id="GO:0007612,biological_process">learning</mark> to rapidly <mark style="background-color:orange;">increase</mark> neural <mark style="background-color:yellow;" id="GO:0007155,biological_process">cell adhesion</mark> molecule ( <mark style="background-color:lightgreen;" id="P13591,P13592,P31836">NCAM</mark> ) expression in the hippocampus of rats.
18636508-1410	Fibril growth was a second-order process with an enthalpy of activation (27 +/- 5 kcal mol(-1)), which is indistinguishable from that of tetramer formation by <mark style="background-color:lightgreen;" id="P08935,P25973,P81061,P81714,Q06445">cystatins</mark> , which involves <mark style="background-color:orange;">limited</mark> conformational <mark style="background-color:orange;">changes</mark> <mark style="background-color:orange;">including</mark> <mark style="background-color:lightblue;" id="614,8988,145742">proline</mark> trans to <mark style="background-color:lightgreen;" id="Q62225">cis</mark> isomerization.
18704096-1413	These results confirm the therapeutic potential of <mark style="background-color:lightgreen;" id="P31424,P41594">mGluR5</mark> blockade on motor symptoms <mark style="background-color:orange;">induced</mark> by <mark style="background-color:orange;">reduced</mark> striatal <mark style="background-color:lightblue;" id="681">dopamine</mark> function.
18704096-1414	Further, they demonstrate that <mark style="background-color:lightgreen;" id="P31424,P41594">mGluR5</mark> blockade may also have beneficial <mark style="background-color:orange;">effects</mark> on cognitive deficits <mark style="background-color:orange;">induced</mark> by <mark style="background-color:lightblue;" id="681">dopamine</mark> depletion.
18618086-1424	Inhibition of acyl-<mark style="background-color:lightblue;" id="317,6816,87642,444624,445126,447444,448506,44216777,44246472">coenzyme A</mark>: <mark style="background-color:lightblue;" id="304,5997,6432564,11025495">cholesterol</mark> <mark style="background-color:lightgreen;" id="P05521,P19197,P21309,P23148,P41302,Q06878,Q7N576,Q9AJA7,Q9S3Z2">acyltransferase</mark> ( <mark style="background-color:lightgreen;" id="O77761,P23141,P24752,P35610,Q60457">ACAT</mark> ), which <mark style="background-color:orange;">generates</mark> <mark style="background-color:yellow;" id="GO:0005622,cellular_component">intracellular</mark> cholesteryl esters from free <mark style="background-color:lightblue;" id="304,5997,6432564,11025495">cholesterol</mark> and fatty acids, <mark style="background-color:orange;">reduces</mark> the biogenesis of the Abeta from the amyloid precursor protein ( <mark style="background-color:lightgreen;" id="O73683,O93279,P05067,P08592,P0A3Z1,P0A3Z2,P0A3Z3,P0A3Z4,P12023,P29216,P47566,P53601,P75313,P79307,Q11207,Q28053,Q28280,Q28748,Q28757,Q29149,Q5IS80,Q60495,Q95241">APP</mark> ).
18618086-1425	The proportion of <mark style="background-color:lightgreen;" id="O73683,O93279,P05067,P08592,P0A3Z1,P0A3Z2,P0A3Z3,P0A3Z4,P12023,P29216,P47566,P53601,P75313,P79307,Q11207,Q28053,Q28280,Q28748,Q28757,Q29149,Q5IS80,Q60495,Q95241">APP</mark> molecules that are directed to the novel cleavage pathway is <mark style="background-color:orange;">regulated</mark> by the ratio of free <mark style="background-color:lightblue;" id="304,5997,6432564,11025495">cholesterol</mark> and cholesteryl esters in cells.
18566887-1426	<mark style="background-color:lightblue;" id="906,444885,445063">Sialic acid</mark>-specific O- <mark style="background-color:lightgreen;" id="P16966">acetyltransferases</mark> and O- <mark style="background-color:lightgreen;" id="P23553,P23872,Q325C0,Q3Z4S3,Q57S73,Q5PFJ2,Q83M39,Q8FK82,Q8XD38,Q8Z8T1,Q8ZRA1">acetylesterases</mark> are responsible for the metabolism of <mark style="background-color:orange;">esterified</mark> <mark style="background-color:lightblue;" id="349960">sialic acids</mark>.
18657000-1427	In conclusion, <mark style="background-color:lightblue;" id="5984">fructose</mark> <mark style="background-color:orange;">overload</mark> in rats <mark style="background-color:orange;">induced</mark> hypertriglyceridemia and <mark style="background-color:lightgreen;" id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">insulin</mark> resistance associated with an enhanced oxidative stress.
18608764-1428	The structure-activity models of the <mark style="background-color:lightgreen;" id="O08775,P35918,P35968,P52583,Q8AXB3">VEGFR2</mark> kinase inhibitory activity of the derivatives of 2-<mark style="background-color:lightblue;" id="137550">anilino</mark>-5-aryloxazole have been <mark style="background-color:orange;">investigated</mark> <mark style="background-color:orange;">using</mark> Combinatorial Protocol in Multiple Linear Regression (CP- <mark style="background-color:lightgreen;" id="P08235,P79404,Q29131,Q4JM28,Q8QHI2,Q9BDJ7,Q9IAC6,Q9N0W8">MLR</mark> ) with nearly 500 topological descriptors which were calculated from DRAGON software.
18657007-1437	<mark style="background-color:lightgreen;" id="O02750,O93416,Q28603,Q95189,Q95234">Leptin</mark> and soluble <mark style="background-color:lightgreen;" id="O02750,O93416,Q28603,Q95189,Q95234">leptin</mark> receptor <mark style="background-color:orange;">changes</mark> after pulmonary endarterectomy: relations to <mark style="background-color:lightblue;" id="5754">cortisol</mark> and cytokine network.
18657007-1438	<mark style="background-color:lightgreen;" id="O02750,O93416,Q28603,Q95189,Q95234">Leptin</mark> and soluble <mark style="background-color:lightgreen;" id="O02750,O93416,Q28603,Q95189,Q95234">leptin</mark> receptor (<mark style="background-color:lightblue;" id="25021189">SLR</mark>) were compared with evolution of <mark style="background-color:lightblue;" id="5754">cortisol</mark> and inflammatory cytokines in twenty-two patients with chronic thromboembolic pulmonary hypertension treated with pulmonary endarterectomy <mark style="background-color:orange;">using</mark> cardiopulmonary <mark style="background-color:orange;">bypass</mark> ( <mark style="background-color:lightgreen;" id="O42720,P00303,P0AEM9,P0AEN0,Q39962,Q61990,Q92793,Q9NWQ8">CBP</mark> ) and deep hypothermic circulatory arrest (DHCA).
18635390-1443	The inhibition of <mark style="background-color:lightblue;" id="6001">DMBA</mark>-carcinogenesis by <mark style="background-color:lightgreen;" id="Q12613,Q42624,Q9XQ94">GLN</mark> application was <mark style="background-color:orange;">associated</mark> with <mark style="background-color:orange;">increased</mark> arterial <mark style="background-color:lightgreen;" id="Q12613,Q42624,Q9XQ94">GLN</mark> and <mark style="background-color:lightblue;" id="124886">GSH</mark>, <mark style="background-color:orange;">elevated</mark> buccal mucosa <mark style="background-color:lightblue;" id="124886">GSH</mark> as well as induction of <mark style="background-color:lightgreen;" id="P27297,Q07813,Q63690">bax</mark> and <mark style="background-color:lightgreen;" id="O50017,P08469,P14043,P31669,P35875,P55057,Q08824,Q11208">PARP</mark> , and inhibition of <mark style="background-color:lightgreen;" id="P10417,P49950">bcl-2</mark> .
18648826-1446	Culture of mid-segments of hair follicles in low calcium culture medium kept on <mark style="background-color:lightblue;" id="11966311">agarose</mark> <mark style="background-color:orange;">increased</mark> expression of <mark style="background-color:lightgreen;" id="P11088,P20930">filaggrin</mark> and <mark style="background-color:lightgreen;" id="O09043">Kdap</mark> , but <mark style="background-color:orange;">downregulated</mark> expression of <mark style="background-color:lightgreen;" id="P07476,P14590,P14591,P14708,P17941,P18174,P18175,P24708,P24709,P24710,P24711,P24712,P48997,P48998,Q95337">involucrin</mark> .
18651093-1447	Two infants with elevated serum <mark style="background-color:lightgreen;" id="Q05902">gamma-GT</mark> had a <mark style="background-color:orange;">decreased</mark> serum <mark style="background-color:lightblue;" id="738,5961">glutamine</mark>.
18656896-1449	<mark style="background-color:lightblue;" id="3559">Haloperidol</mark> strongly <mark style="background-color:orange;">decreased</mark> the expression of <mark style="background-color:lightgreen;" id="O18752,O18753,O18755,O70183,O97759,P14082,P21237,P23363,P23560,P25429,P25430,P25431,P25432,Q02193,Q06225,Q3SAT7,Q4L0Y3,Q5IS78,Q6LCI5,Q7YRB4,Q90322,Q95106,Q9TST3">BDNF</mark> 0.01).
18656896-1450	In contrast, the administration of <mark style="background-color:lightblue;" id="60854">ziprasidone</mark> significantly attenuated the immobilization stress-induced <mark style="background-color:orange;">decrease</mark> in <mark style="background-color:lightgreen;" id="O18752,O18753,O18755,O70183,O97759,P14082,P21237,P23363,P23560,P25429,P25430,P25431,P25432,Q02193,Q06225,Q3SAT7,Q4L0Y3,Q5IS78,Q6LCI5,Q7YRB4,Q90322,Q95106,Q9TST3">BDNF</mark> 0.01).
18656896-1451	<mark style="background-color:lightblue;" id="60854">Ziprasidone</mark> exhibited differential <mark style="background-color:orange;">effects</mark> on <mark style="background-color:lightgreen;" id="O18752,O18753,O18755,O70183,O97759,P14082,P21237,P23363,P23560,P25429,P25430,P25431,P25432,Q02193,Q06225,Q3SAT7,Q4L0Y3,Q5IS78,Q6LCI5,Q7YRB4,Q90322,Q95106,Q9TST3">BDNF</mark> mRNA expression in the rat hippocampus and neocortex.
18656896-1452	These results suggest that <mark style="background-color:lightblue;" id="60854">ziprasidone</mark> might have a neuroprotective <mark style="background-color:orange;">effect</mark> by recovering stress-induced <mark style="background-color:orange;">decreases</mark> in <mark style="background-color:lightgreen;" id="O18752,O18753,O18755,O70183,O97759,P14082,P21237,P23363,P23560,P25429,P25430,P25431,P25432,Q02193,Q06225,Q3SAT7,Q4L0Y3,Q5IS78,Q6LCI5,Q7YRB4,Q90322,Q95106,Q9TST3">BDNF</mark> mRNA expression.
18670892-1460	In this view, this study aimed at the investigating the use of a crude <mark style="background-color:lightgreen;" id="P15984,P16147,P84714">peroxidase</mark> preparation from onion solid by-products for <mark style="background-color:orange;">oxidising</mark> <mark style="background-color:lightblue;" id="689043">caffeic acid</mark>, a widespread <mark style="background-color:lightblue;" id="289">o-diphenol</mark>, whose various derivatives may occur in food industry wastes, such as olive mill waste waters.
18661133-1463	Furthermore, restoration of <mark style="background-color:lightgreen;" id="Q8IVT5">KSR1</mark> expression in <mark style="background-color:lightgreen;" id="Q8IVT5">KSR</mark> (-/-) <mark style="background-color:lightgreen;" id="O15553,Q99607">MEFs</mark> following stable <mark style="background-color:yellow;" id="GO:0009293,biological_process">transduction</mark> of cells with a <mark style="background-color:lightgreen;" id="Q8IVT5">KSR1</mark> expression vector, <mark style="background-color:orange;">enhanced</mark> sensitivity of cells to tunicamycin and <mark style="background-color:lightblue;" id="5351303,6434468,13892272,17751001">cytochalasin H</mark> and <mark style="background-color:orange;">decreased</mark> <mark style="background-color:lightgreen;" id="P27361,P28869,P42525,Q07176">ERK1</mark> /2 activation following exposure to these drugs.
18581264-1465	<mark style="background-color:lightgreen;" id="P06181,P11542,P11543,P20010,P20011,P20012,P20013,P21764,P31837,P31838,P49012,P50622">Lignin peroxidases</mark> have the unique ability to <mark style="background-color:orange;">catalyze</mark> oxidative cleavage of C-C bonds and <mark style="background-color:lightblue;" id="3283,5382654">ether</mark> (C-O-C) bonds in non-phenolic aromatic substrates of high redox potential.
18581264-1466	<mark style="background-color:lightblue;" id="23930,517769">Manganese</mark> <mark style="background-color:lightgreen;" id="P15984,P16147,P84714">peroxidases</mark> <mark style="background-color:orange;">oxidize</mark> <mark style="background-color:lightblue;" id="27854">Mn(II</mark>) to <mark style="background-color:lightblue;" id="105130">Mn(III</mark>), which facilitates the degradation of phenolic compounds or, in turn, oxidizes a second mediator for the breakdown of non-phenolic compounds.
18581264-1467	<mark style="background-color:lightgreen;" id="Q12570">Laccases</mark> are multi-<mark style="background-color:lightblue;" id="23978">copper</mark>-containing proteins that <mark style="background-color:orange;">catalyze</mark> the oxidation of phenolic substrates with concomitant reduction of molecular <mark style="background-color:lightblue;" id="977">oxygen</mark> to water.
18677521-1468	In the absence of <mark style="background-color:lightgreen;" id="P18151,P21354,P23603,P23700,P23701,P26758,P94664,Q253E5,Q3KLQ7,Q548P6,Q933I7,Q9AIS7,Q9PJV0">OmcB</mark> , cells lost the ability to <mark style="background-color:orange;">reduce</mark> soluble or insoluble <mark style="background-color:lightblue;" id="29936">Fe(III</mark>).
18581270-1477	The co-expression of <mark style="background-color:lightgreen;" id="P31645,Q9XT49">SERT</mark> with <mark style="background-color:lightgreen;" id="Q13491,Q5R603">M6B</mark> results in a significant <mark style="background-color:orange;">decrease</mark> in <mark style="background-color:lightgreen;" id="P31645,Q9XT49">SERT</mark> -mediated <mark style="background-color:lightblue;" id="5202">serotonin</mark> uptake caused by a down-regulation of <mark style="background-color:lightgreen;" id="P31645,Q9XT49">SERT</mark> surface expression.
18579232-1493	Inhibition of these enzymes shows that chagasic autoantibodies up-regulation of <mark style="background-color:lightgreen;" id="O02768,O19183,O62698,O62725,P27607,P35354,P35355,P70682,P79208,Q05769">COX-2</mark> / <mark style="background-color:lightgreen;" id="O19114,O46660,O54705,O62699,P29477,P35228,P79290,Q06518,Q27995,Q28314,Q90703,Q92037,Q92091">iNOS</mark> mRNA <mark style="background-color:orange;">level</mark> is under the control of endogenous <mark style="background-color:lightblue;" id="804">iNO</mark>/<mark style="background-color:lightblue;" id="24316">cGMP</mark> signaling system.
18667302-1496	The results indicated that the backbone of <mark style="background-color:lightgreen;" id="Q9XF19">POP</mark> was <mark style="background-color:orange;">composed</mark> of (1--&gt;6)-linked-alpha-<mark style="background-color:lightblue;" id="439271">D-galactopyranosyl</mark> and (1--&gt;2,6)-linked-alpha-<mark style="background-color:lightblue;" id="439271">D-galactopyranosyl</mark> residues, which were <mark style="background-color:orange;">terminated</mark> with a single terminal (1--&gt;)-<mark style="background-color:lightblue;" id="206,64689">beta-D-glucose</mark> residue at the O-2 position of galactosyl along the main chain in the ratio of 1:1:1.
18667302-1497	Preliminary tests in vitro showed <mark style="background-color:lightgreen;" id="Q9XF19">POP</mark> is capable of <mark style="background-color:orange;">enhancing</mark> <mark style="background-color:lightgreen;" id="P81460,P81461">concanavalin A</mark> ( <mark style="background-color:lightgreen;" id="P02866,P14894,P81460,P81461">ConA</mark> )- or <mark style="background-color:lightblue;" id="11970143">lipopolysaccharide</mark> (LPS)-induced <mark style="background-color:yellow;" id="GO:0046651,biological_process">lymphocyte proliferation</mark> , which suggested that <mark style="background-color:lightgreen;" id="Q9XF19">POP</mark> could be a potential immunostimulating agent for use in functional foods or medicine against both pathogens and cancer.
18648877-1504	The <mark style="background-color:lightblue;" id="979">p-hydroxyphenylpyruvate</mark> <mark style="background-color:orange;">produced</mark> by the Escherichia coli <mark style="background-color:yellow;" id="GO:0018995,cellular_component">host</mark> was <mark style="background-color:orange;">converted</mark> to <mark style="background-color:lightblue;" id="449178">HGA</mark> through the oxidation reaction of introduced <mark style="background-color:lightgreen;" id="O42764">HPPD</mark> .
18585399-1508	The anti-convulsant <mark style="background-color:lightblue;" id="5311454">stiripentol</mark> <mark style="background-color:orange;">acts</mark> directly on the <mark style="background-color:lightgreen;" id="P26714,Q08832,Q9BLY8">GABA(A) receptor</mark> as a positive allosteric modulator.
18661183-1518	NH(4)<mark style="background-color:lightblue;" id="312">Cl</mark> treatment causes an <mark style="background-color:orange;">increase</mark> in <mark style="background-color:yellow;" id="GO:0005622,cellular_component">intracellular</mark> [pH]i of sperm, suggesting that <mark style="background-color:lightgreen;" id="O02367,O16305,O60041,O82018,O94739,O96102,O97341,P02594,P02595,P02598,P02599,P04352,P04353,P04464,P05933,P05934,P05935,P06787,P07463,P11118,P11120,P11121,P15094,P17928,P18061,P21251,P23286,P24044,P27161,P27165,P27166,P41040,P41041,P48976,P60204,P60205,P60206,P61859,P61860,P61861,P62144,P62145,P62149,P62151,P62152,P62154,P62155,P62156,P62157,P62158,P62160,P62161,P62162,P62184,P62201,P62202,P62203,P62204,P69097,P69098,P84339,P93087,P93171,Q00168,Q05055,Q39752,Q40302,Q5EHV7,Q5RAD2,Q6IT78,Q6PI52,Q6R520,Q6YNX6,Q71UH5,Q71UH6,Q7T3T2,Q7Y052,Q8STF0,Q8X187,Q95NI4,Q95NR9,Q9GRJ1,Q9HFY6,Q9U6D3,Q9UWF0">CaM</mark> and CaMK are involved in <mark style="background-color:yellow;" id="GO:0030317,biological_process">sperm motility</mark> initiation caused by an increase in [pH]i.
18640717-1523	<mark style="background-color:lightgreen;" id="O00329,O02697,O35904,P23727,P26450,P27986,P32871,P42336,P42337,P42338,P42347,P42348,P48736,P54673,P54674,P54675,P54676,Q63787,Q8BTI9,Q8UUU2,Q9JHG7,Q9Z1L0">PI3K</mark> / <mark style="background-color:lightgreen;" id="P31750,Q8INB9">Akt</mark> activity, analyzed by <mark style="background-color:lightblue;" id="53477912">phosphatidylinositol</mark> trisphosphate production and <mark style="background-color:orange;">phosphorylated</mark> <mark style="background-color:lightgreen;" id="P31750,Q8INB9">Akt</mark> (p- <mark style="background-color:lightgreen;" id="P31750,Q8INB9">Akt</mark> ) expression, was higher in the resistant cell lines than in the sensitive one and inhibition with <mark style="background-color:lightblue;" id="312145">wortmannin</mark> or <mark style="background-color:lightblue;" id="3973">LY294002</mark> improved <mark style="background-color:yellow;" id="GO:0006915,biological_process">apoptosis</mark> in the resistant cell lines.
18640717-1524	<mark style="background-color:lightblue;" id="5978">Vincristine</mark> but not <mark style="background-color:lightblue;" id="31703">doxorubicin</mark> <mark style="background-color:orange;">increased</mark> p- <mark style="background-color:lightgreen;" id="P31750,Q8INB9">Akt</mark> expression whereas co-treatment with <mark style="background-color:lightgreen;" id="O00329,O02697,O35904,P23727,P26450,P27986,P32871,P42336,P42337,P42338,P42347,P42348,P48736,P54673,P54674,P54675,P54676,Q63787,Q8BTI9,Q8UUU2,Q9JHG7,Q9Z1L0">PI3K</mark> inhibitors and <mark style="background-color:lightblue;" id="5978">vincristine</mark> increased <mark style="background-color:yellow;" id="GO:0006915,biological_process">apoptosis</mark> in the three cell lines.
18640717-1525	<mark style="background-color:lightblue;" id="312145">Wortmannin</mark> and <mark style="background-color:lightblue;" id="3973">LY294002</mark> <mark style="background-color:orange;">inhibited</mark> P- <mark style="background-color:lightgreen;" id="P08163">glycoprotein</mark> (<mark style="background-color:lightblue;" id="449562">Pgp</mark>) function and also increased NF-kappaB activity.
18677583-1526	<mark style="background-color:lightblue;" id="3121">Valproate</mark>, an anticonvulsant and mood stabilizer, <mark style="background-color:orange;">up-regulates</mark> <mark style="background-color:lightgreen;" id="P10417,P49950">Bcl-2</mark> , a neurotrophic/neuroprotective protein.
18677583-1527	In this study, we investigated the molecular mechanism through which <mark style="background-color:lightgreen;" id="P10417,P49950">Bcl-2</mark> is <mark style="background-color:orange;">up-regulated</mark> by <mark style="background-color:lightblue;" id="3121">valproate</mark> using cultured human neuron-like cells.
18677583-1528	<mark style="background-color:lightblue;" id="3121">Valproate</mark>, within therapeutically relevant ranges, <mark style="background-color:orange;">induced</mark> time- and concentration-dependent up-regulations of both <mark style="background-color:lightgreen;" id="P10417,P49950">Bcl-2</mark> messenger RNA and protein implicating an underlying gene transcriptional-mediated mechanism.
18677583-1529	<mark style="background-color:lightblue;" id="3121">Valproate</mark> <mark style="background-color:orange;">increased</mark> transcriptional activity of a human <mark style="background-color:lightgreen;" id="P10417,P49950">bcl-2</mark> promoter-reporter gene construct.
18677583-1531	These data collectively suggest that <mark style="background-color:lightblue;" id="3121">valproate</mark> <mark style="background-color:orange;">induces</mark> <mark style="background-color:lightgreen;" id="P10417,P49950">Bcl-2</mark> regulation partially through activations of the <mark style="background-color:lightgreen;" id="P29323">ERK</mark> and <mark style="background-color:lightgreen;" id="O00329,O02697,O35904,P23727,P26450,P27986,P32871,P42336,P42337,P42338,P42347,P42348,P48736,P54673,P54674,P54675,P54676,Q63787,Q8BTI9,Q8UUU2,Q9JHG7,Q9Z1L0">PI3K</mark> cascades and their convergent kinase, <mark style="background-color:lightgreen;" id="P18652">RSK</mark> , although other unknown mechanism(s) are likely involved.
18680550-1533	<mark style="background-color:lightgreen;" id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">Insulin</mark> resistance is a major determinant of <mark style="background-color:orange;">sustained</mark> virological response in genotype 1 chronic hepatitis C patients <mark style="background-color:orange;">receiving</mark> peginterferon alpha-2b plus <mark style="background-color:lightblue;" id="37542">ribavirin</mark>.
18680550-1535	Aim To investigate retrospectively the impact of <mark style="background-color:lightgreen;" id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">insulin</mark> resistance on treatment response in Chinese genotype 1 <mark style="background-color:lightblue;" id="447715">CHC</mark> patients <mark style="background-color:orange;">receiving</mark> a 24-week course therapy with peginterferon alpha-2b/<mark style="background-color:lightblue;" id="37542">ribavirin</mark>.
18703532-1538	<mark style="background-color:lightblue;" id="2754">Cilostazol</mark> <mark style="background-color:orange;">inhibits</mark> cytokine-induced nuclear factor-kappaB activation via <mark style="background-color:lightgreen;" id="O24006">AMP</mark> -activated <mark style="background-color:lightgreen;" id="P00513,P25848">protein kinase</mark> activation in vascular endothelial cells.
18703532-1539	<mark style="background-color:lightblue;" id="2754">Cilostazol</mark> is a selective inhibitor of phosphodiesterase 3 that <mark style="background-color:orange;">increases</mark> <mark style="background-color:yellow;" id="GO:0005622,cellular_component">intracellular</mark> cyclic <mark style="background-color:lightgreen;" id="O24006">AMP</mark> (<mark style="background-color:lightblue;" id="6076">cAMP</mark>) <mark style="background-color:orange;">levels</mark> and <mark style="background-color:orange;">activates</mark> <mark style="background-color:lightgreen;" id="Q05608,Q9RI12">protein kinase A</mark> , thereby inhibiting platelet aggregation and inducing peripheral <mark style="background-color:yellow;" id="GO:0042311,biological_process">vasodilation</mark> .
18703532-1540	We hypothesized that <mark style="background-color:lightblue;" id="2754">cilostazol</mark> may <mark style="background-color:orange;">prevent</mark> inflammatory cytokine induced-nuclear factor (NF)-kappaB activation by <mark style="background-color:orange;">activating</mark> <mark style="background-color:lightgreen;" id="O24006">AMP</mark> -activated <mark style="background-color:lightgreen;" id="P00513,P25848">protein kinase</mark> ( <mark style="background-color:lightgreen;" id="P54646,Q09136,Q9Y478">AMPK</mark> ) in vascular endothelial cells.
18683011-1547	<mark style="background-color:lightblue;" id="5282199">Geranylgeranylacetone</mark> <mark style="background-color:orange;">prevents</mark> acute liver <mark style="background-color:orange;">damage</mark> after massive hepatectomy in rats through suppression of a CXC chemokine <mark style="background-color:lightgreen;" id="P09341">GRO1</mark> and induction of heat shock proteins.
18655070-1550	Altogether these changes offer a straightforward explanation for how following the addition of <mark style="background-color:lightblue;" id="271">Ca(2</mark>+), the <mark style="background-color:lightblue;" id="2830">coelenterazine</mark> could <mark style="background-color:orange;">escape</mark> and become available for <mark style="background-color:yellow;" id="GO:0008218,biological_process">bioluminescence</mark> on Renilla <mark style="background-color:lightgreen;" id="P08659,P13129,Q01158,Q26304,Q27757">luciferase</mark> .
18629605-1551	In aged animals, administration of <mark style="background-color:lightblue;" id="10918">L-carnitine</mark> for 21 days significantly <mark style="background-color:orange;">decreased</mark> the <mark style="background-color:orange;">levels</mark> of lipid peroxides and <mark style="background-color:orange;">improved</mark> the activities of antioxidant enzymes like <mark style="background-color:lightgreen;" id="O50258">superoxide dismutase</mark> , <mark style="background-color:lightgreen;" id="O24339,O52762,O62839,O68146,O77229,O93662,O97492,P00432,P04040,P04762,P07145,P0A323,P0A324,P0A325,P0A326,P0A327,P11934,P17336,P24168,P24270,P25890,P29422,P30265,P30266,P32290,P42321,P44390,P45737,P45739,P55304,P55306,P55310,P55311,P55313,P77872,P81138,P90682,Q27710,Q49XC1,Q4L643,Q59296,Q59337,Q59602,Q59714,Q5HG86,Q5HPK8,Q5RF10,Q64405,Q6G9M4,Q6GH72,Q7A5T2,Q8CPD0,Q8FWU0,Q8NWV5,Q8X1P0,Q8Y3P9,Q926X0,Q99UE2,Q9AXH0,Q9KW19,Q9L4S1,Q9M5L6,Q9PT92,Q9PWF7,Q9Z598,Q9ZKX5,Q9ZN99">catalase</mark> , <mark style="background-color:lightgreen;" id="O32770,O59858,Q00277,Q9CFV1">glutathione peroxidase</mark> and <mark style="background-color:lightgreen;" id="O15770,P06715,P11804,P23189,P41921,P43783,P48638,P48639,P70619,P78965,Q60151,Q6BPI1,Q6C5H4,Q6FRV2,Q6HA23,Q74ZK4,Q873E8,Q94655">glutathione reductase</mark> .
18629605-1552	<mark style="background-color:lightblue;" id="10918">L-Carnitine</mark> <mark style="background-color:orange;">enhanced</mark> T-cell proliferative responses as evaluated by <mark style="background-color:yellow;" id="GO:0042098,biological_process">T-cell proliferation</mark> assay <mark style="background-color:orange;">using</mark> [3H] <mark style="background-color:lightblue;" id="5789">thymidine</mark> incorporation and also significantly <mark style="background-color:orange;">reduced</mark> DNA damage, <mark style="background-color:yellow;" id="GO:0006915,biological_process">apoptosis</mark> and <mark style="background-color:lightgreen;" id="O35734,O77510,O77764,P01375,P04924,P06804,P13296,P16599,P19101,P23383,P23563,P29553,P33620,P36939,P48094,P51435,P51742,P51743,P59684,P59693,P59694,P59695,P79337,P79374,Q06599,Q19LH4,Q1G1A2,Q1WM27,Q2MH05,Q539C2,Q75N23,Q8HZD9,Q8JFG3,Q8MKG8,Q8WNR1,Q9BEA1">TNF-alpha</mark> level in lymphocytes of aged animals.
18693094-1555	<mark style="background-color:lightgreen;" id="O12956,O42143,O42144,P01272,P01273,P01274,P01275,P04093,P05110,P06883,P07449,P09566,P09567,P09682,P09686,P0C235,P13189,P15438,P18108,P22890,P29794,P31297,P33528,P55095,P68259,P68260,P68273,P68274,P68275,P68952,P68953,P68954,P68955,P68956,P68957,P79695,P81880,Q8MJ25,Q9PRQ9">Glucagon</mark> is important to this response because it <mark style="background-color:orange;">increases</mark> <mark style="background-color:lightblue;" id="738,5961">glutamine</mark> uptake.
18640746-1557	Namely, the results obtained for the most active compounds, 5-(chloroacetylamino)<mark style="background-color:lightblue;" id="23648490">uracil (2</mark>) and its acyclic sugar analogue 18, suggest that formation of a covalent bond between reactive substituent and several possible <mark style="background-color:orange;">targets</mark> within the <mark style="background-color:lightgreen;" id="O02604,O26868,O33380,O66108,O76511,O81395,O96650,P00469,P00471,P04818,P06785,P06854,P07382,P07606,P07607,P09249,P0A0M5,P0A884,P0A885,P0A886,P0C0M4,P0C0M5,P12461,P12462,P13100,P13922,P16126,P19368,P20712,P44420,P45350,P45351,P45352,P46103,P47469,P48464,P51820,P57515,P57808,P59427,P67042,P67043,P67044,P67045,P67046,P67047,P67048,P67049,P67050,P67051,P67052,P78029,P80305,P90463,Q05762,Q05763,Q07422,Q23695,Q27713,Q27783,Q27793,Q27828,Q2QRX6,Q4QM04,Q57931,Q5D189,Q5E7P1,Q5FKL6,Q5GWB5,Q5HFZ6,Q5HMP6,Q5KZ25,Q5M0S7,Q5M5B3,Q5NFK5,Q5P233,Q5PEN6,Q5R064,Q5UQG3,Q5WDS1,Q5WSU5,Q5X119,Q5XCM3,Q5YPL7,Q5ZRL3,Q603S2,Q63BV5,Q64PV5,Q65J44,Q65VJ8,Q667F9,Q67JQ1,Q6A761,Q6AFI0,Q6D8I6,Q6F145,Q6FER7,Q6FZ91,Q6G2S8,Q6G9D4,Q6GGY0,Q6HJC7,Q6KIQ6,Q6LUM1,Q6MID2,Q6N447,Q6NIF2,Q6REU8,Q6YQT0,Q71YE1,Q738X7,Q73VZ2,Q74IU3,Q7MNN6,Q7MTB5,Q7N8U4,Q7NZ95,Q7UID0,Q7VMH2,Q7VUE3,Q7W1A9,Q7WP13,Q81E05,Q81R23,Q82WU3,Q834R3,Q83BG2,Q87BT4,Q87SA0,Q87UL4,Q88CN9,Q88W05,Q89940,Q89G35,Q8A639,Q8D2N4,Q8DER9,Q8DUI4,Q8DZ07,Q8E4L6,Q8EH94,Q8EQG0,Q8EV81,Q8FR47,Q8G3T9,Q8K9C3,Q8NS38,Q8P1D1,Q8PCE7,Q8PP46,Q8PXI1,Q8RGP6,Q8THH4,Q8TVL9,Q8UDS3,Q8Y0U6,Q8Y626,Q8Z412,Q8ZHV1,Q8ZMA9,Q92AD4,Q92NQ5,Q97EV3,Q98KH9,Q98Q31,Q9A6H0,Q9CBW0,Q9I6F1,Q9JT57,Q9JY72,Q9K7B5,Q9P4T7,Q9PB13,Q9RAM7,Q9XC19,Q9Z671">thymidylate synthase</mark> mechanism (sulphur of the <mark style="background-color:lightblue;" id="594,5862,5360637">cysteine</mark> residue, basic part of the enzyme, N,N-<mark style="background-color:lightblue;" id="123164">methylene</mark> <mark style="background-color:lightblue;" id="91443">tetrahydrofolate</mark> or its reactive iminium forms) is the most probable mode of action.
18698091-1558	In response to a <mark style="background-color:lightblue;" id="304,5997,6432564,11025495">cholesterol</mark>-containing atherogenic diet, C57BL/6J mice significantly <mark style="background-color:orange;">increased</mark> expression of <mark style="background-color:lightgreen;" id="O97562,P55851,Q9N2J1,Q9W725">UCP2</mark> in the aorta, while mice lacking <mark style="background-color:lightgreen;" id="O97562,P55851,Q9N2J1,Q9W725">UCP2</mark> , in the absence of any other genetic modification, displayed significant endothelial dysfunction following the atherogenic diet.
18698091-1559	These data establish that in the vasculature <mark style="background-color:lightgreen;" id="O97562,P55851,Q9N2J1,Q9W725">UCP2</mark> functions as an adaptive antioxidant defense to <mark style="background-color:orange;">protect</mark> against the <mark style="background-color:yellow;" id="GO:0007275,biological_process">development</mark> of atherosclerosis in response to a fat and <mark style="background-color:lightblue;" id="304,5997,6432564,11025495">cholesterol</mark> diet.
18665326-1562	<mark style="background-color:lightblue;" id="5213,31553,1548994,3086637,24832061,44147684">Silymarin</mark> attenuated mast cell recruitment thereby <mark style="background-color:orange;">decreased</mark> the expressions of <mark style="background-color:lightgreen;" id="P08253,P33434,P33436,P50757,Q90611,Q9GLE5">matrix metalloproteinases-2</mark> and 9 in rat liver carcinogenesis.
18665326-1563	<mark style="background-color:lightblue;" id="5921">NDEA</mark> administered rats showed increased <mark style="background-color:lightgreen;" id="O95822,P12617,Q920F5,Q99J39">MCD</mark> as revealed by <mark style="background-color:lightblue;" id="7084">toluidine blue</mark> <mark style="background-color:orange;">staining</mark> along with <mark style="background-color:orange;">upregulated</mark> expressions of <mark style="background-color:lightgreen;" id="P08253,P33434,P33436,P50757,Q90611,Q9GLE5">MMP-2</mark> and <mark style="background-color:lightgreen;" id="O18733,P14780,P41245,P41246,P50282,P52176">MMP-9</mark> .
18665326-1564	<mark style="background-color:lightblue;" id="5213,31553,1548994,3086637,24832061,44147684">Silymarin</mark> treatment <mark style="background-color:orange;">inhibited</mark> this <mark style="background-color:orange;">increase</mark> in <mark style="background-color:lightgreen;" id="O95822,P12617,Q920F5,Q99J39">MCD</mark> and <mark style="background-color:orange;">downregulated</mark> the expressions of <mark style="background-color:lightgreen;" id="P08253,P33434,P33436,P50757,Q90611,Q9GLE5">MMP-2</mark> and <mark style="background-color:lightgreen;" id="O18733,P14780,P41245,P41246,P50282,P52176">MMP-9</mark> as revealed by Western blotting and immunohistochemistry.
18665326-1565	In conclusion, <mark style="background-color:lightblue;" id="5213,31553,1548994,3086637,24832061,44147684">silymarin</mark> exerted beneficial <mark style="background-color:orange;">effects</mark> on liver carcinogenesis by attenuating the recruitment of mast cells and thereby <mark style="background-color:orange;">decreased</mark> the expressions of <mark style="background-color:lightgreen;" id="P08253,P33434,P33436,P50757,Q90611,Q9GLE5">MMP-2</mark> and <mark style="background-color:lightgreen;" id="O18733,P14780,P41245,P41246,P50282,P52176">MMP-9</mark> .
18661233-1568	We demonstrated the increase in the levels of <mark style="background-color:lightgreen;" id="O09185,O12946,O57538,O93379,P02340,P04637,P10361,P19558,P19559,P56423,P56424,P61260,P79820,P79892,Q29537,Q42578,Q8SPZ3,Q92143,Q9TTA1,Q9TUB2,Q9W678,Q9W679">p53</mark> , <mark style="background-color:lightgreen;" id="P27297,Q07813,Q63690">Bax</mark> , and <mark style="background-color:lightgreen;" id="O07091,O13393,O22642,O93863,P00002,P00003,P00004,P00007,P00008,P00011,P00012,P00013,P00014,P00017,P00018,P00019,P00020,P00021,P00022,P00024,P00025,P00027,P00028,P00029,P00030,P00031,P00032,P00035,P00036,P00037,P00038,P00039,P00040,P00041,P00042,P00043,P00046,P00047,P00048,P00049,P00051,P00052,P00053,P00054,P00055,P00056,P00057,P00058,P00059,P00060,P00061,P00062,P00063,P00064,P00065,P00066,P00067,P00068,P00069,P00070,P00071,P00072,P00073,P00074,P00075,P00076,P00077,P00078,P00079,P12831,P15451,P18822,P19681,P19974,P21665,P22342,P25400,P29380,P32556,P38091,P53698,P56205,P59218,P62772,P62773,P62894,P62895,P62896,P67881,P67882,P68096,P68097,P68098,P68099,P68100,P68517,P68518,P68519,P81280,P81459,P99998,P99999,Q41346,Q4HVX7,Q52V08,Q52V09,Q52V10,Q5RFH4,Q640U4,Q6C9Q0,Q6IQM2,Q6Q4H8,Q6QLW4,Q6WUX8,Q753F4,Q7YR71,Q96VP3">cytochrome c</mark> and <mark style="background-color:orange;">decrease</mark> in the <mark style="background-color:orange;">level</mark> of <mark style="background-color:lightgreen;" id="P10417,P49950">Bcl-2</mark> , which are <mark style="background-color:orange;">associated</mark> with the induction of apoptotic <mark style="background-color:yellow;" id="GO:0008219,biological_process">cell death</mark> after 24 h treatment with <mark style="background-color:lightblue;" id="5281605">baicalein</mark> in N18 cells.
18685817-1575	Combustion products of <mark style="background-color:lightblue;" id="7845">1,3-butadiene</mark> <mark style="background-color:orange;">inhibit</mark> <mark style="background-color:lightgreen;" id="O24339,O52762,O62839,O68146,O77229,O93662,O97492,P00432,P04040,P04762,P07145,P0A323,P0A324,P0A325,P0A326,P0A327,P11934,P17336,P24168,P24270,P25890,P29422,P30265,P30266,P32290,P42321,P44390,P45737,P45739,P55304,P55306,P55310,P55311,P55313,P77872,P81138,P90682,Q27710,Q49XC1,Q4L643,Q59296,Q59337,Q59602,Q59714,Q5HG86,Q5HPK8,Q5RF10,Q64405,Q6G9M4,Q6GH72,Q7A5T2,Q8CPD0,Q8FWU0,Q8NWV5,Q8X1P0,Q8Y3P9,Q926X0,Q99UE2,Q9AXH0,Q9KW19,Q9L4S1,Q9M5L6,Q9PT92,Q9PWF7,Q9Z598,Q9ZKX5,Q9ZN99">catalase</mark> activity and induce expression of oxidative DNA damage repair enzymes in human bronchial epithelial cells.
18633701-1578	Upon <mark style="background-color:lightblue;" id="5994">progesterone</mark> stimulation, an <mark style="background-color:lightgreen;" id="O18158">O-GlcNAc</mark> <mark style="background-color:orange;">level</mark> burst occurred during meiotic resumption long before <mark style="background-color:lightgreen;" id="Q13421,Q61468,Q9ERA7">MPF</mark> and <mark style="background-color:lightgreen;" id="P00536,P00539,P12965">Mos</mark> - <mark style="background-color:lightgreen;" id="P63085,P63086">Erk2</mark> pathways activations.
18618240-1582	In the hormone receptor-positive breast cancer cell line <mark style="background-color:lightblue;" id="242532">T47</mark>-D expression of <mark style="background-color:lightgreen;" id="P78310">hCAR</mark> and its soluble isoforms was <mark style="background-color:orange;">increased</mark> by treatment with <mark style="background-color:lightblue;" id="5757">estradiol</mark> and <mark style="background-color:lightblue;" id="2733526">tamoxifen</mark>.
18618241-1584	In contrast to the <mark style="background-color:yellow;" id="GO:0007610,biological_process">behavior</mark> in aqueous solution, <mark style="background-color:yellow;" id="GO:0030395,molecular_function">lactose binding</mark> in <mark style="background-color:lightblue;" id="679">DMSO</mark> resulted in an <mark style="background-color:orange;">increase</mark> of the <mark style="background-color:lightgreen;" id="P02871,P02873,P02874,P02875,P07386,P16108,P16349,P16351,P16352,P33888,P38662,P42088,P83410,P83511,P84987,Q41114">lectin</mark> 's radius of gyration from 49 +/- 1 to 55.5 +/- 1 A.
18618243-1588	Our study indicates that brain <mark style="background-color:lightgreen;" id="O49046,P00812,P0A2X9,P0A2Y0,P0A2Y1,P14012,P33280,P37818,P39138,P40906,P46637,P53608,P60086,P60087,P60088,Q10066,Q12611,Q1E180,Q6G7E9,Q6GER3,Q74ZW4,Q7M0Z3,Q8NVE3">arginase</mark> activity <mark style="background-color:orange;">decreases</mark> after <mark style="background-color:lightblue;" id="2519">caffeine</mark> administration at doses of 30 mg/kg and 100 mg/kg.
18618245-1590	Comparison of the PTM's of <mark style="background-color:lightgreen;" id="P02686,P02687,P04370,P06906,P13727,P15720,P20939,P25188,P25274,P25336,P81558,P83487,P87346,P98190,Q61878,Q63189,Q91325,Q91439,Q9SAV1">MBP</mark> 's isolated from several vertebrate species reveals <mark style="background-color:orange;">marked</mark> differences in their <mark style="background-color:lightblue;" id="1061,167704,644102">phosphate</mark> content.
18618245-1591	Chicken <mark style="background-color:lightgreen;" id="P02686,P02687,P04370,P06906,P13727,P15720,P20939,P25188,P25274,P25336,P81558,P83487,P87346,P98190,Q61878,Q63189,Q91325,Q91439,Q9SAV1">MBP</mark> does not share any <mark style="background-color:orange;">phosphorylated</mark> sites with dogfish <mark style="background-color:lightgreen;" id="P02686,P02687,P04370,P06906,P13727,P15720,P20939,P25188,P25274,P25336,P81558,P83487,P87346,P98190,Q61878,Q63189,Q91325,Q91439,Q9SAV1">MBP</mark> ; However, it does <mark style="background-color:orange;">contain</mark> phosphorylated <mark style="background-color:lightblue;" id="5951">serine</mark> and <mark style="background-color:lightblue;" id="6288">threonine</mark> residues in common with mammalian <mark style="background-color:lightgreen;" id="P02686,P02687,P04370,P06906,P13727,P15720,P20939,P25188,P25274,P25336,P81558,P83487,P87346,P98190,Q61878,Q63189,Q91325,Q91439,Q9SAV1">MBP</mark> .
18577298-1601	This reduction was associated with the storage of decreased <mark style="background-color:lightgreen;" id="P44321">TAG</mark> and <mark style="background-color:orange;">increased</mark> <mark style="background-color:lightblue;" id="439177">glycogen</mark>, which was a result of <mark style="background-color:orange;">enhanced</mark> <mark style="background-color:lightblue;" id="1153,6057,5460803">tyrosine</mark> <mark style="background-color:yellow;" id="GO:0016310,biological_process">phosphorylation</mark> of anti- <mark style="background-color:lightgreen;" id="P81122,Q9Y4H2">insulin receptor substrate-2</mark> and serine473 phosphporylation of <mark style="background-color:lightgreen;" id="P31749,P31750,P47196,Q01314,Q8INB9">protein kinase B</mark> ( <mark style="background-color:lightgreen;" id="P31749,P31750,P47196,Q01314,Q8INB9">PKB</mark> , <mark style="background-color:lightgreen;" id="P31750,Q8INB9">Akt</mark> ).
18577298-1602	Improved hepatic <mark style="background-color:lightgreen;" id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">insulin</mark> signalling led to <mark style="background-color:orange;">decreased</mark> <mark style="background-color:lightblue;" id="1005">phosphoenolpyruvate</mark> carboxykinase expression and <mark style="background-color:orange;">reduced</mark> hepatic <mark style="background-color:lightblue;" id="206,5793,64689,79025">glucose</mark> output accordingly.
18614168-1607	<mark style="background-color:lightgreen;" id="O15547,O54803,O70397,P34996,P35383,P41231,P41232,P47824,P47900,P48042,P49650,P49651,P49652,P49653,P49654,P51575,P51576,P51577,P51578,P51579,P56373,P59902,Q64663,Q93086,Q99571,Q99572,Q9UBL9,Q9Z1M0">Purinergic receptor</mark> agonists <mark style="background-color:lightblue;" id="5957">ATP</mark> and <mark style="background-color:lightblue;" id="6133">UTP</mark> selectively <mark style="background-color:orange;">activate</mark> certain <mark style="background-color:lightgreen;" id="P05480,Q9WUD9">Src</mark> family <mark style="background-color:lightblue;" id="1153,6057,5460803">tyrosine</mark> kinases and <mark style="background-color:orange;">stimulate</mark> <mark style="background-color:lightblue;" id="923,373840">Na</mark>,K- <mark style="background-color:yellow;" id="GO:0016887,molecular_function">ATPase activity</mark> .
18655138-1615	The <mark style="background-color:lightblue;" id="4346576">APTS</mark> functionalization was then <mark style="background-color:orange;">used</mark> to <mark style="background-color:orange;">immobilize</mark> bone <mark style="background-color:lightgreen;" id="P07580">morphogenetic protein</mark> on the bioactive glasses.
18687985-1621	Studies suggest that <mark style="background-color:lightgreen;" id="O94907">DKK1</mark> activation in osteoblasts is the underlying cause of glucocorticoid- and estrogen deficiency-mediated osteoporosis, and at least partially underlies the teratogenic <mark style="background-color:orange;">effects</mark> of <mark style="background-color:lightblue;" id="5426,75792,92142">thalidomide</mark> on limb <mark style="background-color:yellow;" id="GO:0007275,biological_process">development</mark> .
18665391-1625	While it is clearly demonstrated that members of the <mark style="background-color:lightgreen;" id="Q13507">TRPC3</mark> /6/7 subfamily are <mark style="background-color:orange;">activated</mark> by <mark style="background-color:lightblue;" id="6026790">diacylglycerol</mark>, the mechanism by which phospholipase C <mark style="background-color:orange;">activates</mark> members of the <mark style="background-color:lightgreen;" id="O18784,P48995,Q9TUN9">TRPC1</mark> /4/5 subfamily remains a mystery.
18665391-1626	Depletion of polyphosphatidylinositol 4-<mark style="background-color:lightblue;" id="1061,167704,644102">phosphate</mark> and <mark style="background-color:lightblue;" id="5311358">phosphatidylinositol 4,5-bisphosphate</mark> ( <mark style="background-color:lightgreen;" id="P52488,P52960">PIP2</mark> ) through inhibition of <mark style="background-color:lightgreen;" id="P54677">phosphatidylinositol 4-kinase</mark> <mark style="background-color:orange;">activates</mark> calcium entry and <mark style="background-color:yellow;" id="GO:0016020,cellular_component">membrane</mark> currents in <mark style="background-color:lightgreen;" id="O62852,Q9MYV9,Q9UL62">TRPC5</mark> -expressing but not in <mark style="background-color:lightgreen;" id="Q13507">TRPC3</mark> - or <mark style="background-color:lightgreen;" id="O94759,Q9HCX4">TRPC7</mark> -expressing cells.
18665391-1627	Inclusion of polyphosphatidylinositol 4-<mark style="background-color:lightblue;" id="1061,167704,644102">phosphate</mark> or <mark style="background-color:lightgreen;" id="P52488,P52960">PIP2</mark> , but not <mark style="background-color:lightblue;" id="643963">phosphatidylinositol 3,4,5-trisphosphate</mark>, in the patch pipette <mark style="background-color:orange;">inhibited</mark> <mark style="background-color:lightgreen;" id="O62852,Q9MYV9,Q9UL62">TRPC5</mark> currents.
18655158-1630	L-<mark style="background-color:lightblue;" id="846">Kynurenine</mark> (<mark style="background-color:lightblue;" id="161166">KYN</mark>), a <mark style="background-color:lightblue;" id="1148,6305,9060,5460840">tryptophan</mark> metabolite, is <mark style="background-color:orange;">metabolized</mark> to <mark style="background-color:lightblue;" id="3845">kynurenic acid</mark> (<mark style="background-color:lightblue;" id="3845">KYNA</mark>), which is an antagonist of <mark style="background-color:lightblue;" id="22880">N-methyl-D-aspartate</mark> and alpha7 nicotinic <mark style="background-color:lightblue;" id="187">acetylcholine</mark> receptors, by <mark style="background-color:lightblue;" id="846">kynurenine</mark> <mark style="background-color:yellow;" id="GO:0008483,molecular_function">aminotransferase</mark> ( <mark style="background-color:lightgreen;" id="Q8NFU3">KAT</mark> ) I and <mark style="background-color:lightgreen;" id="Q8NFU3">KAT</mark> II.
18587580-1638	<mark style="background-color:lightblue;" id="400769">CDDO-Me</mark>, a synthetic triterpenoid, <mark style="background-color:orange;">inhibits</mark> expression of <mark style="background-color:lightgreen;" id="O35736,P05231,P08505,P20607,P26892,P26893,P29455,P41323,P41683,P41693,P46650,P51494,P79341,Q25BC2,Q28319,Q28747,Q28819,Q2MH06,Q5I6E3,Q6V919,Q865W7,Q865X6,Q8MKH0,Q95181,Q9MZR1,Q9XT80">IL-6</mark> and <mark style="background-color:lightgreen;" id="P42227,P52631">Stat3</mark>  <mark style="background-color:yellow;" id="GO:0016310,biological_process">phosphorylation</mark> in multi-drug resistant ovarian cancer cells.
18587580-1639	To explore potential therapeutic strategies for interrupting signaling through this pathway, we assessed the ability of <mark style="background-color:lightblue;" id="400769">CDDO-Me</mark>, a synthetic triterpenoid, to <mark style="background-color:orange;">inhibit</mark> <mark style="background-color:lightgreen;" id="O35736,P05231,P08505,P20607,P26892,P26893,P29455,P41323,P41683,P41693,P46650,P51494,P79341,Q25BC2,Q28319,Q28747,Q28819,Q2MH06,Q5I6E3,Q6V919,Q865W7,Q865X6,Q8MKH0,Q95181,Q9MZR1,Q9XT80">IL-6</mark>  <mark style="background-color:yellow;" id="GO:0046903,biological_process">secretion</mark> , <mark style="background-color:lightgreen;" id="P42227,P52631">Stat3</mark>  <mark style="background-color:yellow;" id="GO:0016310,biological_process">phosphorylation</mark> , <mark style="background-color:lightgreen;" id="P42227,P52631">Stat3</mark> nuclear translocation and <mark style="background-color:lightblue;" id="4666,36314,441276,5352019,6713921,6915727,44155032,53313247">paclitaxel</mark> sensitivity in several cell line model systems.
18587580-1640	These studies demonstrated that <mark style="background-color:lightblue;" id="400769">CDDO-Me</mark> significantly <mark style="background-color:orange;">inhibits</mark> <mark style="background-color:lightgreen;" id="O35736,P05231,P08505,P20607,P26892,P26893,P29455,P41323,P41683,P41693,P46650,P51494,P79341,Q25BC2,Q28319,Q28747,Q28819,Q2MH06,Q5I6E3,Q6V919,Q865W7,Q865X6,Q8MKH0,Q95181,Q9MZR1,Q9XT80">IL-6</mark>  <mark style="background-color:yellow;" id="GO:0046903,biological_process">secretion</mark> in <mark style="background-color:lightblue;" id="4666,36314,441276,5352019,6713921,6915727,44155032,53313247">paclitaxel</mark>-resistant ovarian cancer cells and specifically <mark style="background-color:orange;">suppresses</mark> <mark style="background-color:lightgreen;" id="O35736,P05231,P08505,P20607,P26892,P26893,P29455,P41323,P41683,P41693,P46650,P51494,P79341,Q25BC2,Q28319,Q28747,Q28819,Q2MH06,Q5I6E3,Q6V919,Q865W7,Q865X6,Q8MKH0,Q95181,Q9MZR1,Q9XT80">IL-6</mark> - or oncostatin M-induced <mark style="background-color:lightgreen;" id="P42227,P52631">Stat3</mark> nuclear translocation.
18587580-1641	Treatment with <mark style="background-color:lightblue;" id="400769">CDDO-Me</mark> significantly <mark style="background-color:orange;">decreases</mark> the <mark style="background-color:orange;">levels</mark> of <mark style="background-color:lightgreen;" id="P42227,P52631">Stat3</mark> , <mark style="background-color:lightgreen;" id="Q62120,Q62689">Jak2</mark> , and <mark style="background-color:lightgreen;" id="P05480,Q9WUD9">Src</mark>  <mark style="background-color:yellow;" id="GO:0016310,biological_process">phosphorylation</mark> in ovarian and breast cancer cell lines with constitutively activated <mark style="background-color:lightgreen;" id="P42227,P52631">Stat3</mark> .
18587580-1642	Our data confirm that <mark style="background-color:lightblue;" id="400769">CDDO-Me</mark> <mark style="background-color:orange;">interrupts</mark> the signaling of multiple kinases involved in the <mark style="background-color:lightgreen;" id="O35736,P05231,P08505,P20607,P26892,P26893,P29455,P41323,P41683,P41693,P46650,P51494,P79341,Q25BC2,Q28319,Q28747,Q28819,Q2MH06,Q5I6E3,Q6V919,Q865W7,Q865X6,Q8MKH0,Q95181,Q9MZR1,Q9XT80">IL-6</mark> - <mark style="background-color:lightgreen;" id="P42227,P52631">Stat3</mark> and <mark style="background-color:lightgreen;" id="P05480,Q9WUD9">Src</mark> signaling pathways.
18618304-1646	<mark style="background-color:lightblue;" id="5070">Riluzole</mark>/<mark style="background-color:lightblue;" id="4775">NaPB</mark> administration increased acetylation at H4 and <mark style="background-color:orange;">increased</mark> NF-kappaB <mark style="background-color:lightgreen;" id="P23061,P38644,P83939,Q05894,Q28618,Q43731">p50</mark> translocation to the <mark style="background-color:yellow;" id="GO:0005634,cellular_component">nucleus</mark> in G93A mice, consistent with a therapeutic effect.
18663367-1653	Besides the biogenesis of <mark style="background-color:yellow;" id="GO:0005764,cellular_component">lysosome</mark> -related organelles complex 1 and <mark style="background-color:lightgreen;" id="O97592,P11530,P11531,P11532,P11533,Q5GN48">dystrophin</mark> -associated protein complex, several molecules in the <mark style="background-color:lightgreen;" id="Q96EV8">DTNBP1</mark> network likely <mark style="background-color:orange;">provide</mark> insight into the role of <mark style="background-color:lightgreen;" id="Q96EV8">DTNBP1</mark> in biological systems: <mark style="background-color:lightblue;" id="444795">retinoic acid</mark>, <mark style="background-color:lightblue;" id="5757">beta-estradiol</mark>, <mark style="background-color:lightgreen;" id="O02367,O16305,O60041,O82018,O94739,O96102,O97341,P02594,P02595,P02598,P02599,P04352,P04353,P04464,P05933,P05934,P05935,P06787,P07463,P11118,P11120,P11121,P15094,P17928,P18061,P21251,P23286,P24044,P27161,P27165,P27166,P41040,P41041,P48976,P60204,P60205,P60206,P61859,P61860,P61861,P62144,P62145,P62149,P62151,P62152,P62154,P62155,P62156,P62157,P62158,P62160,P62161,P62162,P62184,P62201,P62202,P62203,P62204,P69097,P69098,P84339,P93087,P93171,Q05055,Q39752,Q40302,Q5EHV7,Q5RAD2,Q6IT78,Q6PI52,Q6R520,Q6YNX6,Q71UH5,Q71UH6,Q7T3T2,Q7Y052,Q8STF0,Q8X187,Q95NI4,Q95NR9,Q9GRJ1,Q9HFY6,Q9U6D3,Q9UWF0">calmodulin</mark> and tumour necrosis factor.
18655176-1654	Exposure to <mark style="background-color:lightblue;" id="2336">benzo(a)pyrene</mark> (BaP) by intraperitoneal injection <mark style="background-color:orange;">increased</mark> biliary BaP metabolites and liver <mark style="background-color:lightgreen;" id="Q6JZS3,Q92039,Q9YH64">CYP1A</mark> gene expression.
18626508-1659	Taking advantage of this prostate cancer-specific property of <mark style="background-color:lightgreen;" id="Q04609">PSMA</mark> (E/P), we successfully introduced bacterial <mark style="background-color:lightgreen;" id="Q26998">UPRT</mark> into LNCaP cells where the tumoricidal <mark style="background-color:orange;">effect</mark> of <mark style="background-color:lightblue;" id="3385">5-fluorouracil</mark> (<mark style="background-color:lightblue;" id="3385">5-FU</mark>) was significantly increased when compared with the cells without the exogenous <mark style="background-color:lightgreen;" id="Q26998">UPRT</mark> .
18601937-1660	<mark style="background-color:lightblue;" id="5957">ATP</mark>-gated <mark style="background-color:lightgreen;" id="P13900,P16604">P2X</mark> receptors on excitatory nerve terminals onto interneurons <mark style="background-color:orange;">initiate</mark> a form of asynchronous <mark style="background-color:lightblue;" id="611,23327,33032">glutamate</mark> release.
18601937-1662	However asynchronous EPSCs were increased following synaptic depression and a component of these appeared to be initiated by endogenously released <mark style="background-color:lightblue;" id="5957">ATP</mark> <mark style="background-color:orange;">acting</mark> on presynaptic <mark style="background-color:lightgreen;" id="P13900,P16604">P2X</mark> receptors.
18601937-1663	Unexpectedly, the data suggest <mark style="background-color:lightgreen;" id="P13900,P16604">P2X</mark> receptor activation <mark style="background-color:orange;">initiates</mark> a form of asynchronous <mark style="background-color:lightblue;" id="611,23327,33032">glutamate</mark> release, rather than detectably affecting the vesicles underlying action potential evoked release.
18655190-1668	<mark style="background-color:lightgreen;" id="O62827,O77559,P35318,P43145,P53366,P97297">Adrenomedullin</mark> <mark style="background-color:orange;">reduces</mark> antioxidant defense system and <mark style="background-color:orange;">enhances</mark> kidney tissue <mark style="background-color:orange;">damage</mark> in <mark style="background-color:lightblue;" id="23973">cadmium</mark> and lead exposed rats.
18665432-1672	Osteogenic differentiation was enhanced after treatment with <mark style="background-color:lightblue;" id="2088">alendronate</mark> as confirmed by <mark style="background-color:lightblue;" id="8534">Alizarin Red S</mark> staining, <mark style="background-color:orange;">elevated</mark> <mark style="background-color:lightgreen;" id="O60109,P81800,P83456">alkaline phosphatase</mark> activity and <mark style="background-color:lightgreen;" id="P02819,P02821,P02823,P0C225,P0C226,P15504,P28317,P39056,P81455,P83005,P83238,P83473,P83489,P84348,P84349,P84350,P84351,Q7LZI4,Q8HYY9">osteocalcin</mark> mRNA expression, a greater calcium peak by energy-dispersive xray spectrophotometry, and by immunofluorescence <mark style="background-color:orange;">staining</mark> against <mark style="background-color:lightgreen;" id="P14745,P16070,P20944,Q05078,Q28284,Q29423,Q60522">CD44</mark> by flow cytometric analysis.
18606045-1675	Plasma levels of <mark style="background-color:lightblue;" id="5462224">magnesium</mark>, zinc and carotenoids did not <mark style="background-color:orange;">vary</mark> across quintiles, but weak negative correlations were observed with serum <mark style="background-color:lightgreen;" id="Q26061">ferritin</mark> and <mark style="background-color:lightgreen;" id="P02787,P09571,P12346,P19134,P27425,Q29443,Q921I1">transferrin</mark> saturation.
18597869-1683	<mark style="background-color:lightblue;" id="4091">Metformin</mark> <mark style="background-color:orange;">inhibits</mark> <mark style="background-color:lightgreen;" id="O35734,O77510,O77764,P01375,P04924,P06804,P13296,P16599,P19101,P23383,P23563,P29553,P33620,P36939,P48094,P51435,P51742,P51743,P59684,P59693,P59694,P59695,P79337,P79374,Q06599,Q19LH4,Q1G1A2,Q1WM27,Q2MH05,Q539C2,Q75N23,Q8HZD9,Q8JFG3,Q8MKG8,Q8WNR1,Q9BEA1">TNF-alpha</mark> -induced <mark style="background-color:lightgreen;" id="O15111,Q60680">IkappaB kinase</mark>  <mark style="background-color:yellow;" id="GO:0016310,biological_process">phosphorylation</mark> , <mark style="background-color:lightgreen;" id="P25963,Q08353,Q63746,Q91974,Q9Z1E3">IkappaB-alpha</mark> degradation and <mark style="background-color:lightgreen;" id="O35736,P05231,P08505,P20607,P26892,P26893,P29455,P41323,P41683,P41693,P46650,P51494,P79341,Q25BC2,Q28319,Q28747,Q28819,Q2MH06,Q5I6E3,Q6V919,Q865W7,Q865X6,Q8MKH0,Q95181,Q9MZR1,Q9XT80">IL-6</mark> production in endothelial cells through <mark style="background-color:lightgreen;" id="O00329,O02697,O35904,P23727,P26450,P27986,P32871,P42336,P42337,P42338,P42347,P42348,P48736,P54673,P54674,P54675,P54676,Q63787,Q8BTI9,Q8UUU2,Q9JHG7,Q9Z1L0">PI3K</mark> -dependent <mark style="background-color:lightgreen;" id="P54646,Q09136,Q9Y478">AMPK</mark>  <mark style="background-color:yellow;" id="GO:0016310,biological_process">phosphorylation</mark> .
18691603-1685	This signaling system is engaged by the active component of cannabis, <mark style="background-color:lightblue;" id="16078">Delta9-tetrahydrocannabinol</mark> (<mark style="background-color:lightblue;" id="16078">Delta9-THC</mark>), which exerts its pharmacological <mark style="background-color:orange;">effects</mark> by activation of G protein-coupled type-1 ( <mark style="background-color:lightgreen;" id="O02777,P20272,P21554,P47746,P56971,Q333S9,Q5IS73,Q71SP5,Q801M1,Q9PUI7">CB1</mark> ) and type-2 ( <mark style="background-color:lightgreen;" id="P34972,P47936,Q9QZN9">CB2</mark> ) cannabinoid receptors.
18683889-1688	Treatment of dermal fibroblasts with <mark style="background-color:lightblue;" id="5280795,5283711">vitamin D(3</mark>) <mark style="background-color:orange;">induced</mark> expression of <mark style="background-color:lightgreen;" id="O46576,P12644,P21275,P30885,Q06826,Q29607,Q2KJH1,Q8MJV5,Q90752">BMP-4</mark> (1.2 +/- 0.2, 1.7 +/- 0.2, and 1.8 +/- 0.2 relative fold increase) and <mark style="background-color:lightgreen;" id="P20722,P22004,Q04906">BMP-6</mark> (9.1 +/- 0.3, 23.3 +/- 2.1, and 30.4 +/- 3.0 relative fold increase) at 3, 14, and 21 days, respectively.
18683889-1689	<mark style="background-color:lightblue;" id="5280795,5283711">Vitamin D(3</mark>) was also shown to <mark style="background-color:orange;">induce</mark> the expression of the osteoblast-specific markers, <mark style="background-color:lightgreen;" id="O60109,P81800,P83456">alkaline phosphatase</mark> and <mark style="background-color:lightgreen;" id="P02819,P02821,P02823,P0C225,P0C226,P15504,P28317,P39056,P81455,P83005,P83238,P83473,P83489,P84348,P84349,P84350,P84351,Q7LZI4,Q8HYY9">osteocalcin</mark> , in a dose-dependent manner in human dermal fibroblasts.
18657961-1695	In this study, we examined <mark style="background-color:lightblue;" id="445858">ferulate</mark> for its ability to <mark style="background-color:orange;">suppress</mark> redox-sensitive, proinflammatory NF-kappaB activation via NF-kappaB-inducing kinase ( <mark style="background-color:lightgreen;" id="O95819,Q99558">NIK</mark> )/ <mark style="background-color:lightgreen;" id="O15111,Q60680">IkappaB kinase</mark> (IKK) and <mark style="background-color:lightgreen;" id="Q00859">mitogen-activated protein kinases</mark> ( <mark style="background-color:lightgreen;" id="O42781,P27638,Q00859">MAPKs</mark> ) by reducing oxidative stress in aged rats.
18657961-1696	Data show that in aged kidney tissue, <mark style="background-color:lightblue;" id="445858">ferulate</mark> exhibited its antioxidative action by <mark style="background-color:orange;">maintaining</mark> redox regulation, <mark style="background-color:orange;">suppressing</mark> NF-kappaB activation and <mark style="background-color:orange;">modulating</mark> the expression of NF-kappaB-induced, proinflammatory <mark style="background-color:lightgreen;" id="O02768,O19183,O62698,O62725,P27607,P35354,P35355,P70682,P79208,Q05769">COX-2</mark> , <mark style="background-color:lightgreen;" id="O19114,O46660,O54705,O62699,P29477,P35228,P79290,Q06518,Q27995,Q28314,Q90703,Q92037,Q92091">iNOS</mark> , <mark style="background-color:lightgreen;" id="P19320,P29533,P29534,Q28260">VCAM-1</mark> and <mark style="background-color:lightgreen;" id="P05362,P13597,P33729,Q00238,Q28806,Q5NKV4,Q5NKV6,Q5NKV9,Q95132">ICAM-1</mark> .
18657961-1698	The molecular modulation of NF-kappaB by <mark style="background-color:lightblue;" id="445858">ferulate</mark> was further revealed in endothelial YPEN-1 cells through <mark style="background-color:lightblue;" id="445858">ferulate</mark>'s ability to <mark style="background-color:orange;">suppress</mark> the activation of <mark style="background-color:lightgreen;" id="O95819,Q99558">NIK</mark> /IKK and <mark style="background-color:lightgreen;" id="O42781,P27638,Q00859">MAPKs</mark> .
18657961-1699	Based on these results, we conclude that <mark style="background-color:lightblue;" id="445858">ferulate</mark>'s antioxidative capacity <mark style="background-color:orange;">suppressed</mark> the age-related <mark style="background-color:orange;">increase</mark> in NF-kappaB activity through inhibition of <mark style="background-color:lightgreen;" id="O95819,Q99558">NIK</mark> /IKK and <mark style="background-color:lightgreen;" id="O42781,P27638,Q00859">MAPKs</mark> in vivo.
18651133-1703	None of the compounds altered <mark style="background-color:lightgreen;" id="P15393">Cyp11b1</mark> gene expression, <mark style="background-color:orange;">indicating</mark> that 3-<mark style="background-color:lightblue;" id="119115">MeSO2-DDE</mark> <mark style="background-color:orange;">inhibits</mark> <mark style="background-color:lightgreen;" id="P15150,P15538,P51663,P97720,Q29527,Q29552,Q64408">CYP11B1</mark> activity on the protein level.
